ES2327872T3 - Terapia combinada para el tratamiento de la diabetes y afecciones relacionadas y para el tratamiento de afecciones mejoradas por el incremento del nivel de glp-1 en sangre. - Google Patents
Terapia combinada para el tratamiento de la diabetes y afecciones relacionadas y para el tratamiento de afecciones mejoradas por el incremento del nivel de glp-1 en sangre. Download PDFInfo
- Publication number
- ES2327872T3 ES2327872T3 ES07004743T ES07004743T ES2327872T3 ES 2327872 T3 ES2327872 T3 ES 2327872T3 ES 07004743 T ES07004743 T ES 07004743T ES 07004743 T ES07004743 T ES 07004743T ES 2327872 T3 ES2327872 T3 ES 2327872T3
- Authority
- ES
- Spain
- Prior art keywords
- pyrimidin
- yloxy
- phenyl
- methyl
- alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 210000004369 blood Anatomy 0.000 title claims description 89
- 239000008280 blood Substances 0.000 title claims description 89
- DTHNMHAUYICORS-KTKZVXAJSA-N Glucagon-like peptide 1 Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC=1N=CNC=1)[C@@H](C)O)[C@@H](C)O)C(C)C)C1=CC=CC=C1 DTHNMHAUYICORS-KTKZVXAJSA-N 0.000 title claims description 66
- 206010012601 diabetes mellitus Diseases 0.000 title claims description 50
- 238000011282 treatment Methods 0.000 title claims description 28
- 101710198884 GATA-type zinc finger protein 1 Proteins 0.000 title claims 14
- 238000002648 combination therapy Methods 0.000 title description 3
- 102100025101 GATA-type zinc finger protein 1 Human genes 0.000 title 1
- 102100025012 Dipeptidyl peptidase 4 Human genes 0.000 claims abstract description 174
- 239000003112 inhibitor Substances 0.000 claims abstract description 157
- 229940100607 GPR119 agonist Drugs 0.000 claims abstract description 113
- 239000000203 mixture Substances 0.000 claims abstract description 112
- AJJISMLYIMQAKP-OAHLLOKOSA-N 5-[4-[(2r)-4-(3-fluoro-4-methylsulfonylphenoxy)butan-2-yl]piperidin-1-yl]-3-propan-2-yl-1,2,4-oxadiazole Chemical compound CC(C)C1=NOC(N2CCC(CC2)[C@H](C)CCOC=2C=C(F)C(=CC=2)S(C)(=O)=O)=N1 AJJISMLYIMQAKP-OAHLLOKOSA-N 0.000 claims abstract description 74
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims abstract description 67
- 108010067722 Dipeptidyl Peptidase 4 Proteins 0.000 claims abstract description 29
- VFFZWMWTUSXDCB-ZDUSSCGKSA-N 6-[2-[[2-[(2s)-2-cyanopyrrolidin-1-yl]-2-oxoethyl]amino]ethylamino]pyridine-3-carbonitrile Chemical compound N1([C@@H](CCC1)C#N)C(=O)CNCCNC1=CC=C(C#N)C=N1 VFFZWMWTUSXDCB-ZDUSSCGKSA-N 0.000 claims abstract description 15
- 150000001875 compounds Chemical class 0.000 claims description 95
- 239000000556 agonist Substances 0.000 claims description 79
- 101000996752 Homo sapiens Glucose-dependent insulinotropic receptor Proteins 0.000 claims description 77
- 102100033839 Glucose-dependent insulinotropic receptor Human genes 0.000 claims description 73
- 102400000322 Glucagon-like peptide 1 Human genes 0.000 claims description 66
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 52
- 239000008103 glucose Substances 0.000 claims description 52
- 238000000034 method Methods 0.000 claims description 39
- 239000002552 dosage form Substances 0.000 claims description 34
- 239000003814 drug Substances 0.000 claims description 27
- 241000282414 Homo sapiens Species 0.000 claims description 25
- 230000002265 prevention Effects 0.000 claims description 18
- 208000001072 type 2 diabetes mellitus Diseases 0.000 claims description 17
- 239000008194 pharmaceutical composition Substances 0.000 claims description 15
- 229940079593 drug Drugs 0.000 claims description 13
- 210000004027 cell Anatomy 0.000 claims description 12
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 11
- 125000000031 ethylamino group Chemical group [H]C([H])([H])C([H])([H])N([H])[*] 0.000 claims description 11
- 208000008589 Obesity Diseases 0.000 claims description 9
- 208000006011 Stroke Diseases 0.000 claims description 9
- 235000020824 obesity Nutrition 0.000 claims description 9
- 238000002560 therapeutic procedure Methods 0.000 claims description 9
- 201000001320 Atherosclerosis Diseases 0.000 claims description 8
- 206010020772 Hypertension Diseases 0.000 claims description 7
- 210000004556 brain Anatomy 0.000 claims description 7
- 201000001421 hyperglycemia Diseases 0.000 claims description 7
- 150000003384 small molecules Chemical class 0.000 claims description 7
- 102100020751 Dipeptidyl peptidase 2 Human genes 0.000 claims description 6
- 208000031226 Hyperlipidaemia Diseases 0.000 claims description 6
- 230000003247 decreasing effect Effects 0.000 claims description 6
- 230000001771 impaired effect Effects 0.000 claims description 6
- 238000004519 manufacturing process Methods 0.000 claims description 6
- 208000010125 myocardial infarction Diseases 0.000 claims description 6
- 208000015122 neurodegenerative disease Diseases 0.000 claims description 6
- 238000002360 preparation method Methods 0.000 claims description 6
- 206010022489 Insulin Resistance Diseases 0.000 claims description 5
- 241001465754 Metazoa Species 0.000 claims description 5
- 208000027418 Wounds and injury Diseases 0.000 claims description 5
- 230000006378 damage Effects 0.000 claims description 5
- 208000014674 injury Diseases 0.000 claims description 5
- 208000010444 Acidosis Diseases 0.000 claims description 4
- 208000002177 Cataract Diseases 0.000 claims description 4
- 206010010904 Convulsion Diseases 0.000 claims description 4
- 208000007342 Diabetic Nephropathies Diseases 0.000 claims description 4
- 208000032131 Diabetic Neuropathies Diseases 0.000 claims description 4
- 206010012689 Diabetic retinopathy Diseases 0.000 claims description 4
- 206010018473 Glycosuria Diseases 0.000 claims description 4
- 208000020358 Learning disease Diseases 0.000 claims description 4
- 206010027417 Metabolic acidosis Diseases 0.000 claims description 4
- 208000018737 Parkinson disease Diseases 0.000 claims description 4
- 208000029078 coronary artery disease Diseases 0.000 claims description 4
- 230000007812 deficiency Effects 0.000 claims description 4
- 208000033679 diabetic kidney disease Diseases 0.000 claims description 4
- 208000035475 disorder Diseases 0.000 claims description 4
- 239000003937 drug carrier Substances 0.000 claims description 4
- 231100000318 excitotoxic Toxicity 0.000 claims description 4
- 230000003492 excitotoxic effect Effects 0.000 claims description 4
- 102000056352 human GPR119 Human genes 0.000 claims description 4
- 201000003723 learning disability Diseases 0.000 claims description 4
- 230000028252 learning or memory Effects 0.000 claims description 4
- 206010027175 memory impairment Diseases 0.000 claims description 4
- 238000002156 mixing Methods 0.000 claims description 4
- 208000020431 spinal cord injury Diseases 0.000 claims description 4
- 208000024827 Alzheimer disease Diseases 0.000 claims description 3
- 101000908391 Homo sapiens Dipeptidyl peptidase 4 Proteins 0.000 claims description 3
- 208000014675 Prion-associated disease Diseases 0.000 claims description 3
- 230000002950 deficient Effects 0.000 claims description 3
- 102000045598 human DPP4 Human genes 0.000 claims description 3
- 208000005264 motor neuron disease Diseases 0.000 claims description 3
- 230000000626 neurodegenerative effect Effects 0.000 claims description 3
- 208000033808 peripheral neuropathy Diseases 0.000 claims description 3
- 230000008569 process Effects 0.000 claims description 3
- 230000000472 traumatic effect Effects 0.000 claims description 3
- ZHUTVLURGLOKMO-ZETCQYMHSA-N (2s)-1-acetylpyrrolidine-2-carbonitrile Chemical compound CC(=O)N1CCC[C@H]1C#N ZHUTVLURGLOKMO-ZETCQYMHSA-N 0.000 claims description 2
- 101710087084 Dipeptidyl peptidase 2 Proteins 0.000 claims 3
- 108091005471 CRHR1 Proteins 0.000 claims 2
- 102100038018 Corticotropin-releasing factor receptor 1 Human genes 0.000 claims 2
- 208000013600 Diabetic vascular disease Diseases 0.000 claims 2
- 208000026072 Motor neurone disease Diseases 0.000 claims 2
- 208000030886 Traumatic Brain injury Diseases 0.000 claims 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims 2
- 208000026106 cerebrovascular disease Diseases 0.000 claims 2
- 230000035780 glucosuria Effects 0.000 claims 2
- 230000002503 metabolic effect Effects 0.000 claims 2
- 208000011580 syndromic disease Diseases 0.000 claims 2
- 230000009529 traumatic brain injury Effects 0.000 claims 2
- 239000002253 acid Substances 0.000 description 630
- 150000002148 esters Chemical class 0.000 description 571
- 125000000217 alkyl group Chemical group 0.000 description 551
- -1 alkyl radical Chemical class 0.000 description 486
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 301
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 168
- 125000001188 haloalkyl group Chemical group 0.000 description 145
- 101000930822 Giardia intestinalis Dipeptidyl-peptidase 4 Proteins 0.000 description 144
- 229940124530 sulfonamide Drugs 0.000 description 97
- 125000003545 alkoxy group Chemical group 0.000 description 86
- 229910052736 halogen Inorganic materials 0.000 description 84
- 150000002367 halogens Chemical class 0.000 description 84
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 80
- 229910052799 carbon Inorganic materials 0.000 description 71
- 125000001072 heteroaryl group Chemical group 0.000 description 70
- 125000002252 acyl group Chemical group 0.000 description 69
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 66
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 65
- 125000004093 cyano group Chemical group *C#N 0.000 description 65
- 150000003857 carboxamides Chemical class 0.000 description 56
- 101800000224 Glucagon-like peptide 1 Proteins 0.000 description 54
- 125000004423 acyloxy group Chemical group 0.000 description 49
- 229910052739 hydrogen Inorganic materials 0.000 description 48
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 48
- 125000001424 substituent group Chemical group 0.000 description 47
- 125000000623 heterocyclic group Chemical group 0.000 description 46
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 46
- 125000004765 (C1-C4) haloalkyl group Chemical group 0.000 description 42
- 125000000304 alkynyl group Chemical group 0.000 description 40
- 230000014509 gene expression Effects 0.000 description 39
- 125000003118 aryl group Chemical group 0.000 description 38
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 description 37
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 34
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 description 32
- 229910052717 sulfur Inorganic materials 0.000 description 31
- 125000006272 (C3-C7) cycloalkyl group Chemical group 0.000 description 30
- 102000003688 G-Protein-Coupled Receptors Human genes 0.000 description 30
- 108090000045 G-Protein-Coupled Receptors Proteins 0.000 description 30
- 229910052757 nitrogen Inorganic materials 0.000 description 30
- 125000004767 (C1-C4) haloalkoxy group Chemical group 0.000 description 29
- 125000000753 cycloalkyl group Chemical group 0.000 description 29
- 230000000694 effects Effects 0.000 description 28
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 28
- 125000004438 haloalkoxy group Chemical group 0.000 description 22
- 229910052760 oxygen Inorganic materials 0.000 description 22
- 150000003456 sulfonamides Chemical group 0.000 description 20
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 19
- 102000005962 receptors Human genes 0.000 description 19
- 108020003175 receptors Proteins 0.000 description 19
- RZEKSCRTSJLQBL-UHFFFAOYSA-N 4-[1-(4-methylsulfonylphenyl)pyrazolo[3,4-d]pyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound C1=CC(S(=O)(=O)C)=CC=C1N1C2=NC=NC(OC3CCN(CC3)C(O)=O)=C2C=N1 RZEKSCRTSJLQBL-UHFFFAOYSA-N 0.000 description 16
- 230000003834 intracellular effect Effects 0.000 description 16
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 16
- 239000003446 ligand Substances 0.000 description 16
- 125000002947 alkylene group Chemical group 0.000 description 14
- 230000004044 response Effects 0.000 description 14
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 12
- DNUTZBZXLPWRJG-UHFFFAOYSA-N 1-Piperidine carboxylic acid Chemical compound OC(=O)N1CCCCC1 DNUTZBZXLPWRJG-UHFFFAOYSA-N 0.000 description 11
- 125000004644 alkyl sulfinyl group Chemical group 0.000 description 11
- 108091006027 G proteins Proteins 0.000 description 10
- 102000030782 GTP binding Human genes 0.000 description 10
- 108091000058 GTP-Binding Proteins 0.000 description 10
- 125000003342 alkenyl group Chemical group 0.000 description 10
- 125000005431 alkyl carboxamide group Chemical group 0.000 description 10
- 125000004391 aryl sulfonyl group Chemical group 0.000 description 10
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 description 10
- IVOMOUWHDPKRLL-KQYNXXCUSA-N Cyclic adenosine monophosphate Chemical compound C([C@H]1O2)OP(O)(=O)O[C@H]1[C@@H](O)[C@@H]2N1C(N=CN=C2N)=C2N=C1 IVOMOUWHDPKRLL-KQYNXXCUSA-N 0.000 description 9
- IVOMOUWHDPKRLL-UHFFFAOYSA-N UNPD107823 Natural products O1C2COP(O)(=O)OC2C(O)C1N1C(N=CN=C2N)=C2N=C1 IVOMOUWHDPKRLL-UHFFFAOYSA-N 0.000 description 9
- 229940095074 cyclic amp Drugs 0.000 description 9
- 229910052731 fluorine Inorganic materials 0.000 description 9
- 238000009472 formulation Methods 0.000 description 9
- RQCNHUCCQJMSRG-UHFFFAOYSA-N tert-butyl piperidine-1-carboxylate Chemical compound CC(C)(C)OC(=O)N1CCCCC1 RQCNHUCCQJMSRG-UHFFFAOYSA-N 0.000 description 9
- RWRDLPDLKQPQOW-UHFFFAOYSA-N tetrahydropyrrole Substances C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 description 9
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 8
- 125000003601 C2-C6 alkynyl group Chemical group 0.000 description 8
- 230000004913 activation Effects 0.000 description 8
- 125000003282 alkyl amino group Chemical group 0.000 description 8
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 8
- 125000005432 dialkylcarboxamide group Chemical group 0.000 description 8
- 108090000765 processed proteins & peptides Proteins 0.000 description 8
- 239000003826 tablet Substances 0.000 description 8
- MMWCIQZXVOZEGG-HOZKJCLWSA-N [(1S,2R,3S,4S,5R,6S)-2,3,5-trihydroxy-4,6-diphosphonooxycyclohexyl] dihydrogen phosphate Chemical compound O[C@H]1[C@@H](O)[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](O)[C@H]1OP(O)(O)=O MMWCIQZXVOZEGG-HOZKJCLWSA-N 0.000 description 7
- 150000001413 amino acids Chemical class 0.000 description 7
- 230000015572 biosynthetic process Effects 0.000 description 7
- 229910052794 bromium Inorganic materials 0.000 description 7
- 239000002775 capsule Substances 0.000 description 7
- 125000003739 carbamimidoyl group Chemical group C(N)(=N)* 0.000 description 7
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 7
- 239000000460 chlorine Substances 0.000 description 7
- 229910052801 chlorine Inorganic materials 0.000 description 7
- 125000000392 cycloalkenyl group Chemical group 0.000 description 7
- 201000010099 disease Diseases 0.000 description 7
- 125000003709 fluoroalkyl group Chemical group 0.000 description 7
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 7
- 239000000463 material Substances 0.000 description 7
- 238000007410 oral glucose tolerance test Methods 0.000 description 7
- 239000000546 pharmaceutical excipient Substances 0.000 description 7
- 235000002639 sodium chloride Nutrition 0.000 description 7
- 125000000171 (C1-C6) haloalkyl group Chemical group 0.000 description 6
- NNKIQHFIZLJVAQ-UHFFFAOYSA-N 4-[[[6-(2-fluoro-4-methylsulfonylanilino)pyrimidin-4-yl]-methylamino]methyl]piperidine-1-carboxylic acid Chemical compound C=1C(NC=2C(=CC(=CC=2)S(C)(=O)=O)F)=NC=NC=1N(C)CC1CCN(C(O)=O)CC1 NNKIQHFIZLJVAQ-UHFFFAOYSA-N 0.000 description 6
- 239000003795 chemical substances by application Substances 0.000 description 6
- 210000003158 enteroendocrine cell Anatomy 0.000 description 6
- 125000005843 halogen group Chemical group 0.000 description 6
- 239000001257 hydrogen Substances 0.000 description 6
- 230000005764 inhibitory process Effects 0.000 description 6
- 239000002773 nucleotide Substances 0.000 description 6
- 125000003729 nucleotide group Chemical group 0.000 description 6
- 230000003287 optical effect Effects 0.000 description 6
- 239000004031 partial agonist Substances 0.000 description 6
- 102000004196 processed proteins & peptides Human genes 0.000 description 6
- 150000003839 salts Chemical class 0.000 description 6
- 238000000926 separation method Methods 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 238000003786 synthesis reaction Methods 0.000 description 6
- SYOKIDBDQMKNDQ-XWTIBIIYSA-N vildagliptin Chemical compound C1C(O)(C2)CC(C3)CC1CC32NCC(=O)N1CCC[C@H]1C#N SYOKIDBDQMKNDQ-XWTIBIIYSA-N 0.000 description 6
- NFJYWALXGSKDOO-UHFFFAOYSA-N 4-[[[6-(4-cyano-2-fluoroanilino)pyrimidin-4-yl]-methylamino]methyl]piperidine-1-carboxylic acid Chemical compound C=1C(NC=2C(=CC(=CC=2)C#N)F)=NC=NC=1N(C)CC1CCN(C(O)=O)CC1 NFJYWALXGSKDOO-UHFFFAOYSA-N 0.000 description 5
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 5
- 241000124008 Mammalia Species 0.000 description 5
- 241000699666 Mus <mouse, genus> Species 0.000 description 5
- 241000699670 Mus sp. Species 0.000 description 5
- 235000001014 amino acid Nutrition 0.000 description 5
- 238000003556 assay Methods 0.000 description 5
- JFDZBHWFFUWGJE-UHFFFAOYSA-N benzonitrile Substances N#CC1=CC=CC=C1 JFDZBHWFFUWGJE-UHFFFAOYSA-N 0.000 description 5
- 239000012634 fragment Substances 0.000 description 5
- 125000004474 heteroalkylene group Chemical group 0.000 description 5
- 125000005842 heteroatom Chemical group 0.000 description 5
- 150000002431 hydrogen Chemical class 0.000 description 5
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 5
- 150000002894 organic compounds Chemical class 0.000 description 5
- 125000004527 pyrimidin-4-yl group Chemical group N1=CN=C(C=C1)* 0.000 description 5
- 125000003831 tetrazolyl group Chemical group 0.000 description 5
- 150000003573 thiols Chemical class 0.000 description 5
- 239000003981 vehicle Substances 0.000 description 5
- 125000006583 (C1-C3) haloalkyl group Chemical group 0.000 description 4
- 125000004890 (C1-C6) alkylamino group Chemical group 0.000 description 4
- 125000004737 (C1-C6) haloalkoxy group Chemical group 0.000 description 4
- AYLORMOUKYAKPH-UHFFFAOYSA-N 4-[5-cyano-6-(4-methylsulfonylanilino)pyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound C1=CC(S(=O)(=O)C)=CC=C1NC1=NC=NC(OC2CCN(CC2)C(O)=O)=C1C#N AYLORMOUKYAKPH-UHFFFAOYSA-N 0.000 description 4
- 210000002237 B-cell of pancreatic islet Anatomy 0.000 description 4
- ZRALSGWEFCBTJO-UHFFFAOYSA-N Guanidine Chemical compound NC(N)=N ZRALSGWEFCBTJO-UHFFFAOYSA-N 0.000 description 4
- 241000700159 Rattus Species 0.000 description 4
- 229940124639 Selective inhibitor Drugs 0.000 description 4
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 4
- 150000001412 amines Chemical class 0.000 description 4
- 239000005557 antagonist Substances 0.000 description 4
- 230000001419 dependent effect Effects 0.000 description 4
- 150000001982 diacylglycerols Chemical class 0.000 description 4
- 125000004663 dialkyl amino group Chemical group 0.000 description 4
- 125000005363 dialkylsulfonamide group Chemical group 0.000 description 4
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 description 4
- 125000005223 heteroarylcarbonyl group Chemical group 0.000 description 4
- 125000004356 hydroxy functional group Chemical group O* 0.000 description 4
- 150000002484 inorganic compounds Chemical class 0.000 description 4
- 229910010272 inorganic material Inorganic materials 0.000 description 4
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 4
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 4
- 125000004430 oxygen atom Chemical group O* 0.000 description 4
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 4
- 229920001223 polyethylene glycol Polymers 0.000 description 4
- 229920000642 polymer Polymers 0.000 description 4
- 108091033319 polynucleotide Proteins 0.000 description 4
- 239000002157 polynucleotide Substances 0.000 description 4
- 102000040430 polynucleotide Human genes 0.000 description 4
- 229920001184 polypeptide Polymers 0.000 description 4
- 230000019491 signal transduction Effects 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 238000013268 sustained release Methods 0.000 description 4
- 239000012730 sustained-release form Substances 0.000 description 4
- 230000002195 synergetic effect Effects 0.000 description 4
- ZSOPWZQRZHWYFY-NUXPJIRBSA-N (2s,3s)-2-amino-3-methyl-1-(1,3-thiazolidin-3-yl)pentan-1-one;(e)-but-2-enedioic acid Chemical compound OC(=O)\C=C\C(O)=O.CC[C@H](C)[C@H](N)C(=O)N1CCSC1 ZSOPWZQRZHWYFY-NUXPJIRBSA-N 0.000 description 3
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 description 3
- GBEVJTUHCCPTDP-UHFFFAOYSA-N 4-[6-(2-fluoro-4-methylsulfonylphenoxy)-5-methylpyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound N1=CN=C(OC=2C(=CC(=CC=2)S(C)(=O)=O)F)C(C)=C1OC1CCN(C(O)=O)CC1 GBEVJTUHCCPTDP-UHFFFAOYSA-N 0.000 description 3
- IKDPOFUKGLHSAS-UHFFFAOYSA-N 4-[6-(4-methylsulfonylanilino)-5-nitropyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound C1=CC(S(=O)(=O)C)=CC=C1NC1=NC=NC(OC2CCN(CC2)C(O)=O)=C1[N+]([O-])=O IKDPOFUKGLHSAS-UHFFFAOYSA-N 0.000 description 3
- BPOAOGQDLUETGF-UHFFFAOYSA-N 4-[6-[(6-methoxypyridin-3-yl)amino]pyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound C1=NC(OC)=CC=C1NC1=CC(OC2CCN(CC2)C(O)=O)=NC=N1 BPOAOGQDLUETGF-UHFFFAOYSA-N 0.000 description 3
- CEVGZJCCQGMPIG-UHFFFAOYSA-N 4-[[1-(4-methylsulfonylphenyl)pyrazolo[3,4-d]pyrimidin-4-yl]amino]piperidine-1-carboxylic acid Chemical compound C1=CC(S(=O)(=O)C)=CC=C1N1C2=NC=NC(NC3CCN(CC3)C(O)=O)=C2C=N1 CEVGZJCCQGMPIG-UHFFFAOYSA-N 0.000 description 3
- 101000957724 Catostomus commersonii Corticoliberin-1 Proteins 0.000 description 3
- 108020004414 DNA Proteins 0.000 description 3
- 102100036968 Dipeptidyl peptidase 8 Human genes 0.000 description 3
- 102100036969 Dipeptidyl peptidase 9 Human genes 0.000 description 3
- 102000003779 Dipeptidyl-peptidases and tripeptidyl-peptidases Human genes 0.000 description 3
- 108090000194 Dipeptidyl-peptidases and tripeptidyl-peptidases Proteins 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 3
- 239000005977 Ethylene Substances 0.000 description 3
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 3
- 208000002705 Glucose Intolerance Diseases 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 101000804947 Homo sapiens Dipeptidyl peptidase 8 Proteins 0.000 description 3
- 101000804945 Homo sapiens Dipeptidyl peptidase 9 Proteins 0.000 description 3
- 108090001061 Insulin Proteins 0.000 description 3
- 102000004877 Insulin Human genes 0.000 description 3
- 208000001145 Metabolic Syndrome Diseases 0.000 description 3
- 108091028043 Nucleic acid sequence Proteins 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 3
- 102000014384 Type C Phospholipases Human genes 0.000 description 3
- 108010079194 Type C Phospholipases Proteins 0.000 description 3
- 201000000690 abdominal obesity-metabolic syndrome Diseases 0.000 description 3
- 102000030621 adenylate cyclase Human genes 0.000 description 3
- 108060000200 adenylate cyclase Proteins 0.000 description 3
- 239000002671 adjuvant Substances 0.000 description 3
- 125000004390 alkyl sulfonyl group Chemical group 0.000 description 3
- 125000004414 alkyl thio group Chemical group 0.000 description 3
- 125000003368 amide group Chemical group 0.000 description 3
- 125000003277 amino group Chemical group 0.000 description 3
- 125000005129 aryl carbonyl group Chemical group 0.000 description 3
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 3
- 125000004432 carbon atom Chemical group C* 0.000 description 3
- 239000011203 carbon fibre reinforced carbon Substances 0.000 description 3
- 230000001413 cellular effect Effects 0.000 description 3
- 235000012000 cholesterol Nutrition 0.000 description 3
- 125000002993 cycloalkylene group Chemical group 0.000 description 3
- 239000003085 diluting agent Substances 0.000 description 3
- 108090000212 dipeptidyl peptidase II Proteins 0.000 description 3
- 239000008298 dragée Substances 0.000 description 3
- 239000011737 fluorine Substances 0.000 description 3
- 230000014101 glucose homeostasis Effects 0.000 description 3
- 125000004995 haloalkylthio group Chemical group 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 239000000859 incretin Substances 0.000 description 3
- 229940125396 insulin Drugs 0.000 description 3
- 230000003914 insulin secretion Effects 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- CYEBJEDOHLIWNP-UHFFFAOYSA-N methanethioamide Chemical compound NC=S CYEBJEDOHLIWNP-UHFFFAOYSA-N 0.000 description 3
- 150000004702 methyl esters Chemical class 0.000 description 3
- 201000001119 neuropathy Diseases 0.000 description 3
- HLTMUYBTNSVOFY-UHFFFAOYSA-N pentylcyclohexane Chemical compound CCCCCC1CCCCC1 HLTMUYBTNSVOFY-UHFFFAOYSA-N 0.000 description 3
- 125000005010 perfluoroalkyl group Chemical group 0.000 description 3
- 230000000144 pharmacologic effect Effects 0.000 description 3
- 210000002381 plasma Anatomy 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 201000009104 prediabetes syndrome Diseases 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 150000003254 radicals Chemical class 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 239000000758 substrate Substances 0.000 description 3
- 239000000454 talc Substances 0.000 description 3
- 229910052623 talc Inorganic materials 0.000 description 3
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 3
- 229920002554 vinyl polymer Polymers 0.000 description 3
- WUJXXDYPVODIDN-UHFFFAOYSA-N (3,5-dimethyl-1,2-oxazol-4-yl)-[4-[1-(4-methylsulfonylphenyl)pyrazolo[3,4-d]pyrimidin-4-yl]oxypiperidin-1-yl]methanone Chemical compound CC1=NOC(C)=C1C(=O)N1CCC(OC=2C=3C=NN(C=3N=CN=2)C=2C=CC(=CC=2)S(C)(=O)=O)CC1 WUJXXDYPVODIDN-UHFFFAOYSA-N 0.000 description 2
- 125000004454 (C1-C6) alkoxycarbonyl group Chemical group 0.000 description 2
- XCKPUZAGEYMHKH-UHFFFAOYSA-N 1-[4-[6-(2-fluoro-4-methylsulfonylphenoxy)-5-methylpyrimidin-4-yl]oxypiperidin-1-yl]-3-methoxypropan-2-ol Chemical compound C1CN(CC(O)COC)CCC1OC1=NC=NC(OC=2C(=CC(=CC=2)S(C)(=O)=O)F)=C1C XCKPUZAGEYMHKH-UHFFFAOYSA-N 0.000 description 2
- DFUAXIBBYPOMIV-UHFFFAOYSA-N 1-[4-[6-(2-fluoro-4-methylsulfonylphenoxy)-5-methylpyrimidin-4-yl]oxypiperidin-1-yl]hexan-2-one Chemical compound C1CN(CC(=O)CCCC)CCC1OC1=NC=NC(OC=2C(=CC(=CC=2)S(C)(=O)=O)F)=C1C DFUAXIBBYPOMIV-UHFFFAOYSA-N 0.000 description 2
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- KBRFTJUEHZNTLD-UHFFFAOYSA-N 2-[4-[6-(2-fluoro-4-methylsulfonylphenoxy)-5-methylpyrimidin-4-yl]oxypiperidin-1-yl]-1-pyridin-2-ylethanone Chemical compound N1=CN=C(OC=2C(=CC(=CC=2)S(C)(=O)=O)F)C(C)=C1OC(CC1)CCN1CC(=O)C1=CC=CC=N1 KBRFTJUEHZNTLD-UHFFFAOYSA-N 0.000 description 2
- FFNVQNRYTPFDDP-UHFFFAOYSA-N 2-cyanopyridine Chemical compound N#CC1=CC=CC=N1 FFNVQNRYTPFDDP-UHFFFAOYSA-N 0.000 description 2
- 125000003006 2-dimethylaminoethyl group Chemical group [H]C([H])([H])N(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 2
- IZHVBANLECCAGF-UHFFFAOYSA-N 2-hydroxy-3-(octadecanoyloxy)propyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)COC(=O)CCCCCCCCCCCCCCCCC IZHVBANLECCAGF-UHFFFAOYSA-N 0.000 description 2
- PGRVGFHSZHVGTA-UHFFFAOYSA-N 2-methoxyethyl piperidine-1-carboxylate Chemical compound COCCOC(=O)N1CCCCC1 PGRVGFHSZHVGTA-UHFFFAOYSA-N 0.000 description 2
- ZOOGRGPOEVQQDX-UUOKFMHZSA-N 3',5'-cyclic GMP Chemical compound C([C@H]1O2)OP(O)(=O)O[C@H]1[C@@H](O)[C@@H]2N1C(N=C(NC2=O)N)=C2N=C1 ZOOGRGPOEVQQDX-UUOKFMHZSA-N 0.000 description 2
- KEHSJGTWUGUASF-UHFFFAOYSA-N 3-[[6-(4-methylsulfonylanilino)-5-nitropyrimidin-4-yl]oxymethyl]pyrrolidine-1-carboxylic acid Chemical compound C1=CC(S(=O)(=O)C)=CC=C1NC1=NC=NC(OCC2CN(CC2)C(O)=O)=C1[N+]([O-])=O KEHSJGTWUGUASF-UHFFFAOYSA-N 0.000 description 2
- URBPUXMMHHSMQC-UHFFFAOYSA-N 4-[1-(2,4-difluorophenyl)pyrazolo[3,4-d]pyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound C1CN(C(=O)O)CCC1OC1=NC=NC2=C1C=NN2C1=CC=C(F)C=C1F URBPUXMMHHSMQC-UHFFFAOYSA-N 0.000 description 2
- MGDOWROZYOAOSE-UHFFFAOYSA-N 4-[1-(2-fluoro-4-methylsulfonylphenyl)pyrazolo[3,4-d]pyrimidin-4-yl]sulfanylpiperidine-1-carboxylic acid Chemical compound FC1=CC(S(=O)(=O)C)=CC=C1N1C2=NC=NC(SC3CCN(CC3)C(O)=O)=C2C=N1 MGDOWROZYOAOSE-UHFFFAOYSA-N 0.000 description 2
- JUTLBNXWQPXGLW-UHFFFAOYSA-N 4-[2-(2,5-difluoro-4-propoxyanilino)pyridin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound FC1=C(C=C(C(=C1)OCCC)F)NC1=NC=CC(=C1)OC1CCN(CC1)C(=O)O JUTLBNXWQPXGLW-UHFFFAOYSA-N 0.000 description 2
- FYMGHZVNXYNHGK-UHFFFAOYSA-N 4-[5-amino-6-(2-fluoro-4-methylsulfonylanilino)pyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound FC1=CC(S(=O)(=O)C)=CC=C1NC1=NC=NC(OC2CCN(CC2)C(O)=O)=C1N FYMGHZVNXYNHGK-UHFFFAOYSA-N 0.000 description 2
- KFRMVHSZMJMDEA-UHFFFAOYSA-N 4-[6-(2,4,5-trifluoroanilino)pyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound FC1=C(C=C(C(=C1)F)F)NC1=CC(=NC=N1)OC1CCN(CC1)C(=O)O KFRMVHSZMJMDEA-UHFFFAOYSA-N 0.000 description 2
- JJGIOCLSQXHBNN-UHFFFAOYSA-N 4-[6-(2,5-difluoroanilino)pyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound FC1=C(C=C(C=C1)F)NC1=CC(=NC=N1)OC1CCN(CC1)C(=O)O JJGIOCLSQXHBNN-UHFFFAOYSA-N 0.000 description 2
- NQOTYWIEYJZLEK-UHFFFAOYSA-N 4-[6-(2-fluoro-4-methylsulfonylanilino)pyridin-2-yl]oxypiperidine-1-carboxylic acid Chemical compound FC1=C(C=CC(=C1)S(=O)(=O)C)NC1=CC=CC(=N1)OC1CCN(CC1)C(=O)O NQOTYWIEYJZLEK-UHFFFAOYSA-N 0.000 description 2
- ZFMWBMFPPKJXJE-UHFFFAOYSA-N 4-[6-(2-fluoro-4-methylsulfonylanilino)pyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound CS(=O)(=O)c1ccc(Nc2cc(OC3CCN(CC3)C(O)=O)ncn2)c(F)c1 ZFMWBMFPPKJXJE-UHFFFAOYSA-N 0.000 description 2
- HRJBZSFATQNJEZ-UHFFFAOYSA-N 4-[6-(4-bromo-2,5-difluoroanilino)pyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound BrC1=CC(=C(C=C1F)NC1=CC(=NC=N1)OC1CCN(CC1)C(=O)O)F HRJBZSFATQNJEZ-UHFFFAOYSA-N 0.000 description 2
- AMKTZSOVCMPTIX-UHFFFAOYSA-N 4-[6-(4-cyano-2,5-difluoroanilino)pyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound C(#N)C1=CC(=C(C=C1F)NC1=CC(=NC=N1)OC1CCN(CC1)C(=O)O)F AMKTZSOVCMPTIX-UHFFFAOYSA-N 0.000 description 2
- XRSBQXIFQCJQMU-UHFFFAOYSA-N 4-[6-[(2-chloro-6-methylpyridin-3-yl)amino]pyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound ClC1=NC(C)=CC=C1NC1=CC(OC2CCN(CC2)C(O)=O)=NC=N1 XRSBQXIFQCJQMU-UHFFFAOYSA-N 0.000 description 2
- DBYLYMLJWJWBNZ-UHFFFAOYSA-N 4-[6-[(2-methylpyridin-3-yl)amino]pyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound CC1=NC=CC=C1NC1=CC(OC2CCN(CC2)C(O)=O)=NC=N1 DBYLYMLJWJWBNZ-UHFFFAOYSA-N 0.000 description 2
- MFUGOBDMNRKNGE-UHFFFAOYSA-N 4-[6-[(6-methoxy-2-methylpyridin-3-yl)amino]pyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound COC1=CC=C(C(=N1)C)NC1=CC(=NC=N1)OC1CCN(CC1)C(=O)O MFUGOBDMNRKNGE-UHFFFAOYSA-N 0.000 description 2
- IHIQXURWBSOZKG-UHFFFAOYSA-N 4-[6-[(6-methoxy-5-methylpyridin-3-yl)amino]pyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound C1=C(C)C(OC)=NC=C1NC1=CC(OC2CCN(CC2)C(O)=O)=NC=N1 IHIQXURWBSOZKG-UHFFFAOYSA-N 0.000 description 2
- LOPLSGUJQQGXPT-UHFFFAOYSA-N 4-[9-(6-methylsulfonylpyridin-3-yl)purin-6-yl]oxypiperidine-1-carboxylic acid Chemical compound C1=NC(S(=O)(=O)C)=CC=C1N1C2=NC=NC(OC3CCN(CC3)C(O)=O)=C2N=C1 LOPLSGUJQQGXPT-UHFFFAOYSA-N 0.000 description 2
- HFAIQZKLVHGFII-UHFFFAOYSA-N 4-[[3-(4-methylsulfonylphenyl)-[1,2]oxazolo[4,5-d]pyrimidin-7-yl]oxy]piperidine-1-carboxylic acid Chemical compound C1=CC(S(=O)(=O)C)=CC=C1C(C1=NC=N2)=NOC1=C2OC1CCN(C(O)=O)CC1 HFAIQZKLVHGFII-UHFFFAOYSA-N 0.000 description 2
- YMTHIEMLVFJKEL-UHFFFAOYSA-N 4-[[[6-(2-fluoro-4-methylsulfonylanilino)pyrimidin-4-yl]amino]methyl]piperidine-1-carboxylic acid Chemical compound FC1=C(C=CC(=C1)S(=O)(=O)C)NC1=CC(=NC=N1)NCC1CCN(CC1)C(=O)O YMTHIEMLVFJKEL-UHFFFAOYSA-N 0.000 description 2
- RVTBZTCXUIPZJO-UHFFFAOYSA-N 4-[[cyclopropyl-[6-(2-fluoro-4-methylsulfonylphenoxy)-5-methylpyrimidin-4-yl]amino]methyl]piperidine-1-carboxylic acid Chemical compound C1(CC1)N(C1=NC=NC(=C1C)OC1=C(C=C(C=C1)S(=O)(=O)C)F)CC1CCN(CC1)C(=O)O RVTBZTCXUIPZJO-UHFFFAOYSA-N 0.000 description 2
- ZCBVRSQXZLRELH-UHFFFAOYSA-N 4-[[ethyl-[6-(2-fluoro-4-methylsulfonylanilino)pyrimidin-4-yl]amino]methyl]piperidine-1-carboxylic acid Chemical compound C(C)N(C1=NC=NC(=C1)NC1=C(C=C(C=C1)S(=O)(=O)C)F)CC1CCN(CC1)C(=O)O ZCBVRSQXZLRELH-UHFFFAOYSA-N 0.000 description 2
- IVBMUUJUSBOULG-UHFFFAOYSA-N 4-[[methyl-[(3-pyridin-4-yl-1,2,4-oxadiazol-5-yl)methyl]amino]methyl]piperidine-1-carboxylic acid Chemical compound N=1C(C=2C=CN=CC=2)=NOC=1CN(C)CC1CCN(C(O)=O)CC1 IVBMUUJUSBOULG-UHFFFAOYSA-N 0.000 description 2
- WXZZWGDZIJJBIK-UHFFFAOYSA-N 4-[methyl-[1-(4-methylsulfonylphenyl)pyrazolo[3,4-d]pyrimidin-4-yl]amino]piperidine-1-carboxylic acid Chemical compound N=1C=NC=2N(C=3C=CC(=CC=3)S(C)(=O)=O)N=CC=2C=1N(C)C1CCN(C(O)=O)CC1 WXZZWGDZIJJBIK-UHFFFAOYSA-N 0.000 description 2
- IROVYPNZGCBDQA-UHFFFAOYSA-N 4-n-[1-(4-methylsulfonylphenyl)pyrazolo[3,4-d]pyrimidin-4-yl]cyclohexane-1,4-diamine Chemical compound C1=CC(S(=O)(=O)C)=CC=C1N1C2=NC=NC(NC3CCC(N)CC3)=C2C=N1 IROVYPNZGCBDQA-UHFFFAOYSA-N 0.000 description 2
- QGUCBSXNMDKGML-UHFFFAOYSA-N 5-(4-propylcyclohexyl)-3-(3-pyridinyl)-1,2,4-oxadiazole Chemical compound C1CC(CCC)CCC1C1=NC(C=2C=NC=CC=2)=NO1 QGUCBSXNMDKGML-UHFFFAOYSA-N 0.000 description 2
- OAAGDVLVOKMRCQ-UHFFFAOYSA-N 5-piperidin-4-yl-3-pyridin-4-yl-1,2,4-oxadiazole Chemical compound C1CNCCC1C1=NC(C=2C=CN=CC=2)=NO1 OAAGDVLVOKMRCQ-UHFFFAOYSA-N 0.000 description 2
- 244000215068 Acacia senegal Species 0.000 description 2
- 108700028369 Alleles Proteins 0.000 description 2
- XXHUWNLLQQUGCD-UHFFFAOYSA-N C(C)(=O)C=1C(=NC=NC1NC=1C=NC(=CC1)S(=O)(=O)C)OC1CCN(CC1)C(=O)O Chemical compound C(C)(=O)C=1C(=NC=NC1NC=1C=NC(=CC1)S(=O)(=O)C)OC1CCN(CC1)C(=O)O XXHUWNLLQQUGCD-UHFFFAOYSA-N 0.000 description 2
- KUQXYUDKSUBHPU-UHFFFAOYSA-N CC1=C(C=NC=C1)NC1=CC(=NC=N1)OC1CCN(CC1)C(=O)O Chemical compound CC1=C(C=NC=C1)NC1=CC(=NC=N1)OC1CCN(CC1)C(=O)O KUQXYUDKSUBHPU-UHFFFAOYSA-N 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 2
- 102000004163 DNA-directed RNA polymerases Human genes 0.000 description 2
- 108090000626 DNA-directed RNA polymerases Proteins 0.000 description 2
- 108010016626 Dipeptides Proteins 0.000 description 2
- 108010004460 Gastric Inhibitory Polypeptide Proteins 0.000 description 2
- 102100039994 Gastric inhibitory polypeptide Human genes 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- 108010086246 Glucagon-Like Peptide-1 Receptor Proteins 0.000 description 2
- 102100032882 Glucagon-like peptide 1 receptor Human genes 0.000 description 2
- 229920000084 Gum arabic Polymers 0.000 description 2
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- 102100033115 Mitogen-activated protein kinase kinase kinase 1 Human genes 0.000 description 2
- CHJJGSNFBQVOTG-UHFFFAOYSA-N N-methyl-guanidine Natural products CNC(N)=N CHJJGSNFBQVOTG-UHFFFAOYSA-N 0.000 description 2
- ATHHXGZTWNVVOU-UHFFFAOYSA-N N-methylformamide Chemical compound CNC=O ATHHXGZTWNVVOU-UHFFFAOYSA-N 0.000 description 2
- 208000018262 Peripheral vascular disease Diseases 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- KYQCOXFCLRTKLS-UHFFFAOYSA-N Pyrazine Chemical compound C1=CN=CC=N1 KYQCOXFCLRTKLS-UHFFFAOYSA-N 0.000 description 2
- KAESVJOAVNADME-UHFFFAOYSA-N Pyrrole Chemical compound C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 description 2
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 description 2
- YASAKCUCGLMORW-UHFFFAOYSA-N Rosiglitazone Chemical compound C=1C=CC=NC=1N(C)CCOC(C=C1)=CC=C1CC1SC(=O)NC1=O YASAKCUCGLMORW-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- 206010067584 Type 1 diabetes mellitus Diseases 0.000 description 2
- DGUBIAFSRFMCKF-UHFFFAOYSA-N [1-[6-(2-fluoroanilino)-5-nitropyrimidin-4-yl]piperidin-4-yl]-(4-fluorophenyl)methanone Chemical compound N1=CN=C(N2CCC(CC2)C(=O)C=2C=CC(F)=CC=2)C([N+](=O)[O-])=C1NC1=CC=CC=C1F DGUBIAFSRFMCKF-UHFFFAOYSA-N 0.000 description 2
- 239000000205 acacia gum Substances 0.000 description 2
- 235000010489 acacia gum Nutrition 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 239000000443 aerosol Substances 0.000 description 2
- 125000005907 alkyl ester group Chemical group 0.000 description 2
- ZSBOMTDTBDDKMP-OAHLLOKOSA-N alogliptin Chemical compound C=1C=CC=C(C#N)C=1CN1C(=O)N(C)C(=O)C=C1N1CCC[C@@H](N)C1 ZSBOMTDTBDDKMP-OAHLLOKOSA-N 0.000 description 2
- 150000001408 amides Chemical class 0.000 description 2
- MDFFNEOEWAXZRQ-UHFFFAOYSA-N aminyl Chemical compound [NH2] MDFFNEOEWAXZRQ-UHFFFAOYSA-N 0.000 description 2
- 239000007900 aqueous suspension Substances 0.000 description 2
- 125000003710 aryl alkyl group Chemical group 0.000 description 2
- IOJUPLGTWVMSFF-UHFFFAOYSA-N benzothiazole Chemical compound C1=CC=C2SC=NC2=C1 IOJUPLGTWVMSFF-UHFFFAOYSA-N 0.000 description 2
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 2
- 230000027455 binding Effects 0.000 description 2
- 239000011230 binding agent Substances 0.000 description 2
- 230000008512 biological response Effects 0.000 description 2
- GGBJHURWWWLEQH-UHFFFAOYSA-N butylcyclohexane Chemical compound CCCCC1CCCCC1 GGBJHURWWWLEQH-UHFFFAOYSA-N 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 230000003197 catalytic effect Effects 0.000 description 2
- 210000000170 cell membrane Anatomy 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 125000001309 chloro group Chemical group Cl* 0.000 description 2
- 238000003776 cleavage reaction Methods 0.000 description 2
- 230000008878 coupling Effects 0.000 description 2
- 238000010168 coupling process Methods 0.000 description 2
- 238000005859 coupling reaction Methods 0.000 description 2
- ZOOGRGPOEVQQDX-UHFFFAOYSA-N cyclic GMP Natural products O1C2COP(O)(=O)OC2C(O)C1N1C=NC2=C1NC(N)=NC2=O ZOOGRGPOEVQQDX-UHFFFAOYSA-N 0.000 description 2
- 125000004122 cyclic group Chemical group 0.000 description 2
- NZNMSOFKMUBTKW-UHFFFAOYSA-N cyclohexanecarboxylic acid Chemical compound OC(=O)C1CCCCC1 NZNMSOFKMUBTKW-UHFFFAOYSA-N 0.000 description 2
- 125000002433 cyclopentenyl group Chemical group C1(=CCCC1)* 0.000 description 2
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- SWSQBOPZIKWTGO-UHFFFAOYSA-N dimethylaminoamidine Natural products CN(C)C(N)=N SWSQBOPZIKWTGO-UHFFFAOYSA-N 0.000 description 2
- 239000000975 dye Substances 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- YSPVHAUJXLGZHP-UHFFFAOYSA-N ethyl piperidine-1-carboxylate Chemical compound CCOC(=O)N1CCCCC1 YSPVHAUJXLGZHP-UHFFFAOYSA-N 0.000 description 2
- 239000013604 expression vector Substances 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- 230000002068 genetic effect Effects 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- MGXWVYUBJRZYPE-YUGYIWNOSA-N incretin Chemical class C([C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(N)=O)C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC=1C=CC(O)=CC=1)[C@@H](C)O)[C@@H](C)CC)C1=CC=C(O)C=C1 MGXWVYUBJRZYPE-YUGYIWNOSA-N 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 125000001972 isopentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 2
- AWJUIBRHMBBTKR-UHFFFAOYSA-N isoquinoline Chemical compound C1=NC=CC2=CC=CC=C21 AWJUIBRHMBBTKR-UHFFFAOYSA-N 0.000 description 2
- 235000015110 jellies Nutrition 0.000 description 2
- 239000008274 jelly Substances 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 239000000314 lubricant Substances 0.000 description 2
- 235000019359 magnesium stearate Nutrition 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 230000001404 mediated effect Effects 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- XZWYZXLIPXDOLR-UHFFFAOYSA-N metformin Chemical compound CN(C)C(=N)NC(N)=N XZWYZXLIPXDOLR-UHFFFAOYSA-N 0.000 description 2
- 229960003105 metformin Drugs 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 2
- JRHLLUIOJYVERA-UHFFFAOYSA-N n-(4-methylsulfonylphenyl)-5-nitro-6-[4-[3-[3-(trifluoromethyl)phenyl]-1,2,4-oxadiazol-5-yl]piperidin-1-yl]pyrimidin-4-amine Chemical compound C1=CC(S(=O)(=O)C)=CC=C1NC1=NC=NC(N2CCC(CC2)C=2ON=C(N=2)C=2C=C(C=CC=2)C(F)(F)F)=C1[N+]([O-])=O JRHLLUIOJYVERA-UHFFFAOYSA-N 0.000 description 2
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- VYGZRRKABMHIHB-UHFFFAOYSA-N n-tert-butylpiperidine-1-carboxamide Chemical compound CC(C)(C)NC(=O)N1CCCCC1 VYGZRRKABMHIHB-UHFFFAOYSA-N 0.000 description 2
- 125000001971 neopentyl group Chemical group [H]C([*])([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 2
- 210000002569 neuron Anatomy 0.000 description 2
- 150000002825 nitriles Chemical class 0.000 description 2
- 125000004433 nitrogen atom Chemical group N* 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- SIOXPEMLGUPBBT-UHFFFAOYSA-N picolinic acid Chemical compound OC(=O)C1=CC=CC=N1 SIOXPEMLGUPBBT-UHFFFAOYSA-N 0.000 description 2
- HYAFETHFCAUJAY-UHFFFAOYSA-N pioglitazone Chemical compound N1=CC(CC)=CC=C1CCOC(C=C1)=CC=C1CC1C(=O)NC(=O)S1 HYAFETHFCAUJAY-UHFFFAOYSA-N 0.000 description 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 2
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 2
- GCYXWQUSHADNBF-AAEALURTSA-N preproglucagon 78-108 Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC=1N=CNC=1)[C@@H](C)O)[C@@H](C)O)C(C)C)C1=CC=CC=C1 GCYXWQUSHADNBF-AAEALURTSA-N 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- XSCHRSMBECNVNS-UHFFFAOYSA-N quinoxaline Chemical compound N1=CC=NC2=CC=CC=C21 XSCHRSMBECNVNS-UHFFFAOYSA-N 0.000 description 2
- 230000010076 replication Effects 0.000 description 2
- QGJUIPDUBHWZPV-SGTAVMJGSA-N saxagliptin Chemical compound C1C(C2)CC(C3)CC2(O)CC13[C@H](N)C(=O)N1[C@H](C#N)C[C@@H]2C[C@@H]21 QGJUIPDUBHWZPV-SGTAVMJGSA-N 0.000 description 2
- 108010033693 saxagliptin Proteins 0.000 description 2
- 229960004937 saxagliptin Drugs 0.000 description 2
- 230000007017 scission Effects 0.000 description 2
- 230000000580 secretagogue effect Effects 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 239000007901 soft capsule Substances 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 235000010356 sorbitol Nutrition 0.000 description 2
- 239000003381 stabilizer Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 230000005062 synaptic transmission Effects 0.000 description 2
- 235000012222 talc Nutrition 0.000 description 2
- 229940124597 therapeutic agent Drugs 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 238000013518 transcription Methods 0.000 description 2
- 230000035897 transcription Effects 0.000 description 2
- 238000010361 transduction Methods 0.000 description 2
- 230000026683 transduction Effects 0.000 description 2
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 2
- 208000019553 vascular disease Diseases 0.000 description 2
- 239000013598 vector Substances 0.000 description 2
- BZAZHORFWMABOM-UHFFFAOYSA-N (1-methylpyrrol-2-yl)-[4-[1-(4-methylsulfonylphenyl)pyrazolo[3,4-d]pyrimidin-4-yl]oxypiperidin-1-yl]methanone Chemical compound CN1C=CC=C1C(=O)N1CCC(OC=2C=3C=NN(C=3N=CN=2)C=2C=CC(=CC=2)S(C)(=O)=O)CC1 BZAZHORFWMABOM-UHFFFAOYSA-N 0.000 description 1
- GUBKRXHJTBSKLW-UHFFFAOYSA-N (1-methylpyrrol-3-yl)-[3-[[1-(4-methylsulfonylphenyl)pyrazolo[3,4-d]pyrimidin-4-yl]amino]piperidin-1-yl]methanone Chemical compound CN1C=CC(C(=O)N2CC(CCC2)NC=2C=3C=NN(C=3N=CN=2)C=2C=CC(=CC=2)S(C)(=O)=O)=C1 GUBKRXHJTBSKLW-UHFFFAOYSA-N 0.000 description 1
- IIKMAFKBXGNWLO-UHFFFAOYSA-N (1-tert-butyl-5-methylpyrazol-4-yl)-[4-[1-(4-methylsulfonylphenyl)pyrazolo[3,4-d]pyrimidin-4-yl]oxypiperidin-1-yl]methanone Chemical compound C1=NN(C(C)(C)C)C(C)=C1C(=O)N1CCC(OC=2C=3C=NN(C=3N=CN=2)C=2C=CC(=CC=2)S(C)(=O)=O)CC1 IIKMAFKBXGNWLO-UHFFFAOYSA-N 0.000 description 1
- UMYNYRVVZFOCTO-UHFFFAOYSA-N (2,5-dimethylfuran-3-yl)-[4-[1-(4-methylsulfonylphenyl)pyrazolo[3,4-d]pyrimidin-4-yl]oxypiperidin-1-yl]methanone Chemical compound O1C(C)=CC(C(=O)N2CCC(CC2)OC=2C=3C=NN(C=3N=CN=2)C=2C=CC(=CC=2)S(C)(=O)=O)=C1C UMYNYRVVZFOCTO-UHFFFAOYSA-N 0.000 description 1
- DRFVYRIANGQDOP-UHFFFAOYSA-N (2-chlorophenyl) piperidine-1-carboxylate Chemical compound ClC1=CC=CC=C1OC(=O)N1CCCCC1 DRFVYRIANGQDOP-UHFFFAOYSA-N 0.000 description 1
- GNXFVIIWULQUBL-UHFFFAOYSA-N (2-chloropyridin-3-yl)-[4-[6-(4-methylsulfonylanilino)-5-nitropyrimidin-4-yl]oxypiperidin-1-yl]methanone Chemical compound C1=CC(S(=O)(=O)C)=CC=C1NC1=NC=NC(OC2CCN(CC2)C(=O)C=2C(=NC=CC=2)Cl)=C1[N+]([O-])=O GNXFVIIWULQUBL-UHFFFAOYSA-N 0.000 description 1
- JWJACVXEBVAWQA-UHFFFAOYSA-N (2-chloropyridin-4-yl)-[4-[1-(4-methylsulfonylphenyl)pyrazolo[3,4-d]pyrimidin-4-yl]oxypiperidin-1-yl]methanone Chemical compound C1=CC(S(=O)(=O)C)=CC=C1N1C2=NC=NC(OC3CCN(CC3)C(=O)C=3C=C(Cl)N=CC=3)=C2C=N1 JWJACVXEBVAWQA-UHFFFAOYSA-N 0.000 description 1
- LFRRFDHQOBKTQY-UHFFFAOYSA-N (2-fluoropyridin-3-yl)-[4-[1-(4-methylsulfonylphenyl)pyrazolo[3,4-d]pyrimidin-4-yl]oxypiperidin-1-yl]methanone Chemical compound C1=CC(S(=O)(=O)C)=CC=C1N1C2=NC=NC(OC3CCN(CC3)C(=O)C=3C(=NC=CC=3)F)=C2C=N1 LFRRFDHQOBKTQY-UHFFFAOYSA-N 0.000 description 1
- OVZCZOIXMUZTKC-UHFFFAOYSA-N (2-fluoropyridin-4-yl)-[4-[1-(4-methylsulfonylphenyl)pyrazolo[3,4-d]pyrimidin-4-yl]oxypiperidin-1-yl]methanone Chemical compound C1=CC(S(=O)(=O)C)=CC=C1N1C2=NC=NC(OC3CCN(CC3)C(=O)C=3C=C(F)N=CC=3)=C2C=N1 OVZCZOIXMUZTKC-UHFFFAOYSA-N 0.000 description 1
- YGDYHRLFNMOPCX-UHFFFAOYSA-N (2-methoxyphenyl) piperidine-1-carboxylate Chemical compound COC1=CC=CC=C1OC(=O)N1CCCCC1 YGDYHRLFNMOPCX-UHFFFAOYSA-N 0.000 description 1
- DKIGGYPDUNARNA-UHFFFAOYSA-N (2-methylpyridin-3-yl)-[3-[[1-(4-methylsulfonylphenyl)pyrazolo[3,4-d]pyrimidin-4-yl]amino]piperidin-1-yl]methanone Chemical compound CC1=NC=CC=C1C(=O)N1CC(NC=2C=3C=NN(C=3N=CN=2)C=2C=CC(=CC=2)S(C)(=O)=O)CCC1 DKIGGYPDUNARNA-UHFFFAOYSA-N 0.000 description 1
- LMZSJDJKPJIXSA-UHFFFAOYSA-N (2-methylpyridin-3-yl)-[4-[1-(4-methylsulfonylphenyl)pyrazolo[3,4-d]pyrimidin-4-yl]oxypiperidin-1-yl]methanone Chemical compound CC1=NC=CC=C1C(=O)N1CCC(OC=2C=3C=NN(C=3N=CN=2)C=2C=CC(=CC=2)S(C)(=O)=O)CC1 LMZSJDJKPJIXSA-UHFFFAOYSA-N 0.000 description 1
- XUFXOAAUWZOOIT-SXARVLRPSA-N (2R,3R,4R,5S,6R)-5-[[(2R,3R,4R,5S,6R)-5-[[(2R,3R,4S,5S,6R)-3,4-dihydroxy-6-methyl-5-[[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)-1-cyclohex-2-enyl]amino]-2-oxanyl]oxy]-3,4-dihydroxy-6-(hydroxymethyl)-2-oxanyl]oxy]-6-(hydroxymethyl)oxane-2,3,4-triol Chemical compound O([C@H]1O[C@H](CO)[C@H]([C@@H]([C@H]1O)O)O[C@H]1O[C@@H]([C@H]([C@H](O)[C@H]1O)N[C@@H]1[C@@H]([C@@H](O)[C@H](O)C(CO)=C1)O)C)[C@@H]1[C@@H](CO)O[C@@H](O)[C@H](O)[C@H]1O XUFXOAAUWZOOIT-SXARVLRPSA-N 0.000 description 1
- SUTRBBYEBJZKSL-HXUWFJFHSA-N (2r)-1-[4-[6-(2-fluoro-4-methylsulfonylphenoxy)-5-methylpyrimidin-4-yl]oxypiperidin-1-yl]-3-methyl-2-(methylamino)butan-1-one Chemical compound C1CN(C(=O)[C@@H](C(C)C)NC)CCC1OC1=NC=NC(OC=2C(=CC(=CC=2)S(C)(=O)=O)F)=C1C SUTRBBYEBJZKSL-HXUWFJFHSA-N 0.000 description 1
- SUTRBBYEBJZKSL-FQEVSTJZSA-N (2s)-1-[4-[6-(2-fluoro-4-methylsulfonylphenoxy)-5-methylpyrimidin-4-yl]oxypiperidin-1-yl]-3-methyl-2-(methylamino)butan-1-one Chemical compound C1CN(C(=O)[C@H](C(C)C)NC)CCC1OC1=NC=NC(OC=2C(=CC(=CC=2)S(C)(=O)=O)F)=C1C SUTRBBYEBJZKSL-FQEVSTJZSA-N 0.000 description 1
- JSYGLDMGERSRPC-FQUUOJAGSA-N (2s,4s)-4-fluoro-1-[2-[[(1r,3s)-3-(1,2,4-triazol-1-ylmethyl)cyclopentyl]amino]acetyl]pyrrolidine-2-carbonitrile Chemical group C1[C@@H](F)C[C@@H](C#N)N1C(=O)CN[C@H]1C[C@@H](CN2N=CN=C2)CC1 JSYGLDMGERSRPC-FQUUOJAGSA-N 0.000 description 1
- PBOYCKADGFSAPA-UHFFFAOYSA-N (3,4-dimethyl-1,2-oxazol-5-yl)-[4-[1-(4-methylsulfonylphenyl)pyrazolo[3,4-d]pyrimidin-4-yl]oxypiperidin-1-yl]methanone Chemical compound CC1=NOC(C(=O)N2CCC(CC2)OC=2C=3C=NN(C=3N=CN=2)C=2C=CC(=CC=2)S(C)(=O)=O)=C1C PBOYCKADGFSAPA-UHFFFAOYSA-N 0.000 description 1
- OFNYNMGWULLEEA-UHFFFAOYSA-N (3-fluorophenyl)-[4-[1-(4-methylsulfonylphenyl)pyrazolo[3,4-d]pyrimidin-4-yl]oxypiperidin-1-yl]methanone Chemical compound C1=CC(S(=O)(=O)C)=CC=C1N1C2=NC=NC(OC3CCN(CC3)C(=O)C=3C=C(F)C=CC=3)=C2C=N1 OFNYNMGWULLEEA-UHFFFAOYSA-N 0.000 description 1
- MLBRPYOSSQXKQO-UHFFFAOYSA-N (3-methyl-1,2-oxazol-5-yl)-[4-[1-(4-methylsulfonylphenyl)pyrazolo[3,4-d]pyrimidin-4-yl]oxypiperidin-1-yl]methanone Chemical compound O1N=C(C)C=C1C(=O)N1CCC(OC=2C=3C=NN(C=3N=CN=2)C=2C=CC(=CC=2)S(C)(=O)=O)CC1 MLBRPYOSSQXKQO-UHFFFAOYSA-N 0.000 description 1
- LWJYAHNLVMMSIM-UHFFFAOYSA-N (4-chloro-3-nitrophenyl)-[4-[1-(4-methylsulfonylphenyl)pyrazolo[3,4-d]pyrimidin-4-yl]oxypiperidin-1-yl]methanone Chemical compound C1=CC(S(=O)(=O)C)=CC=C1N1C2=NC=NC(OC3CCN(CC3)C(=O)C=3C=C(C(Cl)=CC=3)[N+]([O-])=O)=C2C=N1 LWJYAHNLVMMSIM-UHFFFAOYSA-N 0.000 description 1
- XKDUIEMPOJNANI-UHFFFAOYSA-N (4-chlorophenyl) piperidine-1-carboxylate Chemical compound C1=CC(Cl)=CC=C1OC(=O)N1CCCCC1 XKDUIEMPOJNANI-UHFFFAOYSA-N 0.000 description 1
- GBTQLAMSRNCKJV-UHFFFAOYSA-N (4-chloropyridin-2-yl)-[4-[1-(4-methylsulfonylphenyl)pyrazolo[3,4-d]pyrimidin-4-yl]oxypiperidin-1-yl]methanone Chemical compound C1=CC(S(=O)(=O)C)=CC=C1N1C2=NC=NC(OC3CCN(CC3)C(=O)C=3N=CC=C(Cl)C=3)=C2C=N1 GBTQLAMSRNCKJV-UHFFFAOYSA-N 0.000 description 1
- YITWAQVRKRVZDA-UHFFFAOYSA-N (4-ethoxyphenyl)-[4-[1-(2-fluoro-4-methylsulfonylphenyl)pyrazolo[3,4-d]pyrimidin-4-yl]oxypiperidin-1-yl]methanone Chemical compound C1=CC(OCC)=CC=C1C(=O)N1CCC(OC=2C=3C=NN(C=3N=CN=2)C=2C(=CC(=CC=2)S(C)(=O)=O)F)CC1 YITWAQVRKRVZDA-UHFFFAOYSA-N 0.000 description 1
- DXTPIMILZQNZKA-UHFFFAOYSA-N (4-fluorophenyl) piperidine-1-carboxylate Chemical compound C1=CC(F)=CC=C1OC(=O)N1CCCCC1 DXTPIMILZQNZKA-UHFFFAOYSA-N 0.000 description 1
- ZPLZBFYIZREONQ-UHFFFAOYSA-N (4-hydroxy-3-methoxyphenyl)-[4-[1-(4-methylsulfonylphenyl)pyrazolo[3,4-d]pyrimidin-4-yl]oxypiperidin-1-yl]methanone Chemical compound C1=C(O)C(OC)=CC(C(=O)N2CCC(CC2)OC=2C=3C=NN(C=3N=CN=2)C=2C=CC(=CC=2)S(C)(=O)=O)=C1 ZPLZBFYIZREONQ-UHFFFAOYSA-N 0.000 description 1
- FTYPIEJTBPMMCU-UHFFFAOYSA-N (4-methoxycarbonylphenyl) piperidine-1-carboxylate Chemical compound N1(CCCCC1)C(=O)OC1=CC=C(C=C1)C(=O)OC FTYPIEJTBPMMCU-UHFFFAOYSA-N 0.000 description 1
- KOHYQJSYGMLPSO-UHFFFAOYSA-N (4-methoxyphenyl) piperidine-1-carboxylate Chemical compound C1=CC(OC)=CC=C1OC(=O)N1CCCCC1 KOHYQJSYGMLPSO-UHFFFAOYSA-N 0.000 description 1
- FJAGMCBQDNJZBX-UHFFFAOYSA-N (4-methoxypyridin-2-yl)-[4-[1-(4-methylsulfonylphenyl)pyrazolo[3,4-d]pyrimidin-4-yl]oxypiperidin-1-yl]methanone Chemical compound COC1=CC=NC(C(=O)N2CCC(CC2)OC=2C=3C=NN(C=3N=CN=2)C=2C=CC(=CC=2)S(C)(=O)=O)=C1 FJAGMCBQDNJZBX-UHFFFAOYSA-N 0.000 description 1
- PYBZSDAGPLZVHU-UHFFFAOYSA-N (4-methoxythiophen-3-yl)-[4-[1-(4-methylsulfonylphenyl)pyrazolo[3,4-d]pyrimidin-4-yl]oxypiperidin-1-yl]methanone Chemical compound COC1=CSC=C1C(=O)N1CCC(OC=2C=3C=NN(C=3N=CN=2)C=2C=CC(=CC=2)S(C)(=O)=O)CC1 PYBZSDAGPLZVHU-UHFFFAOYSA-N 0.000 description 1
- ZOHQOOYPQIBHSS-UHFFFAOYSA-N (4-methylphenyl)-[4-[(3-pyridin-4-yl-1,2,4-oxadiazol-5-yl)methoxy]piperidin-1-yl]methanone Chemical compound C1=CC(C)=CC=C1C(=O)N1CCC(OCC=2ON=C(N=2)C=2C=CN=CC=2)CC1 ZOHQOOYPQIBHSS-UHFFFAOYSA-N 0.000 description 1
- XTJXSDMCGRNICK-UHFFFAOYSA-N (5,6-dichloropyridin-3-yl)-[4-[1-(4-methylsulfonylphenyl)pyrazolo[3,4-d]pyrimidin-4-yl]oxypiperidin-1-yl]methanone Chemical compound C1=CC(S(=O)(=O)C)=CC=C1N1C2=NC=NC(OC3CCN(CC3)C(=O)C=3C=C(Cl)C(Cl)=NC=3)=C2C=N1 XTJXSDMCGRNICK-UHFFFAOYSA-N 0.000 description 1
- XVTAWIPNHJCHPD-UHFFFAOYSA-N (5,6-dichloropyridin-3-yl)-[4-[6-(2-fluoro-4-methylsulfonylanilino)pyrimidin-4-yl]oxypiperidin-1-yl]methanone Chemical compound FC1=CC(S(=O)(=O)C)=CC=C1NC1=CC(OC2CCN(CC2)C(=O)C=2C=C(Cl)C(Cl)=NC=2)=NC=N1 XVTAWIPNHJCHPD-UHFFFAOYSA-N 0.000 description 1
- HKPFJVJKYOJNDS-UHFFFAOYSA-N (5-aminopyridin-2-yl)-[4-[1-(4-methylsulfonylphenyl)pyrazolo[3,4-d]pyrimidin-4-yl]oxypiperidin-1-yl]methanone Chemical compound C1=CC(S(=O)(=O)C)=CC=C1N1C2=NC=NC(OC3CCN(CC3)C(=O)C=3N=CC(N)=CC=3)=C2C=N1 HKPFJVJKYOJNDS-UHFFFAOYSA-N 0.000 description 1
- SYZVBIQKJRRAQH-UHFFFAOYSA-N (5-bromopyridin-3-yl)-[4-[1-(4-methylsulfonylphenyl)pyrazolo[3,4-d]pyrimidin-4-yl]oxypiperidin-1-yl]methanone Chemical compound C1=CC(S(=O)(=O)C)=CC=C1N1C2=NC=NC(OC3CCN(CC3)C(=O)C=3C=C(Br)C=NC=3)=C2C=N1 SYZVBIQKJRRAQH-UHFFFAOYSA-N 0.000 description 1
- FOSPHQSCWSFXGX-UHFFFAOYSA-N (5-bromopyridin-3-yl)-[4-[6-(2-fluoro-4-methylsulfonylanilino)pyrimidin-4-yl]oxypiperidin-1-yl]methanone Chemical compound FC1=CC(S(=O)(=O)C)=CC=C1NC1=CC(OC2CCN(CC2)C(=O)C=2C=C(Br)C=NC=2)=NC=N1 FOSPHQSCWSFXGX-UHFFFAOYSA-N 0.000 description 1
- XERMCTLQCGIQDD-UHFFFAOYSA-N (5-butylpyridin-2-yl)-[4-[1-(2-fluoro-4-methylsulfonylphenyl)pyrazolo[3,4-d]pyrimidin-4-yl]oxypiperidin-1-yl]methanone Chemical compound N1=CC(CCCC)=CC=C1C(=O)N1CCC(OC=2C=3C=NN(C=3N=CN=2)C=2C(=CC(=CC=2)S(C)(=O)=O)F)CC1 XERMCTLQCGIQDD-UHFFFAOYSA-N 0.000 description 1
- TXJOMHNEMRMAKY-UHFFFAOYSA-N (5-butylpyridin-2-yl)-[4-[1-(4-methylsulfonylphenyl)pyrazolo[3,4-d]pyrimidin-4-yl]oxypiperidin-1-yl]methanone Chemical compound N1=CC(CCCC)=CC=C1C(=O)N1CCC(OC=2C=3C=NN(C=3N=CN=2)C=2C=CC(=CC=2)S(C)(=O)=O)CC1 TXJOMHNEMRMAKY-UHFFFAOYSA-N 0.000 description 1
- PBNMEKRQLUGZFA-UHFFFAOYSA-N (5-butylpyridin-2-yl)-[4-[6-(2-fluoro-4-methylsulfonylanilino)pyrimidin-4-yl]oxypiperidin-1-yl]methanone Chemical compound N1=CC(CCCC)=CC=C1C(=O)N1CCC(OC=2N=CN=C(NC=3C(=CC(=CC=3)S(C)(=O)=O)F)C=2)CC1 PBNMEKRQLUGZFA-UHFFFAOYSA-N 0.000 description 1
- QUVDFBPBDRBFGN-UHFFFAOYSA-N (5-chloropyridin-3-yl)-[4-[1-(4-methylsulfonylphenyl)pyrazolo[3,4-d]pyrimidin-4-yl]oxypiperidin-1-yl]methanone Chemical compound C1=CC(S(=O)(=O)C)=CC=C1N1C2=NC=NC(OC3CCN(CC3)C(=O)C=3C=C(Cl)C=NC=3)=C2C=N1 QUVDFBPBDRBFGN-UHFFFAOYSA-N 0.000 description 1
- XAJPXQMYGPLFAT-UHFFFAOYSA-N (5-fluoropyridin-2-yl)-[4-[1-(4-methylsulfonylphenyl)pyrazolo[3,4-d]pyrimidin-4-yl]oxypiperidin-1-yl]methanone Chemical compound C1=CC(S(=O)(=O)C)=CC=C1N1C2=NC=NC(OC3CCN(CC3)C(=O)C=3N=CC(F)=CC=3)=C2C=N1 XAJPXQMYGPLFAT-UHFFFAOYSA-N 0.000 description 1
- QCHXCYSFIDKZJB-UHFFFAOYSA-N (5-methyl-1,2-oxazol-3-yl)-[4-[1-(4-methylsulfonylphenyl)pyrazolo[3,4-d]pyrimidin-4-yl]oxypiperidin-1-yl]methanone Chemical compound O1C(C)=CC(C(=O)N2CCC(CC2)OC=2C=3C=NN(C=3N=CN=2)C=2C=CC(=CC=2)S(C)(=O)=O)=N1 QCHXCYSFIDKZJB-UHFFFAOYSA-N 0.000 description 1
- DCAGPPNAYAUXKU-UHFFFAOYSA-N (5-methylpyrazin-2-yl)-[4-[1-(4-methylsulfonylphenyl)pyrazolo[3,4-d]pyrimidin-4-yl]oxypiperidin-1-yl]methanone Chemical compound C1=NC(C)=CN=C1C(=O)N1CCC(OC=2C=3C=NN(C=3N=CN=2)C=2C=CC(=CC=2)S(C)(=O)=O)CC1 DCAGPPNAYAUXKU-UHFFFAOYSA-N 0.000 description 1
- OJHSZYAPIFGKNJ-UHFFFAOYSA-N (5-methylpyridin-3-yl)-[3-[[1-(4-methylsulfonylphenyl)pyrazolo[3,4-d]pyrimidin-4-yl]amino]piperidin-1-yl]methanone Chemical compound CC1=CN=CC(C(=O)N2CC(CCC2)NC=2C=3C=NN(C=3N=CN=2)C=2C=CC(=CC=2)S(C)(=O)=O)=C1 OJHSZYAPIFGKNJ-UHFFFAOYSA-N 0.000 description 1
- PJIMZBZWIUANSB-UHFFFAOYSA-N (5-methylpyridin-3-yl)-[4-[1-(4-methylsulfonylphenyl)pyrazolo[3,4-d]pyrimidin-4-yl]oxypiperidin-1-yl]methanone Chemical compound CC1=CN=CC(C(=O)N2CCC(CC2)OC=2C=3C=NN(C=3N=CN=2)C=2C=CC(=CC=2)S(C)(=O)=O)=C1 PJIMZBZWIUANSB-UHFFFAOYSA-N 0.000 description 1
- JHPZVOUMYHVHTC-UHFFFAOYSA-N (5-tert-butyl-2-methylpyrazol-3-yl)-[4-[1-(4-methylsulfonylphenyl)pyrazolo[3,4-d]pyrimidin-4-yl]oxypiperidin-1-yl]methanone Chemical compound CN1N=C(C(C)(C)C)C=C1C(=O)N1CCC(OC=2C=3C=NN(C=3N=CN=2)C=2C=CC(=CC=2)S(C)(=O)=O)CC1 JHPZVOUMYHVHTC-UHFFFAOYSA-N 0.000 description 1
- JCZNELDPUPQIOL-UHFFFAOYSA-N (6-aminopyridin-3-yl)-[4-[6-(2-fluoro-4-methylsulfonylphenoxy)-5-methylpyrimidin-4-yl]oxypiperidin-1-yl]methanone Chemical compound N1=CN=C(OC=2C(=CC(=CC=2)S(C)(=O)=O)F)C(C)=C1OC(CC1)CCN1C(=O)C1=CC=C(N)N=C1 JCZNELDPUPQIOL-UHFFFAOYSA-N 0.000 description 1
- CPZYECLLEHOQPD-UHFFFAOYSA-N (6-bromopyridin-2-yl)-[4-[6-(2-fluoro-4-methylsulfonylanilino)pyrimidin-4-yl]oxypiperidin-1-yl]methanone Chemical compound FC1=CC(S(=O)(=O)C)=CC=C1NC1=CC(OC2CCN(CC2)C(=O)C=2N=C(Br)C=CC=2)=NC=N1 CPZYECLLEHOQPD-UHFFFAOYSA-N 0.000 description 1
- MMELAKDWLPCDKT-UHFFFAOYSA-N (6-chloropyridin-2-yl)-[4-[1-(4-methylsulfonylphenyl)pyrazolo[3,4-d]pyrimidin-4-yl]oxypiperidin-1-yl]methanone Chemical compound C1=CC(S(=O)(=O)C)=CC=C1N1C2=NC=NC(OC3CCN(CC3)C(=O)C=3N=C(Cl)C=CC=3)=C2C=N1 MMELAKDWLPCDKT-UHFFFAOYSA-N 0.000 description 1
- UYDMQNYSUYFELE-UHFFFAOYSA-N (6-chloropyridin-2-yl)-[4-[6-(2-fluoro-4-methylsulfonylanilino)pyrimidin-4-yl]oxypiperidin-1-yl]methanone Chemical compound FC1=CC(S(=O)(=O)C)=CC=C1NC1=CC(OC2CCN(CC2)C(=O)C=2N=C(Cl)C=CC=2)=NC=N1 UYDMQNYSUYFELE-UHFFFAOYSA-N 0.000 description 1
- WDRSYCRZMJRODM-UHFFFAOYSA-N (6-chloropyridin-3-yl)-[4-[1-(4-methylsulfonylphenyl)pyrazolo[3,4-d]pyrimidin-4-yl]oxypiperidin-1-yl]methanone Chemical compound C1=CC(S(=O)(=O)C)=CC=C1N1C2=NC=NC(OC3CCN(CC3)C(=O)C=3C=NC(Cl)=CC=3)=C2C=N1 WDRSYCRZMJRODM-UHFFFAOYSA-N 0.000 description 1
- FFHNBQPFBALRQO-UHFFFAOYSA-N (6-fluoropyridin-2-yl)-[4-[1-(4-methylsulfonylphenyl)pyrazolo[3,4-d]pyrimidin-4-yl]oxypiperidin-1-yl]methanone Chemical compound C1=CC(S(=O)(=O)C)=CC=C1N1C2=NC=NC(OC3CCN(CC3)C(=O)C=3N=C(F)C=CC=3)=C2C=N1 FFHNBQPFBALRQO-UHFFFAOYSA-N 0.000 description 1
- DYLRPJTUIKITJR-UHFFFAOYSA-N (6-fluoropyridin-3-yl)-[4-[1-(4-methylsulfonylphenyl)pyrazolo[3,4-d]pyrimidin-4-yl]oxypiperidin-1-yl]methanone Chemical compound C1=CC(S(=O)(=O)C)=CC=C1N1C2=NC=NC(OC3CCN(CC3)C(=O)C=3C=NC(F)=CC=3)=C2C=N1 DYLRPJTUIKITJR-UHFFFAOYSA-N 0.000 description 1
- LLFMWNFREPQUQH-UHFFFAOYSA-N (6-methylpyridin-2-yl)-[4-[1-(4-methylsulfonylphenyl)pyrazolo[3,4-d]pyrimidin-4-yl]oxypiperidin-1-yl]methanone Chemical compound CC1=CC=CC(C(=O)N2CCC(CC2)OC=2C=3C=NN(C=3N=CN=2)C=2C=CC(=CC=2)S(C)(=O)=O)=N1 LLFMWNFREPQUQH-UHFFFAOYSA-N 0.000 description 1
- PZEIUPYNQFYSJO-UHFFFAOYSA-N (6-methylpyridin-3-yl)-[3-[[1-(4-methylsulfonylphenyl)pyrazolo[3,4-d]pyrimidin-4-yl]amino]piperidin-1-yl]methanone Chemical compound C1=NC(C)=CC=C1C(=O)N1CC(NC=2C=3C=NN(C=3N=CN=2)C=2C=CC(=CC=2)S(C)(=O)=O)CCC1 PZEIUPYNQFYSJO-UHFFFAOYSA-N 0.000 description 1
- HHPFLNPBLWRVMU-UHFFFAOYSA-N (6-methylpyridin-3-yl)-[4-[1-(4-methylsulfonylphenyl)pyrazolo[3,4-d]pyrimidin-4-yl]oxypiperidin-1-yl]methanone Chemical compound C1=NC(C)=CC=C1C(=O)N1CCC(OC=2C=3C=NN(C=3N=CN=2)C=2C=CC(=CC=2)S(C)(=O)=O)CC1 HHPFLNPBLWRVMU-UHFFFAOYSA-N 0.000 description 1
- BQOYIOQVTSVXBQ-UHFFFAOYSA-N (6-tert-butylpyridin-3-yl)-[4-[1-(4-methylsulfonylphenyl)pyrazolo[3,4-d]pyrimidin-4-yl]oxypiperidin-1-yl]methanone Chemical compound C1=NC(C(C)(C)C)=CC=C1C(=O)N1CCC(OC=2C=3C=NN(C=3N=CN=2)C=2C=CC(=CC=2)S(C)(=O)=O)CC1 BQOYIOQVTSVXBQ-UHFFFAOYSA-N 0.000 description 1
- 125000006594 (C1-C3) alkylsulfony group Chemical group 0.000 description 1
- 125000004768 (C1-C4) alkylsulfinyl group Chemical group 0.000 description 1
- 125000004769 (C1-C4) alkylsulfonyl group Chemical group 0.000 description 1
- 125000004749 (C1-C6) haloalkylsulfinyl group Chemical group 0.000 description 1
- 125000004741 (C1-C6) haloalkylsulfonyl group Chemical group 0.000 description 1
- XOIYZMDJFLKIEI-UHFFFAOYSA-N (hydroxysulfonimidoyl)oxybenzene Chemical compound NS(=O)(=O)OC1=CC=CC=C1 XOIYZMDJFLKIEI-UHFFFAOYSA-N 0.000 description 1
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 1
- FIARMZDBEGVMLV-UHFFFAOYSA-N 1,1,2,2,2-pentafluoroethanolate Chemical group [O-]C(F)(F)C(F)(F)F FIARMZDBEGVMLV-UHFFFAOYSA-N 0.000 description 1
- BCMCBBGGLRIHSE-UHFFFAOYSA-N 1,3-benzoxazole Chemical compound C1=CC=C2OC=NC2=C1 BCMCBBGGLRIHSE-UHFFFAOYSA-N 0.000 description 1
- OGYGFUAIIOPWQD-UHFFFAOYSA-N 1,3-thiazolidine Chemical compound C1CSCN1 OGYGFUAIIOPWQD-UHFFFAOYSA-N 0.000 description 1
- ZOBPZXTWZATXDG-UHFFFAOYSA-N 1,3-thiazolidine-2,4-dione Chemical compound O=C1CSC(=O)N1 ZOBPZXTWZATXDG-UHFFFAOYSA-N 0.000 description 1
- BZCKFTOJAAQFTA-UHFFFAOYSA-N 1-(1,4-dioxan-2-yl)-2-[4-[6-(2-fluoro-4-methylsulfonylphenoxy)-5-methylpyrimidin-4-yl]oxypiperidin-1-yl]ethanone Chemical compound N1=CN=C(OC=2C(=CC(=CC=2)S(C)(=O)=O)F)C(C)=C1OC(CC1)CCN1CC(=O)C1COCCO1 BZCKFTOJAAQFTA-UHFFFAOYSA-N 0.000 description 1
- XBCOTSINJGZHFA-UHFFFAOYSA-N 1-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-[4-[6-(2-fluoro-4-methylsulfonylphenoxy)-5-methylpyrimidin-4-yl]oxypiperidin-1-yl]ethanone Chemical compound CC1=C(OC2CCN(CC(=O)C=3C=C4OCCOC4=CC=3)CC2)N=CN=C1OC1=CC=C(S(C)(=O)=O)C=C1F XBCOTSINJGZHFA-UHFFFAOYSA-N 0.000 description 1
- ADNWBASSTOAASU-UHFFFAOYSA-N 1-(2,4-dimethoxyphenyl)-2-[4-[1-(4-methylsulfonylphenyl)pyrazolo[3,4-d]pyrimidin-4-yl]oxypiperidin-1-yl]ethanone Chemical compound COC1=CC(OC)=CC=C1C(=O)CN1CCC(OC=2C=3C=NN(C=3N=CN=2)C=2C=CC(=CC=2)S(C)(=O)=O)CC1 ADNWBASSTOAASU-UHFFFAOYSA-N 0.000 description 1
- RVZFZQWLTJQPLS-UHFFFAOYSA-N 1-(2,4-dimethoxyphenyl)-2-[4-[6-(2-fluoro-4-methylsulfonylphenoxy)-5-methylpyrimidin-4-yl]oxypiperidin-1-yl]ethanone Chemical compound COC1=CC(OC)=CC=C1C(=O)CN1CCC(OC=2C(=C(OC=3C(=CC(=CC=3)S(C)(=O)=O)F)N=CN=2)C)CC1 RVZFZQWLTJQPLS-UHFFFAOYSA-N 0.000 description 1
- BYOVXZGDVJRLSG-UHFFFAOYSA-N 1-(2,4-dimethylphenyl)-2-[4-[6-(2-fluoro-4-methylsulfonylphenoxy)-5-methylpyrimidin-4-yl]oxypiperidin-1-yl]ethanone Chemical compound CC1=CC(C)=CC=C1C(=O)CN1CCC(OC=2C(=C(OC=3C(=CC(=CC=3)S(C)(=O)=O)F)N=CN=2)C)CC1 BYOVXZGDVJRLSG-UHFFFAOYSA-N 0.000 description 1
- FXCOOELGVLFKQL-UHFFFAOYSA-N 1-(2,5-dimethoxyphenyl)-2-[4-[6-(2-fluoro-4-methylsulfonylphenoxy)-5-methylpyrimidin-4-yl]oxypiperidin-1-yl]ethanone Chemical compound COC1=CC=C(OC)C(C(=O)CN2CCC(CC2)OC=2C(=C(OC=3C(=CC(=CC=3)S(C)(=O)=O)F)N=CN=2)C)=C1 FXCOOELGVLFKQL-UHFFFAOYSA-N 0.000 description 1
- ZGQWNYLFEIIJJA-UHFFFAOYSA-N 1-(2-chlorophenyl)-2-[4-[6-(2-fluoro-4-methylsulfonylphenoxy)-5-methylpyrimidin-4-yl]oxypiperidin-1-yl]ethanone Chemical compound N1=CN=C(OC=2C(=CC(=CC=2)S(C)(=O)=O)F)C(C)=C1OC(CC1)CCN1CC(=O)C1=CC=CC=C1Cl ZGQWNYLFEIIJJA-UHFFFAOYSA-N 0.000 description 1
- RPFKNCHQAPGBAG-UHFFFAOYSA-N 1-(2-fluoro-4-methylsulfonylphenyl)-4-[1-(5-methyl-4-pyrrolidin-1-ylpyrimidin-2-yl)piperidin-4-yl]oxypyrazolo[3,4-d]pyrimidine Chemical compound CC1=CN=C(N2CCC(CC2)OC=2C=3C=NN(C=3N=CN=2)C=2C(=CC(=CC=2)S(C)(=O)=O)F)N=C1N1CCCC1 RPFKNCHQAPGBAG-UHFFFAOYSA-N 0.000 description 1
- LNQJGGVUQUTGPG-UHFFFAOYSA-N 1-(2-fluoro-4-methylsulfonylphenyl)-4-[1-(5-propan-2-yloxypyridin-2-yl)piperidin-4-yl]oxypyrazolo[3,4-d]pyrimidine Chemical group N1=CC(OC(C)C)=CC=C1N1CCC(OC=2C=3C=NN(C=3N=CN=2)C=2C(=CC(=CC=2)S(C)(=O)=O)F)CC1 LNQJGGVUQUTGPG-UHFFFAOYSA-N 0.000 description 1
- QEXOQIFDXSEDFT-UHFFFAOYSA-N 1-(2-fluoro-4-methylsulfonylphenyl)-4-[1-[3-(trifluoromethoxy)phenyl]piperidin-4-yl]oxypyrazolo[3,4-d]pyrimidine Chemical compound FC1=CC(S(=O)(=O)C)=CC=C1N1C2=NC=NC(OC3CCN(CC3)C=3C=C(OC(F)(F)F)C=CC=3)=C2C=N1 QEXOQIFDXSEDFT-UHFFFAOYSA-N 0.000 description 1
- NYWYTGMKHUQFPH-UHFFFAOYSA-N 1-(2-fluoro-4-methylsulfonylphenyl)-4-[1-[4-(trifluoromethoxy)phenyl]piperidin-4-yl]oxypyrazolo[3,4-d]pyrimidine Chemical compound FC1=CC(S(=O)(=O)C)=CC=C1N1C2=NC=NC(OC3CCN(CC3)C=3C=CC(OC(F)(F)F)=CC=3)=C2C=N1 NYWYTGMKHUQFPH-UHFFFAOYSA-N 0.000 description 1
- FLSWIFTXMOBVGO-UHFFFAOYSA-N 1-(2-fluoro-4-methylsulfonylphenyl)-n-[1-[(3-propan-2-yl-1,2,4-oxadiazol-5-yl)methyl]pyrrolidin-3-yl]pyrazolo[3,4-d]pyrimidin-4-amine Chemical compound CC(C)C1=NOC(CN2CC(CC2)NC=2C=3C=NN(C=3N=CN=2)C=2C(=CC(=CC=2)S(C)(=O)=O)F)=N1 FLSWIFTXMOBVGO-UHFFFAOYSA-N 0.000 description 1
- ADQFDCKNDOZVQK-UHFFFAOYSA-N 1-(3,4-dichlorophenyl)-2-[4-[1-(4-methylsulfonylphenyl)pyrazolo[3,4-d]pyrimidin-4-yl]oxypiperidin-1-yl]ethanone Chemical compound C1=CC(S(=O)(=O)C)=CC=C1N1C2=NC=NC(OC3CCN(CC(=O)C=4C=C(Cl)C(Cl)=CC=4)CC3)=C2C=N1 ADQFDCKNDOZVQK-UHFFFAOYSA-N 0.000 description 1
- WTRLCDYYFXPAPD-UHFFFAOYSA-N 1-(3,4-difluorophenyl)-2-[4-[6-(2-fluoro-4-methylsulfonylphenoxy)-5-methylpyrimidin-4-yl]oxypiperidin-1-yl]ethanone Chemical compound N1=CN=C(OC=2C(=CC(=CC=2)S(C)(=O)=O)F)C(C)=C1OC(CC1)CCN1CC(=O)C1=CC=C(F)C(F)=C1 WTRLCDYYFXPAPD-UHFFFAOYSA-N 0.000 description 1
- PHJXLUZEMQGAHL-UHFFFAOYSA-N 1-(3-chlorophenyl)-2-[4-[6-(2-fluoro-4-methylsulfonylphenoxy)-5-methylpyrimidin-4-yl]oxypiperidin-1-yl]ethanone Chemical compound N1=CN=C(OC=2C(=CC(=CC=2)S(C)(=O)=O)F)C(C)=C1OC(CC1)CCN1CC(=O)C1=CC=CC(Cl)=C1 PHJXLUZEMQGAHL-UHFFFAOYSA-N 0.000 description 1
- DDBIYQMJUXUYPI-UHFFFAOYSA-N 1-(4-chlorophenyl)-2-[4-[1-(4-methylsulfonylphenyl)pyrazolo[3,4-d]pyrimidin-4-yl]oxypiperidin-1-yl]ethanone Chemical compound C1=CC(S(=O)(=O)C)=CC=C1N1C2=NC=NC(OC3CCN(CC(=O)C=4C=CC(Cl)=CC=4)CC3)=C2C=N1 DDBIYQMJUXUYPI-UHFFFAOYSA-N 0.000 description 1
- BMIUMSRQZZKLPW-UHFFFAOYSA-N 1-(4-chlorophenyl)-2-[4-[6-(2-fluoro-4-methylsulfonylphenoxy)-5-methylpyrimidin-4-yl]oxypiperidin-1-yl]ethanone Chemical compound N1=CN=C(OC=2C(=CC(=CC=2)S(C)(=O)=O)F)C(C)=C1OC(CC1)CCN1CC(=O)C1=CC=C(Cl)C=C1 BMIUMSRQZZKLPW-UHFFFAOYSA-N 0.000 description 1
- JROUXWXBUNYYKI-UHFFFAOYSA-N 1-(4-methylsulfonylphenyl)-4-[1-[4-(trifluoromethoxy)phenyl]piperidin-4-yl]oxypyrazolo[3,4-d]pyrimidine Chemical compound C1=CC(S(=O)(=O)C)=CC=C1N1C2=NC=NC(OC3CCN(CC3)C=3C=CC(OC(F)(F)F)=CC=3)=C2C=N1 JROUXWXBUNYYKI-UHFFFAOYSA-N 0.000 description 1
- QJYUQTCIRZEVPQ-UHFFFAOYSA-N 1-(4-methylsulfonylphenyl)-4-[1-[5-(trifluoromethyl)pyridin-2-yl]piperidin-4-yl]oxypyrazolo[3,4-d]pyrimidine Chemical group C1=CC(S(=O)(=O)C)=CC=C1N1C2=NC=NC(OC3CCN(CC3)C=3N=CC(=CC=3)C(F)(F)F)=C2C=N1 QJYUQTCIRZEVPQ-UHFFFAOYSA-N 0.000 description 1
- FDZFKCPEGGCPRC-UHFFFAOYSA-N 1-(4-methylsulfonylphenyl)-4-[1-[6-(trifluoromethyl)pyridin-2-yl]piperidin-4-yl]oxypyrazolo[3,4-d]pyrimidine Chemical group C1=CC(S(=O)(=O)C)=CC=C1N1C2=NC=NC(OC3CCN(CC3)C=3N=C(C=CC=3)C(F)(F)F)=C2C=N1 FDZFKCPEGGCPRC-UHFFFAOYSA-N 0.000 description 1
- BUASULFPEGUFMH-UHFFFAOYSA-N 1-(4-methylsulfonylphenyl)-4-piperidin-4-yloxypyrazolo[3,4-d]pyrimidine Chemical compound C1=CC(S(=O)(=O)C)=CC=C1N1C2=NC=NC(OC3CCNCC3)=C2C=N1 BUASULFPEGUFMH-UHFFFAOYSA-N 0.000 description 1
- ZBHWHXMUTIIYAO-UHFFFAOYSA-N 1-(4-methylsulfonylphenyl)-n-[1-[5-(trifluoromethyl)pyridin-2-yl]piperidin-4-yl]pyrazolo[3,4-d]pyrimidin-4-amine Chemical compound C1=CC(S(=O)(=O)C)=CC=C1N1C2=NC=NC(NC3CCN(CC3)C=3N=CC(=CC=3)C(F)(F)F)=C2C=N1 ZBHWHXMUTIIYAO-UHFFFAOYSA-N 0.000 description 1
- BOVGTQGAOIONJV-BETUJISGSA-N 1-[(3ar,6as)-3,3a,4,5,6,6a-hexahydro-1h-cyclopenta[c]pyrrol-2-yl]-3-(4-methylphenyl)sulfonylurea Chemical compound C1=CC(C)=CC=C1S(=O)(=O)NC(=O)NN1C[C@H]2CCC[C@H]2C1 BOVGTQGAOIONJV-BETUJISGSA-N 0.000 description 1
- YCMRXJUMUXVERL-UHFFFAOYSA-N 1-[1-[6-(2-fluoro-4-methylsulfonylanilino)-5-nitropyrimidin-4-yl]piperidin-4-yl]hexan-1-one Chemical compound C1CC(C(=O)CCCCC)CCN1C1=NC=NC(NC=2C(=CC(=CC=2)S(C)(=O)=O)F)=C1[N+]([O-])=O YCMRXJUMUXVERL-UHFFFAOYSA-N 0.000 description 1
- YPXRIOYBDVXGIO-UHFFFAOYSA-N 1-[1-[6-(4-acetylphenoxy)-3-nitropyridin-2-yl]piperidin-4-yl]ethanone Chemical compound C1CC(C(=O)C)CCN1C1=NC(OC=2C=CC(=CC=2)C(C)=O)=CC=C1[N+]([O-])=O YPXRIOYBDVXGIO-UHFFFAOYSA-N 0.000 description 1
- PRBMRQPCVSEOCV-UHFFFAOYSA-N 1-[1-[6-(4-methylsulfonylanilino)-5-nitropyrimidin-4-yl]piperidin-4-yl]hexan-1-one Chemical compound C1CC(C(=O)CCCCC)CCN1C1=NC=NC(NC=2C=CC(=CC=2)S(C)(=O)=O)=C1[N+]([O-])=O PRBMRQPCVSEOCV-UHFFFAOYSA-N 0.000 description 1
- YFNHEGBRPFNOFX-UHFFFAOYSA-N 1-[2-nitro-3-[4-(3-oxobutyl)phenoxy]phenyl]piperidine-4-carboxylic acid Chemical compound C1=CC(CCC(=O)C)=CC=C1OC1=CC=CC(N2CCC(CC2)C(O)=O)=C1[N+]([O-])=O YFNHEGBRPFNOFX-UHFFFAOYSA-N 0.000 description 1
- UUGBKXJUFRFGMJ-UHFFFAOYSA-N 1-[3-(4-benzoylphenoxy)-4-nitrophenyl]piperidine-4-carboxylic acid Chemical compound C(C1=CC=CC=C1)(=O)C1=CC=C(OC=2C=C(C=CC=2[N+](=O)[O-])N2CCC(CC2)C(=O)O)C=C1 UUGBKXJUFRFGMJ-UHFFFAOYSA-N 0.000 description 1
- VOQZIYNVRLBGCV-UHFFFAOYSA-N 1-[4-(1-benzylazetidin-3-yl)oxy-6-[(6-methylsulfonylpyridin-3-yl)amino]pyrimidin-5-yl]ethanone Chemical compound N1=CN=C(OC2CN(CC=3C=CC=CC=3)C2)C(C(=O)C)=C1NC1=CC=C(S(C)(=O)=O)N=C1 VOQZIYNVRLBGCV-UHFFFAOYSA-N 0.000 description 1
- YKJYNYBOEGIOEM-UHFFFAOYSA-N 1-[4-(diethylamino)phenyl]-2-[4-[1-(4-methylsulfonylphenyl)pyrazolo[3,4-d]pyrimidin-4-yl]oxypiperidin-1-yl]ethanone Chemical compound C1=CC(N(CC)CC)=CC=C1C(=O)CN1CCC(OC=2C=3C=NN(C=3N=CN=2)C=2C=CC(=CC=2)S(C)(=O)=O)CC1 YKJYNYBOEGIOEM-UHFFFAOYSA-N 0.000 description 1
- OILAFPLLAZHETH-UHFFFAOYSA-N 1-[4-(diethylamino)phenyl]-2-[4-[6-(2-fluoro-4-methylsulfonylphenoxy)-5-methylpyrimidin-4-yl]oxypiperidin-1-yl]ethanone Chemical compound C1=CC(N(CC)CC)=CC=C1C(=O)CN1CCC(OC=2C(=C(OC=3C(=CC(=CC=3)S(C)(=O)=O)F)N=CN=2)C)CC1 OILAFPLLAZHETH-UHFFFAOYSA-N 0.000 description 1
- IVEGZSLJRXNOPP-UHFFFAOYSA-N 1-[4-(difluoromethoxy)phenyl]-2-[4-[1-(4-methylsulfonylphenyl)pyrazolo[3,4-d]pyrimidin-4-yl]oxypiperidin-1-yl]ethanone Chemical compound C1=CC(S(=O)(=O)C)=CC=C1N1C2=NC=NC(OC3CCN(CC(=O)C=4C=CC(OC(F)F)=CC=4)CC3)=C2C=N1 IVEGZSLJRXNOPP-UHFFFAOYSA-N 0.000 description 1
- GQYLPBOLAJSQNX-UHFFFAOYSA-N 1-[4-[(3-pyridin-4-yl-1,2,4-oxadiazol-5-yl)methoxy]piperidin-1-yl]butan-1-one Chemical compound C1CN(C(=O)CCC)CCC1OCC1=NC(C=2C=CN=CC=2)=NO1 GQYLPBOLAJSQNX-UHFFFAOYSA-N 0.000 description 1
- CHBDSPHYMMYLRY-UHFFFAOYSA-N 1-[4-[1-(4-methylsulfonylphenyl)pyrazolo[3,4-d]pyrimidin-4-yl]oxypiperidin-1-yl]butan-2-one Chemical compound C1CN(CC(=O)CC)CCC1OC1=NC=NC2=C1C=NN2C1=CC=C(S(C)(=O)=O)C=C1 CHBDSPHYMMYLRY-UHFFFAOYSA-N 0.000 description 1
- UYZMRNXBHUIYIL-UHFFFAOYSA-N 1-[4-[3-[4-(methoxymethyl)piperidin-1-yl]-4-nitrophenoxy]phenyl]ethanone Chemical compound C1CC(COC)CCN1C1=CC(OC=2C=CC(=CC=2)C(C)=O)=CC=C1[N+]([O-])=O UYZMRNXBHUIYIL-UHFFFAOYSA-N 0.000 description 1
- FMLOEBLGSXIREX-UHFFFAOYSA-N 1-[4-[4-nitro-3-(4-propylpiperidin-1-yl)phenoxy]phenyl]butan-1-one Chemical compound C1CC(CCC)CCN1C1=CC(OC=2C=CC(=CC=2)C(=O)CCC)=CC=C1[N+]([O-])=O FMLOEBLGSXIREX-UHFFFAOYSA-N 0.000 description 1
- DBULFMSJWWTZHT-UHFFFAOYSA-N 1-[4-[4-nitro-3-(4-propylpiperidin-1-yl)phenoxy]phenyl]ethanone Chemical compound C1CC(CCC)CCN1C1=CC(OC=2C=CC(=CC=2)C(C)=O)=CC=C1[N+]([O-])=O DBULFMSJWWTZHT-UHFFFAOYSA-N 0.000 description 1
- PZJDKUSWONJXFN-UHFFFAOYSA-N 1-[4-[4-nitro-3-(4-propylpiperidin-1-yl)phenoxy]phenyl]hexan-1-one Chemical compound C1=CC(C(=O)CCCCC)=CC=C1OC1=CC=C([N+]([O-])=O)C(N2CCC(CCC)CC2)=C1 PZJDKUSWONJXFN-UHFFFAOYSA-N 0.000 description 1
- UDUBLFGDNOWYFL-UHFFFAOYSA-N 1-[4-[4-nitro-3-(4-propylpiperidin-1-yl)phenoxy]phenyl]pentan-1-one Chemical compound C1=CC(C(=O)CCCC)=CC=C1OC1=CC=C([N+]([O-])=O)C(N2CCC(CCC)CC2)=C1 UDUBLFGDNOWYFL-UHFFFAOYSA-N 0.000 description 1
- QGCMNWAITFFWRS-UHFFFAOYSA-N 1-[4-[4-nitro-3-(4-pyridin-2-ylsulfanylpiperidin-1-yl)phenoxy]phenyl]ethanone Chemical compound C1=CC(C(=O)C)=CC=C1OC1=CC=C([N+]([O-])=O)C(N2CCC(CC2)SC=2N=CC=CC=2)=C1 QGCMNWAITFFWRS-UHFFFAOYSA-N 0.000 description 1
- OTEOXAURHOATIC-UHFFFAOYSA-N 1-[4-[6-(2-fluoro-4-methylsulfonylanilino)-5-methylpyrimidin-4-yl]oxypiperidin-1-yl]-3-methylbutan-1-one Chemical compound C1CN(C(=O)CC(C)C)CCC1OC1=NC=NC(NC=2C(=CC(=CC=2)S(C)(=O)=O)F)=C1C OTEOXAURHOATIC-UHFFFAOYSA-N 0.000 description 1
- XYTIQXINBAEKPT-UHFFFAOYSA-N 1-[4-[6-(2-fluoro-4-methylsulfonylanilino)-5-methylpyrimidin-4-yl]oxypiperidin-1-yl]butan-1-one Chemical compound C1CN(C(=O)CCC)CCC1OC1=NC=NC(NC=2C(=CC(=CC=2)S(C)(=O)=O)F)=C1C XYTIQXINBAEKPT-UHFFFAOYSA-N 0.000 description 1
- RIAXTBCAPSTEGQ-UHFFFAOYSA-N 1-[4-[6-(2-fluoro-4-methylsulfonylanilino)-5-methylpyrimidin-4-yl]oxypiperidin-1-yl]pentan-1-one Chemical compound C1CN(C(=O)CCCC)CCC1OC1=NC=NC(NC=2C(=CC(=CC=2)S(C)(=O)=O)F)=C1C RIAXTBCAPSTEGQ-UHFFFAOYSA-N 0.000 description 1
- VICZUPAZXUCXHM-UHFFFAOYSA-N 1-[4-[6-(2-fluoro-4-methylsulfonylphenoxy)-2-methylpyrimidin-4-yl]oxypiperidin-1-yl]pentan-1-one Chemical compound C1CN(C(=O)CCCC)CCC1OC1=CC(OC=2C(=CC(=CC=2)S(C)(=O)=O)F)=NC(C)=N1 VICZUPAZXUCXHM-UHFFFAOYSA-N 0.000 description 1
- XRVMQLBTZWLEMK-UHFFFAOYSA-N 1-[4-[6-(2-fluoro-4-methylsulfonylphenoxy)-5-methylpyrimidin-4-yl]oxypiperidin-1-yl]-2-[4-(trifluoromethoxy)phenoxy]ethanone Chemical compound N1=CN=C(OC=2C(=CC(=CC=2)S(C)(=O)=O)F)C(C)=C1OC(CC1)CCN1C(=O)COC1=CC=C(OC(F)(F)F)C=C1 XRVMQLBTZWLEMK-UHFFFAOYSA-N 0.000 description 1
- FTMRLCTWSIIMHS-UHFFFAOYSA-N 1-[4-[6-(2-fluoro-4-methylsulfonylphenoxy)-5-methylpyrimidin-4-yl]oxypiperidin-1-yl]-2-[4-(trifluoromethoxy)phenoxy]propan-1-one Chemical compound C1CC(OC=2C(=C(OC=3C(=CC(=CC=3)S(C)(=O)=O)F)N=CN=2)C)CCN1C(=O)C(C)OC1=CC=C(OC(F)(F)F)C=C1 FTMRLCTWSIIMHS-UHFFFAOYSA-N 0.000 description 1
- NVBZXAUUEARXHX-UHFFFAOYSA-N 1-[4-[6-(2-fluoro-4-methylsulfonylphenoxy)-5-methylpyrimidin-4-yl]oxypiperidin-1-yl]-2-pyridin-2-ylethanone Chemical compound N1=CN=C(OC=2C(=CC(=CC=2)S(C)(=O)=O)F)C(C)=C1OC(CC1)CCN1C(=O)CC1=CC=CC=N1 NVBZXAUUEARXHX-UHFFFAOYSA-N 0.000 description 1
- ZZAIZOQHTKLWHY-UHFFFAOYSA-N 1-[4-[6-(2-fluoro-4-methylsulfonylphenoxy)-5-methylpyrimidin-4-yl]oxypiperidin-1-yl]-3,3-dimethylbutan-2-one Chemical compound N1=CN=C(OC=2C(=CC(=CC=2)S(C)(=O)=O)F)C(C)=C1OC1CCN(CC(=O)C(C)(C)C)CC1 ZZAIZOQHTKLWHY-UHFFFAOYSA-N 0.000 description 1
- CXRLTEZAZIALOU-UHFFFAOYSA-N 1-[4-[6-(2-fluoro-4-methylsulfonylphenoxy)-5-methylpyrimidin-4-yl]oxypiperidin-1-yl]-3-[(2-methylpropan-2-yl)oxy]propan-1-one Chemical compound N1=CN=C(OC=2C(=CC(=CC=2)S(C)(=O)=O)F)C(C)=C1OC1CCN(C(=O)CCOC(C)(C)C)CC1 CXRLTEZAZIALOU-UHFFFAOYSA-N 0.000 description 1
- VSTLULYTHRCXMH-UHFFFAOYSA-N 1-[4-[6-(2-fluoro-4-methylsulfonylphenoxy)-5-methylpyrimidin-4-yl]oxypiperidin-1-yl]-3-hydroxypropan-1-one Chemical compound N1=CN=C(OC=2C(=CC(=CC=2)S(C)(=O)=O)F)C(C)=C1OC1CCN(C(=O)CCO)CC1 VSTLULYTHRCXMH-UHFFFAOYSA-N 0.000 description 1
- PWBXXIOZUSDWDA-UHFFFAOYSA-N 1-[4-[6-(2-fluoro-4-methylsulfonylphenoxy)-5-methylpyrimidin-4-yl]oxypiperidin-1-yl]-3-methoxypropan-1-one Chemical compound C1CN(C(=O)CCOC)CCC1OC1=NC=NC(OC=2C(=CC(=CC=2)S(C)(=O)=O)F)=C1C PWBXXIOZUSDWDA-UHFFFAOYSA-N 0.000 description 1
- IRPQZOIPWFFUFR-UHFFFAOYSA-N 1-[4-[6-(2-fluoro-4-methylsulfonylphenoxy)-5-methylpyrimidin-4-yl]oxypiperidin-1-yl]-3-methylbutan-1-one Chemical compound C1CN(C(=O)CC(C)C)CCC1OC1=NC=NC(OC=2C(=CC(=CC=2)S(C)(=O)=O)F)=C1C IRPQZOIPWFFUFR-UHFFFAOYSA-N 0.000 description 1
- WEGGIOFKNSQVOI-UHFFFAOYSA-N 1-[4-[6-(2-fluoro-4-methylsulfonylphenoxy)-5-methylpyrimidin-4-yl]oxypiperidin-1-yl]-3-propan-2-yloxypropan-1-one Chemical compound C1CN(C(=O)CCOC(C)C)CCC1OC1=NC=NC(OC=2C(=CC(=CC=2)S(C)(=O)=O)F)=C1C WEGGIOFKNSQVOI-UHFFFAOYSA-N 0.000 description 1
- GDMSHVWMVACSPP-UHFFFAOYSA-N 1-[4-[6-(2-fluoro-4-methylsulfonylphenoxy)-5-methylpyrimidin-4-yl]oxypiperidin-1-yl]-4-methylpentan-1-one Chemical compound C1CN(C(=O)CCC(C)C)CCC1OC1=NC=NC(OC=2C(=CC(=CC=2)S(C)(=O)=O)F)=C1C GDMSHVWMVACSPP-UHFFFAOYSA-N 0.000 description 1
- YURFFJUCUZYWPB-UHFFFAOYSA-N 1-[4-[6-(2-fluoro-4-methylsulfonylphenoxy)-5-methylpyrimidin-4-yl]oxypiperidin-1-yl]-4-methylpentan-2-one Chemical compound C1CN(CC(=O)CC(C)C)CCC1OC1=NC=NC(OC=2C(=CC(=CC=2)S(C)(=O)=O)F)=C1C YURFFJUCUZYWPB-UHFFFAOYSA-N 0.000 description 1
- ZZFRFTMOUJBJFW-UHFFFAOYSA-N 1-[4-[6-(2-fluoro-4-methylsulfonylphenoxy)-5-methylpyrimidin-4-yl]oxypiperidin-1-yl]-4-propan-2-yloxybutan-1-one Chemical compound C1CN(C(=O)CCCOC(C)C)CCC1OC1=NC=NC(OC=2C(=CC(=CC=2)S(C)(=O)=O)F)=C1C ZZFRFTMOUJBJFW-UHFFFAOYSA-N 0.000 description 1
- WWJJXDCIMSWYSV-UHFFFAOYSA-N 1-[4-[6-(2-fluoro-4-methylsulfonylphenoxy)-5-methylpyrimidin-4-yl]oxypiperidin-1-yl]-5-methylhexan-1-one Chemical compound C1CN(C(=O)CCCC(C)C)CCC1OC1=NC=NC(OC=2C(=CC(=CC=2)S(C)(=O)=O)F)=C1C WWJJXDCIMSWYSV-UHFFFAOYSA-N 0.000 description 1
- WZZOIYZLYDIDQZ-UHFFFAOYSA-N 1-[4-[6-(2-fluoro-4-methylsulfonylphenoxy)-5-methylpyrimidin-4-yl]oxypiperidin-1-yl]-5-methylhexan-2-one Chemical compound C1CN(CC(=O)CCC(C)C)CCC1OC1=NC=NC(OC=2C(=CC(=CC=2)S(C)(=O)=O)F)=C1C WZZOIYZLYDIDQZ-UHFFFAOYSA-N 0.000 description 1
- GMVBSZZFAASGFW-UHFFFAOYSA-N 1-[4-[6-(2-fluoro-4-methylsulfonylphenoxy)-5-methylpyrimidin-4-yl]oxypiperidin-1-yl]-6-methylheptan-2-one Chemical compound C1CN(CC(=O)CCCC(C)C)CCC1OC1=NC=NC(OC=2C(=CC(=CC=2)S(C)(=O)=O)F)=C1C GMVBSZZFAASGFW-UHFFFAOYSA-N 0.000 description 1
- YLLHCNUBAGBJKE-UHFFFAOYSA-N 1-[4-[6-(2-fluoro-4-methylsulfonylphenoxy)-5-methylpyrimidin-4-yl]oxypiperidin-1-yl]butan-1-one Chemical compound C1CN(C(=O)CCC)CCC1OC1=NC=NC(OC=2C(=CC(=CC=2)S(C)(=O)=O)F)=C1C YLLHCNUBAGBJKE-UHFFFAOYSA-N 0.000 description 1
- RNAIEELRXPBMCX-UHFFFAOYSA-N 1-[4-[6-(2-fluoro-4-methylsulfonylphenoxy)-5-methylpyrimidin-4-yl]oxypiperidin-1-yl]butan-2-one Chemical compound C1CN(CC(=O)CC)CCC1OC1=NC=NC(OC=2C(=CC(=CC=2)S(C)(=O)=O)F)=C1C RNAIEELRXPBMCX-UHFFFAOYSA-N 0.000 description 1
- NJZWVOSVDFHKLH-UHFFFAOYSA-N 1-[4-[6-(2-fluoro-4-methylsulfonylphenoxy)-5-methylpyrimidin-4-yl]oxypiperidin-1-yl]hexan-1-one Chemical compound C1CN(C(=O)CCCCC)CCC1OC1=NC=NC(OC=2C(=CC(=CC=2)S(C)(=O)=O)F)=C1C NJZWVOSVDFHKLH-UHFFFAOYSA-N 0.000 description 1
- PNAPSQUNPXDMNE-UHFFFAOYSA-N 1-[4-[6-(2-fluoro-4-methylsulfonylphenoxy)-5-methylpyrimidin-4-yl]oxypiperidin-1-yl]pentan-2-one Chemical compound C1CN(CC(=O)CCC)CCC1OC1=NC=NC(OC=2C(=CC(=CC=2)S(C)(=O)=O)F)=C1C PNAPSQUNPXDMNE-UHFFFAOYSA-N 0.000 description 1
- IBNIPRMVXVNXAW-UHFFFAOYSA-N 1-[4-[[6-(4-methylsulfonylanilino)-5-nitropyrimidin-4-yl]amino]piperidin-1-yl]ethanone Chemical compound C1CN(C(=O)C)CCC1NC1=NC=NC(NC=2C=CC(=CC=2)S(C)(=O)=O)=C1[N+]([O-])=O IBNIPRMVXVNXAW-UHFFFAOYSA-N 0.000 description 1
- GVEAFDRGNBAMLM-UHFFFAOYSA-N 1-[4-nitro-3-[4-(3-oxobutyl)phenoxy]phenyl]piperidine-4-carboxylic acid Chemical compound [N+](=O)([O-])C1=C(C=C(C=C1)N1CCC(CC1)C(=O)O)OC1=CC=C(C=C1)CCC(C)=O GVEAFDRGNBAMLM-UHFFFAOYSA-N 0.000 description 1
- FZBNUXGZTJEPEE-UHFFFAOYSA-N 1-[5-(2-amino-4-ethylsulfonylphenoxy)-2-nitrophenyl]piperidine-4-carboxylic acid Chemical compound NC1=C(OC=2C=CC(=C(C=2)N2CCC(CC2)C(=O)O)[N+](=O)[O-])C=CC(=C1)S(=O)(=O)CC FZBNUXGZTJEPEE-UHFFFAOYSA-N 0.000 description 1
- APVZZUYMWSHHTF-UHFFFAOYSA-N 1-[5-(4-benzoylphenoxy)-2-nitrophenyl]piperidine-4-carboxylic acid Chemical compound C(C1=CC=CC=C1)(=O)C1=CC=C(OC=2C=CC(=C(C=2)N2CCC(CC2)C(=O)O)[N+](=O)[O-])C=C1 APVZZUYMWSHHTF-UHFFFAOYSA-N 0.000 description 1
- FABWZDHUYWQDKR-UHFFFAOYSA-N 1-[5-(4-ethenylphenoxy)-2-nitrophenyl]-4-propylpiperidine Chemical compound C1CC(CCC)CCN1C1=CC(OC=2C=CC(C=C)=CC=2)=CC=C1[N+]([O-])=O FABWZDHUYWQDKR-UHFFFAOYSA-N 0.000 description 1
- ONZUQTFTJRICHO-UHFFFAOYSA-N 1-[5-(4-ethenylphenoxy)-2-nitrophenyl]piperidine-4-carboxylic acid Chemical compound C1CC(C(=O)O)CCN1C1=CC(OC=2C=CC(C=C)=CC=2)=CC=C1[N+]([O-])=O ONZUQTFTJRICHO-UHFFFAOYSA-N 0.000 description 1
- YXIPEURVYVKHSO-UHFFFAOYSA-N 1-[5-[4-(2-carboxy-2-oxoethyl)phenoxy]-2-nitrophenyl]piperidine-4-carboxylic acid Chemical compound C(=O)(O)C(CC1=CC=C(OC=2C=CC(=C(C=2)N2CCC(CC2)C(=O)O)[N+](=O)[O-])C=C1)=O YXIPEURVYVKHSO-UHFFFAOYSA-N 0.000 description 1
- DCEQMDXGNYKKFU-UHFFFAOYSA-N 1-[5-[4-(2-carboxyethyl)phenoxy]-2-nitrophenyl]piperidine-4-carboxylic acid Chemical compound C(=O)(O)CCC1=CC=C(OC=2C=CC(=C(C=2)N2CCC(CC2)C(=O)O)[N+](=O)[O-])C=C1 DCEQMDXGNYKKFU-UHFFFAOYSA-N 0.000 description 1
- LRCZSKBHKNKLTK-UHFFFAOYSA-N 1-[5-[4-(3-methoxy-3-oxopropanoyl)phenoxy]-2-nitrophenyl]piperidine-4-carboxylic acid Chemical compound COC(=O)CC(=O)C1=CC=C(OC=2C=CC(=C(C=2)N2CCC(CC2)C(=O)O)[N+](=O)[O-])C=C1 LRCZSKBHKNKLTK-UHFFFAOYSA-N 0.000 description 1
- UEEOJLDIIXDOAF-UHFFFAOYSA-N 1-[5-nitro-6-(4-propanoylphenoxy)pyrimidin-4-yl]piperidine-4-carboxylic acid Chemical compound [N+](=O)([O-])C=1C(=NC=NC=1OC1=CC=C(C=C1)C(CC)=O)N1CCC(CC1)C(=O)O UEEOJLDIIXDOAF-UHFFFAOYSA-N 0.000 description 1
- DKMCBYQOIUCQQO-UHFFFAOYSA-N 1-[5-nitro-6-[4-(1,2,4-triazol-1-yl)anilino]pyrimidin-4-yl]piperidine-4-carboxylic acid Chemical compound [N+](=O)([O-])C=1C(=NC=NC=1NC1=CC=C(C=C1)N1N=CN=C1)N1CCC(CC1)C(=O)O DKMCBYQOIUCQQO-UHFFFAOYSA-N 0.000 description 1
- HWYNGEWJVFCEDS-UHFFFAOYSA-N 1-[5-nitro-6-[4-(1,2,4-triazol-1-yl)phenoxy]pyrimidin-4-yl]piperidine-4-carboxylic acid Chemical compound C1CC(C(=O)O)CCN1C1=NC=NC(OC=2C=CC(=CC=2)N2N=CN=C2)=C1[N+]([O-])=O HWYNGEWJVFCEDS-UHFFFAOYSA-N 0.000 description 1
- HJZIZGNRANLHLW-UHFFFAOYSA-N 1-[5-nitro-6-[4-(3-oxobutyl)phenoxy]pyrimidin-4-yl]piperidine-4-carboxylic acid Chemical compound [N+](=O)([O-])C=1C(=NC=NC=1OC1=CC=C(C=C1)CCC(C)=O)N1CCC(CC1)C(=O)O HJZIZGNRANLHLW-UHFFFAOYSA-N 0.000 description 1
- YGBJTEVQLOZOOM-UHFFFAOYSA-N 1-[5-nitro-6-[4-(thiadiazol-4-yl)phenoxy]pyrimidin-4-yl]piperidine-4-carboxylic acid Chemical compound C1CC(C(=O)O)CCN1C1=NC=NC(OC=2C=CC(=CC=2)C=2N=NSC=2)=C1[N+]([O-])=O YGBJTEVQLOZOOM-UHFFFAOYSA-N 0.000 description 1
- PBHXTKQTZJRSJG-UHFFFAOYSA-N 1-[6-(1,3-benzodioxol-5-ylamino)-5-nitropyrimidin-4-yl]piperidine-4-carboxylic acid Chemical compound C1CC(C(=O)O)CCN1C1=NC=NC(NC=2C=C3OCOC3=CC=2)=C1[N+]([O-])=O PBHXTKQTZJRSJG-UHFFFAOYSA-N 0.000 description 1
- AFYKJHSFGKZREE-UHFFFAOYSA-N 1-[6-(1,3-benzodioxol-5-ylmethylamino)-5-nitropyrimidin-4-yl]piperidine-4-carboxylic acid Chemical compound C1CC(C(=O)O)CCN1C1=NC=NC(NCC=2C=C3OCOC3=CC=2)=C1[N+]([O-])=O AFYKJHSFGKZREE-UHFFFAOYSA-N 0.000 description 1
- KLNAUQGLFCINLW-UHFFFAOYSA-N 1-[6-(2,5-dimethoxyanilino)-5-nitropyrimidin-4-yl]piperidine-4-carboxylic acid Chemical compound COC1=CC=C(OC)C(NC=2C(=C(N3CCC(CC3)C(O)=O)N=CN=2)[N+]([O-])=O)=C1 KLNAUQGLFCINLW-UHFFFAOYSA-N 0.000 description 1
- UHVJYEHTJVHAEX-UHFFFAOYSA-N 1-[6-(2-fluoroanilino)-5-nitropyrimidin-4-yl]piperidine-4-carboxylic acid Chemical compound C1CC(C(=O)O)CCN1C1=NC=NC(NC=2C(=CC=CC=2)F)=C1[N+]([O-])=O UHVJYEHTJVHAEX-UHFFFAOYSA-N 0.000 description 1
- ZWQRWZDGFZMTFM-UHFFFAOYSA-N 1-[6-(2-methoxyanilino)-5-nitropyrimidin-4-yl]piperidine-4-carboxylic acid Chemical compound COC1=CC=CC=C1NC1=NC=NC(N2CCC(CC2)C(O)=O)=C1[N+]([O-])=O ZWQRWZDGFZMTFM-UHFFFAOYSA-N 0.000 description 1
- BFVMYFVUJFECDY-UHFFFAOYSA-N 1-[6-(3-fluoroanilino)-5-nitropyrimidin-4-yl]piperidine-4-carboxylic acid Chemical compound FC=1C=C(C=CC=1)NC1=C(C(=NC=N1)N1CCC(CC1)C(=O)O)[N+](=O)[O-] BFVMYFVUJFECDY-UHFFFAOYSA-N 0.000 description 1
- DUAXQQOZBQGUOD-UHFFFAOYSA-N 1-[6-(3-methoxyanilino)-5-nitropyrimidin-4-yl]piperidine-4-carboxylic acid Chemical compound COC1=CC=CC(NC=2C(=C(N3CCC(CC3)C(O)=O)N=CN=2)[N+]([O-])=O)=C1 DUAXQQOZBQGUOD-UHFFFAOYSA-N 0.000 description 1
- PNGQGCVQDUHUCW-UHFFFAOYSA-N 1-[6-(4-acetylphenoxy)-5-nitropyrimidin-4-yl]piperidine-4-carboxylic acid Chemical compound C(C)(=O)C1=CC=C(OC2=C(C(=NC=N2)N2CCC(CC2)C(=O)O)[N+](=O)[O-])C=C1 PNGQGCVQDUHUCW-UHFFFAOYSA-N 0.000 description 1
- NCYRKTCTIJBORQ-UHFFFAOYSA-N 1-[6-(4-cyclohexylanilino)-5-nitropyrimidin-4-yl]piperidine-4-carboxylic acid Chemical compound C1(CCCCC1)C1=CC=C(C=C1)NC1=C(C(=NC=N1)N1CCC(CC1)C(=O)O)[N+](=O)[O-] NCYRKTCTIJBORQ-UHFFFAOYSA-N 0.000 description 1
- QGVGORCUUNGZPS-UHFFFAOYSA-N 1-[6-(4-imidazol-1-ylphenoxy)-5-nitropyrimidin-4-yl]piperidine-4-carboxylic acid Chemical compound N1(C=NC=C1)C1=CC=C(OC2=C(C(=NC=N2)N2CCC(CC2)C(=O)O)[N+](=O)[O-])C=C1 QGVGORCUUNGZPS-UHFFFAOYSA-N 0.000 description 1
- RUIJAHADJHRMOM-UHFFFAOYSA-N 1-[6-(4-methylsulfonylanilino)-5-nitropyrimidin-4-yl]piperidine-4-carboxylic acid Chemical compound CS(=O)(=O)C1=CC=C(C=C1)NC1=C(C(=NC=N1)N1CCC(CC1)C(=O)O)[N+](=O)[O-] RUIJAHADJHRMOM-UHFFFAOYSA-N 0.000 description 1
- WDHMSLMIXNQFDW-UHFFFAOYSA-N 1-[6-(4-methylsulfonylphenoxy)-5-nitropyrimidin-4-yl]piperidine-4-carboxylic acid Chemical compound CS(=O)(=O)C1=CC=C(OC2=C(C(=NC=N2)N2CCC(CC2)C(=O)O)[N+](=O)[O-])C=C1 WDHMSLMIXNQFDW-UHFFFAOYSA-N 0.000 description 1
- QXSOCTIVIWLTFX-UHFFFAOYSA-N 1-[6-[4-(1,3-dioxoisoindol-2-yl)phenoxy]-5-nitropyrimidin-4-yl]piperidine-4-carboxylic acid Chemical compound O=C1N(C(C2=CC=CC=C12)=O)C1=CC=C(OC2=C(C(=NC=N2)N2CCC(CC2)C(=O)O)[N+](=O)[O-])C=C1 QXSOCTIVIWLTFX-UHFFFAOYSA-N 0.000 description 1
- 125000004972 1-butynyl group Chemical group [H]C([H])([H])C([H])([H])C#C* 0.000 description 1
- 125000004899 1-ethylpropylamino group Chemical group C(C)C(CC)N* 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- 125000000530 1-propynyl group Chemical group [H]C([H])([H])C#C* 0.000 description 1
- 125000004214 1-pyrrolidinyl group Chemical group [H]C1([H])N(*)C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
- HYZJCKYKOHLVJF-UHFFFAOYSA-N 1H-benzimidazole Chemical compound C1=CC=C2NC=NC2=C1 HYZJCKYKOHLVJF-UHFFFAOYSA-N 0.000 description 1
- CXUUBWCPFHJUPO-UHFFFAOYSA-N 1h-imidazol-5-yl-[4-[1-(4-methylsulfonylphenyl)pyrazolo[3,4-d]pyrimidin-4-yl]oxypiperidin-1-yl]methanone Chemical compound C1=CC(S(=O)(=O)C)=CC=C1N1C2=NC=NC(OC3CCN(CC3)C(=O)C=3N=CNC=3)=C2C=N1 CXUUBWCPFHJUPO-UHFFFAOYSA-N 0.000 description 1
- MAFGKICBXITNBW-UHFFFAOYSA-N 2,1-benzoxazol-3-yl-[4-[1-(4-methylsulfonylphenyl)pyrazolo[3,4-d]pyrimidin-4-yl]oxypiperidin-1-yl]methanone Chemical compound C1=CC(S(=O)(=O)C)=CC=C1N1C2=NC=NC(OC3CCN(CC3)C(=O)C3=C4C=CC=CC4=NO3)=C2C=N1 MAFGKICBXITNBW-UHFFFAOYSA-N 0.000 description 1
- 125000004206 2,2,2-trifluoroethyl group Chemical group [H]C([H])(*)C(F)(F)F 0.000 description 1
- GGMJFGFKFRAWTH-UHFFFAOYSA-N 2,2-dimethyl-1-[4-[[6-(4-methylsulfonylanilino)-5-nitropyrimidin-4-yl]amino]piperidin-1-yl]propan-1-one Chemical compound C1CN(C(=O)C(C)(C)C)CCC1NC1=NC=NC(NC=2C=CC(=CC=2)S(C)(=O)=O)=C1[N+]([O-])=O GGMJFGFKFRAWTH-UHFFFAOYSA-N 0.000 description 1
- YQTCQNIPQMJNTI-UHFFFAOYSA-N 2,2-dimethylpropan-1-one Chemical group CC(C)(C)[C]=O YQTCQNIPQMJNTI-UHFFFAOYSA-N 0.000 description 1
- 125000004215 2,4-difluorophenyl group Chemical group [H]C1=C([H])C(*)=C(F)C([H])=C1F 0.000 description 1
- NHAAVBJIDDGNEA-UHFFFAOYSA-N 2,5-difluoro-4-[1-methyl-7-[1-(3-propan-2-yl-1,2,4-oxadiazol-5-yl)piperidin-4-yl]oxypyrazolo[4,3-d]pyrimidin-3-yl]benzenesulfonamide Chemical compound CC(C)C1=NOC(N2CCC(CC2)OC=2C=3N(C)N=C(C=3N=CN=2)C=2C(=CC(=C(F)C=2)S(N)(=O)=O)F)=N1 NHAAVBJIDDGNEA-UHFFFAOYSA-N 0.000 description 1
- YSJVANDSBPXOFL-UHFFFAOYSA-N 2,5-difluoro-4-[1-methyl-7-[4-(3-propan-2-yl-1,2,4-oxadiazol-5-yl)cyclohexyl]oxypyrazolo[4,3-d]pyrimidin-3-yl]benzenesulfonamide Chemical compound CC(C)C1=NOC(C2CCC(CC2)OC=2C=3N(C)N=C(C=3N=CN=2)C=2C(=CC(=C(F)C=2)S(N)(=O)=O)F)=N1 YSJVANDSBPXOFL-UHFFFAOYSA-N 0.000 description 1
- YPMWTSZATVZYCQ-UHFFFAOYSA-N 2,5-difluoro-4-[2-methyl-7-[1-(3-propan-2-yl-1,2,4-oxadiazol-5-yl)piperidin-4-yl]oxypyrazolo[1,5-a]pyrimidin-3-yl]benzenesulfonamide Chemical compound CC(C)C1=NOC(N2CCC(CC2)OC=2N3N=C(C)C(=C3N=CC=2)C=2C(=CC(=C(F)C=2)S(N)(=O)=O)F)=N1 YPMWTSZATVZYCQ-UHFFFAOYSA-N 0.000 description 1
- FSDYPEQGJNHMLF-UHFFFAOYSA-N 2,5-difluoro-4-[2-methyl-7-[1-(3-propan-2-yl-1,2,4-oxadiazol-5-yl)piperidin-4-yl]oxypyrazolo[4,3-d]pyrimidin-3-yl]benzenesulfonamide Chemical compound CC(C)C1=NOC(N2CCC(CC2)OC=2C3=NN(C)C(C=4C(=CC(=C(F)C=4)S(N)(=O)=O)F)=C3N=CN=2)=N1 FSDYPEQGJNHMLF-UHFFFAOYSA-N 0.000 description 1
- YEKWQPNEOVYHHS-UHFFFAOYSA-N 2,5-difluoro-4-[2-methyl-7-[4-(3-propan-2-yl-1,2,4-oxadiazol-5-yl)cyclohexyl]oxypyrazolo[1,5-a]pyrimidin-3-yl]benzenesulfonamide Chemical compound CC(C)C1=NOC(C2CCC(CC2)OC=2N3N=C(C)C(=C3N=CC=2)C=2C(=CC(=C(F)C=2)S(N)(=O)=O)F)=N1 YEKWQPNEOVYHHS-UHFFFAOYSA-N 0.000 description 1
- BOGPMRPBODXGSQ-UHFFFAOYSA-N 2,5-difluoro-4-[4-[1-(3-propan-2-yl-1,2,4-oxadiazol-5-yl)piperidin-4-yl]oxypyrazolo[3,4-d]pyrimidin-1-yl]benzenesulfonamide Chemical compound CC(C)C1=NOC(N2CCC(CC2)OC=2C=3C=NN(C=3N=CN=2)C=2C(=CC(=C(F)C=2)S(N)(=O)=O)F)=N1 BOGPMRPBODXGSQ-UHFFFAOYSA-N 0.000 description 1
- IDMDZOOEKKNENS-UHFFFAOYSA-N 2,5-difluoro-4-[4-[1-(3-propan-2-yl-1,2,4-oxadiazol-5-yl)piperidin-4-yl]oxypyrido[3,4-d]pyrimidin-8-yl]benzenesulfonamide Chemical compound CC(C)C1=NOC(N2CCC(CC2)OC=2C3=CC=NC(=C3N=CN=2)C=2C(=CC(=C(F)C=2)S(N)(=O)=O)F)=N1 IDMDZOOEKKNENS-UHFFFAOYSA-N 0.000 description 1
- GQIIQCOIRRMVRP-UHFFFAOYSA-N 2,5-difluoro-4-[4-[1-(3-propan-2-yl-1,2,4-oxadiazol-5-yl)piperidin-4-yl]oxyquinolin-8-yl]benzenesulfonamide Chemical compound CC(C)C1=NOC(N2CCC(CC2)OC=2C3=CC=CC(=C3N=CC=2)C=2C(=CC(=C(F)C=2)S(N)(=O)=O)F)=N1 GQIIQCOIRRMVRP-UHFFFAOYSA-N 0.000 description 1
- QIXUOFALQMHONA-UHFFFAOYSA-N 2,5-difluoro-4-[4-[4-(3-propan-2-yl-1,2,4-oxadiazol-5-yl)cyclohexyl]oxypyrazolo[3,4-d]pyrimidin-1-yl]benzenesulfonamide Chemical compound CC(C)C1=NOC(C2CCC(CC2)OC=2C=3C=NN(C=3N=CN=2)C=2C(=CC(=C(F)C=2)S(N)(=O)=O)F)=N1 QIXUOFALQMHONA-UHFFFAOYSA-N 0.000 description 1
- AFZGQMVQFLBARO-UHFFFAOYSA-N 2,5-difluoro-4-[4-[4-(3-propan-2-yl-1,2,4-oxadiazol-5-yl)cyclohexyl]oxypyrido[3,4-d]pyrimidin-8-yl]benzenesulfonamide Chemical compound CC(C)C1=NOC(C2CCC(CC2)OC=2C3=CC=NC(=C3N=CN=2)C=2C(=CC(=C(F)C=2)S(N)(=O)=O)F)=N1 AFZGQMVQFLBARO-UHFFFAOYSA-N 0.000 description 1
- UDPMPQPUOOOELJ-UHFFFAOYSA-N 2,5-difluoro-4-[4-[4-(3-propan-2-yl-1,2,4-oxadiazol-5-yl)cyclohexyl]oxyquinolin-8-yl]benzenesulfonamide Chemical compound CC(C)C1=NOC(C2CCC(CC2)OC=2C3=CC=CC(=C3N=CC=2)C=2C(=CC(=C(F)C=2)S(N)(=O)=O)F)=N1 UDPMPQPUOOOELJ-UHFFFAOYSA-N 0.000 description 1
- GIPXDAQGZACHNS-UHFFFAOYSA-N 2,5-difluoro-4-[6-[1-(3-propan-2-yl-1,2,4-oxadiazol-5-yl)piperidin-4-yl]oxypurin-9-yl]benzenesulfonamide Chemical compound CC(C)C1=NOC(N2CCC(CC2)OC=2C=3N=CN(C=3N=CN=2)C=2C(=CC(=C(F)C=2)S(N)(=O)=O)F)=N1 GIPXDAQGZACHNS-UHFFFAOYSA-N 0.000 description 1
- GDZRJBJBPTZZNW-UHFFFAOYSA-N 2,5-difluoro-4-[6-[4-(3-propan-2-yl-1,2,4-oxadiazol-5-yl)cyclohexyl]oxypurin-9-yl]benzenesulfonamide Chemical compound CC(C)C1=NOC(C2CCC(CC2)OC=2C=3N=CN(C=3N=CN=2)C=2C(=CC(=C(F)C=2)S(N)(=O)=O)F)=N1 GDZRJBJBPTZZNW-UHFFFAOYSA-N 0.000 description 1
- ACUIRYUOXDAVMG-UHFFFAOYSA-N 2,5-difluoro-4-[7-[1-(3-propan-2-yl-1,2,4-oxadiazol-5-yl)piperidin-4-yl]oxypyrazolo[1,5-a]pyrimidin-3-yl]benzenesulfonamide Chemical compound CC(C)C1=NOC(N2CCC(CC2)OC=2N3N=CC(=C3N=CC=2)C=2C(=CC(=C(F)C=2)S(N)(=O)=O)F)=N1 ACUIRYUOXDAVMG-UHFFFAOYSA-N 0.000 description 1
- RZRRCHZMGZYMQJ-UHFFFAOYSA-N 2,5-difluoro-4-[7-[1-(3-propan-2-yl-1,2,4-oxadiazol-5-yl)piperidin-4-yl]oxytriazolo[4,5-d]pyrimidin-3-yl]benzenesulfonamide Chemical compound CC(C)C1=NOC(N2CCC(CC2)OC=2C=3N=NN(C=3N=CN=2)C=2C(=CC(=C(F)C=2)S(N)(=O)=O)F)=N1 RZRRCHZMGZYMQJ-UHFFFAOYSA-N 0.000 description 1
- ZDYHKRTZRBGLAA-UHFFFAOYSA-N 2,5-difluoro-4-[7-[4-(3-propan-2-yl-1,2,4-oxadiazol-5-yl)cyclohexyl]oxypyrazolo[1,5-a]pyrimidin-3-yl]benzenesulfonamide Chemical compound CC(C)C1=NOC(C2CCC(CC2)OC=2N3N=CC(=C3N=CC=2)C=2C(=CC(=C(F)C=2)S(N)(=O)=O)F)=N1 ZDYHKRTZRBGLAA-UHFFFAOYSA-N 0.000 description 1
- GKMANLIGGADFCS-UHFFFAOYSA-N 2,5-difluoro-4-[7-[4-(3-propan-2-yl-1,2,4-oxadiazol-5-yl)cyclohexyl]oxytriazolo[4,5-d]pyrimidin-3-yl]benzenesulfonamide Chemical compound CC(C)C1=NOC(C2CCC(CC2)OC=2C=3N=NN(C=3N=CN=2)C=2C(=CC(=C(F)C=2)S(N)(=O)=O)F)=N1 GKMANLIGGADFCS-UHFFFAOYSA-N 0.000 description 1
- VOLFOEVWRSBNNA-UHFFFAOYSA-N 2,5-difluoro-4-[[6-[4-(4-propan-2-yloxyphenyl)piperazin-1-yl]pyrimidin-4-yl]amino]benzonitrile Chemical compound C1=CC(OC(C)C)=CC=C1N1CCN(C=2N=CN=C(NC=3C(=CC(=C(F)C=3)C#N)F)C=2)CC1 VOLFOEVWRSBNNA-UHFFFAOYSA-N 0.000 description 1
- GVNVAWHJIKLAGL-UHFFFAOYSA-N 2-(cyclohexen-1-yl)cyclohexan-1-one Chemical compound O=C1CCCCC1C1=CCCCC1 GVNVAWHJIKLAGL-UHFFFAOYSA-N 0.000 description 1
- BZQSVOJMQLADPO-UHFFFAOYSA-N 2-[1-[2-nitro-5-[4-(1,2,4-triazol-1-yl)phenoxy]phenyl]piperidin-4-yl]sulfanylpyridine Chemical compound C1=C(N2CCC(CC2)SC=2N=CC=CC=2)C([N+](=O)[O-])=CC=C1OC(C=C1)=CC=C1N1C=NC=N1 BZQSVOJMQLADPO-UHFFFAOYSA-N 0.000 description 1
- BNHXXPBMPCCDAX-UHFFFAOYSA-N 2-[1-[5-(4-methylsulfonylphenoxy)-2-nitrophenyl]piperidin-4-yl]sulfanylpyridine Chemical compound C1=CC(S(=O)(=O)C)=CC=C1OC1=CC=C([N+]([O-])=O)C(N2CCC(CC2)SC=2N=CC=CC=2)=C1 BNHXXPBMPCCDAX-UHFFFAOYSA-N 0.000 description 1
- AWLVXAXACWYBRU-UHFFFAOYSA-N 2-[1-[6-(2-fluoro-4-methylsulfonylanilino)pyrimidin-4-yl]piperidin-4-yl]acetic acid Chemical compound FC1=C(C=CC(=C1)S(=O)(=O)C)NC1=CC(=NC=N1)N1CCC(CC1)CC(=O)O AWLVXAXACWYBRU-UHFFFAOYSA-N 0.000 description 1
- BGIRKZUIZDFWPJ-UHFFFAOYSA-N 2-[4-[1-(2-fluoro-4-methylsulfonylphenyl)pyrazolo[3,4-d]pyrimidin-4-yl]oxypiperidin-1-yl]-1-(3-fluorophenyl)ethanone Chemical compound FC1=CC(S(=O)(=O)C)=CC=C1N1C2=NC=NC(OC3CCN(CC(=O)C=4C=C(F)C=CC=4)CC3)=C2C=N1 BGIRKZUIZDFWPJ-UHFFFAOYSA-N 0.000 description 1
- JOCFTBJGHSJPQS-UHFFFAOYSA-N 2-[4-[1-(2-fluoro-4-methylsulfonylphenyl)pyrazolo[3,4-d]pyrimidin-4-yl]oxypiperidin-1-yl]-1-[4-(trifluoromethoxy)phenyl]ethanone Chemical compound FC1=CC(S(=O)(=O)C)=CC=C1N1C2=NC=NC(OC3CCN(CC(=O)C=4C=CC(OC(F)(F)F)=CC=4)CC3)=C2C=N1 JOCFTBJGHSJPQS-UHFFFAOYSA-N 0.000 description 1
- MJCNSMVFHGUKLU-UHFFFAOYSA-N 2-[4-[1-(2-fluoro-4-methylsulfonylphenyl)pyrazolo[3,4-d]pyrimidin-4-yl]oxypiperidin-1-yl]-n,n,5-trimethylpyrimidin-4-amine Chemical compound C1=C(C)C(N(C)C)=NC(N2CCC(CC2)OC=2C=3C=NN(C=3N=CN=2)C=2C(=CC(=CC=2)S(C)(=O)=O)F)=N1 MJCNSMVFHGUKLU-UHFFFAOYSA-N 0.000 description 1
- ZNTBLLQZZRBELK-UHFFFAOYSA-N 2-[4-[1-(4-methylsulfonylphenyl)pyrazolo[3,4-d]pyrimidin-4-yl]oxypiperidin-1-yl]-1-[3-(trifluoromethyl)phenyl]ethanone Chemical compound C1=CC(S(=O)(=O)C)=CC=C1N1C2=NC=NC(OC3CCN(CC(=O)C=4C=C(C=CC=4)C(F)(F)F)CC3)=C2C=N1 ZNTBLLQZZRBELK-UHFFFAOYSA-N 0.000 description 1
- ARWMDFKDAYBWHF-UHFFFAOYSA-N 2-[4-[1-(4-methylsulfonylphenyl)pyrazolo[3,4-d]pyrimidin-4-yl]oxypiperidin-1-yl]-1-pyridin-2-ylethanone Chemical compound C1=CC(S(=O)(=O)C)=CC=C1N1C2=NC=NC(OC3CCN(CC(=O)C=4N=CC=CC=4)CC3)=C2C=N1 ARWMDFKDAYBWHF-UHFFFAOYSA-N 0.000 description 1
- HHFFJHKVUBCIRA-UHFFFAOYSA-N 2-[4-[1-(4-methylsulfonylphenyl)pyrazolo[3,4-d]pyrimidin-4-yl]oxypiperidin-1-yl]-1-pyridin-3-ylethanone Chemical compound C1=CC(S(=O)(=O)C)=CC=C1N1C2=NC=NC(OC3CCN(CC(=O)C=4C=NC=CC=4)CC3)=C2C=N1 HHFFJHKVUBCIRA-UHFFFAOYSA-N 0.000 description 1
- OWDYUWDPUZTHEZ-UHFFFAOYSA-N 2-[4-[1-(4-methylsulfonylphenyl)pyrazolo[3,4-d]pyrimidin-4-yl]oxypiperidin-1-yl]-1-thiophen-2-ylethanone Chemical compound C1=CC(S(=O)(=O)C)=CC=C1N1C2=NC=NC(OC3CCN(CC(=O)C=4SC=CC=4)CC3)=C2C=N1 OWDYUWDPUZTHEZ-UHFFFAOYSA-N 0.000 description 1
- IRBWYYBWSXZRDP-UHFFFAOYSA-N 2-[4-[1-(4-methylsulfonylphenyl)pyrazolo[3,4-d]pyrimidin-4-yl]oxypiperidine-1-carbonyl]pyran-4-one Chemical compound C1=CC(S(=O)(=O)C)=CC=C1N1C2=NC=NC(OC3CCN(CC3)C(=O)C=3OC=CC(=O)C=3)=C2C=N1 IRBWYYBWSXZRDP-UHFFFAOYSA-N 0.000 description 1
- HRYZKEMKQDTASY-UHFFFAOYSA-N 2-[4-[6-(2-fluoro-4-methylsulfonylanilino)pyrimidin-4-yl]piperazin-1-yl]acetic acid Chemical compound FC1=C(C=CC(=C1)S(=O)(=O)C)NC1=CC(=NC=N1)N1CCN(CC1)CC(=O)O HRYZKEMKQDTASY-UHFFFAOYSA-N 0.000 description 1
- AODBBNYSKQZUCS-UHFFFAOYSA-N 2-[4-[6-(2-fluoro-4-methylsulfonylphenoxy)-5-methylpyrimidin-4-yl]oxypiperidin-1-yl]-1-(2-methyl-4-phenylfuran-3-yl)ethanone Chemical compound CC=1OC=C(C=2C=CC=CC=2)C=1C(=O)CN(CC1)CCC1OC(C=1C)=NC=NC=1OC1=CC=C(S(C)(=O)=O)C=C1F AODBBNYSKQZUCS-UHFFFAOYSA-N 0.000 description 1
- KMRWDTYHXJTJMK-UHFFFAOYSA-N 2-[4-[6-(2-fluoro-4-methylsulfonylphenoxy)-5-methylpyrimidin-4-yl]oxypiperidin-1-yl]-1-(3-fluorophenyl)ethanone Chemical compound N1=CN=C(OC=2C(=CC(=CC=2)S(C)(=O)=O)F)C(C)=C1OC(CC1)CCN1CC(=O)C1=CC=CC(F)=C1 KMRWDTYHXJTJMK-UHFFFAOYSA-N 0.000 description 1
- XBUBBGIMTPSSQO-UHFFFAOYSA-N 2-[4-[6-(2-fluoro-4-methylsulfonylphenoxy)-5-methylpyrimidin-4-yl]oxypiperidin-1-yl]-1-(4-fluorophenyl)ethanone Chemical compound N1=CN=C(OC=2C(=CC(=CC=2)S(C)(=O)=O)F)C(C)=C1OC(CC1)CCN1CC(=O)C1=CC=C(F)C=C1 XBUBBGIMTPSSQO-UHFFFAOYSA-N 0.000 description 1
- PIOXBAXAQIPSJC-UHFFFAOYSA-N 2-[4-[6-(2-fluoro-4-methylsulfonylphenoxy)-5-methylpyrimidin-4-yl]oxypiperidin-1-yl]-1-(4-methoxyphenyl)ethanone Chemical compound C1=CC(OC)=CC=C1C(=O)CN1CCC(OC=2C(=C(OC=3C(=CC(=CC=3)S(C)(=O)=O)F)N=CN=2)C)CC1 PIOXBAXAQIPSJC-UHFFFAOYSA-N 0.000 description 1
- HYARXWARKOIYRN-UHFFFAOYSA-N 2-[4-[6-(2-fluoro-4-methylsulfonylphenoxy)-5-methylpyrimidin-4-yl]oxypiperidin-1-yl]-1-(4-methylphenyl)ethanone Chemical compound C1=CC(C)=CC=C1C(=O)CN1CCC(OC=2C(=C(OC=3C(=CC(=CC=3)S(C)(=O)=O)F)N=CN=2)C)CC1 HYARXWARKOIYRN-UHFFFAOYSA-N 0.000 description 1
- MJQKSBDLAPJBIJ-UHFFFAOYSA-N 2-[4-[6-(2-fluoro-4-methylsulfonylphenoxy)-5-methylpyrimidin-4-yl]oxypiperidin-1-yl]-1-(4-methylsulfonylphenyl)ethanone Chemical compound N1=CN=C(OC=2C(=CC(=CC=2)S(C)(=O)=O)F)C(C)=C1OC(CC1)CCN1CC(=O)C1=CC=C(S(C)(=O)=O)C=C1 MJQKSBDLAPJBIJ-UHFFFAOYSA-N 0.000 description 1
- UDOJPPPKOOURIB-UHFFFAOYSA-N 2-[4-[6-(2-fluoro-4-methylsulfonylphenoxy)-5-methylpyrimidin-4-yl]oxypiperidin-1-yl]-1-(5-phenylthiophen-2-yl)ethanone Chemical compound N1=CN=C(OC=2C(=CC(=CC=2)S(C)(=O)=O)F)C(C)=C1OC(CC1)CCN1CC(=O)C(S1)=CC=C1C1=CC=CC=C1 UDOJPPPKOOURIB-UHFFFAOYSA-N 0.000 description 1
- KSKUVUKLKZSZLR-UHFFFAOYSA-N 2-[4-[6-(2-fluoro-4-methylsulfonylphenoxy)-5-methylpyrimidin-4-yl]oxypiperidin-1-yl]-1-(5-pyridin-2-ylthiophen-2-yl)ethanone Chemical compound N1=CN=C(OC=2C(=CC(=CC=2)S(C)(=O)=O)F)C(C)=C1OC(CC1)CCN1CC(=O)C(S1)=CC=C1C1=CC=CC=N1 KSKUVUKLKZSZLR-UHFFFAOYSA-N 0.000 description 1
- NSHHEMAHAAEYJH-UHFFFAOYSA-N 2-[4-[6-(2-fluoro-4-methylsulfonylphenoxy)-5-methylpyrimidin-4-yl]oxypiperidin-1-yl]-1-[3-(trifluoromethyl)phenyl]ethanone Chemical compound N1=CN=C(OC=2C(=CC(=CC=2)S(C)(=O)=O)F)C(C)=C1OC(CC1)CCN1CC(=O)C1=CC=CC(C(F)(F)F)=C1 NSHHEMAHAAEYJH-UHFFFAOYSA-N 0.000 description 1
- VGKJEXKKZYGQGF-UHFFFAOYSA-N 2-[4-[6-(2-fluoro-4-methylsulfonylphenoxy)-5-methylpyrimidin-4-yl]oxypiperidin-1-yl]-1-[4-(trifluoromethoxy)phenyl]ethanone Chemical compound N1=CN=C(OC=2C(=CC(=CC=2)S(C)(=O)=O)F)C(C)=C1OC(CC1)CCN1CC(=O)C1=CC=C(OC(F)(F)F)C=C1 VGKJEXKKZYGQGF-UHFFFAOYSA-N 0.000 description 1
- GCSBEPIRNMWBPR-UHFFFAOYSA-N 2-[4-[6-(2-fluoro-4-methylsulfonylphenoxy)-5-methylpyrimidin-4-yl]oxypiperidin-1-yl]-1-[4-(trifluoromethyl)phenyl]ethanone Chemical compound N1=CN=C(OC=2C(=CC(=CC=2)S(C)(=O)=O)F)C(C)=C1OC(CC1)CCN1CC(=O)C1=CC=C(C(F)(F)F)C=C1 GCSBEPIRNMWBPR-UHFFFAOYSA-N 0.000 description 1
- JTMYPOICVRARKK-UHFFFAOYSA-N 2-[4-[6-(2-fluoro-4-methylsulfonylphenoxy)-5-methylpyrimidin-4-yl]oxypiperidin-1-yl]-1-morpholin-4-ylethanone Chemical compound N1=CN=C(OC=2C(=CC(=CC=2)S(C)(=O)=O)F)C(C)=C1OC(CC1)CCN1CC(=O)N1CCOCC1 JTMYPOICVRARKK-UHFFFAOYSA-N 0.000 description 1
- ILUJEJKVTTZYGJ-UHFFFAOYSA-N 2-[4-[6-(2-fluoro-4-methylsulfonylphenoxy)-5-methylpyrimidin-4-yl]oxypiperidin-1-yl]-1-phenylethanone Chemical compound N1=CN=C(OC=2C(=CC(=CC=2)S(C)(=O)=O)F)C(C)=C1OC(CC1)CCN1CC(=O)C1=CC=CC=C1 ILUJEJKVTTZYGJ-UHFFFAOYSA-N 0.000 description 1
- HUBNTPOXFSZGTG-UHFFFAOYSA-N 2-[4-[6-(2-fluoro-4-methylsulfonylphenoxy)-5-methylpyrimidin-4-yl]oxypiperidin-1-yl]-1-pyridin-3-ylethanone Chemical compound N1=CN=C(OC=2C(=CC(=CC=2)S(C)(=O)=O)F)C(C)=C1OC(CC1)CCN1CC(=O)C1=CC=CN=C1 HUBNTPOXFSZGTG-UHFFFAOYSA-N 0.000 description 1
- VQAKENAYCYDJEL-UHFFFAOYSA-N 2-[4-[6-(2-fluoro-4-methylsulfonylphenoxy)-5-methylpyrimidin-4-yl]oxypiperidin-1-yl]-1-pyridin-4-ylethanone Chemical compound N1=CN=C(OC=2C(=CC(=CC=2)S(C)(=O)=O)F)C(C)=C1OC(CC1)CCN1CC(=O)C1=CC=NC=C1 VQAKENAYCYDJEL-UHFFFAOYSA-N 0.000 description 1
- DQDOQWDMORTGOE-UHFFFAOYSA-N 2-[4-[6-(2-fluoro-4-methylsulfonylphenoxy)-5-methylpyrimidin-4-yl]oxypiperidin-1-yl]-1-thiophen-2-ylethanone Chemical compound N1=CN=C(OC=2C(=CC(=CC=2)S(C)(=O)=O)F)C(C)=C1OC(CC1)CCN1CC(=O)C1=CC=CS1 DQDOQWDMORTGOE-UHFFFAOYSA-N 0.000 description 1
- FHMHSBNXXPGLBG-UHFFFAOYSA-N 2-[4-[6-(2-fluoro-4-methylsulfonylphenoxy)-5-methylpyrimidin-4-yl]oxypiperidin-1-yl]-1-thiophen-3-ylethanone Chemical compound N1=CN=C(OC=2C(=CC(=CC=2)S(C)(=O)=O)F)C(C)=C1OC(CC1)CCN1CC(=O)C=1C=CSC=1 FHMHSBNXXPGLBG-UHFFFAOYSA-N 0.000 description 1
- XZXFZWYWQSKEFG-UHFFFAOYSA-N 2-[4-[6-(2-fluoro-4-methylsulfonylphenoxy)-5-methylpyrimidin-4-yl]oxypiperidin-1-yl]-n-(4-methoxyphenyl)acetamide Chemical compound C1=CC(OC)=CC=C1NC(=O)CN1CCC(OC=2C(=C(OC=3C(=CC(=CC=3)S(C)(=O)=O)F)N=CN=2)C)CC1 XZXFZWYWQSKEFG-UHFFFAOYSA-N 0.000 description 1
- VTXXGGZSMRSJOR-UHFFFAOYSA-N 2-[4-[6-(2-fluoro-4-methylsulfonylphenoxy)-5-methylpyrimidin-4-yl]oxypiperidin-1-yl]-n-(4-propan-2-ylphenyl)acetamide Chemical compound C1=CC(C(C)C)=CC=C1NC(=O)CN1CCC(OC=2C(=C(OC=3C(=CC(=CC=3)S(C)(=O)=O)F)N=CN=2)C)CC1 VTXXGGZSMRSJOR-UHFFFAOYSA-N 0.000 description 1
- KIPAKJCXFDIVGX-UHFFFAOYSA-N 2-[4-[6-(2-fluoro-4-methylsulfonylphenoxy)-5-methylpyrimidin-4-yl]oxypiperidin-1-yl]-n-[3-(trifluoromethyl)phenyl]acetamide Chemical compound N1=CN=C(OC=2C(=CC(=CC=2)S(C)(=O)=O)F)C(C)=C1OC(CC1)CCN1CC(=O)NC1=CC=CC(C(F)(F)F)=C1 KIPAKJCXFDIVGX-UHFFFAOYSA-N 0.000 description 1
- PIFHIJHFTFGODF-UHFFFAOYSA-N 2-[4-[6-(2-fluoro-4-methylsulfonylphenoxy)-5-methylpyrimidin-4-yl]oxypiperidin-1-yl]-n-[4-(trifluoromethyl)phenyl]acetamide Chemical compound N1=CN=C(OC=2C(=CC(=CC=2)S(C)(=O)=O)F)C(C)=C1OC(CC1)CCN1CC(=O)NC1=CC=C(C(F)(F)F)C=C1 PIFHIJHFTFGODF-UHFFFAOYSA-N 0.000 description 1
- SATVVULHAHBBOR-UHFFFAOYSA-N 2-[4-[6-(2-fluoro-4-methylsulfonylphenoxy)-5-methylpyrimidin-4-yl]oxypiperidin-1-yl]-n-phenylacetamide Chemical compound N1=CN=C(OC=2C(=CC(=CC=2)S(C)(=O)=O)F)C(C)=C1OC(CC1)CCN1CC(=O)NC1=CC=CC=C1 SATVVULHAHBBOR-UHFFFAOYSA-N 0.000 description 1
- OWOHOOATILOEMZ-UHFFFAOYSA-N 2-[4-[6-(4-methylsulfonylanilino)-5-nitropyrimidin-4-yl]piperazin-1-yl]acetic acid Chemical compound CS(=O)(=O)C1=CC=C(C=C1)NC1=C(C(=NC=N1)N1CCN(CC1)CC(=O)O)[N+](=O)[O-] OWOHOOATILOEMZ-UHFFFAOYSA-N 0.000 description 1
- YVCMBGPPTCBEDP-UHFFFAOYSA-N 2-[4-nitro-3-(4-propylpiperidin-1-yl)phenoxy]-5-(trifluoromethyl)pyridine Chemical compound C1CC(CCC)CCN1C1=CC(OC=2N=CC(=CC=2)C(F)(F)F)=CC=C1[N+]([O-])=O YVCMBGPPTCBEDP-UHFFFAOYSA-N 0.000 description 1
- IHBAVXVTGLANPI-QMMMGPOBSA-N 2-amino-3-methyl-1-pyrrolidin-1-yl-butan-1-one Chemical group CC(C)[C@H](N)C(=O)N1CCCC1 IHBAVXVTGLANPI-QMMMGPOBSA-N 0.000 description 1
- 125000004974 2-butenyl group Chemical group C(C=CC)* 0.000 description 1
- 125000000069 2-butynyl group Chemical group [H]C([H])([H])C#CC([H])([H])* 0.000 description 1
- OJQUDOGHLNVJIY-UHFFFAOYSA-N 2-cyclopentyl-1-[4-(3-pyridin-4-yl-1,2,4-oxadiazol-5-yl)piperidin-1-yl]ethanone Chemical compound C1CC(C=2ON=C(N=2)C=2C=CN=CC=2)CCN1C(=O)CC1CCCC1 OJQUDOGHLNVJIY-UHFFFAOYSA-N 0.000 description 1
- DVZOQPICOLLIIU-UHFFFAOYSA-N 2-cyclopropylethyl 4-[1-(2-fluoro-4-methylsulfonylphenyl)pyrazolo[3,4-d]pyrimidin-4-yl]sulfanylpiperidine-1-carboxylate Chemical compound FC1=CC(S(=O)(=O)C)=CC=C1N1C2=NC=NC(SC3CCN(CC3)C(=O)OCCC3CC3)=C2C=N1 DVZOQPICOLLIIU-UHFFFAOYSA-N 0.000 description 1
- 125000003635 2-dimethylaminoethoxy group Chemical group [H]C([H])([H])N(C([H])([H])[H])C([H])([H])C([H])([H])O* 0.000 description 1
- CTRHWJHUOVIWML-UHFFFAOYSA-N 2-ethoxy-1-[4-[6-(2-fluoro-4-methylsulfonylphenoxy)-5-methylpyrimidin-4-yl]oxypiperidin-1-yl]ethanone Chemical compound C1CN(C(=O)COCC)CCC1OC1=NC=NC(OC=2C(=CC(=CC=2)S(C)(=O)=O)F)=C1C CTRHWJHUOVIWML-UHFFFAOYSA-N 0.000 description 1
- MBIROTPNYCKNLG-UHFFFAOYSA-N 2-ethylbutyl 4-[1-(4-methylsulfonylphenyl)pyrazolo[3,4-d]pyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OCC(CC)CC)CCC1OC1=NC=NC2=C1C=NN2C1=CC=C(S(C)(=O)=O)C=C1 MBIROTPNYCKNLG-UHFFFAOYSA-N 0.000 description 1
- VBJYSFVJPYTZMR-UHFFFAOYSA-N 2-ethylhexyl piperidine-1-carboxylate Chemical compound C(C)C(COC(=O)N1CCCCC1)CCCC VBJYSFVJPYTZMR-UHFFFAOYSA-N 0.000 description 1
- 125000006040 2-hexenyl group Chemical group 0.000 description 1
- VZTIKEHOIYTQOD-UHFFFAOYSA-N 2-methoxyethyl 4-[1-(2-fluoro-4-methylsulfonylphenyl)pyrazolo[3,4-d]pyrimidin-4-yl]sulfanylpiperidine-1-carboxylate Chemical compound C1CN(C(=O)OCCOC)CCC1SC1=NC=NC2=C1C=NN2C1=CC=C(S(C)(=O)=O)C=C1F VZTIKEHOIYTQOD-UHFFFAOYSA-N 0.000 description 1
- 125000004200 2-methoxyethyl group Chemical group [H]C([H])([H])OC([H])([H])C([H])([H])* 0.000 description 1
- MFCHYWIMSNKJMB-UHFFFAOYSA-N 2-methyl-5-[4-[4-nitro-3-(4-propylpiperidin-1-yl)phenoxy]phenyl]-1,3,4-oxadiazole Chemical compound C1CC(CCC)CCN1C1=CC(OC=2C=CC(=CC=2)C=2OC(C)=NN=2)=CC=C1[N+]([O-])=O MFCHYWIMSNKJMB-UHFFFAOYSA-N 0.000 description 1
- 125000004493 2-methylbut-1-yl group Chemical group CC(C*)CC 0.000 description 1
- IVBBHPTZEFPTFZ-UHFFFAOYSA-N 2-methylpropyl 4-(3-pyridin-4-yl-1,2,4-oxadiazol-5-yl)piperidine-1-carboxylate Chemical compound C1CN(C(=O)OCC(C)C)CCC1C1=NC(C=2C=CN=CC=2)=NO1 IVBBHPTZEFPTFZ-UHFFFAOYSA-N 0.000 description 1
- HTOQALXUSKONGW-UHFFFAOYSA-N 2-methylpropyl cyclohexanecarboxylate Chemical compound CC(C)COC(=O)C1CCCCC1 HTOQALXUSKONGW-UHFFFAOYSA-N 0.000 description 1
- NGXGHWAPEVIOJK-UHFFFAOYSA-N 2-methylpropyl piperidine-1-carboxylate Chemical compound CC(C)COC(=O)N1CCCCC1 NGXGHWAPEVIOJK-UHFFFAOYSA-N 0.000 description 1
- PWXJKFXCCYJKKM-UHFFFAOYSA-N 2-morpholin-4-ylethyl 4-[1-(4-methylsulfonylphenyl)pyrazolo[3,4-d]pyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1=CC(S(=O)(=O)C)=CC=C1N1C2=NC=NC(OC3CCN(CC3)C(=O)OCCN3CCOCC3)=C2C=N1 PWXJKFXCCYJKKM-UHFFFAOYSA-N 0.000 description 1
- 125000006024 2-pentenyl group Chemical group 0.000 description 1
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 1
- 125000001494 2-propynyl group Chemical group [H]C#CC([H])([H])* 0.000 description 1
- NODHOSUVZOYAPG-UHFFFAOYSA-N 2-pyrrolidin-1-ylethyl 4-[1-(4-methylsulfonylphenyl)pyrazolo[3,4-d]pyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1=CC(S(=O)(=O)C)=CC=C1N1C2=NC=NC(OC3CCN(CC3)C(=O)OCCN3CCCC3)=C2C=N1 NODHOSUVZOYAPG-UHFFFAOYSA-N 0.000 description 1
- GIIGHSIIKVOWKZ-UHFFFAOYSA-N 2h-triazolo[4,5-d]pyrimidine Chemical compound N1=CN=CC2=NNN=C21 GIIGHSIIKVOWKZ-UHFFFAOYSA-N 0.000 description 1
- MWPYGSNIIWFGJW-UHFFFAOYSA-N 3,3-dimethyl-1-[4-(3-pyridin-4-yl-1,2,4-oxadiazol-5-yl)piperidin-1-yl]butan-1-one Chemical compound C1CN(C(=O)CC(C)(C)C)CCC1C1=NC(C=2C=CN=CC=2)=NO1 MWPYGSNIIWFGJW-UHFFFAOYSA-N 0.000 description 1
- GTJPEGQKRJAWMY-UHFFFAOYSA-N 3,3-dimethyl-1-[4-[(3-pyridin-4-yl-1,2,4-oxadiazol-5-yl)methoxy]piperidin-1-yl]butan-1-one Chemical compound C1CN(C(=O)CC(C)(C)C)CCC1OCC1=NC(C=2C=CN=CC=2)=NO1 GTJPEGQKRJAWMY-UHFFFAOYSA-N 0.000 description 1
- WFRWDJZTEDLJAW-UHFFFAOYSA-N 3,3-dimethyl-1-[4-[6-(4-methylsulfonylanilino)-5-nitropyrimidin-4-yl]oxypiperidin-1-yl]butan-1-one Chemical compound C1CN(C(=O)CC(C)(C)C)CCC1OC1=NC=NC(NC=2C=CC(=CC=2)S(C)(=O)=O)=C1[N+]([O-])=O WFRWDJZTEDLJAW-UHFFFAOYSA-N 0.000 description 1
- MDZBNPSMIWSWGH-UHFFFAOYSA-N 3,3-dimethyl-1-[4-[6-(4-methylsulfonylanilino)-5-nitropyrimidin-4-yl]oxypiperidin-1-yl]butan-2-one Chemical compound C1CN(CC(=O)C(C)(C)C)CCC1OC1=NC=NC(NC=2C=CC(=CC=2)S(C)(=O)=O)=C1[N+]([O-])=O MDZBNPSMIWSWGH-UHFFFAOYSA-N 0.000 description 1
- VLDUYWYCDNPRGP-UHFFFAOYSA-N 3,3-dimethyl-1-[4-[methyl-[1-(4-methylsulfonylphenyl)pyrrolo[3,4-d]pyrimidin-4-yl]amino]piperidin-1-yl]butan-2-one Chemical compound N1=CN(C=2C=CC(=CC=2)S(C)(=O)=O)C2=CN=CC2=C1N(C)C1CCN(CC(=O)C(C)(C)C)CC1 VLDUYWYCDNPRGP-UHFFFAOYSA-N 0.000 description 1
- 125000004189 3,4-dichlorophenyl group Chemical group [H]C1=C([H])C(Cl)=C(Cl)C([H])=C1* 0.000 description 1
- HYJRMMRMBZXKQZ-UHFFFAOYSA-N 3-[(2-methylpropan-2-yl)oxy]-n-[4-[[1-(4-methylsulfonylphenyl)pyrazolo[3,4-d]pyrimidin-4-yl]amino]cyclohexyl]propanamide Chemical compound C1CC(NC(=O)CCOC(C)(C)C)CCC1NC1=NC=NC2=C1C=NN2C1=CC=C(S(C)(=O)=O)C=C1 HYJRMMRMBZXKQZ-UHFFFAOYSA-N 0.000 description 1
- OKDNXWNGWXHGEC-UHFFFAOYSA-N 3-[1-(4-methylsulfonylphenyl)pyrazolo[3,4-d]pyrimidin-4-yl]oxyazetidine-1-carboxylic acid Chemical compound C1=CC(S(=O)(=O)C)=CC=C1N1C2=NC=NC(OC3CN(C3)C(O)=O)=C2C=N1 OKDNXWNGWXHGEC-UHFFFAOYSA-N 0.000 description 1
- KXSYUPYYQLCSAQ-UHFFFAOYSA-N 3-[2-[4-[6-(2-fluoro-4-methylsulfonylphenoxy)-5-methylpyrimidin-4-yl]oxypiperidin-1-yl]acetyl]benzonitrile Chemical compound N1=CN=C(OC=2C(=CC(=CC=2)S(C)(=O)=O)F)C(C)=C1OC(CC1)CCN1CC(=O)C1=CC=CC(C#N)=C1 KXSYUPYYQLCSAQ-UHFFFAOYSA-N 0.000 description 1
- QSVZPIWHTNURDS-UHFFFAOYSA-N 3-[4-[1-(4-methylsulfonylphenyl)pyrazolo[3,4-d]pyrimidin-4-yl]oxypiperidine-1-carbonyl]-1h-pyridin-2-one Chemical compound C1=CC(S(=O)(=O)C)=CC=C1N1C2=NC=NC(OC3CCN(CC3)C(=O)C=3C(=NC=CC=3)O)=C2C=N1 QSVZPIWHTNURDS-UHFFFAOYSA-N 0.000 description 1
- LWNRMDVXXLXCFI-UHFFFAOYSA-N 3-[4-[6-(2-fluoro-4-methylsulfonylphenoxy)-5-methylpyrimidin-4-yl]oxypiperidin-1-yl]-3-oxopropane-1-sulfonic acid Chemical compound N1=CN=C(OC=2C(=CC(=CC=2)S(C)(=O)=O)F)C(C)=C1OC1CCN(C(=O)CCS(O)(=O)=O)CC1 LWNRMDVXXLXCFI-UHFFFAOYSA-N 0.000 description 1
- AAKKTAQDSDLOAV-UHFFFAOYSA-N 3-[6-(4-methylsulfonylanilino)-5-nitropyrimidin-4-yl]oxypyrrolidine-1-carboxylic acid Chemical compound CS(=O)(=O)C1=CC=C(C=C1)NC1=C(C(=NC=N1)OC1CN(CC1)C(=O)O)[N+](=O)[O-] AAKKTAQDSDLOAV-UHFFFAOYSA-N 0.000 description 1
- GRFMTZXXLRLOSB-UHFFFAOYSA-N 3-[[1-(2-fluoro-4-methylsulfonylphenyl)pyrazolo[3,4-d]pyrimidin-4-yl]amino]piperidine-1-carboxylic acid Chemical compound FC1=CC(S(=O)(=O)C)=CC=C1N1C2=NC=NC(NC3CN(CCC3)C(O)=O)=C2C=N1 GRFMTZXXLRLOSB-UHFFFAOYSA-N 0.000 description 1
- AKVNFEBTNRDWRQ-UHFFFAOYSA-N 3-[[1-(4-methylsulfonylphenyl)pyrazolo[3,4-d]pyrimidin-4-yl]amino]piperidine-1-carboxylic acid Chemical compound C1=CC(S(=O)(=O)C)=CC=C1N1C2=NC=NC(NC3CN(CCC3)C(O)=O)=C2C=N1 AKVNFEBTNRDWRQ-UHFFFAOYSA-N 0.000 description 1
- VEEMFZLBXQVQKA-UHFFFAOYSA-N 3-[[[1-(4-methylsulfonylphenyl)pyrazolo[3,4-d]pyrimidin-4-yl]amino]methyl]piperidine-1-carboxylic acid Chemical compound C1=CC(S(=O)(=O)C)=CC=C1N1C2=NC=NC(NCC3CN(CCC3)C(O)=O)=C2C=N1 VEEMFZLBXQVQKA-UHFFFAOYSA-N 0.000 description 1
- 125000004975 3-butenyl group Chemical group C(CC=C)* 0.000 description 1
- 125000000474 3-butynyl group Chemical group [H]C#CC([H])([H])C([H])([H])* 0.000 description 1
- GGUXFXPGTFEOGQ-UHFFFAOYSA-N 3-ethyl-5-[4-[5-ethynyl-6-(2-fluoro-4-methylsulfonylphenoxy)pyrimidin-4-yl]oxypiperidin-1-yl]-1,2,4-oxadiazole Chemical compound CCC1=NOC(N2CCC(CC2)OC=2C(=C(OC=3C(=CC(=CC=3)S(C)(=O)=O)F)N=CN=2)C#C)=N1 GGUXFXPGTFEOGQ-UHFFFAOYSA-N 0.000 description 1
- ZICSYHWVNYHXEV-UHFFFAOYSA-N 3-ethyl-5-[4-[6-(2-fluoro-4-methylsulfonylphenoxy)-5-methylpyrimidin-4-yl]oxypiperidin-1-yl]-1,2,4-oxadiazole Chemical compound CCC1=NOC(N2CCC(CC2)OC=2C(=C(OC=3C(=CC(=CC=3)S(C)(=O)=O)F)N=CN=2)C)=N1 ZICSYHWVNYHXEV-UHFFFAOYSA-N 0.000 description 1
- ZSIALONUBKQGKY-UHFFFAOYSA-N 3-fluoro-4-[1-methyl-7-[1-(3-propan-2-yl-1,2,4-oxadiazol-5-yl)piperidin-4-yl]oxypyrazolo[4,3-d]pyrimidin-3-yl]benzenesulfonamide Chemical compound CC(C)C1=NOC(N2CCC(CC2)OC=2C=3N(C)N=C(C=3N=CN=2)C=2C(=CC(=CC=2)S(N)(=O)=O)F)=N1 ZSIALONUBKQGKY-UHFFFAOYSA-N 0.000 description 1
- PWWZXKMRRPDTCB-UHFFFAOYSA-N 3-fluoro-4-[1-methyl-7-[1-(3-propan-2-yl-1,2,4-oxadiazol-5-yl)piperidin-4-yl]oxypyrazolo[4,3-d]pyrimidin-3-yl]benzonitrile Chemical compound CC(C)C1=NOC(N2CCC(CC2)OC=2C=3N(C)N=C(C=3N=CN=2)C=2C(=CC(=CC=2)C#N)F)=N1 PWWZXKMRRPDTCB-UHFFFAOYSA-N 0.000 description 1
- FNYLDSNQIMHTQQ-UHFFFAOYSA-N 3-fluoro-4-[1-methyl-7-[4-(3-propan-2-yl-1,2,4-oxadiazol-5-yl)cyclohexyl]oxypyrazolo[4,3-d]pyrimidin-3-yl]benzenesulfonamide Chemical compound CC(C)C1=NOC(C2CCC(CC2)OC=2C=3N(C)N=C(C=3N=CN=2)C=2C(=CC(=CC=2)S(N)(=O)=O)F)=N1 FNYLDSNQIMHTQQ-UHFFFAOYSA-N 0.000 description 1
- DMPWVCFHSLELGH-UHFFFAOYSA-N 3-fluoro-4-[1-methyl-7-[4-(3-propan-2-yl-1,2,4-oxadiazol-5-yl)cyclohexyl]oxypyrazolo[4,3-d]pyrimidin-3-yl]benzonitrile Chemical compound CC(C)C1=NOC(C2CCC(CC2)OC=2C=3N(C)N=C(C=3N=CN=2)C=2C(=CC(=CC=2)C#N)F)=N1 DMPWVCFHSLELGH-UHFFFAOYSA-N 0.000 description 1
- KOVAZSXTRIATIP-UHFFFAOYSA-N 3-fluoro-4-[2-methyl-7-[1-(3-propan-2-yl-1,2,4-oxadiazol-5-yl)piperidin-4-yl]oxypyrazolo[1,5-a]pyrimidin-3-yl]benzenesulfonamide Chemical compound CC(C)C1=NOC(N2CCC(CC2)OC=2N3N=C(C)C(=C3N=CC=2)C=2C(=CC(=CC=2)S(N)(=O)=O)F)=N1 KOVAZSXTRIATIP-UHFFFAOYSA-N 0.000 description 1
- XKEKSJJJCBAPDQ-UHFFFAOYSA-N 3-fluoro-4-[2-methyl-7-[1-(3-propan-2-yl-1,2,4-oxadiazol-5-yl)piperidin-4-yl]oxypyrazolo[1,5-a]pyrimidin-3-yl]benzonitrile Chemical compound CC(C)C1=NOC(N2CCC(CC2)OC=2N3N=C(C)C(=C3N=CC=2)C=2C(=CC(=CC=2)C#N)F)=N1 XKEKSJJJCBAPDQ-UHFFFAOYSA-N 0.000 description 1
- PSHLMMRNDOFUPJ-UHFFFAOYSA-N 3-fluoro-4-[2-methyl-7-[1-(3-propan-2-yl-1,2,4-oxadiazol-5-yl)piperidin-4-yl]oxypyrazolo[4,3-d]pyrimidin-3-yl]benzenesulfonamide Chemical compound CC(C)C1=NOC(N2CCC(CC2)OC=2C3=NN(C)C(C=4C(=CC(=CC=4)S(N)(=O)=O)F)=C3N=CN=2)=N1 PSHLMMRNDOFUPJ-UHFFFAOYSA-N 0.000 description 1
- HBUIACGPTPHGIP-UHFFFAOYSA-N 3-fluoro-4-[2-methyl-7-[1-(3-propan-2-yl-1,2,4-oxadiazol-5-yl)piperidin-4-yl]oxypyrazolo[4,3-d]pyrimidin-3-yl]benzonitrile Chemical compound CC(C)C1=NOC(N2CCC(CC2)OC=2C3=NN(C)C(C=4C(=CC(=CC=4)C#N)F)=C3N=CN=2)=N1 HBUIACGPTPHGIP-UHFFFAOYSA-N 0.000 description 1
- SYTUPTBHQKJNKD-UHFFFAOYSA-N 3-fluoro-4-[2-methyl-7-[4-(3-propan-2-yl-1,2,4-oxadiazol-5-yl)cyclohexyl]oxypyrazolo[4,3-d]pyrimidin-3-yl]benzenesulfonamide Chemical compound CC(C)C1=NOC(C2CCC(CC2)OC=2C3=NN(C)C(C=4C(=CC(=CC=4)S(N)(=O)=O)F)=C3N=CN=2)=N1 SYTUPTBHQKJNKD-UHFFFAOYSA-N 0.000 description 1
- TUASNIIIKHYSNX-UHFFFAOYSA-N 3-fluoro-4-[2-methyl-7-[4-(3-propan-2-yl-1,2,4-oxadiazol-5-yl)cyclohexyl]oxypyrazolo[4,3-d]pyrimidin-3-yl]benzonitrile Chemical compound CC(C)C1=NOC(C2CCC(CC2)OC=2C3=NN(C)C(C=4C(=CC(=CC=4)C#N)F)=C3N=CN=2)=N1 TUASNIIIKHYSNX-UHFFFAOYSA-N 0.000 description 1
- DILPFBFQKXEVNJ-UHFFFAOYSA-N 3-fluoro-4-[4-[1-(3-propan-2-yl-1,2,4-oxadiazol-5-yl)piperidin-4-yl]oxyquinolin-8-yl]benzenesulfonamide Chemical compound CC(C)C1=NOC(N2CCC(CC2)OC=2C3=CC=CC(=C3N=CC=2)C=2C(=CC(=CC=2)S(N)(=O)=O)F)=N1 DILPFBFQKXEVNJ-UHFFFAOYSA-N 0.000 description 1
- GSPKHYLJWLZJLS-UHFFFAOYSA-N 3-fluoro-4-[4-[1-(3-propan-2-yl-1,2,4-oxadiazol-5-yl)piperidin-4-yl]oxyquinolin-8-yl]benzonitrile Chemical compound CC(C)C1=NOC(N2CCC(CC2)OC=2C3=CC=CC(=C3N=CC=2)C=2C(=CC(=CC=2)C#N)F)=N1 GSPKHYLJWLZJLS-UHFFFAOYSA-N 0.000 description 1
- XHTQFUUTEPHBIK-UHFFFAOYSA-N 3-fluoro-4-[4-[4-(3-propan-2-yl-1,2,4-oxadiazol-5-yl)cyclohexyl]oxypyrazolo[3,4-d]pyrimidin-1-yl]benzenesulfonamide Chemical compound CC(C)C1=NOC(C2CCC(CC2)OC=2C=3C=NN(C=3N=CN=2)C=2C(=CC(=CC=2)S(N)(=O)=O)F)=N1 XHTQFUUTEPHBIK-UHFFFAOYSA-N 0.000 description 1
- WPBYHWQXEPTMGD-UHFFFAOYSA-N 3-fluoro-4-[4-[4-(3-propan-2-yl-1,2,4-oxadiazol-5-yl)cyclohexyl]oxypyrazolo[3,4-d]pyrimidin-1-yl]benzonitrile Chemical compound CC(C)C1=NOC(C2CCC(CC2)OC=2C=3C=NN(C=3N=CN=2)C=2C(=CC(=CC=2)C#N)F)=N1 WPBYHWQXEPTMGD-UHFFFAOYSA-N 0.000 description 1
- KLJLSHVJNCWFKK-UHFFFAOYSA-N 3-fluoro-4-[4-[4-(3-propan-2-yl-1,2,4-oxadiazol-5-yl)cyclohexyl]oxypyrazolo[3,4-d]pyrimidin-1-yl]phenol Chemical compound CC(C)C1=NOC(C2CCC(CC2)OC=2C=3C=NN(C=3N=CN=2)C=2C(=CC(O)=CC=2)F)=N1 KLJLSHVJNCWFKK-UHFFFAOYSA-N 0.000 description 1
- HAAWNDYNXIXYRH-UHFFFAOYSA-N 3-fluoro-4-[4-[4-(3-propan-2-yl-1,2,4-oxadiazol-5-yl)cyclohexyl]oxypyrido[3,4-d]pyrimidin-8-yl]benzenesulfonamide Chemical compound CC(C)C1=NOC(C2CCC(CC2)OC=2C3=CC=NC(=C3N=CN=2)C=2C(=CC(=CC=2)S(N)(=O)=O)F)=N1 HAAWNDYNXIXYRH-UHFFFAOYSA-N 0.000 description 1
- AVWZFQKEUORGQH-UHFFFAOYSA-N 3-fluoro-4-[4-[4-(3-propan-2-yl-1,2,4-oxadiazol-5-yl)cyclohexyl]oxypyrido[3,4-d]pyrimidin-8-yl]benzonitrile Chemical compound CC(C)C1=NOC(C2CCC(CC2)OC=2C3=CC=NC(=C3N=CN=2)C=2C(=CC(=CC=2)C#N)F)=N1 AVWZFQKEUORGQH-UHFFFAOYSA-N 0.000 description 1
- PPHFARLSVSKEIU-UHFFFAOYSA-N 3-fluoro-4-[4-[4-(3-propan-2-yl-1,2,4-oxadiazol-5-yl)cyclohexyl]oxyquinolin-8-yl]benzenesulfonamide Chemical compound CC(C)C1=NOC(C2CCC(CC2)OC=2C3=CC=CC(=C3N=CC=2)C=2C(=CC(=CC=2)S(N)(=O)=O)F)=N1 PPHFARLSVSKEIU-UHFFFAOYSA-N 0.000 description 1
- UAATYYSKEGEMJS-UHFFFAOYSA-N 3-fluoro-4-[4-[4-(3-propan-2-yl-1,2,4-oxadiazol-5-yl)cyclohexyl]oxyquinolin-8-yl]benzonitrile Chemical compound CC(C)C1=NOC(C2CCC(CC2)OC=2C3=CC=CC(=C3N=CC=2)C=2C(=CC(=CC=2)C#N)F)=N1 UAATYYSKEGEMJS-UHFFFAOYSA-N 0.000 description 1
- KZMAXLPGELOJRP-UHFFFAOYSA-N 3-fluoro-4-[5-methyl-6-(1-propan-2-yloxycarbonylpiperidin-4-yl)oxypyrimidin-4-yl]oxybenzenesulfonic acid Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=NC=NC(OC=2C(=CC(=CC=2)S(O)(=O)=O)F)=C1C KZMAXLPGELOJRP-UHFFFAOYSA-N 0.000 description 1
- OUSFXWIPPWCKHI-UHFFFAOYSA-N 3-fluoro-4-[6-[1-(3-propan-2-yl-1,2,4-oxadiazol-5-yl)piperidin-4-yl]oxypurin-9-yl]benzenesulfonamide Chemical compound CC(C)C1=NOC(N2CCC(CC2)OC=2C=3N=CN(C=3N=CN=2)C=2C(=CC(=CC=2)S(N)(=O)=O)F)=N1 OUSFXWIPPWCKHI-UHFFFAOYSA-N 0.000 description 1
- HRQCIRVQDUDKHS-UHFFFAOYSA-N 3-fluoro-4-[6-[1-(3-propan-2-yl-1,2,4-oxadiazol-5-yl)piperidin-4-yl]oxypurin-9-yl]benzonitrile Chemical compound CC(C)C1=NOC(N2CCC(CC2)OC=2C=3N=CN(C=3N=CN=2)C=2C(=CC(=CC=2)C#N)F)=N1 HRQCIRVQDUDKHS-UHFFFAOYSA-N 0.000 description 1
- XZXHKDOYGNZLML-UHFFFAOYSA-N 3-fluoro-4-[6-[4-(3-propan-2-yl-1,2,4-oxadiazol-5-yl)cyclohexyl]oxypurin-9-yl]benzenesulfonamide Chemical compound CC(C)C1=NOC(C2CCC(CC2)OC=2C=3N=CN(C=3N=CN=2)C=2C(=CC(=CC=2)S(N)(=O)=O)F)=N1 XZXHKDOYGNZLML-UHFFFAOYSA-N 0.000 description 1
- QTOGZCDRJAWYNT-UHFFFAOYSA-N 3-fluoro-4-[6-[4-(3-propan-2-yl-1,2,4-oxadiazol-5-yl)cyclohexyl]oxypurin-9-yl]benzonitrile Chemical compound CC(C)C1=NOC(C2CCC(CC2)OC=2C=3N=CN(C=3N=CN=2)C=2C(=CC(=CC=2)C#N)F)=N1 QTOGZCDRJAWYNT-UHFFFAOYSA-N 0.000 description 1
- BYHZOEFFVVDCCK-UHFFFAOYSA-N 3-fluoro-4-[7-[1-(3-propan-2-yl-1,2,4-oxadiazol-5-yl)piperidin-4-yl]oxytriazolo[4,5-d]pyrimidin-3-yl]benzenesulfonamide Chemical compound CC(C)C1=NOC(N2CCC(CC2)OC=2C=3N=NN(C=3N=CN=2)C=2C(=CC(=CC=2)S(N)(=O)=O)F)=N1 BYHZOEFFVVDCCK-UHFFFAOYSA-N 0.000 description 1
- ZSVMNNNLPAYGLG-UHFFFAOYSA-N 3-fluoro-4-[7-[1-(3-propan-2-yl-1,2,4-oxadiazol-5-yl)piperidin-4-yl]oxytriazolo[4,5-d]pyrimidin-3-yl]benzonitrile Chemical compound CC(C)C1=NOC(N2CCC(CC2)OC=2C=3N=NN(C=3N=CN=2)C=2C(=CC(=CC=2)C#N)F)=N1 ZSVMNNNLPAYGLG-UHFFFAOYSA-N 0.000 description 1
- OSXMHOSXOJEASP-UHFFFAOYSA-N 3-fluoro-4-[7-[4-(3-propan-2-yl-1,2,4-oxadiazol-5-yl)cyclohexyl]oxypyrazolo[1,5-a]pyrimidin-3-yl]benzenesulfonamide Chemical compound CC(C)C1=NOC(C2CCC(CC2)OC=2N3N=CC(=C3N=CC=2)C=2C(=CC(=CC=2)S(N)(=O)=O)F)=N1 OSXMHOSXOJEASP-UHFFFAOYSA-N 0.000 description 1
- AMFXBGLDNJOXCK-UHFFFAOYSA-N 3-fluoro-4-[7-[4-(3-propan-2-yl-1,2,4-oxadiazol-5-yl)cyclohexyl]oxypyrazolo[1,5-a]pyrimidin-3-yl]benzonitrile Chemical compound CC(C)C1=NOC(C2CCC(CC2)OC=2N3N=CC(=C3N=CC=2)C=2C(=CC(=CC=2)C#N)F)=N1 AMFXBGLDNJOXCK-UHFFFAOYSA-N 0.000 description 1
- GHFNWSLANCHTTP-UHFFFAOYSA-N 3-fluoro-4-[7-[4-(3-propan-2-yl-1,2,4-oxadiazol-5-yl)cyclohexyl]oxytriazolo[4,5-d]pyrimidin-3-yl]benzenesulfonamide Chemical compound CC(C)C1=NOC(C2CCC(CC2)OC=2C=3N=NN(C=3N=CN=2)C=2C(=CC(=CC=2)S(N)(=O)=O)F)=N1 GHFNWSLANCHTTP-UHFFFAOYSA-N 0.000 description 1
- VAAGAYYORNDSNK-UHFFFAOYSA-N 3-fluoro-4-[[6-[methyl(piperidin-4-ylmethyl)amino]pyrimidin-4-yl]amino]-n-propan-2-ylbenzenesulfonamide Chemical compound FC1=CC(S(=O)(=O)NC(C)C)=CC=C1NC1=CC(N(C)CC2CCNCC2)=NC=N1 VAAGAYYORNDSNK-UHFFFAOYSA-N 0.000 description 1
- 125000004180 3-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(F)=C1[H] 0.000 description 1
- 125000006041 3-hexenyl group Chemical group 0.000 description 1
- LEXHQPSGNJBARN-UHFFFAOYSA-N 3-methyl-1-[4-[(3-pyridin-4-yl-1,2,4-oxadiazol-5-yl)methoxy]piperidin-1-yl]butan-1-one Chemical compound C1CN(C(=O)CC(C)C)CCC1OCC1=NC(C=2C=CN=CC=2)=NO1 LEXHQPSGNJBARN-UHFFFAOYSA-N 0.000 description 1
- MOROPZCUIKKDHW-UHFFFAOYSA-N 3-methyl-1-[4-[1-(4-methylsulfonylphenyl)pyrazolo[3,4-d]pyrimidin-4-yl]oxypiperidin-1-yl]butan-1-one Chemical compound C1CN(C(=O)CC(C)C)CCC1OC1=NC=NC2=C1C=NN2C1=CC=C(S(C)(=O)=O)C=C1 MOROPZCUIKKDHW-UHFFFAOYSA-N 0.000 description 1
- VFVIASZDGVBAEW-UHFFFAOYSA-N 3-methyl-5-[3-[4-nitro-3-(4-propylpiperidin-1-yl)phenoxy]phenyl]-1,2,4-oxadiazole Chemical compound C1CC(CCC)CCN1C1=CC(OC=2C=C(C=CC=2)C=2ON=C(C)N=2)=CC=C1[N+]([O-])=O VFVIASZDGVBAEW-UHFFFAOYSA-N 0.000 description 1
- JZFCBKUAMUYDSE-UHFFFAOYSA-N 3-pyridin-4-yl-5-[(1-pyridin-3-ylpiperidin-4-yl)oxymethyl]-1,2,4-oxadiazole Chemical group N=1C(C=2C=CN=CC=2)=NOC=1COC(CC1)CCN1C1=CC=CN=C1 JZFCBKUAMUYDSE-UHFFFAOYSA-N 0.000 description 1
- KVIVOKHZDMAFKP-UHFFFAOYSA-N 3-pyridin-4-yl-5-[(1-pyrimidin-2-ylpiperidin-4-yl)oxymethyl]-1,2,4-oxadiazole Chemical compound N=1C(C=2C=CN=CC=2)=NOC=1COC(CC1)CCN1C1=NC=CC=N1 KVIVOKHZDMAFKP-UHFFFAOYSA-N 0.000 description 1
- 125000003349 3-pyridyl group Chemical group N1=C([H])C([*])=C([H])C([H])=C1[H] 0.000 description 1
- 125000004575 3-pyrrolidinyl group Chemical group [H]N1C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- DMNXUHOKZFMWPQ-UHFFFAOYSA-N 4-(1-benzylazetidin-3-yl)oxy-1-(4-methylsulfonylphenyl)pyrazolo[3,4-d]pyrimidine Chemical compound C1=CC(S(=O)(=O)C)=CC=C1N1C2=NC=NC(OC3CN(CC=4C=CC=CC=4)C3)=C2C=N1 DMNXUHOKZFMWPQ-UHFFFAOYSA-N 0.000 description 1
- MBPWZHDZEVESMX-UHFFFAOYSA-N 4-(1-butylpiperidin-4-yl)oxy-6-(2-fluoro-4-methylsulfonylphenoxy)-5-methylpyrimidine Chemical compound C1CN(CCCC)CCC1OC1=NC=NC(OC=2C(=CC(=CC=2)S(C)(=O)=O)F)=C1C MBPWZHDZEVESMX-UHFFFAOYSA-N 0.000 description 1
- AZQKDCFSKVWQQO-UHFFFAOYSA-N 4-(1-formylpiperidin-4-yl)oxy-6-(4-methylsulfonylanilino)pyrimidine-5-carbonitrile Chemical compound C1=CC(S(=O)(=O)C)=CC=C1NC1=NC=NC(OC2CCN(CC2)C=O)=C1C#N AZQKDCFSKVWQQO-UHFFFAOYSA-N 0.000 description 1
- VIOOOBWVQCZXIP-UHFFFAOYSA-N 4-(2,4-difluorophenoxy)-5-nitro-6-(4-pyridin-2-ylsulfanylpiperidin-1-yl)pyrimidine Chemical compound N1=CN=C(N2CCC(CC2)SC=2N=CC=CC=2)C([N+](=O)[O-])=C1OC1=CC=C(F)C=C1F VIOOOBWVQCZXIP-UHFFFAOYSA-N 0.000 description 1
- PGHCNXHAKQGQKA-UHFFFAOYSA-N 4-(2-fluoro-4-methylsulfonylphenoxy)-5-methyl-6-(1-pentylpiperidin-4-yl)oxypyrimidine Chemical compound C1CN(CCCCC)CCC1OC1=NC=NC(OC=2C(=CC(=CC=2)S(C)(=O)=O)F)=C1C PGHCNXHAKQGQKA-UHFFFAOYSA-N 0.000 description 1
- NUCBMLTYQHSURX-UHFFFAOYSA-N 4-(2-fluoro-4-methylsulfonylphenoxy)-5-methyl-6-[1-(2-pyridin-3-ylethyl)piperidin-4-yl]oxypyrimidine Chemical compound N1=CN=C(OC=2C(=CC(=CC=2)S(C)(=O)=O)F)C(C)=C1OC(CC1)CCN1CCC1=CC=CN=C1 NUCBMLTYQHSURX-UHFFFAOYSA-N 0.000 description 1
- WKDDGTJMOBLSEP-UHFFFAOYSA-N 4-(2-fluoro-4-methylsulfonylphenoxy)-5-methyl-6-[1-(3-methylbutyl)piperidin-4-yl]oxypyrimidine Chemical compound C1CN(CCC(C)C)CCC1OC1=NC=NC(OC=2C(=CC(=CC=2)S(C)(=O)=O)F)=C1C WKDDGTJMOBLSEP-UHFFFAOYSA-N 0.000 description 1
- TUTHICCOPAUTTP-UHFFFAOYSA-N 4-(2-fluoro-4-methylsulfonylphenoxy)-5-methyl-6-[1-(4-methylpentyl)piperidin-4-yl]oxypyrimidine Chemical compound C1CN(CCCC(C)C)CCC1OC1=NC=NC(OC=2C(=CC(=CC=2)S(C)(=O)=O)F)=C1C TUTHICCOPAUTTP-UHFFFAOYSA-N 0.000 description 1
- JZQGRHDMONUUBS-UHFFFAOYSA-N 4-(2-fluoro-4-methylsulfonylphenoxy)-5-methyl-6-[1-(5-methylhexyl)piperidin-4-yl]oxypyrimidine Chemical compound C1CN(CCCCC(C)C)CCC1OC1=NC=NC(OC=2C(=CC(=CC=2)S(C)(=O)=O)F)=C1C JZQGRHDMONUUBS-UHFFFAOYSA-N 0.000 description 1
- HSWSVHVEPTZPHW-UHFFFAOYSA-N 4-(2-fluoro-4-methylsulfonylphenoxy)-6-(1-hexylpiperidin-4-yl)oxy-5-methylpyrimidine Chemical compound C1CN(CCCCCC)CCC1OC1=NC=NC(OC=2C(=CC(=CC=2)S(C)(=O)=O)F)=C1C HSWSVHVEPTZPHW-UHFFFAOYSA-N 0.000 description 1
- DKAKENLLKAAJLB-UHFFFAOYSA-N 4-(2-fluoro-4-methylsulfonylphenoxy)-6-[1-(3-methoxypropyl)piperidin-4-yl]oxy-5-methylpyrimidine Chemical compound C1CN(CCCOC)CCC1OC1=NC=NC(OC=2C(=CC(=CC=2)S(C)(=O)=O)F)=C1C DKAKENLLKAAJLB-UHFFFAOYSA-N 0.000 description 1
- FMPWSSDQCGMCEM-UHFFFAOYSA-N 4-(2-fluoro-4-methylsulfonylphenoxy)-6-[1-(4-methoxycyclohexyl)piperidin-4-yl]oxy-5-methylpyrimidine Chemical compound C1CC(OC)CCC1N1CCC(OC=2C(=C(OC=3C(=CC(=CC=3)S(C)(=O)=O)F)N=CN=2)C)CC1 FMPWSSDQCGMCEM-UHFFFAOYSA-N 0.000 description 1
- FHDLQRHYTSOMNV-UHFFFAOYSA-N 4-(4-methylsulfanylanilino)-6-[4-(3-propan-2-yl-1,2,4-oxadiazol-5-yl)piperidin-1-yl]pyrimidine-5-carbonitrile Chemical compound C1=CC(SC)=CC=C1NC1=NC=NC(N2CCC(CC2)C=2ON=C(N=2)C(C)C)=C1C#N FHDLQRHYTSOMNV-UHFFFAOYSA-N 0.000 description 1
- KXIDQKYSJZODOI-UHFFFAOYSA-N 4-(4-methylsulfinylanilino)-6-[4-(3-propan-2-yl-1,2,4-oxadiazol-5-yl)piperidin-1-yl]pyrimidine-5-carbonitrile Chemical compound CC(C)C1=NOC(C2CCN(CC2)C=2C(=C(NC=3C=CC(=CC=3)S(C)=O)N=CN=2)C#N)=N1 KXIDQKYSJZODOI-UHFFFAOYSA-N 0.000 description 1
- DBOSVHCPPHXLBM-UHFFFAOYSA-N 4-(4-methylsulfonylanilino)-6-[1-(oxolane-2-carbonyl)piperidin-4-yl]oxypyrimidine-5-carbonitrile Chemical compound C1=CC(S(=O)(=O)C)=CC=C1NC1=NC=NC(OC2CCN(CC2)C(=O)C2OCCC2)=C1C#N DBOSVHCPPHXLBM-UHFFFAOYSA-N 0.000 description 1
- FLKMZINWQJKEFD-UHFFFAOYSA-N 4-(4-methylsulfonylanilino)-6-[1-(pyridine-2-carbonyl)piperidin-4-yl]oxypyrimidine-5-carbonitrile Chemical compound C1=CC(S(=O)(=O)C)=CC=C1NC1=NC=NC(OC2CCN(CC2)C(=O)C=2N=CC=CC=2)=C1C#N FLKMZINWQJKEFD-UHFFFAOYSA-N 0.000 description 1
- SXDKQBADJIVKAE-UHFFFAOYSA-N 4-(4-methylsulfonylanilino)-6-[4-(3-propan-2-yl-1,2,4-oxadiazol-5-yl)piperidin-1-yl]pyrimidine-5-carbonitrile Chemical compound CC(C)C1=NOC(C2CCN(CC2)C=2C(=C(NC=3C=CC(=CC=3)S(C)(=O)=O)N=CN=2)C#N)=N1 SXDKQBADJIVKAE-UHFFFAOYSA-N 0.000 description 1
- IMSWXVXQPSEOIU-UHFFFAOYSA-N 4-(4-methylsulfonylphenoxy)-5-nitro-6-(4-phenylsulfanylcyclohexyl)pyrimidine Chemical compound C1=CC(S(=O)(=O)C)=CC=C1OC1=NC=NC(C2CCC(CC2)SC=2C=CC=CC=2)=C1[N+]([O-])=O IMSWXVXQPSEOIU-UHFFFAOYSA-N 0.000 description 1
- XWSTXBAOJHDPRK-UHFFFAOYSA-N 4-(4-methylsulfonylphenoxy)-5-nitro-6-(4-pyridin-2-ylsulfanylcyclohexyl)pyrimidine Chemical compound C1=CC(S(=O)(=O)C)=CC=C1OC1=NC=NC(C2CCC(CC2)SC=2N=CC=CC=2)=C1[N+]([O-])=O XWSTXBAOJHDPRK-UHFFFAOYSA-N 0.000 description 1
- PBKMHXCTKFHYJC-UHFFFAOYSA-N 4-(4-methylsulfonylphenoxy)-5-nitro-6-(4-pyridin-4-ylsulfanylcyclohexyl)pyrimidine Chemical compound C1=CC(S(=O)(=O)C)=CC=C1OC1=NC=NC(C2CCC(CC2)SC=2C=CN=CC=2)=C1[N+]([O-])=O PBKMHXCTKFHYJC-UHFFFAOYSA-N 0.000 description 1
- UJWBXHLJYWZSNF-UHFFFAOYSA-N 4-(4-methylsulfonylphenoxy)-6-[4-(3-propan-2-yl-1,2,4-oxadiazol-5-yl)piperidin-1-yl]pyrimidine-5-carbaldehyde Chemical compound CC(C)C1=NOC(C2CCN(CC2)C=2C(=C(OC=3C=CC(=CC=3)S(C)(=O)=O)N=CN=2)C=O)=N1 UJWBXHLJYWZSNF-UHFFFAOYSA-N 0.000 description 1
- OBTFDFKKMPJGQN-UHFFFAOYSA-N 4-(4-methylsulfonylphenoxy)-6-[4-(3-propan-2-yl-1,2,4-oxadiazol-5-yl)piperidin-1-yl]pyrimidine-5-carbonitrile Chemical compound CC(C)C1=NOC(C2CCN(CC2)C=2C(=C(OC=3C=CC(=CC=3)S(C)(=O)=O)N=CN=2)C#N)=N1 OBTFDFKKMPJGQN-UHFFFAOYSA-N 0.000 description 1
- CPEFIXYLXBMPIK-UHFFFAOYSA-N 4-[1-(2-fluoro-4-methylsulfonylphenyl)pyrazolo[3,4-d]pyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound FC1=CC(S(=O)(=O)C)=CC=C1N1C2=NC=NC(OC3CCN(CC3)C(O)=O)=C2C=N1 CPEFIXYLXBMPIK-UHFFFAOYSA-N 0.000 description 1
- LIGNNMGXVMPANI-UHFFFAOYSA-N 4-[1-(3,3-dimethyl-2-oxobutyl)piperidin-4-yl]oxy-6-(4-methylsulfonylanilino)pyrimidine-5-carbonitrile Chemical compound C1CN(CC(=O)C(C)(C)C)CCC1OC1=NC=NC(NC=2C=CC(=CC=2)S(C)(=O)=O)=C1C#N LIGNNMGXVMPANI-UHFFFAOYSA-N 0.000 description 1
- XYSFBFRJKZWCAJ-UHFFFAOYSA-N 4-[1-(3-fluorophenyl)pyrazolo[3,4-d]pyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound C1CN(C(=O)O)CCC1OC1=NC=NC2=C1C=NN2C1=CC=CC(F)=C1 XYSFBFRJKZWCAJ-UHFFFAOYSA-N 0.000 description 1
- YQSQZAOZSRRQOA-UHFFFAOYSA-N 4-[1-(5-ethylpyrimidin-2-yl)piperidin-4-yl]sulfanyl-1-(2-fluoro-4-methylsulfonylphenyl)pyrazolo[3,4-d]pyrimidine Chemical compound N1=CC(CC)=CN=C1N1CCC(SC=2C=3C=NN(C=3N=CN=2)C=2C(=CC(=CC=2)S(C)(=O)=O)F)CC1 YQSQZAOZSRRQOA-UHFFFAOYSA-N 0.000 description 1
- CHBPUEJQBDNIRR-UHFFFAOYSA-N 4-[1-[3,5-bis(trifluoromethyl)phenyl]pyrazolo[3,4-d]pyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound OC(=O)N1CCC(CC1)Oc1ncnc2n(ncc12)-c1cc(cc(c1)C(F)(F)F)C(F)(F)F CHBPUEJQBDNIRR-UHFFFAOYSA-N 0.000 description 1
- XAJDLHWXMSVDMS-UHFFFAOYSA-N 4-[2-(2-fluoro-4-methylsulfonylanilino)-3-methylpyridin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound FC1=C(C=CC(=C1)S(=O)(=O)C)NC1=NC=CC(=C1C)OC1CCN(CC1)C(=O)O XAJDLHWXMSVDMS-UHFFFAOYSA-N 0.000 description 1
- VONIEENDKRLUIT-UHFFFAOYSA-N 4-[2-(2-fluoro-4-methylsulfonylanilino)pyridin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound FC1=C(C=CC(=C1)S(=O)(=O)C)NC1=NC=CC(=C1)OC1CCN(CC1)C(=O)O VONIEENDKRLUIT-UHFFFAOYSA-N 0.000 description 1
- SWLAMJPTOQZTAE-UHFFFAOYSA-N 4-[2-[(5-chloro-2-methoxybenzoyl)amino]ethyl]benzoic acid Chemical compound COC1=CC=C(Cl)C=C1C(=O)NCCC1=CC=C(C(O)=O)C=C1 SWLAMJPTOQZTAE-UHFFFAOYSA-N 0.000 description 1
- OXSWPFICEVAYLI-UHFFFAOYSA-N 4-[2-[4-[6-(2-fluoro-4-methylsulfonylphenoxy)-5-methylpyrimidin-4-yl]oxypiperidin-1-yl]acetyl]benzonitrile Chemical compound N1=CN=C(OC=2C(=CC(=CC=2)S(C)(=O)=O)F)C(C)=C1OC(CC1)CCN1CC(=O)C1=CC=C(C#N)C=C1 OXSWPFICEVAYLI-UHFFFAOYSA-N 0.000 description 1
- WGUCGZCWRGUGTR-UHFFFAOYSA-N 4-[2-[6-(4-methylsulfonylanilino)-5-nitropyrimidin-4-yl]oxyethyl]piperidine-1-carboxylic acid Chemical compound CS(=O)(=O)C1=CC=C(C=C1)NC1=C(C(=NC=N1)OCCC1CCN(CC1)C(=O)O)[N+](=O)[O-] WGUCGZCWRGUGTR-UHFFFAOYSA-N 0.000 description 1
- BKYSEWOSYCIMMM-UHFFFAOYSA-N 4-[3,6-dimethyl-1-(4-methylsulfonylphenyl)pyrazolo[3,4-d]pyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound C12=NC(C)=NC(OC3CCN(CC3)C(O)=O)=C2C(C)=NN1C1=CC=C(S(C)(=O)=O)C=C1 BKYSEWOSYCIMMM-UHFFFAOYSA-N 0.000 description 1
- MLKYXPRZAFIGTR-UHFFFAOYSA-N 4-[3-(2,5-difluoro-4-methylsulfonylphenyl)-2-methylpyrazolo[1,5-a]pyrimidin-7-yl]oxypiperidine-1-carboxylic acid Chemical compound C=1C=NC2=C(C=3C(=CC(=C(F)C=3)S(C)(=O)=O)F)C(C)=NN2C=1OC1CCN(C(O)=O)CC1 MLKYXPRZAFIGTR-UHFFFAOYSA-N 0.000 description 1
- HWILUTCNIPMZJH-UHFFFAOYSA-N 4-[3-(2,5-difluoro-4-methylsulfonylphenyl)pyrazolo[1,5-a]pyrimidin-7-yl]oxypiperidine-1-carboxylic acid Chemical compound C1=C(F)C(S(=O)(=O)C)=CC(F)=C1C1=C2N=CC=C(OC3CCN(CC3)C(O)=O)N2N=C1 HWILUTCNIPMZJH-UHFFFAOYSA-N 0.000 description 1
- PLZQIJKDAPMEOZ-UHFFFAOYSA-N 4-[3-(2,5-difluoro-4-methylsulfonylphenyl)triazolo[4,5-d]pyrimidin-7-yl]oxypiperidine-1-carboxylic acid Chemical compound C1=C(F)C(S(=O)(=O)C)=CC(F)=C1N1C2=NC=NC(OC3CCN(CC3)C(O)=O)=C2N=N1 PLZQIJKDAPMEOZ-UHFFFAOYSA-N 0.000 description 1
- BFQWXKPKDDBURE-UHFFFAOYSA-N 4-[3-(2-fluoro-4-methylsulfonylphenyl)-1-methylpyrazolo[4,3-d]pyrimidin-7-yl]oxypiperidine-1-carboxylic acid Chemical compound FC1=C(C=CC(=C1)S(=O)(=O)C)C1=NN(C2=C1N=CN=C2OC1CCN(CC1)C(=O)O)C BFQWXKPKDDBURE-UHFFFAOYSA-N 0.000 description 1
- ZCUKJKTUPRBQCW-UHFFFAOYSA-N 4-[3-(2-fluoro-4-methylsulfonylphenyl)-2-methylpyrazolo[4,3-d]pyrimidin-7-yl]oxypiperidine-1-carboxylic acid Chemical compound N=1C=NC2=C(C=3C(=CC(=CC=3)S(C)(=O)=O)F)N(C)N=C2C=1OC1CCN(C(O)=O)CC1 ZCUKJKTUPRBQCW-UHFFFAOYSA-N 0.000 description 1
- LIMMEAQBEFUTSC-UHFFFAOYSA-N 4-[3-(2-fluoro-4-methylsulfonylphenyl)triazolo[4,5-d]pyrimidin-7-yl]oxypiperidine-1-carboxylic acid Chemical compound FC1=CC(S(=O)(=O)C)=CC=C1N1C2=NC=NC(OC3CCN(CC3)C(O)=O)=C2N=N1 LIMMEAQBEFUTSC-UHFFFAOYSA-N 0.000 description 1
- NVXNGDFNOQLPDL-UHFFFAOYSA-N 4-[3-(2-fluoro-4-sulfamoylphenyl)-1-methylpyrazolo[4,3-d]pyrimidin-7-yl]oxypiperidine-1-carboxylic acid Chemical compound C12=NC=NC(OC3CCN(CC3)C(O)=O)=C2N(C)N=C1C1=CC=C(S(N)(=O)=O)C=C1F NVXNGDFNOQLPDL-UHFFFAOYSA-N 0.000 description 1
- DFGZTGOUUMTXES-UHFFFAOYSA-N 4-[3-(4-cyano-2-fluorophenyl)-2-methylpyrazolo[1,5-a]pyrimidin-7-yl]oxypiperidine-1-carboxylic acid Chemical compound C=1C=NC2=C(C=3C(=CC(=CC=3)C#N)F)C(C)=NN2C=1OC1CCN(C(O)=O)CC1 DFGZTGOUUMTXES-UHFFFAOYSA-N 0.000 description 1
- VBKZIGLEZXLBPW-UHFFFAOYSA-N 4-[3-(4-cyano-2-fluorophenyl)pyrazolo[1,5-a]pyrimidin-7-yl]oxypiperidine-1-carboxylic acid Chemical compound C1CN(C(=O)O)CCC1OC1=CC=NC2=C(C=3C(=CC(=CC=3)C#N)F)C=NN12 VBKZIGLEZXLBPW-UHFFFAOYSA-N 0.000 description 1
- QKXPTZREOJBAAQ-UHFFFAOYSA-N 4-[3-(4-fluoro-6-methoxypyridin-3-yl)-2-methylpyrazolo[1,5-a]pyrimidin-7-yl]oxypiperidine-1-carboxylic acid Chemical compound C1=NC(OC)=CC(F)=C1C1=C2N=CC=C(OC3CCN(CC3)C(O)=O)N2N=C1C QKXPTZREOJBAAQ-UHFFFAOYSA-N 0.000 description 1
- RUYZWSHDCXDIHS-UHFFFAOYSA-N 4-[3-(4-fluoro-6-methoxypyridin-3-yl)pyrazolo[1,5-a]pyrimidin-7-yl]oxypiperidine-1-carboxylic acid Chemical compound C1=NC(OC)=CC(F)=C1C1=C2N=CC=C(OC3CCN(CC3)C(O)=O)N2N=C1 RUYZWSHDCXDIHS-UHFFFAOYSA-N 0.000 description 1
- XHYROPWPTBWRLC-UHFFFAOYSA-N 4-[3-(4-methylsulfonylphenyl)triazolo[4,5-d]pyrimidin-7-yl]oxypiperidine-1-carboxylic acid Chemical compound C1=CC(S(=O)(=O)C)=CC=C1N1C2=NC=NC(OC3CCN(CC3)C(O)=O)=C2N=N1 XHYROPWPTBWRLC-UHFFFAOYSA-N 0.000 description 1
- PFJSEWHWXNHTBF-UHFFFAOYSA-N 4-[3-(6-methoxy-2-methylpyridin-3-yl)pyrazolo[1,5-a]pyrimidin-7-yl]oxypiperidine-1-carboxylic acid Chemical compound CC1=NC(OC)=CC=C1C1=C2N=CC=C(OC3CCN(CC3)C(O)=O)N2N=C1 PFJSEWHWXNHTBF-UHFFFAOYSA-N 0.000 description 1
- ALIFRQVWKIOCDN-UHFFFAOYSA-N 4-[3-[2-fluoro-4-(propanoylsulfamoyl)phenyl]-2-methylpyrazolo[1,5-a]pyrimidin-7-yl]oxypiperidine-1-carboxylic acid Chemical compound FC1=CC(S(=O)(=O)NC(=O)CC)=CC=C1C1=C2N=CC=C(OC3CCN(CC3)C(O)=O)N2N=C1C ALIFRQVWKIOCDN-UHFFFAOYSA-N 0.000 description 1
- MYATXSOTUPKMTD-UHFFFAOYSA-N 4-[3-[2-fluoro-4-(propanoylsulfamoyl)phenyl]pyrazolo[1,5-a]pyrimidin-7-yl]oxypiperidine-1-carboxylic acid Chemical compound FC1=CC(S(=O)(=O)NC(=O)CC)=CC=C1C1=C2N=CC=C(OC3CCN(CC3)C(O)=O)N2N=C1 MYATXSOTUPKMTD-UHFFFAOYSA-N 0.000 description 1
- SAVGIMJMNLCHCQ-UHFFFAOYSA-N 4-[3-[2-fluoro-4-(propanoylsulfamoyl)phenyl]triazolo[4,5-d]pyrimidin-7-yl]oxypiperidine-1-carboxylic acid Chemical compound FC1=CC(S(=O)(=O)NC(=O)CC)=CC=C1N1C2=NC=NC(OC3CCN(CC3)C(O)=O)=C2N=N1 SAVGIMJMNLCHCQ-UHFFFAOYSA-N 0.000 description 1
- WKICESIIRCUDHT-UHFFFAOYSA-N 4-[3-methyl-1-(4-methylsulfonylphenyl)pyrazolo[3,4-d]pyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound C12=NC=NC(OC3CCN(CC3)C(O)=O)=C2C(C)=NN1C1=CC=C(S(C)(=O)=O)C=C1 WKICESIIRCUDHT-UHFFFAOYSA-N 0.000 description 1
- ZIZFRXNKNUNXCV-UHFFFAOYSA-N 4-[4-(2,5-difluoro-4-propoxyanilino)pyridin-2-yl]oxypiperidine-1-carboxylic acid Chemical compound FC1=C(C=C(C(=C1)OCCC)F)NC1=CC(=NC=C1)OC1CCN(CC1)C(=O)O ZIZFRXNKNUNXCV-UHFFFAOYSA-N 0.000 description 1
- CVUBOYFMJIJYGV-UHFFFAOYSA-N 4-[4-(2-fluoro-4-methylsulfonylanilino)pyridin-2-yl]oxypiperidine-1-carboxylic acid Chemical compound FC1=C(C=CC(=C1)S(=O)(=O)C)NC1=CC(=NC=C1)OC1CCN(CC1)C(=O)O CVUBOYFMJIJYGV-UHFFFAOYSA-N 0.000 description 1
- CZJBSMLOCJUQJW-UHFFFAOYSA-N 4-[4-(3-propan-2-yl-1,2,4-oxadiazol-5-yl)piperidin-1-yl]-6-[4-(thiadiazol-4-yl)phenoxy]pyrimidine-5-carbaldehyde Chemical compound CC(C)C1=NOC(C2CCN(CC2)C=2C(=C(OC=3C=CC(=CC=3)C=3N=NSC=3)N=CN=2)C=O)=N1 CZJBSMLOCJUQJW-UHFFFAOYSA-N 0.000 description 1
- QVNISXFLVXAVCU-UHFFFAOYSA-N 4-[4-(3-propan-2-yl-1,2,4-oxadiazol-5-yl)piperidin-1-yl]-6-[4-(thiadiazol-4-yl)phenoxy]pyrimidine-5-carboxylic acid Chemical compound CC(C)C1=NOC(C2CCN(CC2)C=2C(=C(OC=3C=CC(=CC=3)C=3N=NSC=3)N=CN=2)C(O)=O)=N1 QVNISXFLVXAVCU-UHFFFAOYSA-N 0.000 description 1
- QTVLQPAOZWHNFH-UHFFFAOYSA-N 4-[4-[2-nitro-5-(4-propylpiperidin-1-yl)phenoxy]phenyl]butan-2-one Chemical compound C1CC(CCC)CCN1C1=CC=C([N+]([O-])=O)C(OC=2C=CC(CCC(C)=O)=CC=2)=C1 QTVLQPAOZWHNFH-UHFFFAOYSA-N 0.000 description 1
- SSZRMWSKPKWIIG-UHFFFAOYSA-N 4-[4-[3-[4-(3-methyl-1,2,4-oxadiazol-5-yl)piperidin-1-yl]-4-nitrophenoxy]phenyl]butan-2-one Chemical compound C1=CC(CCC(=O)C)=CC=C1OC1=CC=C([N+]([O-])=O)C(N2CCC(CC2)C=2ON=C(C)N=2)=C1 SSZRMWSKPKWIIG-UHFFFAOYSA-N 0.000 description 1
- HIBOMQBOJFSMRJ-UHFFFAOYSA-N 4-[4-[3-[4-(methoxymethyl)piperidin-1-yl]-4-nitrophenoxy]phenyl]butan-2-one Chemical compound C1CC(COC)CCN1C1=CC(OC=2C=CC(CCC(C)=O)=CC=2)=CC=C1[N+]([O-])=O HIBOMQBOJFSMRJ-UHFFFAOYSA-N 0.000 description 1
- QAQHPPBTEWEEJM-UHFFFAOYSA-N 4-[4-[4-nitro-3-(4-propylpiperidin-1-yl)phenoxy]phenyl]butan-2-one Chemical compound C1CC(CCC)CCN1C1=CC(OC=2C=CC(CCC(C)=O)=CC=2)=CC=C1[N+]([O-])=O QAQHPPBTEWEEJM-UHFFFAOYSA-N 0.000 description 1
- JFIDBMRSEIBNAE-UHFFFAOYSA-N 4-[4-[4-nitro-3-(4-pyridin-2-ylsulfanylpiperidin-1-yl)phenoxy]phenyl]butan-2-one Chemical compound C1=CC(CCC(=O)C)=CC=C1OC1=CC=C([N+]([O-])=O)C(N2CCC(CC2)SC=2N=CC=CC=2)=C1 JFIDBMRSEIBNAE-UHFFFAOYSA-N 0.000 description 1
- SOMGOTJVNWMMAF-UHFFFAOYSA-N 4-[4-[5-nitro-6-(4-propylpiperidin-1-yl)pyridin-2-yl]oxyphenyl]butan-2-one Chemical compound C1CC(CCC)CCN1C1=NC(OC=2C=CC(CCC(C)=O)=CC=2)=CC=C1[N+]([O-])=O SOMGOTJVNWMMAF-UHFFFAOYSA-N 0.000 description 1
- YWCCANLUHWZFLR-UHFFFAOYSA-N 4-[4-[5-nitro-6-(4-pyridin-2-ylsulfanylpiperidin-1-yl)pyridin-2-yl]oxyphenyl]butan-2-one Chemical compound C1=CC(CCC(=O)C)=CC=C1OC1=CC=C([N+]([O-])=O)C(N2CCC(CC2)SC=2N=CC=CC=2)=N1 YWCCANLUHWZFLR-UHFFFAOYSA-N 0.000 description 1
- CQDBBMXEJJUGIO-UHFFFAOYSA-N 4-[4-[5-nitro-6-(4-pyridin-2-ylsulfanylpiperidin-1-yl)pyrimidin-4-yl]oxyphenyl]butan-2-one Chemical compound C1=CC(CCC(=O)C)=CC=C1OC1=NC=NC(N2CCC(CC2)SC=2N=CC=CC=2)=C1[N+]([O-])=O CQDBBMXEJJUGIO-UHFFFAOYSA-N 0.000 description 1
- MBFIERWVMWYQNG-UHFFFAOYSA-N 4-[4-[5-nitro-6-[4-(propoxymethyl)piperidin-1-yl]pyrimidin-4-yl]oxyphenyl]butan-2-one Chemical compound C1CC(COCCC)CCN1C1=NC=NC(OC=2C=CC(CCC(C)=O)=CC=2)=C1[N+]([O-])=O MBFIERWVMWYQNG-UHFFFAOYSA-N 0.000 description 1
- KZDBVWHQNGGDHM-UHFFFAOYSA-N 4-[4-[5-nitro-6-[4-[2-(trifluoromethyl)phenoxy]piperidin-1-yl]pyrimidin-4-yl]oxyphenyl]butan-2-one Chemical compound C1=CC(CCC(=O)C)=CC=C1OC1=NC=NC(N2CCC(CC2)OC=2C(=CC=CC=2)C(F)(F)F)=C1[N+]([O-])=O KZDBVWHQNGGDHM-UHFFFAOYSA-N 0.000 description 1
- UZBYFVFRWANJMR-UHFFFAOYSA-N 4-[4-[6-(2-fluoro-4-methylsulfonylphenoxy)-5-methylpyrimidin-4-yl]oxypiperidin-1-yl]-4-oxobutanoic acid Chemical compound N1=CN=C(OC=2C(=CC(=CC=2)S(C)(=O)=O)F)C(C)=C1OC1CCN(C(=O)CCC(O)=O)CC1 UZBYFVFRWANJMR-UHFFFAOYSA-N 0.000 description 1
- JRFBERKQAWMFIA-UHFFFAOYSA-N 4-[4-[6-(2-fluoro-4-methylsulfonylphenoxy)-5-methylpyrimidin-4-yl]oxypiperidin-1-yl]butanoic acid Chemical compound N1=CN=C(OC=2C(=CC(=CC=2)S(C)(=O)=O)F)C(C)=C1OC1CCN(CCCC(O)=O)CC1 JRFBERKQAWMFIA-UHFFFAOYSA-N 0.000 description 1
- OPVUBJGKKGMRHF-UHFFFAOYSA-N 4-[4-[6-(2-fluoro-4-methylsulfonylphenoxy)-5-methylpyrimidin-4-yl]oxypiperidin-1-yl]cyclohexane-1-carboxylic acid Chemical compound N1=CN=C(OC=2C(=CC(=CC=2)S(C)(=O)=O)F)C(C)=C1OC(CC1)CCN1C1CCC(C(O)=O)CC1 OPVUBJGKKGMRHF-UHFFFAOYSA-N 0.000 description 1
- NACUMEUULNCYGO-UHFFFAOYSA-N 4-[4-[6-[4-(2-methylpropoxymethyl)piperidin-1-yl]-5-nitropyrimidin-4-yl]oxyphenyl]butan-2-one Chemical compound C1CC(COCC(C)C)CCN1C1=NC=NC(OC=2C=CC(CCC(C)=O)=CC=2)=C1[N+]([O-])=O NACUMEUULNCYGO-UHFFFAOYSA-N 0.000 description 1
- YBCDEACHYDFKGV-UHFFFAOYSA-N 4-[4-[6-[4-(3-methyl-1,2,4-oxadiazol-5-yl)piperidin-1-yl]-5-nitropyrimidin-4-yl]oxyphenyl]butan-2-one Chemical compound C1=CC(CCC(=O)C)=CC=C1OC1=NC=NC(N2CCC(CC2)C=2ON=C(C)N=2)=C1[N+]([O-])=O YBCDEACHYDFKGV-UHFFFAOYSA-N 0.000 description 1
- IFQNJVZMNAJLGZ-UHFFFAOYSA-N 4-[4-[6-[4-(4-fluorobenzoyl)piperidin-1-yl]-5-nitropyrimidin-4-yl]oxyphenyl]butan-2-one Chemical compound C1=CC(CCC(=O)C)=CC=C1OC1=NC=NC(N2CCC(CC2)C(=O)C=2C=CC(F)=CC=2)=C1[N+]([O-])=O IFQNJVZMNAJLGZ-UHFFFAOYSA-N 0.000 description 1
- FDBRCFDCKVFGPN-UHFFFAOYSA-N 4-[4-[6-[4-(butoxymethyl)piperidin-1-yl]-5-nitropyrimidin-4-yl]oxyphenyl]butan-2-one Chemical compound C1CC(COCCCC)CCN1C1=NC=NC(OC=2C=CC(CCC(C)=O)=CC=2)=C1[N+]([O-])=O FDBRCFDCKVFGPN-UHFFFAOYSA-N 0.000 description 1
- UQGQQTQKNHKMRH-UHFFFAOYSA-N 4-[4-[6-[4-(cyclopropylmethoxymethyl)piperidin-1-yl]-5-nitropyrimidin-4-yl]oxyphenyl]butan-2-one Chemical compound C1=CC(CCC(=O)C)=CC=C1OC1=NC=NC(N2CCC(COCC3CC3)CC2)=C1[N+]([O-])=O UQGQQTQKNHKMRH-UHFFFAOYSA-N 0.000 description 1
- DTIOMMMYDLNOKK-UHFFFAOYSA-N 4-[5-(2-fluoro-4-methylsulfonylanilino)pyridin-3-yl]oxypiperidine-1-carboxylic acid Chemical compound FC1=C(C=CC(=C1)S(=O)(=O)C)NC=1C=C(C=NC=1)OC1CCN(CC1)C(=O)O DTIOMMMYDLNOKK-UHFFFAOYSA-N 0.000 description 1
- BTOQRHMUUUDTIM-UHFFFAOYSA-N 4-[5-bromo-6-(2-fluoro-4-methylsulfonylphenoxy)pyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound BrC=1C(=NC=NC=1OC1=C(C=C(C=C1)S(=O)(=O)C)F)OC1CCN(CC1)C(=O)O BTOQRHMUUUDTIM-UHFFFAOYSA-N 0.000 description 1
- PEGFQYSHPSRFIQ-UHFFFAOYSA-N 4-[5-cyano-6-(2-fluoro-4-morpholin-4-ylanilino)pyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound C1CN(C(=O)O)CCC1OC1=NC=NC(NC=2C(=CC(=CC=2)N2CCOCC2)F)=C1C#N PEGFQYSHPSRFIQ-UHFFFAOYSA-N 0.000 description 1
- WWRLUQAKPLVQGR-UHFFFAOYSA-N 4-[5-cyano-6-(2-fluoro-4-propoxyanilino)pyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound C(#N)C=1C(=NC=NC=1NC1=C(C=C(C=C1)OCCC)F)OC1CCN(CC1)C(=O)O WWRLUQAKPLVQGR-UHFFFAOYSA-N 0.000 description 1
- XXIWOUAACYDOSR-UHFFFAOYSA-N 4-[5-cyano-6-(3-fluoro-4-methylsulfonylanilino)pyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound C(#N)C=1C(=NC=NC=1NC1=CC(=C(C=C1)S(=O)(=O)C)F)OC1CCN(CC1)C(=O)O XXIWOUAACYDOSR-UHFFFAOYSA-N 0.000 description 1
- AHGSUVIJVVOBTP-UHFFFAOYSA-N 4-[5-cyano-6-[(6-methylsulfanylpyridin-3-yl)amino]pyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound C(#N)C=1C(=NC=NC=1NC=1C=NC(=CC=1)SC)OC1CCN(CC1)C(=O)O AHGSUVIJVVOBTP-UHFFFAOYSA-N 0.000 description 1
- QZVWCLVTWAVKRC-UHFFFAOYSA-N 4-[5-cyano-6-[2-fluoro-4-(3-methylbutylamino)anilino]pyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound C(#N)C=1C(=NC=NC=1NC1=C(C=C(C=C1)NCCC(C)C)F)OC1CCN(CC1)C(=O)O QZVWCLVTWAVKRC-UHFFFAOYSA-N 0.000 description 1
- YXUBMCYZNILKLU-UHFFFAOYSA-N 4-[5-cyano-6-[2-fluoro-4-(4-methylpiperazin-1-yl)anilino]pyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound C(#N)C=1C(=NC=NC=1NC1=C(C=C(C=C1)N1CCN(CC1)C)F)OC1CCN(CC1)C(=O)O YXUBMCYZNILKLU-UHFFFAOYSA-N 0.000 description 1
- OBSHCPYVRVJGJZ-UHFFFAOYSA-N 4-[5-cyano-6-[2-fluoro-4-(propylamino)anilino]pyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound C(#N)C=1C(=NC=NC=1NC1=C(C=C(C=C1)NCCC)F)OC1CCN(CC1)C(=O)O OBSHCPYVRVJGJZ-UHFFFAOYSA-N 0.000 description 1
- RNDHQEWVVFJSNT-UHFFFAOYSA-N 4-[5-cyano-6-[4-(dimethylamino)-2-fluoroanilino]pyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound C(#N)C=1C(=NC=NC=1NC1=C(C=C(C=C1)N(C)C)F)OC1CCN(CC1)C(=O)O RNDHQEWVVFJSNT-UHFFFAOYSA-N 0.000 description 1
- JFGFOIXFVIYIDL-UHFFFAOYSA-N 4-[5-cyano-6-[4-[2-(dimethylamino)ethylamino]-2-fluoroanilino]pyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound C(#N)C=1C(=NC=NC=1NC1=C(C=C(C=C1)NCCN(C)C)F)OC1CCN(CC1)C(=O)O JFGFOIXFVIYIDL-UHFFFAOYSA-N 0.000 description 1
- AORCQDHAHMAHNZ-UHFFFAOYSA-N 4-[5-cyclopropyl-6-(2-fluoro-4-methylsulfonylphenoxy)pyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound C1(CC1)C=1C(=NC=NC=1OC1=C(C=C(C=C1)S(=O)(=O)C)F)OC1CCN(CC1)C(=O)O AORCQDHAHMAHNZ-UHFFFAOYSA-N 0.000 description 1
- GZBYWIDSCQHNRT-UHFFFAOYSA-N 4-[5-ethyl-6-(2-fluoro-4-methylsulfonylphenoxy)pyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound C(C)C=1C(=NC=NC=1OC1=C(C=C(C=C1)S(=O)(=O)C)F)OC1CCN(CC1)C(=O)O GZBYWIDSCQHNRT-UHFFFAOYSA-N 0.000 description 1
- IAGAGOZYIUZZGA-UHFFFAOYSA-N 4-[5-ethynyl-6-(2-fluoro-4-methoxyphenoxy)pyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound FC1=CC(OC)=CC=C1OC1=NC=NC(OC2CCN(CC2)C(O)=O)=C1C#C IAGAGOZYIUZZGA-UHFFFAOYSA-N 0.000 description 1
- WKETTYXQHDGAGU-UHFFFAOYSA-N 4-[5-ethynyl-6-(2-fluoro-4-methylsulfonylphenoxy)pyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound C(#C)C=1C(=NC=NC=1OC1=C(C=C(C=C1)S(=O)(=O)C)F)OC1CCN(CC1)C(=O)O WKETTYXQHDGAGU-UHFFFAOYSA-N 0.000 description 1
- WUAPNOGRFMNQBW-UHFFFAOYSA-N 4-[5-ethynyl-6-[1-(3-propan-2-yl-1,2,4-oxadiazol-5-yl)piperidin-4-yl]oxypyrimidin-4-yl]oxy-3-fluorobenzonitrile Chemical compound CC(C)C1=NOC(N2CCC(CC2)OC=2C(=C(OC=3C(=CC(=CC=3)C#N)F)N=CN=2)C#C)=N1 WUAPNOGRFMNQBW-UHFFFAOYSA-N 0.000 description 1
- SLRPNLREIRXDJT-UHFFFAOYSA-N 4-[5-ethynyl-6-[2-fluoro-4-(1,2,4-triazol-1-yl)anilino]pyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound C(#C)C=1C(=NC=NC=1NC1=C(C=C(C=C1)N1N=CN=C1)F)OC1CCN(CC1)C(=O)O SLRPNLREIRXDJT-UHFFFAOYSA-N 0.000 description 1
- FXFWYVDQWQXCHW-UHFFFAOYSA-N 4-[5-ethynyl-6-[2-fluoro-4-(1,2,4-triazol-1-yl)phenoxy]pyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound C(#C)C=1C(=NC=NC=1OC1=C(C=C(C=C1)N1N=CN=C1)F)OC1CCN(CC1)C(=O)O FXFWYVDQWQXCHW-UHFFFAOYSA-N 0.000 description 1
- BFHWRIUZAXRELT-UHFFFAOYSA-N 4-[5-ethynyl-6-[2-fluoro-4-(4-methoxypyridin-2-yl)anilino]pyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound C(#C)C=1C(=NC=NC=1NC1=C(C=C(C=C1)C1=NC=CC(=C1)OC)F)OC1CCN(CC1)C(=O)O BFHWRIUZAXRELT-UHFFFAOYSA-N 0.000 description 1
- KBCJLQFMAMWVKH-HSZRJFAPSA-N 4-[5-ethynyl-6-[2-fluoro-4-[2-[(2R)-2-methoxypiperidin-1-yl]ethyl]phenoxy]pyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound C(#C)C=1C(=NC=NC=1OC1=C(C=C(C=C1)CCN1[C@@H](CCCC1)OC)F)OC1CCN(CC1)C(=O)O KBCJLQFMAMWVKH-HSZRJFAPSA-N 0.000 description 1
- CFIWFMOSPYHDJG-UHFFFAOYSA-N 4-[5-methyl-6-(4-methylsulfonylphenoxy)pyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound CS(=O)(=O)C1=CC=C(OC2=C(C(=NC=N2)OC2CCN(CC2)C(=O)O)C)C=C1 CFIWFMOSPYHDJG-UHFFFAOYSA-N 0.000 description 1
- YBUIDTQXLNAXDX-UHFFFAOYSA-N 4-[5-methyl-6-(4-sulfophenoxy)pyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound N1=CN=C(OC=2C=CC(=CC=2)S(O)(=O)=O)C(C)=C1OC1CCN(C(O)=O)CC1 YBUIDTQXLNAXDX-UHFFFAOYSA-N 0.000 description 1
- OXDBLUGATQGVPM-UHFFFAOYSA-N 4-[5-methyl-6-(5-methylsulfonylpyridin-2-yl)oxypyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound CS(=O)(=O)C=1C=CC(=NC=1)OC1=C(C(=NC=N1)OC1CCN(CC1)C(=O)O)C OXDBLUGATQGVPM-UHFFFAOYSA-N 0.000 description 1
- KFGWYMUQHCTAKP-UHFFFAOYSA-N 4-[5-methyl-6-[(2-methyl-6-morpholin-4-ylpyridin-3-yl)amino]pyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound CC=1C(=NC=NC=1NC=1C(=NC(=CC=1)N1CCOCC1)C)OC1CCN(CC1)C(=O)O KFGWYMUQHCTAKP-UHFFFAOYSA-N 0.000 description 1
- HCGZDGWYZIWQIZ-UHFFFAOYSA-N 4-[5-methyl-6-[(4-methyl-6-morpholin-4-ylpyridin-3-yl)amino]pyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound Cc1cc(ncc1Nc1ncnc(OC2CCN(CC2)C(O)=O)c1C)N1CCOCC1 HCGZDGWYZIWQIZ-UHFFFAOYSA-N 0.000 description 1
- FXAOWWSGGHNHHS-UHFFFAOYSA-N 4-[6-(2,3-dihydro-1,4-benzodioxin-6-ylamino)pyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound O1CCOC2=C1C=CC(=C2)NC1=CC(=NC=N1)OC1CCN(CC1)C(=O)O FXAOWWSGGHNHHS-UHFFFAOYSA-N 0.000 description 1
- YOIJRMXWDXJMHO-UHFFFAOYSA-N 4-[6-(2,4-difluoroanilino)pyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound FC1=C(C=CC(=C1)F)NC1=CC(=NC=N1)OC1CCN(CC1)C(=O)O YOIJRMXWDXJMHO-UHFFFAOYSA-N 0.000 description 1
- OYPBLJJWKFJVIS-UHFFFAOYSA-N 4-[6-(2,4-difluorophenoxy)-5-methylpyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound FC1=C(OC2=C(C(=NC=N2)OC2CCN(CC2)C(=O)O)C)C=CC(=C1)F OYPBLJJWKFJVIS-UHFFFAOYSA-N 0.000 description 1
- QTRGZNXITIUHQN-UHFFFAOYSA-N 4-[6-(2,4-dimethoxyanilino)pyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound COC1=C(C=CC(=C1)OC)NC1=CC(=NC=N1)OC1CCN(CC1)C(=O)O QTRGZNXITIUHQN-UHFFFAOYSA-N 0.000 description 1
- JUCQXUOQPWMRCY-UHFFFAOYSA-N 4-[6-(2,5-difluoro-4-methylsulfonylanilino)pyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound FC1=C(C=C(C(=C1)S(=O)(=O)C)F)NC1=CC(=NC=N1)OC1CCN(CC1)C(=O)O JUCQXUOQPWMRCY-UHFFFAOYSA-N 0.000 description 1
- VXFVQUVOKHRQAG-UHFFFAOYSA-N 4-[6-(2,5-difluoro-4-morpholin-4-ylanilino)-5-methylpyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound FC1=C(C=C(C(=C1)N1CCOCC1)F)NC1=C(C(=NC=N1)OC1CCN(CC1)C(=O)O)C VXFVQUVOKHRQAG-UHFFFAOYSA-N 0.000 description 1
- STEKVILNPZVIHZ-UHFFFAOYSA-N 4-[6-(2,5-difluoro-4-morpholin-4-ylanilino)pyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound FC1=C(C=C(C(=C1)N1CCOCC1)F)NC1=CC(=NC=N1)OC1CCN(CC1)C(=O)O STEKVILNPZVIHZ-UHFFFAOYSA-N 0.000 description 1
- AWJDDCUYFDMTTN-UHFFFAOYSA-N 4-[6-(2,5-difluoro-4-propan-2-yloxyanilino)pyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound FC1=C(C=C(C(=C1)OC(C)C)F)NC1=CC(=NC=N1)OC1CCN(CC1)C(=O)O AWJDDCUYFDMTTN-UHFFFAOYSA-N 0.000 description 1
- WHDSXTQOAQIRCU-UHFFFAOYSA-N 4-[6-(2,5-difluoro-4-propoxyanilino)pyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound FC1=C(C=C(C(=C1)OCCC)F)NC1=CC(=NC=N1)OC1CCN(CC1)C(=O)O WHDSXTQOAQIRCU-UHFFFAOYSA-N 0.000 description 1
- AVQQCYUQFKZHOM-UHFFFAOYSA-N 4-[6-(2-amino-4-ethylsulfonylphenoxy)-5-methylpyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound NC1=CC(S(=O)(=O)CC)=CC=C1OC1=NC=NC(OC2CCN(CC2)C(O)=O)=C1C AVQQCYUQFKZHOM-UHFFFAOYSA-N 0.000 description 1
- KBKVMRBVABSDNP-UHFFFAOYSA-N 4-[6-(2-ethynylanilino)pyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound C1CN(C(=O)O)CCC1OC1=CC(NC=2C(=CC=CC=2)C#C)=NC=N1 KBKVMRBVABSDNP-UHFFFAOYSA-N 0.000 description 1
- GEJJMUBCAJTPFO-UHFFFAOYSA-N 4-[6-(2-fluoro-4-iodoanilino)pyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound FC1=C(C=CC(=C1)I)NC1=CC(=NC=N1)OC1CCN(CC1)C(=O)O GEJJMUBCAJTPFO-UHFFFAOYSA-N 0.000 description 1
- HCLJXGGDUVXFSX-UHFFFAOYSA-N 4-[6-(2-fluoro-4-methylsulfonylanilino)-2-methylpyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound C=1C(OC2CCN(CC2)C(O)=O)=NC(C)=NC=1NC1=CC=C(S(C)(=O)=O)C=C1F HCLJXGGDUVXFSX-UHFFFAOYSA-N 0.000 description 1
- XWTXOUOALJMINW-UHFFFAOYSA-N 4-[6-(2-fluoro-4-methylsulfonylanilino)-5-(N'-hydroxycarbamimidoyl)pyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound FC1=C(C=CC(=C1)S(=O)(=O)C)NC1=C(C(=NC=N1)OC1CCN(CC1)C(=O)O)C(NO)=N XWTXOUOALJMINW-UHFFFAOYSA-N 0.000 description 1
- GBJALODQIAJCJN-UHFFFAOYSA-N 4-[6-(2-fluoro-4-methylsulfonylanilino)-5-methylpyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound FC1=C(C=CC(=C1)S(=O)(=O)C)NC1=C(C(=NC=N1)OC1CCN(CC1)C(=O)O)C GBJALODQIAJCJN-UHFFFAOYSA-N 0.000 description 1
- JQKWYFLXRCFRRG-UHFFFAOYSA-N 4-[6-(2-fluoro-4-methylsulfonylanilino)-5-nitropyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound FC1=CC(S(=O)(=O)C)=CC=C1NC1=NC=NC(OC2CCN(CC2)C(O)=O)=C1[N+]([O-])=O JQKWYFLXRCFRRG-UHFFFAOYSA-N 0.000 description 1
- FAHLOGGVRQATRN-UHFFFAOYSA-N 4-[6-(2-fluoro-4-morpholin-4-ylanilino)-5-methylpyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound FC1=C(C=CC(=C1)N1CCOCC1)NC1=C(C(=NC=N1)OC1CCN(CC1)C(=O)O)C FAHLOGGVRQATRN-UHFFFAOYSA-N 0.000 description 1
- IUBFTYDMMRHLMI-UHFFFAOYSA-N 4-[6-(2-fluoro-4-morpholin-4-ylphenoxy)-5-methylpyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound FC1=C(OC2=C(C(=NC=N2)OC2CCN(CC2)C(=O)O)C)C=CC(=C1)N1CCOCC1 IUBFTYDMMRHLMI-UHFFFAOYSA-N 0.000 description 1
- FROLGXRMEWFWDX-UHFFFAOYSA-N 4-[6-(2-fluoro-4-morpholin-4-ylphenoxy)pyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound FC1=C(OC2=CC(=NC=N2)OC2CCN(CC2)C(=O)O)C=CC(=C1)N1CCOCC1 FROLGXRMEWFWDX-UHFFFAOYSA-N 0.000 description 1
- LEKFSNMRVSPPHH-UHFFFAOYSA-N 4-[6-(2-fluoro-4-sulfamoylphenoxy)-5-methylpyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound FC1=C(OC2=C(C(=NC=N2)OC2CCN(CC2)C(=O)O)C)C=CC(=C1)S(N)(=O)=O LEKFSNMRVSPPHH-UHFFFAOYSA-N 0.000 description 1
- CYJLMBMHQQYDHO-UHFFFAOYSA-N 4-[6-(2-fluoro-5-methylanilino)pyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound FC1=C(C=C(C=C1)C)NC1=CC(=NC=N1)OC1CCN(CC1)C(=O)O CYJLMBMHQQYDHO-UHFFFAOYSA-N 0.000 description 1
- DIJHJXKGTJWDMT-UHFFFAOYSA-N 4-[6-(3,4-dimethoxyanilino)pyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound COC1=C(OC)C=C(NC2=NC=NC(OC3CCN(CC3)C(O)=O)=C2)C=C1 DIJHJXKGTJWDMT-UHFFFAOYSA-N 0.000 description 1
- QMTVAQHSHJRQKH-UHFFFAOYSA-N 4-[6-(3,5-dimethoxyanilino)pyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound COC=1C=C(C=C(C=1)OC)NC1=CC(=NC=N1)OC1CCN(CC1)C(=O)O QMTVAQHSHJRQKH-UHFFFAOYSA-N 0.000 description 1
- KTGABWWNCBQJHD-UHFFFAOYSA-N 4-[6-(3-chloro-4-cyanoanilino)pyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound ClC=1C=C(C=CC=1C#N)NC1=CC(=NC=N1)OC1CCN(CC1)C(=O)O KTGABWWNCBQJHD-UHFFFAOYSA-N 0.000 description 1
- BXHVSIQHNPWUNT-UHFFFAOYSA-N 4-[6-(3-chloro-4-fluoroanilino)pyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound ClC=1C=C(C=CC=1F)NC1=CC(=NC=N1)OC1CCN(CC1)C(=O)O BXHVSIQHNPWUNT-UHFFFAOYSA-N 0.000 description 1
- ZNZCJQRPSSYKJU-UHFFFAOYSA-N 4-[6-(3-fluoro-4-hydroxyanilino)pyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound FC=1C=C(C=CC=1O)NC1=CC(=NC=N1)OC1CCN(CC1)C(=O)O ZNZCJQRPSSYKJU-UHFFFAOYSA-N 0.000 description 1
- SYRASDDSADGRKU-UHFFFAOYSA-N 4-[6-(3-fluoro-4-methoxyanilino)pyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound FC=1C=C(C=CC1OC)NC1=CC(=NC=N1)OC1CCN(CC1)C(=O)O SYRASDDSADGRKU-UHFFFAOYSA-N 0.000 description 1
- URGKOYOAPKSJND-UHFFFAOYSA-N 4-[6-(3-fluoro-4-methylanilino)pyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound FC=1C=C(C=CC1C)NC1=CC(=NC=N1)OC1CCN(CC1)C(=O)O URGKOYOAPKSJND-UHFFFAOYSA-N 0.000 description 1
- KCPSQPLLBNHOKG-UHFFFAOYSA-N 4-[6-(3-hydroxy-4-methoxyanilino)pyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound OC=1C=C(C=CC=1OC)NC1=CC(=NC=N1)OC1CCN(CC1)C(=O)O KCPSQPLLBNHOKG-UHFFFAOYSA-N 0.000 description 1
- XGCBEHDIFSWQJZ-UHFFFAOYSA-N 4-[6-(3-iodo-4-methylanilino)pyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound IC=1C=C(C=CC=1C)NC1=CC(=NC=N1)OC1CCN(CC1)C(=O)O XGCBEHDIFSWQJZ-UHFFFAOYSA-N 0.000 description 1
- DCGNEJIPVWTQLV-UHFFFAOYSA-N 4-[6-(4-acetamido-3-methylanilino)pyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound C(C)(=O)NC1=C(C=C(C=C1)NC1=CC(=NC=N1)OC1CCN(CC1)C(=O)O)C DCGNEJIPVWTQLV-UHFFFAOYSA-N 0.000 description 1
- XNEKCAFCMSCCBQ-UHFFFAOYSA-N 4-[6-(4-bromo-2,5-difluoroanilino)-5-methylpyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound N1=CN=C(OC2CCN(CC2)C(O)=O)C(C)=C1NC1=CC(F)=C(Br)C=C1F XNEKCAFCMSCCBQ-UHFFFAOYSA-N 0.000 description 1
- WLIKPBULNMACIU-UHFFFAOYSA-N 4-[6-(4-bromo-2-fluorophenoxy)-5-methylpyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound BrC1=CC(=C(OC2=C(C(=NC=N2)OC2CCN(CC2)C(=O)O)C)C=C1)F WLIKPBULNMACIU-UHFFFAOYSA-N 0.000 description 1
- BGAOXHJQLTYGGR-UHFFFAOYSA-N 4-[6-(4-carbamimidoyl-2,5-difluoroanilino)-5-methylpyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound N1=CN=C(OC2CCN(CC2)C(O)=O)C(C)=C1NC1=CC(F)=C(C(N)=N)C=C1F BGAOXHJQLTYGGR-UHFFFAOYSA-N 0.000 description 1
- NHBKGIYENRMAJP-UHFFFAOYSA-N 4-[6-(4-carbamoyl-2,5-difluoroanilino)-5-methylpyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound C(N)(=O)C1=CC(=C(C=C1F)NC1=C(C(=NC=N1)OC1CCN(CC1)C(=O)O)C)F NHBKGIYENRMAJP-UHFFFAOYSA-N 0.000 description 1
- IPXWVZRMRBZAJJ-UHFFFAOYSA-N 4-[6-(4-carbamoyl-2-fluorophenoxy)-5-methylpyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound C(N)(=O)C1=CC(=C(OC2=C(C(=NC=N2)OC2CCN(CC2)C(=O)O)C)C=C1)F IPXWVZRMRBZAJJ-UHFFFAOYSA-N 0.000 description 1
- NWVOGALLQSFVCY-UHFFFAOYSA-N 4-[6-(4-carboxy-2-fluorophenoxy)-5-methylpyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound C(=O)(O)C1=CC(=C(OC2=C(C(=NC=N2)OC2CCN(CC2)C(=O)O)C)C=C1)F NWVOGALLQSFVCY-UHFFFAOYSA-N 0.000 description 1
- XIRFGSQKPUHEGH-UHFFFAOYSA-N 4-[6-(4-chloro-2-fluoroanilino)pyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound ClC1=CC(=C(C=C1)NC1=CC(=NC=N1)OC1CCN(CC1)C(=O)O)F XIRFGSQKPUHEGH-UHFFFAOYSA-N 0.000 description 1
- NCBZLFHESBZDHY-UHFFFAOYSA-N 4-[6-(4-cyano-2,5-difluoroanilino)-5-methylpyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound C(#N)C1=CC(=C(C=C1F)NC1=C(C(=NC=N1)OC1CCN(CC1)C(=O)O)C)F NCBZLFHESBZDHY-UHFFFAOYSA-N 0.000 description 1
- KNWFLOYJXDXYPW-UHFFFAOYSA-N 4-[6-(4-cyano-2-fluoroanilino)-5-ethynylpyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound C(#N)C1=CC(=C(C=C1)NC1=C(C(=NC=N1)OC1CCN(CC1)C(=O)O)C#C)F KNWFLOYJXDXYPW-UHFFFAOYSA-N 0.000 description 1
- BUBBCTXROWLIDO-UHFFFAOYSA-N 4-[6-(4-cyano-2-fluoroanilino)-5-methylpyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound C(#N)C1=CC(=C(C=C1)NC1=C(C(=NC=N1)OC1CCN(CC1)C(=O)O)C)F BUBBCTXROWLIDO-UHFFFAOYSA-N 0.000 description 1
- NIWCJQDURVAGBD-UHFFFAOYSA-N 4-[6-(4-cyano-2-fluorophenoxy)-5-methylpyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound C(#N)C1=CC(=C(OC2=C(C(=NC=N2)OC2CCN(CC2)C(=O)O)C)C=C1)F NIWCJQDURVAGBD-UHFFFAOYSA-N 0.000 description 1
- MXFYDKPVNMBTQE-UHFFFAOYSA-N 4-[6-(4-cyano-2-methylanilino)pyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound C(#N)C1=CC(=C(C=C1)NC1=CC(=NC=N1)OC1CCN(CC1)C(=O)O)C MXFYDKPVNMBTQE-UHFFFAOYSA-N 0.000 description 1
- PETMIGWSZDXDGL-UHFFFAOYSA-N 4-[6-(4-cyano-3-methoxyanilino)pyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound C(#N)C1=C(C=C(C=C1)NC1=CC(=NC=N1)OC1CCN(CC1)C(=O)O)OC PETMIGWSZDXDGL-UHFFFAOYSA-N 0.000 description 1
- FVMNJKTXBILXQZ-UHFFFAOYSA-N 4-[6-(4-ethoxy-2,5-difluoroanilino)pyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound C(C)OC1=CC(=C(C=C1F)NC1=CC(=NC=N1)OC1CCN(CC1)C(=O)O)F FVMNJKTXBILXQZ-UHFFFAOYSA-N 0.000 description 1
- OQAOMYGOTZMLJF-UHFFFAOYSA-N 4-[6-(4-ethylsulfanylanilino)pyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound C(C)SC1=CC=C(C=C1)NC1=CC(=NC=N1)OC1CCN(CC1)C(=O)O OQAOMYGOTZMLJF-UHFFFAOYSA-N 0.000 description 1
- IBZLIFVESNLZKZ-UHFFFAOYSA-N 4-[6-(4-iodo-2-methylanilino)pyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound IC1=CC(=C(C=C1)NC1=CC(=NC=N1)OC1CCN(CC1)C(=O)O)C IBZLIFVESNLZKZ-UHFFFAOYSA-N 0.000 description 1
- GZHRXWPJEZLZOZ-UHFFFAOYSA-N 4-[6-(4-methoxy-2-methylanilino)pyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound COC1=CC(=C(C=C1)NC1=CC(=NC=N1)OC1CCN(CC1)C(=O)O)C GZHRXWPJEZLZOZ-UHFFFAOYSA-N 0.000 description 1
- VMJPEEFKZTXPAX-UHFFFAOYSA-N 4-[6-(4-methylsulfonylanilino)pyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound CS(=O)(=O)C1=CC=C(C=C1)NC1=CC(=NC=N1)OC1CCN(CC1)C(=O)O VMJPEEFKZTXPAX-UHFFFAOYSA-N 0.000 description 1
- NACIVPYKIIIEOR-UHFFFAOYSA-N 4-[6-(4-piperidin-1-ylanilino)pyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound N1(CCCCC1)C1=CC=C(C=C1)NC1=CC(=NC=N1)OC1CCN(CC1)C(=O)O NACIVPYKIIIEOR-UHFFFAOYSA-N 0.000 description 1
- KJEXTMXEHIJOQC-UHFFFAOYSA-N 4-[6-(5-iodopyridin-2-yl)oxy-5-methylpyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound IC=1C=CC(=NC=1)OC1=C(C(=NC=N1)OC1CCN(CC1)C(=O)O)C KJEXTMXEHIJOQC-UHFFFAOYSA-N 0.000 description 1
- JXRZNFNQLZAYBV-UHFFFAOYSA-N 4-[6-(N-acetyl-2-fluoro-4-methylsulfonylanilino)pyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound C(C)(=O)N(C1=CC(=NC=N1)OC1CCN(CC1)C(=O)O)C1=C(C=C(C=C1)S(=O)(=O)C)F JXRZNFNQLZAYBV-UHFFFAOYSA-N 0.000 description 1
- HLXAYTMHIFEDME-UHFFFAOYSA-N 4-[6-(N-acetyl-4-methylsulfonylanilino)pyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound C(C)(=O)N(C1=CC(=NC=N1)OC1CCN(CC1)C(=O)O)C1=CC=C(C=C1)S(=O)(=O)C HLXAYTMHIFEDME-UHFFFAOYSA-N 0.000 description 1
- BIUGUXLGXCKAEC-UHFFFAOYSA-N 4-[6-(dimethylamino)-1-(4-methylsulfonylphenyl)pyrazolo[3,4-d]pyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound C=12C=NN(C=3C=CC(=CC=3)S(C)(=O)=O)C2=NC(N(C)C)=NC=1OC1CCN(C(O)=O)CC1 BIUGUXLGXCKAEC-UHFFFAOYSA-N 0.000 description 1
- IGJCXUAMNDXPFU-UHFFFAOYSA-N 4-[6-(pyridin-3-ylamino)pyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound OC(=O)N1CCC(CC1)OC1=CC(NC2=CC=CN=C2)=NC=N1 IGJCXUAMNDXPFU-UHFFFAOYSA-N 0.000 description 1
- GQIQMAKBSRJVRI-UHFFFAOYSA-N 4-[6-(pyridin-4-ylamino)pyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound N1=CC=C(C=C1)NC1=CC(=NC=N1)OC1CCN(CC1)C(=O)O GQIQMAKBSRJVRI-UHFFFAOYSA-N 0.000 description 1
- OULBZZHWUVTOIN-UHFFFAOYSA-N 4-[6-[(1-oxo-2,3-dihydroinden-5-yl)amino]pyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound O=C1CCC2=CC(=CC=C12)NC1=CC(=NC=N1)OC1CCN(CC1)C(=O)O OULBZZHWUVTOIN-UHFFFAOYSA-N 0.000 description 1
- FGVXMGCMCSSVEN-UHFFFAOYSA-N 4-[6-[(2-chloro-4-methylpyridin-3-yl)amino]pyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound ClC1=NC=CC(=C1NC1=CC(=NC=N1)OC1CCN(CC1)C(=O)O)C FGVXMGCMCSSVEN-UHFFFAOYSA-N 0.000 description 1
- AAIUTKLRHDOOFH-UHFFFAOYSA-N 4-[6-[(2-fluoropyridin-3-yl)amino]pyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound FC1=NC=CC=C1NC1=CC(=NC=N1)OC1CCN(CC1)C(=O)O AAIUTKLRHDOOFH-UHFFFAOYSA-N 0.000 description 1
- SGQRLNUSYQPAPK-UHFFFAOYSA-N 4-[6-[(2-methoxypyridin-3-yl)amino]pyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound COC1=NC=CC=C1NC1=CC(=NC=N1)OC1CCN(CC1)C(=O)O SGQRLNUSYQPAPK-UHFFFAOYSA-N 0.000 description 1
- FXISZGFWQJEKMX-UHFFFAOYSA-N 4-[6-[(2-methyl-6-propoxypyridin-3-yl)amino]pyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound CC1=NC(=CC=C1NC1=CC(=NC=N1)OC1CCN(CC1)C(=O)O)OCCC FXISZGFWQJEKMX-UHFFFAOYSA-N 0.000 description 1
- MVZRETLTLLVZCD-UHFFFAOYSA-N 4-[6-[(2-methylpyrazol-3-yl)amino]pyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound CN1N=CC=C1NC1=CC(=NC=N1)OC1CCN(CC1)C(=O)O MVZRETLTLLVZCD-UHFFFAOYSA-N 0.000 description 1
- DMBGKLJPHVCFJE-UHFFFAOYSA-N 4-[6-[(2-methylpyridin-4-yl)amino]pyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound CC1=NC=CC(=C1)NC1=CC(=NC=N1)OC1CCN(CC1)C(=O)O DMBGKLJPHVCFJE-UHFFFAOYSA-N 0.000 description 1
- JDLIZAVFXWAARC-UHFFFAOYSA-N 4-[6-[(2-methylsulfanyl-1,3-benzothiazol-6-yl)amino]pyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound CSC=1SC2=C(N=1)C=CC(=C2)NC1=CC(=NC=N1)OC1CCN(CC1)C(=O)O JDLIZAVFXWAARC-UHFFFAOYSA-N 0.000 description 1
- UCXCRELDYAJMOQ-UHFFFAOYSA-N 4-[6-[(2-phenylpyrazol-3-yl)amino]pyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound C1CN(C(=O)O)CCC1OC1=CC(NC=2N(N=CC=2)C=2C=CC=CC=2)=NC=N1 UCXCRELDYAJMOQ-UHFFFAOYSA-N 0.000 description 1
- WMJORCHFKCFYNX-UHFFFAOYSA-N 4-[6-[(3,5-dimethyl-1,2-oxazol-4-yl)amino]pyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound CC1=NOC(=C1NC1=CC(=NC=N1)OC1CCN(CC1)C(=O)O)C WMJORCHFKCFYNX-UHFFFAOYSA-N 0.000 description 1
- YVGIZMOFWYQKFI-UHFFFAOYSA-N 4-[6-[(5-bromo-3-methylpyridin-2-yl)amino]pyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound BrC=1C=C(C(=NC=1)NC1=CC(=NC=N1)OC1CCN(CC1)C(=O)O)C YVGIZMOFWYQKFI-UHFFFAOYSA-N 0.000 description 1
- UZYVBVMXUNOQFN-UHFFFAOYSA-N 4-[6-[(5-chloro-3-methylpyridin-2-yl)amino]pyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound ClC=1C=C(C(=NC=1)NC1=CC(=NC=N1)OC1CCN(CC1)C(=O)O)C UZYVBVMXUNOQFN-UHFFFAOYSA-N 0.000 description 1
- PMOVQNPJQJNRGC-UHFFFAOYSA-N 4-[6-[(5-cyanopyridin-2-yl)amino]pyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound C(#N)C=1C=CC(=NC=1)NC1=CC(=NC=N1)OC1CCN(CC1)C(=O)O PMOVQNPJQJNRGC-UHFFFAOYSA-N 0.000 description 1
- RLPDLUQAMMEKBS-UHFFFAOYSA-N 4-[6-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]pyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound C1(CC1)C1=CC(=NN1)NC1=CC(=NC=N1)OC1CCN(CC1)C(=O)O RLPDLUQAMMEKBS-UHFFFAOYSA-N 0.000 description 1
- OZLMGHDGAACIJG-UHFFFAOYSA-N 4-[6-[(5-fluoro-4-methylpyridin-2-yl)amino]pyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound C1=C(F)C(C)=CC(NC=2N=CN=C(OC3CCN(CC3)C(O)=O)C=2)=N1 OZLMGHDGAACIJG-UHFFFAOYSA-N 0.000 description 1
- JJDUJIHRJLNVHO-UHFFFAOYSA-N 4-[6-[(5-fluoropyridin-2-yl)amino]pyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound FC=1C=CC(=NC=1)NC1=CC(=NC=N1)OC1CCN(CC1)C(=O)O JJDUJIHRJLNVHO-UHFFFAOYSA-N 0.000 description 1
- YYHRFZPRYNHIQN-UHFFFAOYSA-N 4-[6-[(5-oxo-1-phenylpyrazolidin-3-ylidene)amino]pyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound O=C1CC(=NN1C1=CC=CC=C1)NC1=CC(=NC=N1)OC1CCN(CC1)C(=O)O YYHRFZPRYNHIQN-UHFFFAOYSA-N 0.000 description 1
- KLOLSKMYIJDMIW-UHFFFAOYSA-N 4-[6-[(5-oxo-7,8-dihydro-6H-naphthalen-2-yl)amino]pyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound O=C1C=2C=CC(=CC=2CCC1)NC1=CC(=NC=N1)OC1CCN(CC1)C(=O)O KLOLSKMYIJDMIW-UHFFFAOYSA-N 0.000 description 1
- CCSVIXFSYWQAFC-UHFFFAOYSA-N 4-[6-[(5-pyridin-2-ylthiophen-2-yl)methylamino]pyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound N1=C(C=CC=C1)C1=CC=C(S1)CNC1=CC(=NC=N1)OC1CCN(CC1)C(=O)O CCSVIXFSYWQAFC-UHFFFAOYSA-N 0.000 description 1
- LVAXOVURHUSQMS-UHFFFAOYSA-N 4-[6-[(5-tert-butyl-1H-pyrazol-3-yl)amino]pyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound C(C)(C)(C)C1=CC(=NN1)NC1=CC(=NC=N1)OC1CCN(CC1)C(=O)O LVAXOVURHUSQMS-UHFFFAOYSA-N 0.000 description 1
- FGBPBWHMTQXUBQ-UHFFFAOYSA-N 4-[6-[(6-acetamido-4-methylpyridin-3-yl)amino]pyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound C(C)(=O)NC1=CC(=C(C=N1)NC1=CC(=NC=N1)OC1CCN(CC1)C(=O)O)C FGBPBWHMTQXUBQ-UHFFFAOYSA-N 0.000 description 1
- LBGWMKCXITXGJD-UHFFFAOYSA-N 4-[6-[(6-chloro-2-methylpyridin-3-yl)amino]-5-methylpyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound CC1=NC(Cl)=CC=C1NC1=NC=NC(OC2CCN(CC2)C(O)=O)=C1C LBGWMKCXITXGJD-UHFFFAOYSA-N 0.000 description 1
- LALUSZJQFLDTQB-UHFFFAOYSA-N 4-[6-[(6-chloro-2-methylpyridin-3-yl)amino]pyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound ClC1=CC=C(C(=N1)C)NC1=CC(=NC=N1)OC1CCN(CC1)C(=O)O LALUSZJQFLDTQB-UHFFFAOYSA-N 0.000 description 1
- WJUSAAPJXAVBAA-UHFFFAOYSA-N 4-[6-[(6-chloro-4-methylpyridin-3-yl)amino]-5-methylpyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound ClC1=CC(=C(C=N1)NC1=C(C(=NC=N1)OC1CCN(CC1)C(=O)O)C)C WJUSAAPJXAVBAA-UHFFFAOYSA-N 0.000 description 1
- KNMQDBOZQSXPBK-UHFFFAOYSA-N 4-[6-[(6-chloro-5-methylpyridin-3-yl)amino]pyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound ClC1=C(C=C(C=N1)NC1=CC(=NC=N1)OC1CCN(CC1)C(=O)O)C KNMQDBOZQSXPBK-UHFFFAOYSA-N 0.000 description 1
- HVMIWDBTDKGPAT-UHFFFAOYSA-N 4-[6-[(6-chloropyridin-3-yl)amino]pyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound ClC1=CC=C(C=N1)NC1=CC(=NC=N1)OC1CCN(CC1)C(=O)O HVMIWDBTDKGPAT-UHFFFAOYSA-N 0.000 description 1
- QKTKCMPGVQYGSF-UHFFFAOYSA-N 4-[6-[(6-cyanopyridin-3-yl)amino]pyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound C(#N)C1=CC=C(C=N1)NC1=CC(=NC=N1)OC1CCN(CC1)C(=O)O QKTKCMPGVQYGSF-UHFFFAOYSA-N 0.000 description 1
- YNHPVLFLSAMFEL-UHFFFAOYSA-N 4-[6-[(6-fluoro-5-methylpyridin-3-yl)amino]pyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound FC1=C(C=C(C=N1)NC1=CC(=NC=N1)OC1CCN(CC1)C(=O)O)C YNHPVLFLSAMFEL-UHFFFAOYSA-N 0.000 description 1
- YHAINYCHPNZIQC-UHFFFAOYSA-N 4-[6-[(6-fluoropyridin-3-yl)amino]pyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound C1CN(C(=O)O)CCC1OC1=CC(NC=2C=NC(F)=CC=2)=NC=N1 YHAINYCHPNZIQC-UHFFFAOYSA-N 0.000 description 1
- QTZHNLLROTVKTR-UHFFFAOYSA-N 4-[6-[(6-methyl-1h-pyrazolo[3,4-b]pyridin-3-yl)amino]pyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound N=1NC2=NC(C)=CC=C2C=1NC(N=CN=1)=CC=1OC1CCN(C(O)=O)CC1 QTZHNLLROTVKTR-UHFFFAOYSA-N 0.000 description 1
- JFMQUVIQNSEWOO-UHFFFAOYSA-N 4-[6-[(6-methylsulfonylpyridin-3-yl)amino]-5-nitropyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound CS(=O)(=O)C1=CC=C(C=N1)NC1=C(C(=NC=N1)OC1CCN(CC1)C(=O)O)[N+](=O)[O-] JFMQUVIQNSEWOO-UHFFFAOYSA-N 0.000 description 1
- JYKMDRFQLPHQSH-UHFFFAOYSA-N 4-[6-[(6-morpholin-4-ylpyridin-3-yl)amino]pyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound N1(CCOCC1)C1=CC=C(C=N1)NC1=CC(=NC=N1)OC1CCN(CC1)C(=O)O JYKMDRFQLPHQSH-UHFFFAOYSA-N 0.000 description 1
- WUISWVBXEFCHFM-UHFFFAOYSA-N 4-[6-[2,5-difluoro-4-(2-methoxyethylamino)anilino]pyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound FC1=C(C=C(C(=C1)NCCOC)F)NC1=CC(=NC=N1)OC1CCN(CC1)C(=O)O WUISWVBXEFCHFM-UHFFFAOYSA-N 0.000 description 1
- RHRBNAMUCBRWIC-UHFFFAOYSA-N 4-[6-[2,5-difluoro-4-(2-morpholin-4-ylethoxy)anilino]pyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound FC1=C(C=C(C(=C1)OCCN1CCOCC1)F)NC1=CC(=NC=N1)OC1CCN(CC1)C(=O)O RHRBNAMUCBRWIC-UHFFFAOYSA-N 0.000 description 1
- PBZCCTVBFWHART-UHFFFAOYSA-N 4-[6-[2,5-difluoro-4-(2-morpholin-4-ylethylamino)anilino]pyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound C1CN(C(=O)O)CCC1OC1=CC(NC=2C(=CC(NCCN3CCOCC3)=C(F)C=2)F)=NC=N1 PBZCCTVBFWHART-UHFFFAOYSA-N 0.000 description 1
- CIOURZYRVLTQHX-UHFFFAOYSA-N 4-[6-[2,5-difluoro-4-(2-pyrrolidin-1-ylethoxy)anilino]pyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound FC1=C(C=C(C(=C1)OCCN1CCCC1)F)NC1=CC(=NC=N1)OC1CCN(CC1)C(=O)O CIOURZYRVLTQHX-UHFFFAOYSA-N 0.000 description 1
- DAJLAXMHPUPJDT-UHFFFAOYSA-N 4-[6-[2,5-difluoro-4-(3-methylbutylamino)anilino]pyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound FC1=C(C=C(C(=C1)NCCC(C)C)F)NC1=CC(=NC=N1)OC1CCN(CC1)C(=O)O DAJLAXMHPUPJDT-UHFFFAOYSA-N 0.000 description 1
- ZVRPDKFWVINCMK-UHFFFAOYSA-N 4-[6-[2,5-difluoro-4-(4-methylpiperazin-1-yl)anilino]pyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound FC1=C(C=C(C(=C1)N1CCN(CC1)C)F)NC1=CC(=NC=N1)OC1CCN(CC1)C(=O)O ZVRPDKFWVINCMK-UHFFFAOYSA-N 0.000 description 1
- SIYLYOZKHJHFRY-UHFFFAOYSA-N 4-[6-[2,5-difluoro-4-(oxolan-2-ylmethoxy)anilino]pyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound FC1=C(C=C(C(=C1)OCC1OCCC1)F)NC1=CC(=NC=N1)OC1CCN(CC1)C(=O)O SIYLYOZKHJHFRY-UHFFFAOYSA-N 0.000 description 1
- HLVCBRFCZTVKPE-UHFFFAOYSA-N 4-[6-[2,5-difluoro-4-(oxolan-2-ylmethylamino)anilino]pyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound FC1=C(C=C(C(=C1)NCC1OCCC1)F)NC1=CC(=NC=N1)OC1CCN(CC1)C(=O)O HLVCBRFCZTVKPE-UHFFFAOYSA-N 0.000 description 1
- TWHUZSFRRUJJKR-UHFFFAOYSA-N 4-[6-[2,5-difluoro-4-(propylamino)anilino]pyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound FC1=C(C=C(C(=C1)NCCC)F)NC1=CC(=NC=N1)OC1CCN(CC1)C(=O)O TWHUZSFRRUJJKR-UHFFFAOYSA-N 0.000 description 1
- JACOQDGTMQQZCC-UHFFFAOYSA-N 4-[6-[2,5-difluoro-4-[(Z)-N'-hydroxycarbamimidoyl]anilino]-5-methylpyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound FC1=C(C=C(C(=C1)C(NO)=N)F)NC1=C(C(=NC=N1)OC1CCN(CC1)C(=O)O)C JACOQDGTMQQZCC-UHFFFAOYSA-N 0.000 description 1
- MJTLPWULFVWREQ-UHFFFAOYSA-N 4-[6-[2,5-difluoro-4-[2-(1,2,4-triazol-1-yl)ethyl]anilino]-5-methylpyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound FC1=C(C=C(C(=C1)CCN1N=CN=C1)F)NC1=C(C(=NC=N1)OC1CCN(CC1)C(=O)O)C MJTLPWULFVWREQ-UHFFFAOYSA-N 0.000 description 1
- MYYVTNVFDUJADH-UHFFFAOYSA-N 4-[6-[2-(2,5-difluorophenoxy)ethylamino]pyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound FC1=C(OCCNC2=CC(=NC=N2)OC2CCN(CC2)C(=O)O)C=C(C=C1)F MYYVTNVFDUJADH-UHFFFAOYSA-N 0.000 description 1
- MCROTOACFDLDMF-UHFFFAOYSA-N 4-[6-[2-fluoro-4-(2-hydroxyethoxy)anilino]-5-methylpyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound FC1=C(C=CC(=C1)OCCO)NC1=C(C(=NC=N1)OC1CCN(CC1)C(=O)O)C MCROTOACFDLDMF-UHFFFAOYSA-N 0.000 description 1
- AJEXXRCJPJMTEH-UHFFFAOYSA-N 4-[6-[2-fluoro-4-(2-imidazol-1-ylethyl)phenoxy]-5-methylpyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound FC1=C(OC2=C(C(=NC=N2)OC2CCN(CC2)C(=O)O)C)C=CC(=C1)CCN1C=NC=C1 AJEXXRCJPJMTEH-UHFFFAOYSA-N 0.000 description 1
- NGMCRNJTMDUGAJ-UHFFFAOYSA-N 4-[6-[2-fluoro-4-(2-methoxyethoxy)anilino]-5-methylpyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound FC1=CC(OCCOC)=CC=C1NC1=NC=NC(OC2CCN(CC2)C(O)=O)=C1C NGMCRNJTMDUGAJ-UHFFFAOYSA-N 0.000 description 1
- KDMRJIFTGLAZSG-UHFFFAOYSA-N 4-[6-[2-fluoro-4-(2-methoxyethylamino)anilino]-5-methylpyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound FC1=CC(NCCOC)=CC=C1NC1=NC=NC(OC2CCN(CC2)C(O)=O)=C1C KDMRJIFTGLAZSG-UHFFFAOYSA-N 0.000 description 1
- GEESTTGNULVBLK-UHFFFAOYSA-N 4-[6-[2-fluoro-4-(2-methoxyethylcarbamoyl)phenoxy]-5-methylpyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound FC1=C(OC2=C(C(=NC=N2)OC2CCN(CC2)C(=O)O)C)C=CC(=C1)C(NCCOC)=O GEESTTGNULVBLK-UHFFFAOYSA-N 0.000 description 1
- GWKJFFRBRZKVQE-UHFFFAOYSA-N 4-[6-[2-fluoro-4-(2-methylsulfonylethyl)anilino]-5-methylpyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound FC1=C(C=CC(=C1)CCS(=O)(=O)C)NC1=C(C(=NC=N1)OC1CCN(CC1)C(=O)O)C GWKJFFRBRZKVQE-UHFFFAOYSA-N 0.000 description 1
- LKXHMTIVCXAWOA-UHFFFAOYSA-N 4-[6-[2-fluoro-4-(2-methylsulfonylethyl)phenoxy]-5-methylpyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound FC1=C(OC2=C(C(=NC=N2)OC2CCN(CC2)C(=O)O)C)C=CC(=C1)CCS(=O)(=O)C LKXHMTIVCXAWOA-UHFFFAOYSA-N 0.000 description 1
- YFAUEXQPFFLUKF-UHFFFAOYSA-N 4-[6-[2-fluoro-4-(2-morpholin-4-yl-2-oxoethyl)phenoxy]-5-methylpyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound N1=CN=C(OC=2C(=CC(CC(=O)N3CCOCC3)=CC=2)F)C(C)=C1OC1CCN(C(O)=O)CC1 YFAUEXQPFFLUKF-UHFFFAOYSA-N 0.000 description 1
- KINRBMRINWDLKS-UHFFFAOYSA-N 4-[6-[2-fluoro-4-(2-morpholin-4-ylethyl)phenoxy]-5-methylpyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound FC1=C(OC2=C(C(=NC=N2)OC2CCN(CC2)C(=O)O)C)C=CC(=C1)CCN1CCOCC1 KINRBMRINWDLKS-UHFFFAOYSA-N 0.000 description 1
- ZRJIGRXFVRTVQL-UHFFFAOYSA-N 4-[6-[2-fluoro-4-(2-phosphonooxyethyl)phenoxy]-5-methylpyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound FC1=C(OC2=C(C(=NC=N2)OC2CCN(CC2)C(=O)O)C)C=CC(=C1)CCOP(=O)(O)O ZRJIGRXFVRTVQL-UHFFFAOYSA-N 0.000 description 1
- KLWBMXNBGHVCCW-UHFFFAOYSA-N 4-[6-[2-fluoro-4-(2-propan-2-yloxyethoxy)phenoxy]-5-methylpyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound CC(C)OCCOc1ccc(Oc2ncnc(OC3CCN(CC3)C(O)=O)c2C)c(F)c1 KLWBMXNBGHVCCW-UHFFFAOYSA-N 0.000 description 1
- MRGBRUNTAISNQK-UHFFFAOYSA-N 4-[6-[2-fluoro-4-(2-propan-2-yloxyethylamino)phenoxy]-5-methylpyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound FC1=C(OC2=C(C(=NC=N2)OC2CCN(CC2)C(=O)O)C)C=CC(=C1)NCCOC(C)C MRGBRUNTAISNQK-UHFFFAOYSA-N 0.000 description 1
- QWLANLFHXWZBGV-UHFFFAOYSA-N 4-[6-[2-fluoro-4-(2-propan-2-yloxyethylcarbamoyl)phenoxy]-5-methylpyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound FC1=C(OC2=C(C(=NC=N2)OC2CCN(CC2)C(=O)O)C)C=CC(=C1)C(NCCOC(C)C)=O QWLANLFHXWZBGV-UHFFFAOYSA-N 0.000 description 1
- SWCPEOUCMUJQHX-UHFFFAOYSA-N 4-[6-[2-fluoro-4-(2-pyrrolidin-1-ylethylcarbamoyl)phenoxy]-5-methylpyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound FC1=C(OC2=C(C(=NC=N2)OC2CCN(CC2)C(=O)O)C)C=CC(=C1)C(NCCN1CCCC1)=O SWCPEOUCMUJQHX-UHFFFAOYSA-N 0.000 description 1
- OOCMDZCFBDPKFB-UHFFFAOYSA-N 4-[6-[2-fluoro-4-(2-sulfamoylethyl)anilino]-5-methylpyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound N1=CN=C(OC2CCN(CC2)C(O)=O)C(C)=C1NC1=CC=C(CCS(N)(=O)=O)C=C1F OOCMDZCFBDPKFB-UHFFFAOYSA-N 0.000 description 1
- BGDXMVYQHYPZOZ-UHFFFAOYSA-N 4-[6-[2-fluoro-4-(6-methoxypyridin-3-yl)phenoxy]-5-methylpyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound FC1=C(OC2=C(C(=NC=N2)OC2CCN(CC2)C(=O)O)C)C=CC(=C1)C=1C=NC(=CC=1)OC BGDXMVYQHYPZOZ-UHFFFAOYSA-N 0.000 description 1
- XHSHVDIORIWUCH-UHFFFAOYSA-N 4-[6-[2-fluoro-4-(oxan-4-yloxy)anilino]-5-methylpyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound FC1=C(C=CC(=C1)OC1CCOCC1)NC1=C(C(=NC=N1)OC1CCN(CC1)C(=O)O)C XHSHVDIORIWUCH-UHFFFAOYSA-N 0.000 description 1
- SKGBCLUSIYESFM-UHFFFAOYSA-N 4-[6-[2-fluoro-4-(oxolan-2-ylmethoxy)anilino]-5-methylpyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound N1=CN=C(OC2CCN(CC2)C(O)=O)C(C)=C1NC(C(=C1)F)=CC=C1OCC1CCCO1 SKGBCLUSIYESFM-UHFFFAOYSA-N 0.000 description 1
- CFMNQIJKQQPYIU-UHFFFAOYSA-N 4-[6-[2-fluoro-4-(propan-2-ylamino)anilino]pyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound FC1=C(C=CC(=C1)NC(C)C)NC1=CC(=NC=N1)OC1CCN(CC1)C(=O)O CFMNQIJKQQPYIU-UHFFFAOYSA-N 0.000 description 1
- CRYOJKNBPGOXPI-UHFFFAOYSA-N 4-[6-[2-fluoro-4-(propylamino)anilino]-5-methylpyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound FC1=CC(NCCC)=CC=C1NC1=NC=NC(OC2CCN(CC2)C(O)=O)=C1C CRYOJKNBPGOXPI-UHFFFAOYSA-N 0.000 description 1
- TTXPUPVGESBECN-UHFFFAOYSA-N 4-[6-[2-fluoro-4-(propylamino)anilino]pyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound CCCNC1=CC(F)=C(NC2=NC=NC(OC3CCN(CC3)C(O)=O)=C2)C=C1 TTXPUPVGESBECN-UHFFFAOYSA-N 0.000 description 1
- DFEUANXGALKWBQ-UHFFFAOYSA-N 4-[6-[2-fluoro-4-(pyridin-2-ylmethoxy)anilino]-5-methylpyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound FC1=C(C=CC(=C1)OCC1=NC=CC=C1)NC1=C(C(=NC=N1)OC1CCN(CC1)C(=O)O)C DFEUANXGALKWBQ-UHFFFAOYSA-N 0.000 description 1
- UPXQTCWZTYPTGF-UHFFFAOYSA-N 4-[6-[2-fluoro-4-[2-(2-hydroxyethylamino)-2-oxoethyl]phenoxy]-5-methylpyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound FC1=C(OC2=C(C(=NC=N2)OC2CCN(CC2)C(=O)O)C)C=CC(=C1)CC(NCCO)=O UPXQTCWZTYPTGF-UHFFFAOYSA-N 0.000 description 1
- MIXDQCSHHMGLRE-UHFFFAOYSA-N 4-[6-[2-fluoro-4-[2-(2-methylsulfonylpyrrolidin-1-yl)-2-oxoethyl]phenoxy]-5-methylpyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound FC1=C(OC2=C(C(=NC=N2)OC2CCN(CC2)C(=O)O)C)C=CC(=C1)CC(=O)N1C(CCC1)S(=O)(=O)C MIXDQCSHHMGLRE-UHFFFAOYSA-N 0.000 description 1
- RMDRPSOKYFQGEN-UHFFFAOYSA-N 4-[6-[2-fluoro-4-[2-(triazol-1-yl)ethyl]phenoxy]-5-methylpyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound FC1=C(OC2=C(C(=NC=N2)OC2CCN(CC2)C(=O)O)C)C=CC(=C1)CCN1N=NC=C1 RMDRPSOKYFQGEN-UHFFFAOYSA-N 0.000 description 1
- KZRIQTOFKKMEFV-UHFFFAOYSA-N 4-[6-[2-fluoro-4-[2-oxo-2-(oxolan-2-ylmethylamino)ethyl]phenoxy]-5-methylpyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound FC1=C(OC2=C(C(=NC=N2)OC2CCN(CC2)C(=O)O)C)C=CC(=C1)CC(NCC1OCCC1)=O KZRIQTOFKKMEFV-UHFFFAOYSA-N 0.000 description 1
- DUIHTZVJVWBKTO-UHFFFAOYSA-N 4-[6-[2-fluoro-4-[methyl(2-methylsulfonylethyl)amino]anilino]-5-methylpyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound FC1=CC(N(CCS(C)(=O)=O)C)=CC=C1NC1=NC=NC(OC2CCN(CC2)C(O)=O)=C1C DUIHTZVJVWBKTO-UHFFFAOYSA-N 0.000 description 1
- QFCKTUFEMMGCEG-UHFFFAOYSA-N 4-[6-[2-methyl-4-(propylamino)anilino]pyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound CC1=CC(NCCC)=CC=C1NC1=CC(OC2CCN(CC2)C(O)=O)=NC=N1 QFCKTUFEMMGCEG-UHFFFAOYSA-N 0.000 description 1
- RIOTVIQDNPZHCH-UHFFFAOYSA-N 4-[6-[3-(1,3-oxazol-5-yl)anilino]pyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound C1CN(C(=O)O)CCC1OC1=CC(NC=2C=C(C=CC=2)C=2OC=NC=2)=NC=N1 RIOTVIQDNPZHCH-UHFFFAOYSA-N 0.000 description 1
- GVIGJEKAYGENQK-UHFFFAOYSA-N 4-[6-[4-(2-amino-2-oxoethyl)-2-fluorophenoxy]-5-methylpyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound CC1=C(OC2CCN(CC2)C(O)=O)N=CN=C1OC1=C(F)C=C(CC(N)=O)C=C1 GVIGJEKAYGENQK-UHFFFAOYSA-N 0.000 description 1
- JDVKICPNJUXQNB-UHFFFAOYSA-N 4-[6-[4-(2-ethoxyethoxy)-2-fluoroanilino]-5-methylpyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound C(C)OCCOC1=CC(=C(C=C1)NC1=C(C(=NC=N1)OC1CCN(CC1)C(=O)O)C)F JDVKICPNJUXQNB-UHFFFAOYSA-N 0.000 description 1
- LMAAPXAVVXXEET-UHFFFAOYSA-N 4-[6-[4-(butylamino)-2,5-difluoroanilino]pyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound C1=C(F)C(NCCCC)=CC(F)=C1NC1=CC(OC2CCN(CC2)C(O)=O)=NC=N1 LMAAPXAVVXXEET-UHFFFAOYSA-N 0.000 description 1
- XNHWOFJOXJOARK-UHFFFAOYSA-N 4-[6-[4-(carboxymethyl)-2-fluorophenoxy]-2-methylpyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound C=1C(OC=2C(=CC(CC(O)=O)=CC=2)F)=NC(C)=NC=1OC1CCN(C(O)=O)CC1 XNHWOFJOXJOARK-UHFFFAOYSA-N 0.000 description 1
- WATPUTBOZZMQET-UHFFFAOYSA-N 4-[6-[4-(dimethylamino)-2-fluoroanilino]pyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound CN(C1=CC(=C(C=C1)NC1=CC(=NC=N1)OC1CCN(CC1)C(=O)O)F)C WATPUTBOZZMQET-UHFFFAOYSA-N 0.000 description 1
- YNEWACCYCORYPN-UHFFFAOYSA-N 4-[6-[4-(ethylamino)-2-fluoroanilino]pyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound FC1=CC(NCC)=CC=C1NC1=CC(OC2CCN(CC2)C(O)=O)=NC=N1 YNEWACCYCORYPN-UHFFFAOYSA-N 0.000 description 1
- FAMKJESHKQNXSX-UHFFFAOYSA-N 4-[6-[4-[2-(dimethylamino)ethoxy]-2,5-difluoroanilino]pyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound CN(CCOC1=CC(=C(C=C1F)NC1=CC(=NC=N1)OC1CCN(CC1)C(=O)O)F)C FAMKJESHKQNXSX-UHFFFAOYSA-N 0.000 description 1
- ZARNHWGDMDDOEK-UHFFFAOYSA-N 4-[6-[4-bromo-2-(trifluoromethoxy)anilino]pyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound BrC1=CC(=C(C=C1)NC1=CC(=NC=N1)OC1CCN(CC1)C(=O)O)OC(F)(F)F ZARNHWGDMDDOEK-UHFFFAOYSA-N 0.000 description 1
- PWIMYRUIQHXQCE-UHFFFAOYSA-N 4-[6-[4-chloro-2-(trifluoromethoxy)anilino]pyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound C1CN(C(=O)O)CCC1OC1=CC(NC=2C(=CC(Cl)=CC=2)OC(F)(F)F)=NC=N1 PWIMYRUIQHXQCE-UHFFFAOYSA-N 0.000 description 1
- RBQXKQOCUWJRRK-UHFFFAOYSA-N 4-[6-[6-(2-hydroxyethylamino)-2-methylpyridin-3-yl]oxy-5-methylpyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound OCCNC1=CC=C(C(=N1)C)OC1=C(C(=NC=N1)OC1CCN(CC1)C(=O)O)C RBQXKQOCUWJRRK-UHFFFAOYSA-N 0.000 description 1
- GBFVSCASGJDRGW-UHFFFAOYSA-N 4-[6-[6-(2-hydroxyethylsulfanyl)-2-methylpyridin-3-yl]oxy-5-methylpyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound CC1=NC(SCCO)=CC=C1OC1=NC=NC(OC2CCN(CC2)C(O)=O)=C1C GBFVSCASGJDRGW-UHFFFAOYSA-N 0.000 description 1
- ZUNNXLPRXRZAEO-UHFFFAOYSA-N 4-[6-[6-(2-methoxyethylsulfanyl)-2-methylpyridin-3-yl]oxy-5-methylpyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound COCCSC1=CC=C(C(=N1)C)OC1=C(C(=NC=N1)OC1CCN(CC1)C(=O)O)C ZUNNXLPRXRZAEO-UHFFFAOYSA-N 0.000 description 1
- ONLLYVQXKGMDHT-UHFFFAOYSA-N 4-[6-[6-(benzylamino)-2-methylpyridin-3-yl]oxy-5-methylpyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound CC1=NC(NCC2=CC=CC=C2)=CC=C1OC1=NC=NC(OC2CCN(CC2)C(O)=O)=C1C ONLLYVQXKGMDHT-UHFFFAOYSA-N 0.000 description 1
- DXBLCDFBRPXKNW-UHFFFAOYSA-N 4-[6-[[2-methyl-6-(propan-2-ylamino)pyridin-3-yl]amino]pyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound CC1=NC(NC(C)C)=CC=C1NC1=CC(OC2CCN(CC2)C(O)=O)=NC=N1 DXBLCDFBRPXKNW-UHFFFAOYSA-N 0.000 description 1
- RTRWPTTUNMJNNT-UHFFFAOYSA-N 4-[6-[[2-methyl-6-(propylamino)pyridin-3-yl]amino]pyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound CC1=NC(=CC=C1NC1=CC(=NC=N1)OC1CCN(CC1)C(=O)O)NCCC RTRWPTTUNMJNNT-UHFFFAOYSA-N 0.000 description 1
- GRDLOUQNKMXHEN-UHFFFAOYSA-N 4-[6-[[4-(3,4-difluorophenyl)-1,3-thiazol-2-yl]amino]pyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound FC=1C=C(C=CC=1F)C=1N=C(SC=1)NC1=CC(=NC=N1)OC1CCN(CC1)C(=O)O GRDLOUQNKMXHEN-UHFFFAOYSA-N 0.000 description 1
- FWYJRNICUZPYHX-UHFFFAOYSA-N 4-[6-[[4-(benzenesulfonyl)thiophen-3-yl]amino]pyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound C1(=CC=CC=C1)S(=O)(=O)C=1C(=CSC=1)NC1=CC(=NC=N1)OC1CCN(CC1)C(=O)O FWYJRNICUZPYHX-UHFFFAOYSA-N 0.000 description 1
- ZMGHZVMPDHNMQP-UHFFFAOYSA-N 4-[6-[[4-(trifluoromethyl)pyridin-2-yl]amino]pyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound FC(C1=CC(=NC=C1)NC1=CC(=NC=N1)OC1CCN(CC1)C(=O)O)(F)F ZMGHZVMPDHNMQP-UHFFFAOYSA-N 0.000 description 1
- VDSNHIBABKWFDS-UHFFFAOYSA-N 4-[6-[[5-(1-methylpyrrolidin-2-yl)pyridin-2-yl]amino]pyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound CN1C(CCC1)C=1C=CC(=NC=1)NC1=CC(=NC=N1)OC1CCN(CC1)C(=O)O VDSNHIBABKWFDS-UHFFFAOYSA-N 0.000 description 1
- LBPJXSSYSALTGE-UHFFFAOYSA-N 4-[6-[[5-(4-chlorophenyl)-1h-pyrazol-3-yl]amino]pyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound C1CN(C(=O)O)CCC1OC1=CC(NC2=NNC(=C2)C=2C=CC(Cl)=CC=2)=NC=N1 LBPJXSSYSALTGE-UHFFFAOYSA-N 0.000 description 1
- UYJFYEDBARFOBO-UHFFFAOYSA-N 4-[6-[[5-(4-methoxyphenyl)-1,3,4-thiadiazol-2-yl]amino]pyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound COC1=CC=C(C=C1)C1=NN=C(S1)NC1=CC(=NC=N1)OC1CCN(CC1)C(=O)O UYJFYEDBARFOBO-UHFFFAOYSA-N 0.000 description 1
- GHOSIDTVCOATLJ-UHFFFAOYSA-N 4-[6-[[5-(4-methylphenyl)-1h-pyrazol-3-yl]amino]pyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound C1=CC(C)=CC=C1C1=CC(NC=2N=CN=C(OC3CCN(CC3)C(O)=O)C=2)=NN1 GHOSIDTVCOATLJ-UHFFFAOYSA-N 0.000 description 1
- DWIWOPYXUSDUBW-UHFFFAOYSA-N 4-[6-[[5-(trifluoromethyl)pyridin-2-yl]amino]pyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound FC(C=1C=CC(=NC=1)NC1=CC(=NC=N1)OC1CCN(CC1)C(=O)O)(F)F DWIWOPYXUSDUBW-UHFFFAOYSA-N 0.000 description 1
- OKRVASZQANUSGD-UHFFFAOYSA-N 4-[6-[[6-(2-fluoroethyl)-2-methylpyridin-3-yl]amino]-5-methylpyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound FCCC1=CC=C(C(=N1)C)NC1=C(C(=NC=N1)OC1CCN(CC1)C(=O)O)C OKRVASZQANUSGD-UHFFFAOYSA-N 0.000 description 1
- NUTLOBGWDTYMOP-UHFFFAOYSA-N 4-[6-[[6-(2-methoxyethoxy)-4-methylpyridin-3-yl]amino]-5-methylpyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound COCCOC1=CC(=C(C=N1)NC1=C(C(=NC=N1)OC1CCN(CC1)C(=O)O)C)C NUTLOBGWDTYMOP-UHFFFAOYSA-N 0.000 description 1
- ADQYEQYOFQINMF-UHFFFAOYSA-N 4-[6-[methyl-(2-methyl-4,5,6,7-tetrahydroindazol-3-yl)amino]pyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound CN(C1=CC(=NC=N1)OC1CCN(CC1)C(=O)O)C=1N(N=C2CCCCC=12)C ADQYEQYOFQINMF-UHFFFAOYSA-N 0.000 description 1
- OVNDAOUCOMNZSS-UHFFFAOYSA-N 4-[8-(2,5-difluoro-4-methylsulfonylphenyl)pyrido[3,4-d]pyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound C1=C(F)C(S(=O)(=O)C)=CC(F)=C1C(C1=NC=N2)=NC=CC1=C2OC1CCN(C(O)=O)CC1 OVNDAOUCOMNZSS-UHFFFAOYSA-N 0.000 description 1
- BKNYFOLIUVRGFH-UHFFFAOYSA-N 4-[8-(2,5-difluoro-4-methylsulfonylphenyl)quinolin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound C1=C(F)C(S(=O)(=O)C)=CC(F)=C1C(C1=NC=C2)=CC=CC1=C2OC1CCN(C(O)=O)CC1 BKNYFOLIUVRGFH-UHFFFAOYSA-N 0.000 description 1
- BWNXYFLLNNKIDF-UHFFFAOYSA-N 4-[8-(2,5-difluoro-4-sulfamoylphenyl)pyrido[3,4-d]pyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound C1=C(F)C(S(=O)(=O)N)=CC(F)=C1C(C1=NC=N2)=NC=CC1=C2OC1CCN(C(O)=O)CC1 BWNXYFLLNNKIDF-UHFFFAOYSA-N 0.000 description 1
- OZNKIIRVYIRAHS-UHFFFAOYSA-N 4-[8-(2,5-difluoro-4-sulfamoylphenyl)quinolin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound C1=C(F)C(S(=O)(=O)N)=CC(F)=C1C(C1=NC=C2)=CC=CC1=C2OC1CCN(C(O)=O)CC1 OZNKIIRVYIRAHS-UHFFFAOYSA-N 0.000 description 1
- ZXYPMMQQQGADPV-UHFFFAOYSA-N 4-[8-(2-fluoro-4-methylsulfonylphenyl)pyrido[3,4-d]pyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound FC1=CC(S(=O)(=O)C)=CC=C1C(C1=NC=N2)=NC=CC1=C2OC1CCN(C(O)=O)CC1 ZXYPMMQQQGADPV-UHFFFAOYSA-N 0.000 description 1
- ZHSLKVPJSDKOHI-UHFFFAOYSA-N 4-[8-(2-fluoro-4-methylsulfonylphenyl)quinolin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound FC1=CC(S(=O)(=O)C)=CC=C1C(C1=NC=C2)=CC=CC1=C2OC1CCN(C(O)=O)CC1 ZHSLKVPJSDKOHI-UHFFFAOYSA-N 0.000 description 1
- INYKSSBZFKKDGV-UHFFFAOYSA-N 4-[8-(2-fluoro-4-sulfamoylphenyl)pyrido[3,4-d]pyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound FC1=CC(S(=O)(=O)N)=CC=C1C(C1=NC=N2)=NC=CC1=C2OC1CCN(C(O)=O)CC1 INYKSSBZFKKDGV-UHFFFAOYSA-N 0.000 description 1
- QNEWKSZEXAVXAD-UHFFFAOYSA-N 4-[8-(2-fluoro-4-sulfamoylphenyl)quinolin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound FC1=CC(S(=O)(=O)N)=CC=C1C(C1=NC=C2)=CC=CC1=C2OC1CCN(C(O)=O)CC1 QNEWKSZEXAVXAD-UHFFFAOYSA-N 0.000 description 1
- NBDSOMHMMPJZRO-UHFFFAOYSA-N 4-[8-(4-bromo-2-fluorophenyl)quinolin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound C1CN(C(=O)O)CCC1OC1=CC=NC2=C(C=3C(=CC(Br)=CC=3)F)C=CC=C12 NBDSOMHMMPJZRO-UHFFFAOYSA-N 0.000 description 1
- DMXUAHQZWIBCQU-UHFFFAOYSA-N 4-[8-(4-cyano-2-fluorophenyl)pyrido[3,4-d]pyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound C1CN(C(=O)O)CCC1OC1=NC=NC2=C(C=3C(=CC(=CC=3)C#N)F)N=CC=C12 DMXUAHQZWIBCQU-UHFFFAOYSA-N 0.000 description 1
- FXXMBWBVARSHQO-UHFFFAOYSA-N 4-[8-(4-cyano-2-fluorophenyl)quinolin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound C1CN(C(=O)O)CCC1OC1=CC=NC2=C(C=3C(=CC(=CC=3)C#N)F)C=CC=C12 FXXMBWBVARSHQO-UHFFFAOYSA-N 0.000 description 1
- UDOOKOSXGZHZJT-UHFFFAOYSA-N 4-[8-(4-fluoro-6-methoxypyridin-3-yl)pyrido[3,4-d]pyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound C1=NC(OC)=CC(F)=C1C(C1=NC=N2)=NC=CC1=C2OC1CCN(C(O)=O)CC1 UDOOKOSXGZHZJT-UHFFFAOYSA-N 0.000 description 1
- BTYUBESNSUXIJV-UHFFFAOYSA-N 4-[8-(4-fluoro-6-methoxypyridin-3-yl)quinolin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound C1=NC(OC)=CC(F)=C1C(C1=NC=C2)=CC=CC1=C2OC1CCN(C(O)=O)CC1 BTYUBESNSUXIJV-UHFFFAOYSA-N 0.000 description 1
- JOOONLNEXWRIGL-UHFFFAOYSA-N 4-[8-(4-methylsulfanylphenyl)quinolin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound C1=CC(SC)=CC=C1C(C1=NC=C2)=CC=CC1=C2OC1CCN(C(O)=O)CC1 JOOONLNEXWRIGL-UHFFFAOYSA-N 0.000 description 1
- ZAXXSSISSPGJOW-UHFFFAOYSA-N 4-[8-(4-methylsulfonylphenyl)quinolin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound C1=CC(S(=O)(=O)C)=CC=C1C(C1=NC=C2)=CC=CC1=C2OC1CCN(C(O)=O)CC1 ZAXXSSISSPGJOW-UHFFFAOYSA-N 0.000 description 1
- YZJCWTSYUMUZLY-UHFFFAOYSA-N 4-[8-(4-propan-2-yloxyphenyl)quinolin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound C1=CC(OC(C)C)=CC=C1C(C1=NC=C2)=CC=CC1=C2OC1CCN(C(O)=O)CC1 YZJCWTSYUMUZLY-UHFFFAOYSA-N 0.000 description 1
- OLMQUPBSQCKIPF-UHFFFAOYSA-N 4-[8-(6-methoxy-2-methylpyridin-3-yl)pyrido[3,4-d]pyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound CC1=NC(OC)=CC=C1C(C1=NC=N2)=NC=CC1=C2OC1CCN(C(O)=O)CC1 OLMQUPBSQCKIPF-UHFFFAOYSA-N 0.000 description 1
- WODVNFLVFQCCEM-UHFFFAOYSA-N 4-[8-(6-methoxy-2-methylpyridin-3-yl)quinolin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound CC1=NC(OC)=CC=C1C(C1=NC=C2)=CC=CC1=C2OC1CCN(C(O)=O)CC1 WODVNFLVFQCCEM-UHFFFAOYSA-N 0.000 description 1
- BHLQNWMHALWIMV-UHFFFAOYSA-N 4-[8-[2-fluoro-4-(propanoylsulfamoyl)phenyl]pyrido[3,4-d]pyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound FC1=CC(S(=O)(=O)NC(=O)CC)=CC=C1C(C1=NC=N2)=NC=CC1=C2OC1CCN(C(O)=O)CC1 BHLQNWMHALWIMV-UHFFFAOYSA-N 0.000 description 1
- LMIOOFCQQZFTCJ-UHFFFAOYSA-N 4-[8-[2-fluoro-4-(propanoylsulfamoyl)phenyl]quinolin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound FC1=CC(S(=O)(=O)NC(=O)CC)=CC=C1C(C1=NC=C2)=CC=CC1=C2OC1CCN(C(O)=O)CC1 LMIOOFCQQZFTCJ-UHFFFAOYSA-N 0.000 description 1
- ZZDARJZACZVQED-UHFFFAOYSA-N 4-[9-(2,5-difluoro-4-sulfamoylphenyl)purin-6-yl]oxypiperidine-1-carboxylic acid Chemical compound C1=C(F)C(S(=O)(=O)N)=CC(F)=C1N1C2=NC=NC(OC3CCN(CC3)C(O)=O)=C2N=C1 ZZDARJZACZVQED-UHFFFAOYSA-N 0.000 description 1
- JLXRNZRDZDCIDZ-UHFFFAOYSA-N 4-[9-(2-fluoro-4-methylsulfonylphenyl)purin-6-yl]oxypiperidine-1-carboxylic acid Chemical compound FC1=CC(S(=O)(=O)C)=CC=C1N1C2=NC=NC(OC3CCN(CC3)C(O)=O)=C2N=C1 JLXRNZRDZDCIDZ-UHFFFAOYSA-N 0.000 description 1
- GEMZXMHGFAWLIP-UHFFFAOYSA-N 4-[9-(2-fluoro-4-sulfamoylphenyl)purin-6-yl]oxypiperidine-1-carboxylic acid Chemical compound FC1=CC(S(=O)(=O)N)=CC=C1N1C2=NC=NC(OC3CCN(CC3)C(O)=O)=C2N=C1 GEMZXMHGFAWLIP-UHFFFAOYSA-N 0.000 description 1
- IAMHAFLWTCJMQO-UHFFFAOYSA-N 4-[9-(4-cyano-2-fluorophenyl)purin-6-yl]oxypiperidine-1-carboxylic acid Chemical compound C1CN(C(=O)O)CCC1OC1=NC=NC2=C1N=CN2C1=CC=C(C#N)C=C1F IAMHAFLWTCJMQO-UHFFFAOYSA-N 0.000 description 1
- QZCFFYWGAJONKV-UHFFFAOYSA-N 4-[9-(4-methylsulfonylphenyl)purin-6-yl]oxypiperidine-1-carboxylic acid Chemical compound C1=CC(S(=O)(=O)C)=CC=C1N1C2=NC=NC(OC3CCN(CC3)C(O)=O)=C2N=C1 QZCFFYWGAJONKV-UHFFFAOYSA-N 0.000 description 1
- VBKGKGMQJPOGEX-UHFFFAOYSA-N 4-[9-[2-fluoro-4-(propanoylsulfamoyl)phenyl]purin-6-yl]oxypiperidine-1-carboxylic acid Chemical compound FC1=CC(S(=O)(=O)NC(=O)CC)=CC=C1N1C2=NC=NC(OC3CCN(CC3)C(O)=O)=C2N=C1 VBKGKGMQJPOGEX-UHFFFAOYSA-N 0.000 description 1
- YXLDVSFRLDYSCP-UHFFFAOYSA-N 4-[[3-(4-methylsulfonylphenyl)-[1,2]oxazolo[4,5-d]pyrimidin-7-yl]sulfanyl]piperidine-1-carboxylic acid Chemical compound C1=CC(S(=O)(=O)C)=CC=C1C(C1=NC=N2)=NOC1=C2SC1CCN(C(O)=O)CC1 YXLDVSFRLDYSCP-UHFFFAOYSA-N 0.000 description 1
- LQSICFFOXDPWHB-UHFFFAOYSA-N 4-[[6-(2-fluoro-4-methylsulfonylanilino)pyrimidin-4-yl]-methylamino]piperidine-1-carboxylic acid Chemical compound FC1=C(C=CC(=C1)S(=O)(=O)C)NC1=CC(=NC=N1)N(C1CCN(CC1)C(=O)O)C LQSICFFOXDPWHB-UHFFFAOYSA-N 0.000 description 1
- UQFNIGXQAXSHJS-UHFFFAOYSA-N 4-[[6-(2-fluoro-4-methylsulfonylanilino)pyrimidin-4-yl]amino]piperidine-1-carboxylic acid Chemical compound FC1=C(C=CC(=C1)S(=O)(=O)C)NC1=CC(=NC=N1)NC1CCN(CC1)C(=O)O UQFNIGXQAXSHJS-UHFFFAOYSA-N 0.000 description 1
- NCNVAMJVBSZJNE-UHFFFAOYSA-N 4-[[6-(4-methylsulfonylanilino)-5-nitropyrimidin-4-yl]amino]piperidine-1-carboxylic acid Chemical compound C1=CC(S(=O)(=O)C)=CC=C1NC1=NC=NC(NC2CCN(CC2)C(O)=O)=C1[N+]([O-])=O NCNVAMJVBSZJNE-UHFFFAOYSA-N 0.000 description 1
- CAJYJVUJYIAGMP-UHFFFAOYSA-N 4-[[6-(4-methylsulfonylanilino)-5-nitropyrimidin-4-yl]oxymethyl]piperidine-1-carboxylic acid Chemical compound CS(=O)(=O)C1=CC=C(C=C1)NC1=C(C(=NC=N1)OCC1CCN(CC1)C(=O)O)[N+](=O)[O-] CAJYJVUJYIAGMP-UHFFFAOYSA-N 0.000 description 1
- RBPCLDRHRIIJHK-UHFFFAOYSA-N 4-[[8-(2-fluoro-4-methylsulfonylphenyl)-1,7-naphthyridin-4-yl]oxy]piperidine-1-carboxylic acid Chemical compound FC1=CC(S(=O)(=O)C)=CC=C1C(C1=NC=C2)=NC=CC1=C2OC1CCN(C(O)=O)CC1 RBPCLDRHRIIJHK-UHFFFAOYSA-N 0.000 description 1
- ZDZSNNITYOLRRI-UHFFFAOYSA-N 4-[[[1-(4-methylsulfonylphenyl)pyrazolo[3,4-d]pyrimidin-4-yl]amino]methyl]piperidine-1-carboxylic acid Chemical compound C1=CC(S(=O)(=O)C)=CC=C1N1C2=NC=NC(NCC3CCN(CC3)C(O)=O)=C2C=N1 ZDZSNNITYOLRRI-UHFFFAOYSA-N 0.000 description 1
- JXPFHVXRBLURHX-UHFFFAOYSA-N 4-[[[4-(2-fluoro-4-methylsulfonylanilino)pyridin-2-yl]-methylamino]methyl]piperidine-1-carboxylic acid Chemical compound FC1=C(C=CC(=C1)S(=O)(=O)C)NC1=CC(=NC=C1)N(C)CC1CCN(CC1)C(=O)O JXPFHVXRBLURHX-UHFFFAOYSA-N 0.000 description 1
- GWIKYROSBFWBGE-UHFFFAOYSA-N 4-[[[6-(1,3-benzodioxol-5-ylamino)pyrimidin-4-yl]-methylamino]methyl]piperidine-1-carboxylic acid Chemical compound O1COC2=C1C=CC(=C2)NC1=CC(=NC=N1)N(C)CC1CCN(CC1)C(=O)O GWIKYROSBFWBGE-UHFFFAOYSA-N 0.000 description 1
- MBZIOEKRKFEHTA-UHFFFAOYSA-N 4-[[[6-(1,3-benzodioxol-5-ylmethylamino)pyrimidin-4-yl]-methylamino]methyl]piperidine-1-carboxylic acid Chemical compound O1COC2=C1C=CC(=C2)CNC1=CC(=NC=N1)N(C)CC1CCN(CC1)C(=O)O MBZIOEKRKFEHTA-UHFFFAOYSA-N 0.000 description 1
- DGHFIVPHTLAERB-UHFFFAOYSA-N 4-[[[6-(2,3-difluoroanilino)pyrimidin-4-yl]-methylamino]methyl]piperidine-1-carboxylic acid Chemical compound FC1=C(C=CC=C1F)NC1=CC(=NC=N1)N(C)CC1CCN(CC1)C(=O)O DGHFIVPHTLAERB-UHFFFAOYSA-N 0.000 description 1
- KYQRYFZBESQSGS-UHFFFAOYSA-N 4-[[[6-(2,4-difluoroanilino)pyrimidin-4-yl]-methylamino]methyl]piperidine-1-carboxylic acid Chemical compound CN(CC1CCN(CC1)C(O)=O)C1=CC(NC2=C(F)C=C(F)C=C2)=NC=N1 KYQRYFZBESQSGS-UHFFFAOYSA-N 0.000 description 1
- BPBHWASSWGUNGT-UHFFFAOYSA-N 4-[[[6-(2,5-difluoro-4-hydroxyanilino)pyrimidin-4-yl]-methylamino]methyl]piperidine-1-carboxylic acid Chemical compound C=1C(NC=2C(=CC(O)=C(F)C=2)F)=NC=NC=1N(C)CC1CCN(C(O)=O)CC1 BPBHWASSWGUNGT-UHFFFAOYSA-N 0.000 description 1
- IHUDHNLSOMBUBL-UHFFFAOYSA-N 4-[[[6-(2,5-difluoro-4-methoxyanilino)pyrimidin-4-yl]-ethylamino]methyl]piperidine-1-carboxylic acid Chemical compound CCN(CC1CCN(CC1)C(O)=O)C1=CC(NC2=C(F)C=C(OC)C(F)=C2)=NC=N1 IHUDHNLSOMBUBL-UHFFFAOYSA-N 0.000 description 1
- QBUXDDNSENYJLY-UHFFFAOYSA-N 4-[[[6-(2,5-difluoro-4-methylsulfonylanilino)pyrimidin-4-yl]-methylamino]methyl]piperidine-1-carboxylic acid Chemical compound FC1=C(C=C(C(=C1)S(=O)(=O)C)F)NC1=CC(=NC=N1)N(C)CC1CCN(CC1)C(=O)O QBUXDDNSENYJLY-UHFFFAOYSA-N 0.000 description 1
- TVYRVUOLWSLQBX-UHFFFAOYSA-N 4-[[[6-(2,5-difluoroanilino)pyrimidin-4-yl]-methylamino]methyl]piperidine-1-carboxylic acid Chemical compound FC1=C(C=C(C=C1)F)NC1=CC(=NC=N1)N(C)CC1CCN(CC1)C(=O)O TVYRVUOLWSLQBX-UHFFFAOYSA-N 0.000 description 1
- TWSCKMAVMAFPNH-UHFFFAOYSA-N 4-[[[6-(2,5-difluorophenoxy)pyrimidin-4-yl]-methylamino]methyl]piperidine-1-carboxylic acid Chemical compound FC1=C(OC2=CC(=NC=N2)N(C)CC2CCN(CC2)C(=O)O)C=C(C=C1)F TWSCKMAVMAFPNH-UHFFFAOYSA-N 0.000 description 1
- JRGZLMMADSLQEB-UHFFFAOYSA-N 4-[[[6-(2,6-difluoroanilino)pyrimidin-4-yl]-methylamino]methyl]piperidine-1-carboxylic acid Chemical compound FC1=C(C(=CC=C1)F)NC1=CC(=NC=N1)N(C)CC1CCN(CC1)C(=O)O JRGZLMMADSLQEB-UHFFFAOYSA-N 0.000 description 1
- WIDDVPZOIJBVHG-UHFFFAOYSA-N 4-[[[6-(2-chlorophenoxy)pyrimidin-4-yl]-methylamino]methyl]piperidine-1-carboxylic acid Chemical compound ClC1=C(OC2=CC(=NC=N2)N(C)CC2CCN(CC2)C(=O)O)C=CC=C1 WIDDVPZOIJBVHG-UHFFFAOYSA-N 0.000 description 1
- YUKNZEOGGYGSHS-UHFFFAOYSA-N 4-[[[6-(2-fluoro-4-methylanilino)pyrimidin-4-yl]-methylamino]methyl]piperidine-1-carboxylic acid Chemical compound FC1=C(C=CC(=C1)C)NC1=CC(=NC=N1)N(C)CC1CCN(CC1)C(=O)O YUKNZEOGGYGSHS-UHFFFAOYSA-N 0.000 description 1
- AEAUWFYPNPNUCQ-UHFFFAOYSA-N 4-[[[6-(2-fluoro-4-methylsulfonylanilino)-5-methylpyrimidin-4-yl]-propan-2-ylamino]methyl]piperidine-1-carboxylic acid Chemical compound FC1=C(C=CC(=C1)S(=O)(=O)C)NC1=C(C(=NC=N1)N(C(C)C)CC1CCN(CC1)C(=O)O)C AEAUWFYPNPNUCQ-UHFFFAOYSA-N 0.000 description 1
- URXAXUUYYNUDLY-UHFFFAOYSA-N 4-[[[6-(2-fluoro-4-methylsulfonylanilino)pyrimidin-4-yl]-propan-2-ylamino]methyl]piperidine-1-carboxylic acid Chemical compound FC1=C(C=CC(=C1)S(=O)(=O)C)NC1=CC(=NC=N1)N(C(C)C)CC1CCN(CC1)C(=O)O URXAXUUYYNUDLY-UHFFFAOYSA-N 0.000 description 1
- MJHOLBGCDGJNOX-UHFFFAOYSA-N 4-[[[6-(2-fluoro-4-methylsulfonylphenoxy)-5-methylpyrimidin-4-yl]-propan-2-ylamino]methyl]piperidine-1-carboxylic acid Chemical compound FC1=C(OC2=C(C(=NC=N2)N(C(C)C)CC2CCN(CC2)C(=O)O)C)C=CC(=C1)S(=O)(=O)C MJHOLBGCDGJNOX-UHFFFAOYSA-N 0.000 description 1
- XFVLSVWHPMNAMN-UHFFFAOYSA-N 4-[[[6-(2-fluoro-5-methylsulfonylanilino)pyrimidin-4-yl]-methylamino]methyl]piperidine-1-carboxylic acid Chemical compound CN(CC1CCN(CC1)C(O)=O)C1=CC(NC2=C(F)C=CC(=C2)S(C)(=O)=O)=NC=N1 XFVLSVWHPMNAMN-UHFFFAOYSA-N 0.000 description 1
- HJPVXSYSBNELOV-UHFFFAOYSA-N 4-[[[6-(2-fluoroanilino)pyrimidin-4-yl]-methylamino]methyl]piperidine-1-carboxylic acid Chemical compound FC1=C(C=CC=C1)NC1=CC(=NC=N1)N(C)CC1CCN(CC1)C(=O)O HJPVXSYSBNELOV-UHFFFAOYSA-N 0.000 description 1
- CKWDWCWHUGMMLO-UHFFFAOYSA-N 4-[[[6-(2-fluorophenoxy)pyrimidin-4-yl]-methylamino]methyl]piperidine-1-carboxylic acid Chemical compound FC1=C(OC2=CC(=NC=N2)N(C)CC2CCN(CC2)C(=O)O)C=CC=C1 CKWDWCWHUGMMLO-UHFFFAOYSA-N 0.000 description 1
- VBMJJUPZYVPBHE-UHFFFAOYSA-N 4-[[[6-(3,4-difluoroanilino)pyrimidin-4-yl]-methylamino]methyl]piperidine-1-carboxylic acid Chemical compound CN(CC1CCN(CC1)C(O)=O)C1=CC(NC2=CC(F)=C(F)C=C2)=NC=N1 VBMJJUPZYVPBHE-UHFFFAOYSA-N 0.000 description 1
- ZOZVBYYDQLXRHT-UHFFFAOYSA-N 4-[[[6-(3,5-dimethoxyanilino)pyrimidin-4-yl]-methylamino]methyl]piperidine-1-carboxylic acid Chemical compound COC1=CC(OC)=CC(NC=2N=CN=C(C=2)N(C)CC2CCN(CC2)C(O)=O)=C1 ZOZVBYYDQLXRHT-UHFFFAOYSA-N 0.000 description 1
- GSOQCHWRCJJCEY-UHFFFAOYSA-N 4-[[[6-(3-carboxy-4-fluoroanilino)pyrimidin-4-yl]-methylamino]methyl]piperidine-1-carboxylic acid Chemical compound C(=O)(O)C=1C=C(C=CC=1F)NC1=CC(=NC=N1)N(C)CC1CCN(CC1)C(=O)O GSOQCHWRCJJCEY-UHFFFAOYSA-N 0.000 description 1
- DOJMHUCCHCDFSL-UHFFFAOYSA-N 4-[[[6-(3-chloro-2-fluoroanilino)pyrimidin-4-yl]-methylamino]methyl]piperidine-1-carboxylic acid Chemical compound ClC=1C(=C(C=CC=1)NC1=CC(=NC=N1)N(C)CC1CCN(CC1)C(=O)O)F DOJMHUCCHCDFSL-UHFFFAOYSA-N 0.000 description 1
- ZNAOHJULKIHAMO-UHFFFAOYSA-N 4-[[[6-(4-amino-2,5-difluorophenoxy)pyrimidin-4-yl]-ethylamino]methyl]piperidine-1-carboxylic acid Chemical compound NC1=CC(=C(OC2=CC(=NC=N2)N(CC)CC2CCN(CC2)C(=O)O)C=C1F)F ZNAOHJULKIHAMO-UHFFFAOYSA-N 0.000 description 1
- FTWNPZGCZLIGKG-UHFFFAOYSA-N 4-[[[6-(4-bromo-2,5-difluoroanilino)pyrimidin-4-yl]-ethylamino]methyl]piperidine-1-carboxylic acid Chemical compound BrC1=CC(=C(C=C1F)NC1=CC(=NC=N1)N(CC)CC1CCN(CC1)C(=O)O)F FTWNPZGCZLIGKG-UHFFFAOYSA-N 0.000 description 1
- ZVYSIHWCCKJXNH-UHFFFAOYSA-N 4-[[[6-(4-bromo-2,5-difluoroanilino)pyrimidin-4-yl]-methylamino]methyl]piperidine-1-carboxylic acid Chemical compound BrC1=CC(=C(C=C1F)NC1=CC(=NC=N1)N(C)CC1CCN(CC1)C(=O)O)F ZVYSIHWCCKJXNH-UHFFFAOYSA-N 0.000 description 1
- ZNHOXJRNQZTTRM-UHFFFAOYSA-N 4-[[[6-(4-bromo-2-fluoroanilino)pyrimidin-4-yl]-methylamino]methyl]piperidine-1-carboxylic acid Chemical compound BrC1=CC(=C(C=C1)NC1=CC(=NC=N1)N(C)CC1CCN(CC1)C(=O)O)F ZNHOXJRNQZTTRM-UHFFFAOYSA-N 0.000 description 1
- QGRYRYRKBQSJPL-UHFFFAOYSA-N 4-[[[6-(4-butanoylanilino)pyrimidin-4-yl]-methylamino]methyl]piperidine-1-carboxylic acid Chemical compound C(CCC)(=O)C1=CC=C(C=C1)NC1=CC(=NC=N1)N(C)CC1CCN(CC1)C(=O)O QGRYRYRKBQSJPL-UHFFFAOYSA-N 0.000 description 1
- JBJLMFSZYSJGBY-UHFFFAOYSA-N 4-[[[6-(4-carbamimidoyl-2-fluoroanilino)pyrimidin-4-yl]-methylamino]methyl]piperidine-1-carboxylic acid Chemical compound C(N)(=N)C1=CC(=C(C=C1)NC1=CC(=NC=N1)N(C)CC1CCN(CC1)C(=O)O)F JBJLMFSZYSJGBY-UHFFFAOYSA-N 0.000 description 1
- KJRFMXPLXPQDCI-UHFFFAOYSA-N 4-[[[6-(4-carboxy-2-fluoroanilino)pyrimidin-4-yl]-methylamino]methyl]piperidine-1-carboxylic acid Chemical compound C=1C(NC=2C(=CC(=CC=2)C(O)=O)F)=NC=NC=1N(C)CC1CCN(C(O)=O)CC1 KJRFMXPLXPQDCI-UHFFFAOYSA-N 0.000 description 1
- LFAFHLTZIHQWGP-UHFFFAOYSA-N 4-[[[6-(4-cyano-2,5-difluoroanilino)pyrimidin-4-yl]-ethylamino]methyl]piperidine-1-carboxylic acid Chemical compound C(#N)C1=CC(=C(C=C1F)NC1=CC(=NC=N1)N(CC)CC1CCN(CC1)C(=O)O)F LFAFHLTZIHQWGP-UHFFFAOYSA-N 0.000 description 1
- JKYZXUHCBDAHBV-UHFFFAOYSA-N 4-[[[6-(4-cyano-2,5-difluoroanilino)pyrimidin-4-yl]-methylamino]methyl]piperidine-1-carboxylic acid Chemical compound C(#N)C1=CC(=C(C=C1F)NC1=CC(=NC=N1)N(C)CC1CCN(CC1)C(=O)O)F JKYZXUHCBDAHBV-UHFFFAOYSA-N 0.000 description 1
- PUXBKLIYGJPCOZ-UHFFFAOYSA-N 4-[[[6-(4-cyano-2-ethylanilino)pyrimidin-4-yl]-methylamino]methyl]piperidine-1-carboxylic acid Chemical compound C(#N)C1=CC(=C(C=C1)NC1=CC(=NC=N1)N(C)CC1CCN(CC1)C(=O)O)CC PUXBKLIYGJPCOZ-UHFFFAOYSA-N 0.000 description 1
- FYSQHKUWYNQBIU-UHFFFAOYSA-N 4-[[[6-(4-ethylsulfanylanilino)pyrimidin-4-yl]-methylamino]methyl]piperidine-1-carboxylic acid Chemical compound C(C)SC1=CC=C(C=C1)NC1=CC(=NC=N1)N(C)CC1CCN(CC1)C(=O)O FYSQHKUWYNQBIU-UHFFFAOYSA-N 0.000 description 1
- QDHYZKONYUERQN-UHFFFAOYSA-N 4-[[[6-(5-carboxy-2-fluoroanilino)pyrimidin-4-yl]-methylamino]methyl]piperidine-1-carboxylic acid Chemical compound C(=O)(O)C=1C=CC(=C(C1)NC1=CC(=NC=N1)N(C)CC1CCN(CC1)C(=O)O)F QDHYZKONYUERQN-UHFFFAOYSA-N 0.000 description 1
- CVYVCLVIPDAOFK-UHFFFAOYSA-N 4-[[[6-[(2,2-difluoro-1,3-benzodioxol-5-yl)amino]pyrimidin-4-yl]-methylamino]methyl]piperidine-1-carboxylic acid Chemical compound FC1(OC2=C(O1)C=CC(=C2)NC1=CC(=NC=N1)N(C)CC1CCN(CC1)C(=O)O)F CVYVCLVIPDAOFK-UHFFFAOYSA-N 0.000 description 1
- RZEYBDCEQAQBOR-UHFFFAOYSA-N 4-[[[6-[(2,6-dimethoxypyridin-3-yl)amino]pyrimidin-4-yl]-methylamino]methyl]piperidine-1-carboxylic acid Chemical compound COC1=CC=C(NC2=NC=NC(=C2)N(C)CC2CCN(CC2)C(O)=O)C(OC)=N1 RZEYBDCEQAQBOR-UHFFFAOYSA-N 0.000 description 1
- FZLFGJBDYFWOOC-UHFFFAOYSA-N 4-[[[6-[(3-bromo-5-methylpyridin-2-yl)amino]pyrimidin-4-yl]-methylamino]methyl]piperidine-1-carboxylic acid Chemical compound BrC=1C(=NC=C(C=1)C)NC1=CC(=NC=N1)N(C)CC1CCN(CC1)C(=O)O FZLFGJBDYFWOOC-UHFFFAOYSA-N 0.000 description 1
- QFFDVXOWMZJUGK-UHFFFAOYSA-N 4-[[[6-[(5-bromo-3-methylpyridin-2-yl)amino]pyrimidin-4-yl]-methylamino]methyl]piperidine-1-carboxylic acid Chemical compound BrC=1C=C(C(=NC=1)NC1=CC(=NC=N1)N(C)CC1CCN(CC1)C(=O)O)C QFFDVXOWMZJUGK-UHFFFAOYSA-N 0.000 description 1
- DZKCBKYQBOJEMP-UHFFFAOYSA-N 4-[[[6-[(6-acetamidopyridin-3-yl)amino]pyrimidin-4-yl]-methylamino]methyl]piperidine-1-carboxylic acid Chemical compound C(C)(=O)NC1=CC=C(C=N1)NC1=CC(=NC=N1)N(C)CC1CCN(CC1)C(=O)O DZKCBKYQBOJEMP-UHFFFAOYSA-N 0.000 description 1
- KNLMMWHWQXABAM-UHFFFAOYSA-N 4-[[[6-[(6-methoxypyridin-3-yl)amino]pyrimidin-4-yl]-methylamino]methyl]piperidine-1-carboxylic acid Chemical compound COC1=CC=C(C=N1)NC1=CC(=NC=N1)N(C)CC1CCN(CC1)C(=O)O KNLMMWHWQXABAM-UHFFFAOYSA-N 0.000 description 1
- UFWKXIDBVHVCFS-UHFFFAOYSA-N 4-[[[6-[2-(2-chlorophenoxy)ethylamino]pyrimidin-4-yl]-methylamino]methyl]piperidine-1-carboxylic acid Chemical compound ClC1=C(OCCNC2=CC(=NC=N2)N(C)CC2CCN(CC2)C(=O)O)C=CC=C1 UFWKXIDBVHVCFS-UHFFFAOYSA-N 0.000 description 1
- FTDIRYVOTODROK-UHFFFAOYSA-N 4-[[[6-[2-(2-fluorophenoxy)ethylamino]pyrimidin-4-yl]-methylamino]methyl]piperidine-1-carboxylic acid Chemical compound CN(CC1CCN(CC1)C(O)=O)C1=CC(NCCOC2=C(F)C=CC=C2)=NC=N1 FTDIRYVOTODROK-UHFFFAOYSA-N 0.000 description 1
- KEGQMOZDPSAZOD-UHFFFAOYSA-N 4-[[[6-[2-(4-fluorophenoxy)propylamino]pyrimidin-4-yl]-methylamino]methyl]piperidine-1-carboxylic acid Chemical compound FC1=CC=C(OC(CNC2=CC(=NC=N2)N(C)CC2CCN(CC2)C(=O)O)C)C=C1 KEGQMOZDPSAZOD-UHFFFAOYSA-N 0.000 description 1
- SSGVVOLCHWNYNZ-UHFFFAOYSA-N 4-[[[6-[2-fluoro-4-(N'-hydroxycarbamimidoyl)anilino]pyrimidin-4-yl]-methylamino]methyl]piperidine-1-carboxylic acid Chemical compound FC1=C(C=CC(=C1)C(NO)=N)NC1=CC(=NC=N1)N(C)CC1CCN(CC1)C(=O)O SSGVVOLCHWNYNZ-UHFFFAOYSA-N 0.000 description 1
- IFJAGTLUUYONFN-UHFFFAOYSA-N 4-[[[6-[2-fluoro-4-(propan-2-ylsulfamoyl)anilino]pyrimidin-4-yl]-methylamino]methyl]piperidine-1-carboxylic acid Chemical compound FC1=C(C=CC(=C1)S(NC(C)C)(=O)=O)NC1=CC(=NC=N1)N(C)CC1CCN(CC1)C(=O)O IFJAGTLUUYONFN-UHFFFAOYSA-N 0.000 description 1
- OHUYFCPLPCOATA-UHFFFAOYSA-N 4-[[[6-[4-(dimethylsulfamoyl)anilino]pyrimidin-4-yl]-methylamino]methyl]piperidine-1-carboxylic acid Chemical compound C1=CC(S(=O)(=O)N(C)C)=CC=C1NC1=CC(N(C)CC2CCN(CC2)C(O)=O)=NC=N1 OHUYFCPLPCOATA-UHFFFAOYSA-N 0.000 description 1
- JTYJMVPYFRLXKZ-UHFFFAOYSA-N 4-[[[6-[4-(ethylsulfamoyl)-2-fluoroanilino]pyrimidin-4-yl]-methylamino]methyl]piperidine-1-carboxylic acid Chemical compound C(C)NS(=O)(=O)C1=CC(=C(C=C1)NC1=CC(=NC=N1)N(C)CC1CCN(CC1)C(=O)O)F JTYJMVPYFRLXKZ-UHFFFAOYSA-N 0.000 description 1
- VKXOFVZAJPXYSW-UHFFFAOYSA-N 4-[[[6-[4-(ethylsulfamoyl)anilino]pyrimidin-4-yl]-methylamino]methyl]piperidine-1-carboxylic acid Chemical compound C(C)NS(=O)(=O)C1=CC=C(C=C1)NC1=CC(=NC=N1)N(C)CC1CCN(CC1)C(=O)O VKXOFVZAJPXYSW-UHFFFAOYSA-N 0.000 description 1
- FYVKHXKQDBYZAF-UHFFFAOYSA-N 4-[[[6-[5-(2-aminoethylamino)-4-cyano-2-fluoroanilino]pyrimidin-4-yl]-ethylamino]methyl]piperidine-1-carboxylic acid Chemical compound C=1C(NC=2C(=CC(=C(NCCN)C=2)C#N)F)=NC=NC=1N(CC)CC1CCN(C(O)=O)CC1 FYVKHXKQDBYZAF-UHFFFAOYSA-N 0.000 description 1
- MHVUIEPWVGYRAA-UHFFFAOYSA-N 4-[[ethyl-[1-(2-fluoro-4-methylsulfonylphenyl)pyrazolo[3,4-d]pyrimidin-4-yl]amino]methyl]piperidine-1-carboxylic acid Chemical compound N=1C=NC=2N(C=3C(=CC(=CC=3)S(C)(=O)=O)F)N=CC=2C=1N(CC)CC1CCN(C(O)=O)CC1 MHVUIEPWVGYRAA-UHFFFAOYSA-N 0.000 description 1
- NBCDXJONAAAZOE-UHFFFAOYSA-N 4-[[ethyl-[1-(4-methylsulfonylphenyl)pyrazolo[3,4-d]pyrimidin-4-yl]amino]methyl]piperidine-1-carboxylic acid Chemical compound N=1C=NC=2N(C=3C=CC(=CC=3)S(C)(=O)=O)N=CC=2C=1N(CC)CC1CCN(C(O)=O)CC1 NBCDXJONAAAZOE-UHFFFAOYSA-N 0.000 description 1
- CTZRLKKYYJOPOC-UHFFFAOYSA-N 4-[[ethyl-[3-(4-methylsulfonylphenyl)-[1,2]oxazolo[4,5-d]pyrimidin-7-yl]amino]methyl]piperidine-1-carboxylic acid Chemical compound N=1C=NC=2C(C=3C=CC(=CC=3)S(C)(=O)=O)=NOC=2C=1N(CC)CC1CCN(C(O)=O)CC1 CTZRLKKYYJOPOC-UHFFFAOYSA-N 0.000 description 1
- WTEZKYHZNUFXEM-UHFFFAOYSA-N 4-[[ethyl-[6-[4-(N'-ethylcarbamimidoyl)-2,5-difluoroanilino]pyrimidin-4-yl]amino]methyl]piperidine-1-carboxylic acid Chemical compound C(C)N(C1=NC=NC(=C1)NC1=C(C=C(C(=C1)F)C(NCC)=N)F)CC1CCN(CC1)C(=O)O WTEZKYHZNUFXEM-UHFFFAOYSA-N 0.000 description 1
- SCMWEQWCRFINFT-UHFFFAOYSA-N 4-[[methyl-[1-(4-methylsulfonylphenyl)pyrazolo[3,4-d]pyrimidin-4-yl]amino]methyl]piperidine-1-carboxylic acid Chemical compound CS(=O)(=O)C1=CC=C(C=C1)N1N=CC=2C1=NC=NC2N(C)CC2CCN(CC2)C(=O)O SCMWEQWCRFINFT-UHFFFAOYSA-N 0.000 description 1
- VIPNFBLEWVVKNG-UHFFFAOYSA-N 4-[[methyl-[1-[4-(2-methylsulfonylethyl)phenyl]pyrazolo[3,4-d]pyrimidin-4-yl]amino]methyl]piperidine-1-carboxylic acid Chemical compound CS(=O)(=O)CCC1=CC=C(C=C1)N1N=CC=2C1=NC=NC=2N(C)CC1CCN(CC1)C(=O)O VIPNFBLEWVVKNG-UHFFFAOYSA-N 0.000 description 1
- OEOGLWTXIGICBV-UHFFFAOYSA-N 4-[[methyl-[6-(2,3,5-trifluoroanilino)pyrimidin-4-yl]amino]methyl]piperidine-1-carboxylic acid Chemical compound CN(C1=NC=NC(=C1)NC1=C(C(=CC(=C1)F)F)F)CC1CCN(CC1)C(=O)O OEOGLWTXIGICBV-UHFFFAOYSA-N 0.000 description 1
- NIRPKMROLFLFLQ-UHFFFAOYSA-N 4-[[methyl-[6-(2-pyridin-3-ylethylamino)pyrimidin-4-yl]amino]methyl]piperidine-1-carboxylic acid Chemical compound CN(C1=NC=NC(=C1)NCCC=1C=NC=CC=1)CC1CCN(CC1)C(=O)O NIRPKMROLFLFLQ-UHFFFAOYSA-N 0.000 description 1
- GBAWTCKQHNYFHQ-UHFFFAOYSA-N 4-[[methyl-[6-(2-pyridin-4-ylethylamino)pyrimidin-4-yl]amino]methyl]piperidine-1-carboxylic acid Chemical compound CN(C1=NC=NC(=C1)NCCC1=CC=NC=C1)CC1CCN(CC1)C(=O)O GBAWTCKQHNYFHQ-UHFFFAOYSA-N 0.000 description 1
- FAONVKJLCKPTMZ-UHFFFAOYSA-N 4-[[methyl-[6-(4-methylsulfonylanilino)pyrimidin-4-yl]amino]methyl]piperidine-1-carboxylic acid Chemical compound CS(=O)(=O)C1=CC=C(C=C1)NC1=CC(=NC=N1)N(C)CC1CCN(CC1)C(=O)O FAONVKJLCKPTMZ-UHFFFAOYSA-N 0.000 description 1
- CEOGWBGJESYEND-UHFFFAOYSA-N 4-[[methyl-[6-(4-morpholin-4-ylsulfonylanilino)pyrimidin-4-yl]amino]methyl]piperidine-1-carboxylic acid Chemical compound CN(C1=NC=NC(=C1)NC1=CC=C(C=C1)S(=O)(=O)N1CCOCC1)CC1CCN(CC1)C(=O)O CEOGWBGJESYEND-UHFFFAOYSA-N 0.000 description 1
- AMULMYDOBXALHT-UHFFFAOYSA-N 4-[[methyl-[6-(4-propan-2-ylsulfanylanilino)pyrimidin-4-yl]amino]methyl]piperidine-1-carboxylic acid Chemical compound C(C)(C)SC1=CC=C(C=C1)NC1=CC(=NC=N1)N(C)CC1CCN(CC1)C(=O)O AMULMYDOBXALHT-UHFFFAOYSA-N 0.000 description 1
- BVYGMVGFDDIPLX-UHFFFAOYSA-N 4-[[methyl-[6-(4-pyrazol-1-ylanilino)pyrimidin-4-yl]amino]methyl]piperidine-1-carboxylic acid Chemical compound CN(CC1CCN(CC1)C(O)=O)C1=CC(NC2=CC=C(C=C2)N2C=CC=N2)=NC=N1 BVYGMVGFDDIPLX-UHFFFAOYSA-N 0.000 description 1
- BZKQLXWFBCUOJP-UHFFFAOYSA-N 4-[[methyl-[6-(4-sulfamoylanilino)pyrimidin-4-yl]amino]methyl]piperidine-1-carboxylic acid Chemical compound CN(C1=NC=NC(=C1)NC1=CC=C(C=C1)S(N)(=O)=O)CC1CCN(CC1)C(=O)O BZKQLXWFBCUOJP-UHFFFAOYSA-N 0.000 description 1
- JGPQDQJVYDWFDE-UHFFFAOYSA-N 4-[[methyl-[6-(pyridin-3-ylmethylamino)pyrimidin-4-yl]amino]methyl]piperidine-1-carboxylic acid Chemical compound CN(C1=NC=NC(=C1)NCC=1C=NC=CC=1)CC1CCN(CC1)C(=O)O JGPQDQJVYDWFDE-UHFFFAOYSA-N 0.000 description 1
- PWPGNRSGDHULDD-UHFFFAOYSA-N 4-[[methyl-[6-[(6-methylsulfonylpyridin-3-yl)amino]pyrimidin-4-yl]amino]methyl]piperidine-1-carboxylic acid Chemical compound CS(=O)(=O)C1=CC=C(C=N1)NC1=CC(=NC=N1)N(C)CC1CCN(CC1)C(=O)O PWPGNRSGDHULDD-UHFFFAOYSA-N 0.000 description 1
- OXZFXPBYGXZUCD-UHFFFAOYSA-N 4-[[methyl-[6-[2-(pyridine-2-carbonyl)anilino]pyrimidin-4-yl]amino]methyl]piperidine-1-carboxylic acid Chemical compound CN(C1=NC=NC(=C1)NC1=C(C=CC=C1)C(=O)C1=NC=CC=C1)CC1CCN(CC1)C(=O)O OXZFXPBYGXZUCD-UHFFFAOYSA-N 0.000 description 1
- ZGQLLXCMXSYRQR-UHFFFAOYSA-N 4-[[methyl-[6-[4-(1,2,4-triazol-1-yl)anilino]pyrimidin-4-yl]amino]methyl]piperidine-1-carboxylic acid Chemical compound CN(C1=NC=NC(=C1)NC1=CC=C(C=C1)N1N=CN=C1)CC1CCN(CC1)C(=O)O ZGQLLXCMXSYRQR-UHFFFAOYSA-N 0.000 description 1
- UBWJHHNSOJZHGH-UHFFFAOYSA-N 4-[[methyl-[6-[4-(1,2,4-triazol-1-ylmethyl)anilino]pyrimidin-4-yl]amino]methyl]piperidine-1-carboxylic acid Chemical compound CN(C1=NC=NC(=C1)NC1=CC=C(C=C1)CN1N=CN=C1)CC1CCN(CC1)C(=O)O UBWJHHNSOJZHGH-UHFFFAOYSA-N 0.000 description 1
- OGYVKUCSYGJAFV-UHFFFAOYSA-N 4-[[methyl-[6-[4-(2-methylsulfonylethyl)anilino]pyrimidin-4-yl]amino]methyl]piperidine-1-carboxylic acid Chemical compound CS(=O)(=O)CCC1=CC=C(C=C1)NC1=CC(=NC=N1)N(C)CC1CCN(CC1)C(=O)O OGYVKUCSYGJAFV-UHFFFAOYSA-N 0.000 description 1
- USAFAOLXRFEKIE-UHFFFAOYSA-N 4-[[methyl-[6-[4-(methylsulfamoyl)anilino]pyrimidin-4-yl]amino]methyl]piperidine-1-carboxylic acid Chemical compound CN(C1=NC=NC(=C1)NC1=CC=C(C=C1)S(NC)(=O)=O)CC1CCN(CC1)C(=O)O USAFAOLXRFEKIE-UHFFFAOYSA-N 0.000 description 1
- LIQKMCQPTSBTPX-UHFFFAOYSA-N 4-[[methyl-[6-[4-(methylsulfamoylmethyl)anilino]pyrimidin-4-yl]amino]methyl]piperidine-1-carboxylic acid Chemical compound C1=CC(CS(=O)(=O)NC)=CC=C1NC1=CC(N(C)CC2CCN(CC2)C(O)=O)=NC=N1 LIQKMCQPTSBTPX-UHFFFAOYSA-N 0.000 description 1
- GEWLBRSMUDNCQH-UHFFFAOYSA-N 4-[[methyl-[6-[4-(trifluoromethylsulfonyl)anilino]pyrimidin-4-yl]amino]methyl]piperidine-1-carboxylic acid Chemical compound CN(C1=NC=NC(=C1)NC1=CC=C(C=C1)S(=O)(=O)C(F)(F)F)CC1CCN(CC1)C(=O)O GEWLBRSMUDNCQH-UHFFFAOYSA-N 0.000 description 1
- SEBQCUIPRUMHHH-UHFFFAOYSA-N 4-[[methyl-[6-[4-[(2-oxo-1,3-oxazolidin-4-yl)methyl]anilino]pyrimidin-4-yl]amino]methyl]piperidine-1-carboxylic acid Chemical compound CN(C1=NC=NC(=C1)NC1=CC=C(C=C1)CC1NC(OC1)=O)CC1CCN(CC1)C(=O)O SEBQCUIPRUMHHH-UHFFFAOYSA-N 0.000 description 1
- BYFCTGFNZCIOBS-UHFFFAOYSA-N 4-[[methyl-[6-[4-[2-(1,2,4-triazol-1-yl)ethyl]anilino]pyrimidin-4-yl]amino]methyl]piperidine-1-carboxylic acid Chemical compound C=1C(NC=2C=CC(CCN3N=CN=C3)=CC=2)=NC=NC=1N(C)CC1CCN(C(O)=O)CC1 BYFCTGFNZCIOBS-UHFFFAOYSA-N 0.000 description 1
- WYIZGJJMQTWZOS-UHFFFAOYSA-N 4-[[methyl-[6-[[5-(trifluoromethyl)pyridin-2-yl]amino]pyrimidin-4-yl]amino]methyl]piperidine-1-carboxylic acid Chemical compound CN(C1=NC=NC(=C1)NC1=NC=C(C=C1)C(F)(F)F)CC1CCN(CC1)C(=O)O WYIZGJJMQTWZOS-UHFFFAOYSA-N 0.000 description 1
- ZQKPJVACBXDNIR-UHFFFAOYSA-N 4-[methyl-[(3-pyridin-4-yl-1,2,4-oxadiazol-5-yl)methyl]amino]piperidine-1-carboxylic acid Chemical compound C1CN(C(O)=O)CCC1N(C)CC(ON=1)=NC=1C1=CC=NC=C1 ZQKPJVACBXDNIR-UHFFFAOYSA-N 0.000 description 1
- NUKYPUAOHBNCPY-UHFFFAOYSA-N 4-aminopyridine Chemical compound NC1=CC=NC=C1 NUKYPUAOHBNCPY-UHFFFAOYSA-N 0.000 description 1
- 125000006042 4-hexenyl group Chemical group 0.000 description 1
- KUMFGIPCSXJYTJ-UHFFFAOYSA-N 4-n-[1-(2,4-difluorophenyl)pyrazolo[3,4-d]pyrimidin-4-yl]cyclohexane-1,4-diamine Chemical compound C1CC(N)CCC1NC1=NC=NC2=C1C=NN2C1=CC=C(F)C=C1F KUMFGIPCSXJYTJ-UHFFFAOYSA-N 0.000 description 1
- 125000000339 4-pyridyl group Chemical group N1=C([H])C([H])=C([*])C([H])=C1[H] 0.000 description 1
- WNRLDLCEQOLDLS-UHFFFAOYSA-N 5-(1-butylsulfonylpiperidin-4-yl)-3-pyridin-4-yl-1,2,4-oxadiazole Chemical compound C1CN(S(=O)(=O)CCCC)CCC1C1=NC(C=2C=CN=CC=2)=NO1 WNRLDLCEQOLDLS-UHFFFAOYSA-N 0.000 description 1
- UZZBXCUUTXRYAY-UHFFFAOYSA-N 5-[(1-diphenoxyphosphorylpiperidin-4-yl)oxymethyl]-3-pyridin-4-yl-1,2,4-oxadiazole Chemical compound C=1C=CC=CC=1OP(N1CCC(CC1)OCC=1ON=C(N=1)C=1C=CN=CC=1)(=O)OC1=CC=CC=C1 UZZBXCUUTXRYAY-UHFFFAOYSA-N 0.000 description 1
- ZLAHUUQGNRAKSF-UHFFFAOYSA-N 5-[(1-pyrazin-2-ylpiperidin-4-yl)oxymethyl]-3-pyridin-4-yl-1,2,4-oxadiazole Chemical compound N=1C(C=2C=CN=CC=2)=NOC=1COC(CC1)CCN1C1=CN=CC=N1 ZLAHUUQGNRAKSF-UHFFFAOYSA-N 0.000 description 1
- KFTJVYMSAMNFPV-UFLZEWODSA-N 5-[(3aS,4S,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoic acid pyridine-2-carboxylic acid Chemical compound OC(=O)CCCC[C@@H]1SC[C@@H]2NC(=O)N[C@H]12.N1=C(C=CC=C1)C(=O)O KFTJVYMSAMNFPV-UFLZEWODSA-N 0.000 description 1
- CSWMUBFXTSMLFU-UHFFFAOYSA-N 5-[1-[5-(1,3-dioxolan-2-yl)-6-(4-methylsulfonylphenoxy)pyrimidin-4-yl]piperidin-4-yl]-3-propan-2-yl-1,2,4-oxadiazole Chemical compound CC(C)C1=NOC(C2CCN(CC2)C=2C(=C(OC=3C=CC(=CC=3)S(C)(=O)=O)N=CN=2)C2OCCO2)=N1 CSWMUBFXTSMLFU-UHFFFAOYSA-N 0.000 description 1
- VMCQUTXUDKCUNQ-UHFFFAOYSA-N 5-[1-[5-(1,3-dioxolan-2-yl)-6-[4-(thiadiazol-4-yl)phenoxy]pyrimidin-4-yl]piperidin-4-yl]-3-propan-2-yl-1,2,4-oxadiazole Chemical compound CC(C)C1=NOC(C2CCN(CC2)C=2C(=C(OC=3C=CC(=CC=3)C=3N=NSC=3)N=CN=2)C2OCCO2)=N1 VMCQUTXUDKCUNQ-UHFFFAOYSA-N 0.000 description 1
- HPPQAPANBWHEBE-UHFFFAOYSA-N 5-[1-[6-(4-methylsulfonylphenoxy)pyrimidin-4-yl]piperidin-4-yl]-3-propan-2-yl-1,2,4-oxadiazole Chemical compound CC(C)C1=NOC(C2CCN(CC2)C=2N=CN=C(OC=3C=CC(=CC=3)S(C)(=O)=O)C=2)=N1 HPPQAPANBWHEBE-UHFFFAOYSA-N 0.000 description 1
- FTXYXULNXQOMSI-UHFFFAOYSA-N 5-[4-[1-(2,5-difluoro-4-methylsulfonylphenyl)pyrazolo[3,4-d]pyrimidin-4-yl]oxycyclohexyl]-3-propan-2-yl-1,2,4-oxadiazole Chemical compound CC(C)C1=NOC(C2CCC(CC2)OC=2C=3C=NN(C=3N=CN=2)C=2C(=CC(=C(F)C=2)S(C)(=O)=O)F)=N1 FTXYXULNXQOMSI-UHFFFAOYSA-N 0.000 description 1
- QSCXUIPSVNVQAJ-UHFFFAOYSA-N 5-[4-[1-(2,5-difluoro-4-methylsulfonylphenyl)pyrazolo[3,4-d]pyrimidin-4-yl]oxypiperidin-1-yl]-3-propan-2-yl-1,2,4-oxadiazole Chemical compound CC(C)C1=NOC(N2CCC(CC2)OC=2C=3C=NN(C=3N=CN=2)C=2C(=CC(=C(F)C=2)S(C)(=O)=O)F)=N1 QSCXUIPSVNVQAJ-UHFFFAOYSA-N 0.000 description 1
- BPZPPKOFWVZVSK-UHFFFAOYSA-N 5-[4-[1-(2-fluoro-4-methoxyphenyl)pyrazolo[3,4-d]pyrimidin-4-yl]oxycyclohexyl]-3-propan-2-yl-1,2,4-oxadiazole Chemical compound FC1=CC(OC)=CC=C1N1C2=NC=NC(OC3CCC(CC3)C=3ON=C(N=3)C(C)C)=C2C=N1 BPZPPKOFWVZVSK-UHFFFAOYSA-N 0.000 description 1
- FZJAHUQSWRETAA-UHFFFAOYSA-N 5-[4-[1-(2-fluoro-4-methoxyphenyl)pyrazolo[3,4-d]pyrimidin-4-yl]oxypiperidin-1-yl]-3-propan-2-yl-1,2,4-oxadiazole Chemical compound FC1=CC(OC)=CC=C1N1C2=NC=NC(OC3CCN(CC3)C=3ON=C(N=3)C(C)C)=C2C=N1 FZJAHUQSWRETAA-UHFFFAOYSA-N 0.000 description 1
- ZVOJGYGXCQYYEF-UHFFFAOYSA-N 5-[4-[1-(2-fluoro-4-methylsulfonylphenyl)pyrazolo[3,4-d]pyrimidin-4-yl]oxypiperidin-1-yl]-3-propan-2-yl-1,2,4-oxadiazole Chemical compound CC(C)C1=NOC(N2CCC(CC2)OC=2C=3C=NN(C=3N=CN=2)C=2C(=CC(=CC=2)S(C)(=O)=O)F)=N1 ZVOJGYGXCQYYEF-UHFFFAOYSA-N 0.000 description 1
- BOFRGQSQHJXMIP-UHFFFAOYSA-N 5-[4-[1-(4-fluoro-6-methoxypyridin-3-yl)pyrazolo[3,4-d]pyrimidin-4-yl]oxycyclohexyl]-3-propan-2-yl-1,2,4-oxadiazole Chemical compound C1=NC(OC)=CC(F)=C1N1C2=NC=NC(OC3CCC(CC3)C=3ON=C(N=3)C(C)C)=C2C=N1 BOFRGQSQHJXMIP-UHFFFAOYSA-N 0.000 description 1
- MZWXSDSBUVUWBJ-UHFFFAOYSA-N 5-[4-[1-(4-fluoro-6-methoxypyridin-3-yl)pyrazolo[3,4-d]pyrimidin-4-yl]oxypiperidin-1-yl]-3-propan-2-yl-1,2,4-oxadiazole Chemical compound C1=NC(OC)=CC(F)=C1N1C2=NC=NC(OC3CCN(CC3)C=3ON=C(N=3)C(C)C)=C2C=N1 MZWXSDSBUVUWBJ-UHFFFAOYSA-N 0.000 description 1
- ZIGNQSOUONKDDX-UHFFFAOYSA-N 5-[4-[1-(4-methylsulfonylphenyl)pyrazolo[3,4-d]pyrimidin-4-yl]oxypiperidine-1-carbonyl]pyridine-3-carbonitrile Chemical compound C1=CC(S(=O)(=O)C)=CC=C1N1C2=NC=NC(OC3CCN(CC3)C(=O)C=3C=C(C=NC=3)C#N)=C2C=N1 ZIGNQSOUONKDDX-UHFFFAOYSA-N 0.000 description 1
- CHVAPBFTFNUECX-UHFFFAOYSA-N 5-[4-[1-(4-methylsulfonylphenyl)pyrazolo[3,4-d]pyrimidin-4-yl]oxypiperidine-1-carbonyl]pyridine-3-carboxylic acid Chemical compound C1=CC(S(=O)(=O)C)=CC=C1N1C2=NC=NC(OC3CCN(CC3)C(=O)C=3C=C(C=NC=3)C(O)=O)=C2C=N1 CHVAPBFTFNUECX-UHFFFAOYSA-N 0.000 description 1
- JIWRICIOKKVKQU-UHFFFAOYSA-N 5-[4-[1-(6-methoxy-2-methylpyridin-3-yl)pyrazolo[3,4-d]pyrimidin-4-yl]oxycyclohexyl]-3-propan-2-yl-1,2,4-oxadiazole Chemical compound CC1=NC(OC)=CC=C1N1C2=NC=NC(OC3CCC(CC3)C=3ON=C(N=3)C(C)C)=C2C=N1 JIWRICIOKKVKQU-UHFFFAOYSA-N 0.000 description 1
- YWNPZUGZYUTFOC-UHFFFAOYSA-N 5-[4-[1-(6-methoxy-2-methylpyridin-3-yl)pyrazolo[3,4-d]pyrimidin-4-yl]oxypiperidin-1-yl]-3-propan-2-yl-1,2,4-oxadiazole Chemical compound CC1=NC(OC)=CC=C1N1C2=NC=NC(OC3CCN(CC3)C=3ON=C(N=3)C(C)C)=C2C=N1 YWNPZUGZYUTFOC-UHFFFAOYSA-N 0.000 description 1
- TXSOHLXLTQWAKT-UHFFFAOYSA-N 5-[4-[1-[2-fluoro-4-(trifluoromethoxy)phenyl]pyrazolo[3,4-d]pyrimidin-4-yl]oxycyclohexyl]-3-propan-2-yl-1,2,4-oxadiazole Chemical compound CC(C)C1=NOC(C2CCC(CC2)OC=2C=3C=NN(C=3N=CN=2)C=2C(=CC(OC(F)(F)F)=CC=2)F)=N1 TXSOHLXLTQWAKT-UHFFFAOYSA-N 0.000 description 1
- QQKIEKPKURYNRO-UHFFFAOYSA-N 5-[4-[1-[2-fluoro-4-(trifluoromethoxy)phenyl]pyrazolo[3,4-d]pyrimidin-4-yl]oxypiperidin-1-yl]-3-propan-2-yl-1,2,4-oxadiazole Chemical compound CC(C)C1=NOC(N2CCC(CC2)OC=2C=3C=NN(C=3N=CN=2)C=2C(=CC(OC(F)(F)F)=CC=2)F)=N1 QQKIEKPKURYNRO-UHFFFAOYSA-N 0.000 description 1
- IPNGTEATWNXLML-UHFFFAOYSA-N 5-[4-[1-[4-(difluoromethoxy)-2-fluorophenyl]pyrazolo[3,4-d]pyrimidin-4-yl]oxycyclohexyl]-3-propan-2-yl-1,2,4-oxadiazole Chemical compound CC(C)C1=NOC(C2CCC(CC2)OC=2C=3C=NN(C=3N=CN=2)C=2C(=CC(OC(F)F)=CC=2)F)=N1 IPNGTEATWNXLML-UHFFFAOYSA-N 0.000 description 1
- SGUKNVVUFAJILU-UHFFFAOYSA-N 5-[4-[1-[4-(difluoromethoxy)-2-fluorophenyl]pyrazolo[3,4-d]pyrimidin-4-yl]oxypiperidin-1-yl]-3-propan-2-yl-1,2,4-oxadiazole Chemical compound CC(C)C1=NOC(N2CCC(CC2)OC=2C=3C=NN(C=3N=CN=2)C=2C(=CC(OC(F)F)=CC=2)F)=N1 SGUKNVVUFAJILU-UHFFFAOYSA-N 0.000 description 1
- CPJQWPZQBMOUJJ-UHFFFAOYSA-N 5-[4-[3-(2,5-difluoro-4-methylsulfonylphenyl)-1-methylpyrazolo[4,3-d]pyrimidin-7-yl]oxycyclohexyl]-3-propan-2-yl-1,2,4-oxadiazole Chemical compound CC(C)C1=NOC(C2CCC(CC2)OC=2C=3N(C)N=C(C=3N=CN=2)C=2C(=CC(=C(F)C=2)S(C)(=O)=O)F)=N1 CPJQWPZQBMOUJJ-UHFFFAOYSA-N 0.000 description 1
- MFDQCGFSVPPVOA-UHFFFAOYSA-N 5-[4-[3-(2,5-difluoro-4-methylsulfonylphenyl)-1-methylpyrazolo[4,3-d]pyrimidin-7-yl]oxypiperidin-1-yl]-3-propan-2-yl-1,2,4-oxadiazole Chemical compound CC(C)C1=NOC(N2CCC(CC2)OC=2C=3N(C)N=C(C=3N=CN=2)C=2C(=CC(=C(F)C=2)S(C)(=O)=O)F)=N1 MFDQCGFSVPPVOA-UHFFFAOYSA-N 0.000 description 1
- YJRDRIQABPPLRA-UHFFFAOYSA-N 5-[4-[3-(2,5-difluoro-4-methylsulfonylphenyl)-2-methylpyrazolo[1,5-a]pyrimidin-7-yl]oxycyclohexyl]-3-propan-2-yl-1,2,4-oxadiazole Chemical compound CC(C)C1=NOC(C2CCC(CC2)OC=2N3N=C(C)C(=C3N=CC=2)C=2C(=CC(=C(F)C=2)S(C)(=O)=O)F)=N1 YJRDRIQABPPLRA-UHFFFAOYSA-N 0.000 description 1
- MFDRTLFTQWPQPM-UHFFFAOYSA-N 5-[4-[3-(2,5-difluoro-4-methylsulfonylphenyl)-2-methylpyrazolo[1,5-a]pyrimidin-7-yl]oxypiperidin-1-yl]-3-propan-2-yl-1,2,4-oxadiazole Chemical compound CC(C)C1=NOC(N2CCC(CC2)OC=2N3N=C(C)C(=C3N=CC=2)C=2C(=CC(=C(F)C=2)S(C)(=O)=O)F)=N1 MFDRTLFTQWPQPM-UHFFFAOYSA-N 0.000 description 1
- RVECKEPAZZSWSP-UHFFFAOYSA-N 5-[4-[3-(2,5-difluoro-4-methylsulfonylphenyl)-2-methylpyrazolo[4,3-d]pyrimidin-7-yl]oxycyclohexyl]-3-propan-2-yl-1,2,4-oxadiazole Chemical compound CC(C)C1=NOC(C2CCC(CC2)OC=2C3=NN(C)C(C=4C(=CC(=C(F)C=4)S(C)(=O)=O)F)=C3N=CN=2)=N1 RVECKEPAZZSWSP-UHFFFAOYSA-N 0.000 description 1
- BJUOQZOVTGEWKV-UHFFFAOYSA-N 5-[4-[3-(2,5-difluoro-4-methylsulfonylphenyl)-2-methylpyrazolo[4,3-d]pyrimidin-7-yl]oxypiperidin-1-yl]-3-propan-2-yl-1,2,4-oxadiazole Chemical compound CC(C)C1=NOC(N2CCC(CC2)OC=2C3=NN(C)C(C=4C(=CC(=C(F)C=4)S(C)(=O)=O)F)=C3N=CN=2)=N1 BJUOQZOVTGEWKV-UHFFFAOYSA-N 0.000 description 1
- HASKNHLYZSZNRH-UHFFFAOYSA-N 5-[4-[3-(2,5-difluoro-4-methylsulfonylphenyl)pyrazolo[1,5-a]pyrimidin-7-yl]oxycyclohexyl]-3-propan-2-yl-1,2,4-oxadiazole Chemical compound CC(C)C1=NOC(C2CCC(CC2)OC=2N3N=CC(=C3N=CC=2)C=2C(=CC(=C(F)C=2)S(C)(=O)=O)F)=N1 HASKNHLYZSZNRH-UHFFFAOYSA-N 0.000 description 1
- HXLUQIZOAXZQDD-UHFFFAOYSA-N 5-[4-[3-(2,5-difluoro-4-methylsulfonylphenyl)pyrazolo[1,5-a]pyrimidin-7-yl]oxypiperidin-1-yl]-3-propan-2-yl-1,2,4-oxadiazole Chemical compound CC(C)C1=NOC(N2CCC(CC2)OC=2N3N=CC(=C3N=CC=2)C=2C(=CC(=C(F)C=2)S(C)(=O)=O)F)=N1 HXLUQIZOAXZQDD-UHFFFAOYSA-N 0.000 description 1
- GTZKMMLPBWOAOQ-UHFFFAOYSA-N 5-[4-[3-(2,5-difluoro-4-methylsulfonylphenyl)triazolo[4,5-d]pyrimidin-5-yl]oxypiperidin-1-yl]-3-propan-2-yl-1,2,4-oxadiazole Chemical compound CC(C)C1=NOC(N2CCC(CC2)OC=2N=C3N(C=4C(=CC(=C(F)C=4)S(C)(=O)=O)F)N=NC3=CN=2)=N1 GTZKMMLPBWOAOQ-UHFFFAOYSA-N 0.000 description 1
- MESVTIMHXQORGT-UHFFFAOYSA-N 5-[4-[3-(2,5-difluoro-4-methylsulfonylphenyl)triazolo[4,5-d]pyrimidin-7-yl]oxycyclohexyl]-3-propan-2-yl-1,2,4-oxadiazole Chemical compound CC(C)C1=NOC(C2CCC(CC2)OC=2C=3N=NN(C=3N=CN=2)C=2C(=CC(=C(F)C=2)S(C)(=O)=O)F)=N1 MESVTIMHXQORGT-UHFFFAOYSA-N 0.000 description 1
- ATOIWAOLKDCNRX-UHFFFAOYSA-N 5-[4-[3-(2-fluoro-4-methylsulfonylphenyl)-1-methylpyrazolo[4,3-d]pyrimidin-7-yl]oxycyclohexyl]-3-propan-2-yl-1,2,4-oxadiazole Chemical compound CC(C)C1=NOC(C2CCC(CC2)OC=2C=3N(C)N=C(C=3N=CN=2)C=2C(=CC(=CC=2)S(C)(=O)=O)F)=N1 ATOIWAOLKDCNRX-UHFFFAOYSA-N 0.000 description 1
- PCJHQGPUGQXOTO-UHFFFAOYSA-N 5-[4-[3-(2-fluoro-4-methylsulfonylphenyl)-1-methylpyrazolo[4,3-d]pyrimidin-7-yl]oxypiperidin-1-yl]-3-propan-2-yl-1,2,4-oxadiazole Chemical compound CC(C)C1=NOC(N2CCC(CC2)OC=2C=3N(C)N=C(C=3N=CN=2)C=2C(=CC(=CC=2)S(C)(=O)=O)F)=N1 PCJHQGPUGQXOTO-UHFFFAOYSA-N 0.000 description 1
- OOQQHYAABSVACC-UHFFFAOYSA-N 5-[4-[3-(2-fluoro-4-methylsulfonylphenyl)-2-methylpyrazolo[1,5-a]pyrimidin-7-yl]oxycyclohexyl]-3-propan-2-yl-1,2,4-oxadiazole Chemical compound CC(C)C1=NOC(C2CCC(CC2)OC=2N3N=C(C)C(=C3N=CC=2)C=2C(=CC(=CC=2)S(C)(=O)=O)F)=N1 OOQQHYAABSVACC-UHFFFAOYSA-N 0.000 description 1
- KCFYAPMLZUWYTQ-UHFFFAOYSA-N 5-[4-[3-(2-fluoro-4-methylsulfonylphenyl)-2-methylpyrazolo[1,5-a]pyrimidin-7-yl]oxypiperidin-1-yl]-3-propan-2-yl-1,2,4-oxadiazole Chemical compound CC(C)C1=NOC(N2CCC(CC2)OC=2N3N=C(C)C(=C3N=CC=2)C=2C(=CC(=CC=2)S(C)(=O)=O)F)=N1 KCFYAPMLZUWYTQ-UHFFFAOYSA-N 0.000 description 1
- KMXSGASYBTZRLV-UHFFFAOYSA-N 5-[4-[3-(2-fluoro-4-methylsulfonylphenyl)-2-methylpyrazolo[4,3-d]pyrimidin-7-yl]oxycyclohexyl]-3-propan-2-yl-1,2,4-oxadiazole Chemical compound CC(C)C1=NOC(C2CCC(CC2)OC=2C3=NN(C)C(C=4C(=CC(=CC=4)S(C)(=O)=O)F)=C3N=CN=2)=N1 KMXSGASYBTZRLV-UHFFFAOYSA-N 0.000 description 1
- IACFKKOLIJMDFY-UHFFFAOYSA-N 5-[4-[3-(2-fluoro-4-methylsulfonylphenyl)-2-methylpyrazolo[4,3-d]pyrimidin-7-yl]oxypiperidin-1-yl]-3-propan-2-yl-1,2,4-oxadiazole Chemical compound CC(C)C1=NOC(N2CCC(CC2)OC=2C3=NN(C)C(C=4C(=CC(=CC=4)S(C)(=O)=O)F)=C3N=CN=2)=N1 IACFKKOLIJMDFY-UHFFFAOYSA-N 0.000 description 1
- VPNKPVKLLCJIFI-UHFFFAOYSA-N 5-[4-[3-(2-fluoro-4-methylsulfonylphenyl)pyrazolo[1,5-a]pyrimidin-7-yl]oxycyclohexyl]-3-propan-2-yl-1,2,4-oxadiazole Chemical compound CC(C)C1=NOC(C2CCC(CC2)OC=2N3N=CC(=C3N=CC=2)C=2C(=CC(=CC=2)S(C)(=O)=O)F)=N1 VPNKPVKLLCJIFI-UHFFFAOYSA-N 0.000 description 1
- OFEUIPKONJEKAF-UHFFFAOYSA-N 5-[4-[3-(2-fluoro-4-methylsulfonylphenyl)pyrazolo[1,5-a]pyrimidin-7-yl]oxypiperidin-1-yl]-3-propan-2-yl-1,2,4-oxadiazole Chemical compound CC(C)C1=NOC(N2CCC(CC2)OC=2N3N=CC(=C3N=CC=2)C=2C(=CC(=CC=2)S(C)(=O)=O)F)=N1 OFEUIPKONJEKAF-UHFFFAOYSA-N 0.000 description 1
- JNJLHEWBEIYTTI-UHFFFAOYSA-N 5-[4-[3-(2-fluoro-4-methylsulfonylphenyl)triazolo[4,5-d]pyrimidin-7-yl]oxycyclohexyl]-3-propan-2-yl-1,2,4-oxadiazole Chemical compound CC(C)C1=NOC(C2CCC(CC2)OC=2C=3N=NN(C=3N=CN=2)C=2C(=CC(=CC=2)S(C)(=O)=O)F)=N1 JNJLHEWBEIYTTI-UHFFFAOYSA-N 0.000 description 1
- YNVPPWKJVRWJGF-UHFFFAOYSA-N 5-[4-[3-(2-fluoro-4-methylsulfonylphenyl)triazolo[4,5-d]pyrimidin-7-yl]oxypiperidin-1-yl]-3-propan-2-yl-1,2,4-oxadiazole Chemical compound CC(C)C1=NOC(N2CCC(CC2)OC=2C=3N=NN(C=3N=CN=2)C=2C(=CC(=CC=2)S(C)(=O)=O)F)=N1 YNVPPWKJVRWJGF-UHFFFAOYSA-N 0.000 description 1
- GZCRQBHWFCXEHA-UHFFFAOYSA-N 5-[4-[3-(4-fluoro-6-methoxypyridin-3-yl)-1-methylpyrazolo[4,3-d]pyrimidin-7-yl]oxycyclohexyl]-3-propan-2-yl-1,2,4-oxadiazole Chemical compound C1=NC(OC)=CC(F)=C1C(C1=NC=N2)=NN(C)C1=C2OC1CCC(C=2ON=C(N=2)C(C)C)CC1 GZCRQBHWFCXEHA-UHFFFAOYSA-N 0.000 description 1
- LOXMJEVQUJYPLP-UHFFFAOYSA-N 5-[4-[3-(4-fluoro-6-methoxypyridin-3-yl)-1-methylpyrazolo[4,3-d]pyrimidin-7-yl]oxypiperidin-1-yl]-3-propan-2-yl-1,2,4-oxadiazole Chemical compound C1=NC(OC)=CC(F)=C1C(C1=NC=N2)=NN(C)C1=C2OC1CCN(C=2ON=C(N=2)C(C)C)CC1 LOXMJEVQUJYPLP-UHFFFAOYSA-N 0.000 description 1
- HIZKFFZASKYLCW-UHFFFAOYSA-N 5-[4-[3-(4-fluoro-6-methoxypyridin-3-yl)-2-methylpyrazolo[1,5-a]pyrimidin-7-yl]oxycyclohexyl]-3-propan-2-yl-1,2,4-oxadiazole Chemical compound C1=NC(OC)=CC(F)=C1C1=C2N=CC=C(OC3CCC(CC3)C=3ON=C(N=3)C(C)C)N2N=C1C HIZKFFZASKYLCW-UHFFFAOYSA-N 0.000 description 1
- ZXPSCLSXQMJHOW-UHFFFAOYSA-N 5-[4-[3-(4-fluoro-6-methoxypyridin-3-yl)-2-methylpyrazolo[1,5-a]pyrimidin-7-yl]oxypiperidin-1-yl]-3-propan-2-yl-1,2,4-oxadiazole Chemical compound C1=NC(OC)=CC(F)=C1C1=C2N=CC=C(OC3CCN(CC3)C=3ON=C(N=3)C(C)C)N2N=C1C ZXPSCLSXQMJHOW-UHFFFAOYSA-N 0.000 description 1
- AVYPXMITCMCWHB-UHFFFAOYSA-N 5-[4-[3-(4-fluoro-6-methoxypyridin-3-yl)-2-methylpyrazolo[4,3-d]pyrimidin-7-yl]oxycyclohexyl]-3-propan-2-yl-1,2,4-oxadiazole Chemical compound C1=NC(OC)=CC(F)=C1C1=C2N=CN=C(OC3CCC(CC3)C=3ON=C(N=3)C(C)C)C2=NN1C AVYPXMITCMCWHB-UHFFFAOYSA-N 0.000 description 1
- ULWCAKYTMFUHEM-UHFFFAOYSA-N 5-[4-[3-(4-fluoro-6-methoxypyridin-3-yl)-2-methylpyrazolo[4,3-d]pyrimidin-7-yl]oxypiperidin-1-yl]-3-propan-2-yl-1,2,4-oxadiazole Chemical compound C1=NC(OC)=CC(F)=C1C1=C2N=CN=C(OC3CCN(CC3)C=3ON=C(N=3)C(C)C)C2=NN1C ULWCAKYTMFUHEM-UHFFFAOYSA-N 0.000 description 1
- IAQLMHGBVQYMSZ-UHFFFAOYSA-N 5-[4-[3-(4-fluoro-6-methoxypyridin-3-yl)pyrazolo[1,5-a]pyrimidin-7-yl]oxycyclohexyl]-3-propan-2-yl-1,2,4-oxadiazole Chemical compound C1=NC(OC)=CC(F)=C1C1=C2N=CC=C(OC3CCC(CC3)C=3ON=C(N=3)C(C)C)N2N=C1 IAQLMHGBVQYMSZ-UHFFFAOYSA-N 0.000 description 1
- WSQGMXYYDLAOGU-UHFFFAOYSA-N 5-[4-[3-(4-fluoro-6-methoxypyridin-3-yl)pyrazolo[1,5-a]pyrimidin-7-yl]oxypiperidin-1-yl]-3-propan-2-yl-1,2,4-oxadiazole Chemical compound C1=NC(OC)=CC(F)=C1C1=C2N=CC=C(OC3CCN(CC3)C=3ON=C(N=3)C(C)C)N2N=C1 WSQGMXYYDLAOGU-UHFFFAOYSA-N 0.000 description 1
- AJUANXWOIBLUEZ-UHFFFAOYSA-N 5-[4-[3-(4-fluoro-6-methoxypyridin-3-yl)triazolo[4,5-d]pyrimidin-7-yl]oxycyclohexyl]-3-propan-2-yl-1,2,4-oxadiazole Chemical compound C1=NC(OC)=CC(F)=C1N1C2=NC=NC(OC3CCC(CC3)C=3ON=C(N=3)C(C)C)=C2N=N1 AJUANXWOIBLUEZ-UHFFFAOYSA-N 0.000 description 1
- MKHNCQAVDVYRBT-UHFFFAOYSA-N 5-[4-[3-(4-fluoro-6-methoxypyridin-3-yl)triazolo[4,5-d]pyrimidin-7-yl]oxypiperidin-1-yl]-3-propan-2-yl-1,2,4-oxadiazole Chemical compound C1=NC(OC)=CC(F)=C1N1C2=NC=NC(OC3CCN(CC3)C=3ON=C(N=3)C(C)C)=C2N=N1 MKHNCQAVDVYRBT-UHFFFAOYSA-N 0.000 description 1
- MFUOFWFNVHOLRT-UHFFFAOYSA-N 5-[4-[3-(6-methoxy-2-methylpyridin-3-yl)-1-methylpyrazolo[4,3-d]pyrimidin-7-yl]oxypiperidin-1-yl]-3-propan-2-yl-1,2,4-oxadiazole Chemical compound CC1=NC(OC)=CC=C1C(C1=NC=N2)=NN(C)C1=C2OC1CCN(C=2ON=C(N=2)C(C)C)CC1 MFUOFWFNVHOLRT-UHFFFAOYSA-N 0.000 description 1
- XEYLZUALJFTWCR-UHFFFAOYSA-N 5-[4-[3-(6-methoxy-2-methylpyridin-3-yl)-2-methylpyrazolo[1,5-a]pyrimidin-7-yl]oxypiperidin-1-yl]-3-propan-2-yl-1,2,4-oxadiazole Chemical compound CC1=NC(OC)=CC=C1C1=C2N=CC=C(OC3CCN(CC3)C=3ON=C(N=3)C(C)C)N2N=C1C XEYLZUALJFTWCR-UHFFFAOYSA-N 0.000 description 1
- SYJPXRJAQNHNHP-UHFFFAOYSA-N 5-[4-[3-(6-methoxy-2-methylpyridin-3-yl)-2-methylpyrazolo[4,3-d]pyrimidin-7-yl]oxycyclohexyl]-3-propan-2-yl-1,2,4-oxadiazole Chemical compound CC1=NC(OC)=CC=C1C1=C2N=CN=C(OC3CCC(CC3)C=3ON=C(N=3)C(C)C)C2=NN1C SYJPXRJAQNHNHP-UHFFFAOYSA-N 0.000 description 1
- QZFPARMUXLMBAD-UHFFFAOYSA-N 5-[4-[3-(6-methoxy-2-methylpyridin-3-yl)-2-methylpyrazolo[4,3-d]pyrimidin-7-yl]oxypiperidin-1-yl]-3-propan-2-yl-1,2,4-oxadiazole Chemical compound CC1=NC(OC)=CC=C1C1=C2N=CN=C(OC3CCN(CC3)C=3ON=C(N=3)C(C)C)C2=NN1C QZFPARMUXLMBAD-UHFFFAOYSA-N 0.000 description 1
- PDKHAFQOYMPELU-UHFFFAOYSA-N 5-[4-[3-(6-methoxy-2-methylpyridin-3-yl)pyrazolo[1,5-a]pyrimidin-7-yl]oxycyclohexyl]-3-propan-2-yl-1,2,4-oxadiazole Chemical compound CC1=NC(OC)=CC=C1C1=C2N=CC=C(OC3CCC(CC3)C=3ON=C(N=3)C(C)C)N2N=C1 PDKHAFQOYMPELU-UHFFFAOYSA-N 0.000 description 1
- NCRLYXCBSQXYKK-UHFFFAOYSA-N 5-[4-[3-(6-methoxy-2-methylpyridin-3-yl)pyrazolo[1,5-a]pyrimidin-7-yl]oxypiperidin-1-yl]-3-propan-2-yl-1,2,4-oxadiazole Chemical compound CC1=NC(OC)=CC=C1C1=C2N=CC=C(OC3CCN(CC3)C=3ON=C(N=3)C(C)C)N2N=C1 NCRLYXCBSQXYKK-UHFFFAOYSA-N 0.000 description 1
- QVKWMICXGLQASD-UHFFFAOYSA-N 5-[4-[3-(6-methoxy-2-methylpyridin-3-yl)triazolo[4,5-d]pyrimidin-7-yl]oxycyclohexyl]-3-propan-2-yl-1,2,4-oxadiazole Chemical compound CC1=NC(OC)=CC=C1N1C2=NC=NC(OC3CCC(CC3)C=3ON=C(N=3)C(C)C)=C2N=N1 QVKWMICXGLQASD-UHFFFAOYSA-N 0.000 description 1
- HIQWBSMZSYOGER-UHFFFAOYSA-N 5-[4-[5-ethynyl-6-(2-fluoro-4-methylsulfonylphenoxy)pyrimidin-4-yl]oxypiperidin-1-yl]-3-propan-2-yl-1,2,4-oxadiazole Chemical compound CC(C)C1=NOC(N2CCC(CC2)OC=2C(=C(OC=3C(=CC(=CC=3)S(C)(=O)=O)F)N=CN=2)C#C)=N1 HIQWBSMZSYOGER-UHFFFAOYSA-N 0.000 description 1
- ZWNVNAGORNWSJM-UHFFFAOYSA-N 5-[4-[6-(2-fluoro-4-methylsulfonylphenoxy)-5-methylpyrimidin-4-yl]oxypiperidin-1-yl]-3-methyl-1,2,4-oxadiazole Chemical compound CC1=NOC(N2CCC(CC2)OC=2C(=C(OC=3C(=CC(=CC=3)S(C)(=O)=O)F)N=CN=2)C)=N1 ZWNVNAGORNWSJM-UHFFFAOYSA-N 0.000 description 1
- OZKKNPMLZOJSHG-UHFFFAOYSA-N 5-[4-[6-(2-fluoro-4-methylsulfonylphenoxy)-5-methylpyrimidin-4-yl]oxypiperidin-1-yl]-3-propan-2-yl-1,2,4-oxadiazole Chemical compound CC(C)C1=NOC(N2CCC(CC2)OC=2C(=C(OC=3C(=CC(=CC=3)S(C)(=O)=O)F)N=CN=2)C)=N1 OZKKNPMLZOJSHG-UHFFFAOYSA-N 0.000 description 1
- JOMRUCMOWQYVPH-UHFFFAOYSA-N 5-[4-[6-(2-fluoro-4-methylsulfonylphenoxy)-5-methylpyrimidin-4-yl]oxypiperidin-1-yl]-4-oxopentanenitrile Chemical compound N1=CN=C(OC=2C(=CC(=CC=2)S(C)(=O)=O)F)C(C)=C1OC1CCN(CC(=O)CCC#N)CC1 JOMRUCMOWQYVPH-UHFFFAOYSA-N 0.000 description 1
- DSEYJRQXCPNOQS-UHFFFAOYSA-N 5-[4-[6-(4-bromo-2-fluorophenoxy)-5-methylpyrimidin-4-yl]oxypiperidin-1-yl]-3-propan-2-yl-1,2,4-oxadiazole Chemical compound CC(C)C1=NOC(N2CCC(CC2)OC=2C(=C(OC=3C(=CC(Br)=CC=3)F)N=CN=2)C)=N1 DSEYJRQXCPNOQS-UHFFFAOYSA-N 0.000 description 1
- UKDASAUQSUVKCF-UHFFFAOYSA-N 5-[4-[8-(2,5-difluoro-4-methylsulfonylphenyl)pyrido[3,4-d]pyrimidin-4-yl]oxycyclohexyl]-3-propan-2-yl-1,2,4-oxadiazole Chemical compound CC(C)C1=NOC(C2CCC(CC2)OC=2C3=CC=NC(=C3N=CN=2)C=2C(=CC(=C(F)C=2)S(C)(=O)=O)F)=N1 UKDASAUQSUVKCF-UHFFFAOYSA-N 0.000 description 1
- HDEPXMQAGZKNMY-UHFFFAOYSA-N 5-[4-[8-(2,5-difluoro-4-methylsulfonylphenyl)pyrido[3,4-d]pyrimidin-4-yl]oxypiperidin-1-yl]-3-propan-2-yl-1,2,4-oxadiazole Chemical compound CC(C)C1=NOC(N2CCC(CC2)OC=2C3=CC=NC(=C3N=CN=2)C=2C(=CC(=C(F)C=2)S(C)(=O)=O)F)=N1 HDEPXMQAGZKNMY-UHFFFAOYSA-N 0.000 description 1
- DDGQIJRMIFYACD-UHFFFAOYSA-N 5-[4-[8-(2,5-difluoro-4-methylsulfonylphenyl)quinolin-4-yl]oxycyclohexyl]-3-propan-2-yl-1,2,4-oxadiazole Chemical compound CC(C)C1=NOC(C2CCC(CC2)OC=2C3=CC=CC(=C3N=CC=2)C=2C(=CC(=C(F)C=2)S(C)(=O)=O)F)=N1 DDGQIJRMIFYACD-UHFFFAOYSA-N 0.000 description 1
- MMIBDVXAARGFKL-UHFFFAOYSA-N 5-[4-[8-(2,5-difluoro-4-methylsulfonylphenyl)quinolin-4-yl]oxypiperidin-1-yl]-3-propan-2-yl-1,2,4-oxadiazole Chemical compound CC(C)C1=NOC(N2CCC(CC2)OC=2C3=CC=CC(=C3N=CC=2)C=2C(=CC(=C(F)C=2)S(C)(=O)=O)F)=N1 MMIBDVXAARGFKL-UHFFFAOYSA-N 0.000 description 1
- YANFZFLBDUWQPX-UHFFFAOYSA-N 5-[4-[8-(2-fluoro-4-methylsulfonylphenyl)pyrido[3,4-d]pyrimidin-4-yl]oxycyclohexyl]-3-propan-2-yl-1,2,4-oxadiazole Chemical compound CC(C)C1=NOC(C2CCC(CC2)OC=2C3=CC=NC(=C3N=CN=2)C=2C(=CC(=CC=2)S(C)(=O)=O)F)=N1 YANFZFLBDUWQPX-UHFFFAOYSA-N 0.000 description 1
- UYJYTEDDMYOICC-UHFFFAOYSA-N 5-[4-[8-(2-fluoro-4-methylsulfonylphenyl)pyrido[3,4-d]pyrimidin-4-yl]oxypiperidin-1-yl]-3-propan-2-yl-1,2,4-oxadiazole Chemical compound CC(C)C1=NOC(N2CCC(CC2)OC=2C3=CC=NC(=C3N=CN=2)C=2C(=CC(=CC=2)S(C)(=O)=O)F)=N1 UYJYTEDDMYOICC-UHFFFAOYSA-N 0.000 description 1
- XQKVIWBLHPOZRF-UHFFFAOYSA-N 5-[4-[8-(2-fluoro-4-methylsulfonylphenyl)quinolin-4-yl]oxycyclohexyl]-3-propan-2-yl-1,2,4-oxadiazole Chemical compound CC(C)C1=NOC(C2CCC(CC2)OC=2C3=CC=CC(=C3N=CC=2)C=2C(=CC(=CC=2)S(C)(=O)=O)F)=N1 XQKVIWBLHPOZRF-UHFFFAOYSA-N 0.000 description 1
- GYYHNTFWRCXOJR-UHFFFAOYSA-N 5-[4-[8-(2-fluoro-4-methylsulfonylphenyl)quinolin-4-yl]oxypiperidin-1-yl]-3-propan-2-yl-1,2,4-oxadiazole Chemical compound CC(C)C1=NOC(N2CCC(CC2)OC=2C3=CC=CC(=C3N=CC=2)C=2C(=CC(=CC=2)S(C)(=O)=O)F)=N1 GYYHNTFWRCXOJR-UHFFFAOYSA-N 0.000 description 1
- XSHWFZBGEPSJND-UHFFFAOYSA-N 5-[4-[8-(4-fluoro-6-methoxypyridin-3-yl)pyrido[3,4-d]pyrimidin-4-yl]oxycyclohexyl]-3-propan-2-yl-1,2,4-oxadiazole Chemical compound C1=NC(OC)=CC(F)=C1C(C1=NC=N2)=NC=CC1=C2OC1CCC(C=2ON=C(N=2)C(C)C)CC1 XSHWFZBGEPSJND-UHFFFAOYSA-N 0.000 description 1
- GUJMGVKVPCHOST-UHFFFAOYSA-N 5-[4-[8-(4-fluoro-6-methoxypyridin-3-yl)pyrido[3,4-d]pyrimidin-4-yl]oxypiperidin-1-yl]-3-propan-2-yl-1,2,4-oxadiazole Chemical compound C1=NC(OC)=CC(F)=C1C(C1=NC=N2)=NC=CC1=C2OC1CCN(C=2ON=C(N=2)C(C)C)CC1 GUJMGVKVPCHOST-UHFFFAOYSA-N 0.000 description 1
- XEXUWFGEXNBYJY-UHFFFAOYSA-N 5-[4-[8-(4-fluoro-6-methoxypyridin-3-yl)quinolin-4-yl]oxycyclohexyl]-3-propan-2-yl-1,2,4-oxadiazole Chemical compound C1=NC(OC)=CC(F)=C1C(C1=NC=C2)=CC=CC1=C2OC1CCC(C=2ON=C(N=2)C(C)C)CC1 XEXUWFGEXNBYJY-UHFFFAOYSA-N 0.000 description 1
- RPXSWLAEOQYWDT-UHFFFAOYSA-N 5-[4-[8-(4-fluoro-6-methoxypyridin-3-yl)quinolin-4-yl]oxypiperidin-1-yl]-3-propan-2-yl-1,2,4-oxadiazole Chemical compound C1=NC(OC)=CC(F)=C1C(C1=NC=C2)=CC=CC1=C2OC1CCN(C=2ON=C(N=2)C(C)C)CC1 RPXSWLAEOQYWDT-UHFFFAOYSA-N 0.000 description 1
- XXTIWLXOEMZJOA-UHFFFAOYSA-N 5-[4-[8-(6-methoxy-2-methylpyridin-3-yl)pyrido[3,4-d]pyrimidin-4-yl]oxycyclohexyl]-3-propan-2-yl-1,2,4-oxadiazole Chemical compound CC1=NC(OC)=CC=C1C(C1=NC=N2)=NC=CC1=C2OC1CCC(C=2ON=C(N=2)C(C)C)CC1 XXTIWLXOEMZJOA-UHFFFAOYSA-N 0.000 description 1
- KYVKZXUEKDIBSX-UHFFFAOYSA-N 5-[4-[8-(6-methoxy-2-methylpyridin-3-yl)pyrido[3,4-d]pyrimidin-4-yl]oxypiperidin-1-yl]-3-propan-2-yl-1,2,4-oxadiazole Chemical compound CC1=NC(OC)=CC=C1C(C1=NC=N2)=NC=CC1=C2OC1CCN(C=2ON=C(N=2)C(C)C)CC1 KYVKZXUEKDIBSX-UHFFFAOYSA-N 0.000 description 1
- ADJLAEQTLJWPQZ-UHFFFAOYSA-N 5-[4-[8-(6-methoxy-2-methylpyridin-3-yl)quinolin-4-yl]oxycyclohexyl]-3-propan-2-yl-1,2,4-oxadiazole Chemical compound CC1=NC(OC)=CC=C1C(C1=NC=C2)=CC=CC1=C2OC1CCC(C=2ON=C(N=2)C(C)C)CC1 ADJLAEQTLJWPQZ-UHFFFAOYSA-N 0.000 description 1
- FTIAJCNLIHDVEP-UHFFFAOYSA-N 5-[4-[8-(6-methoxy-2-methylpyridin-3-yl)quinolin-4-yl]oxypiperidin-1-yl]-3-propan-2-yl-1,2,4-oxadiazole Chemical compound CC1=NC(OC)=CC=C1C(C1=NC=C2)=CC=CC1=C2OC1CCN(C=2ON=C(N=2)C(C)C)CC1 FTIAJCNLIHDVEP-UHFFFAOYSA-N 0.000 description 1
- FUXKOOLZOBRZLO-UHFFFAOYSA-N 5-[4-[9-(2,5-difluoro-4-methylsulfonylphenyl)purin-6-yl]oxycyclohexyl]-3-propan-2-yl-1,2,4-oxadiazole Chemical compound CC(C)C1=NOC(C2CCC(CC2)OC=2C=3N=CN(C=3N=CN=2)C=2C(=CC(=C(F)C=2)S(C)(=O)=O)F)=N1 FUXKOOLZOBRZLO-UHFFFAOYSA-N 0.000 description 1
- IOUSRUKCPUAVKN-UHFFFAOYSA-N 5-[4-[9-(2,5-difluoro-4-methylsulfonylphenyl)purin-6-yl]oxypiperidin-1-yl]-3-propan-2-yl-1,2,4-oxadiazole Chemical compound CC(C)C1=NOC(N2CCC(CC2)OC=2C=3N=CN(C=3N=CN=2)C=2C(=CC(=C(F)C=2)S(C)(=O)=O)F)=N1 IOUSRUKCPUAVKN-UHFFFAOYSA-N 0.000 description 1
- RQIMPIVCIROENY-UHFFFAOYSA-N 5-[4-[9-(2-fluoro-4-methylsulfonylphenyl)purin-6-yl]oxycyclohexyl]-3-propan-2-yl-1,2,4-oxadiazole Chemical compound CC(C)C1=NOC(C2CCC(CC2)OC=2C=3N=CN(C=3N=CN=2)C=2C(=CC(=CC=2)S(C)(=O)=O)F)=N1 RQIMPIVCIROENY-UHFFFAOYSA-N 0.000 description 1
- ZXVJTHCOASJPBM-UHFFFAOYSA-N 5-[4-[9-(2-fluoro-4-methylsulfonylphenyl)purin-6-yl]oxypiperidin-1-yl]-3-propan-2-yl-1,2,4-oxadiazole Chemical compound CC(C)C1=NOC(N2CCC(CC2)OC=2C=3N=CN(C=3N=CN=2)C=2C(=CC(=CC=2)S(C)(=O)=O)F)=N1 ZXVJTHCOASJPBM-UHFFFAOYSA-N 0.000 description 1
- DCOQNOFLEGQPSI-UHFFFAOYSA-N 5-[4-[9-(4-fluoro-6-methoxypyridin-3-yl)purin-6-yl]oxycyclohexyl]-3-propan-2-yl-1,2,4-oxadiazole Chemical compound C1=NC(OC)=CC(F)=C1N1C2=NC=NC(OC3CCC(CC3)C=3ON=C(N=3)C(C)C)=C2N=C1 DCOQNOFLEGQPSI-UHFFFAOYSA-N 0.000 description 1
- ALHTYBKZBDELCX-UHFFFAOYSA-N 5-[4-[9-(4-fluoro-6-methoxypyridin-3-yl)purin-6-yl]oxypiperidin-1-yl]-3-propan-2-yl-1,2,4-oxadiazole Chemical compound C1=NC(OC)=CC(F)=C1N1C2=NC=NC(OC3CCN(CC3)C=3ON=C(N=3)C(C)C)=C2N=C1 ALHTYBKZBDELCX-UHFFFAOYSA-N 0.000 description 1
- AQOUHVRLNPODJR-UHFFFAOYSA-N 5-[4-[9-(6-methoxy-2-methylpyridin-3-yl)purin-6-yl]oxycyclohexyl]-3-propan-2-yl-1,2,4-oxadiazole Chemical compound CC1=NC(OC)=CC=C1N1C2=NC=NC(OC3CCC(CC3)C=3ON=C(N=3)C(C)C)=C2N=C1 AQOUHVRLNPODJR-UHFFFAOYSA-N 0.000 description 1
- PHCHBZTWVZJVTH-UHFFFAOYSA-N 5-[4-[9-(6-methoxy-2-methylpyridin-3-yl)purin-6-yl]oxypiperidin-1-yl]-3-propan-2-yl-1,2,4-oxadiazole Chemical compound CC1=NC(OC)=CC=C1N1C2=NC=NC(OC3CCN(CC3)C=3ON=C(N=3)C(C)C)=C2N=C1 PHCHBZTWVZJVTH-UHFFFAOYSA-N 0.000 description 1
- CWOMABNSBAMNCT-UHFFFAOYSA-N 5-[[3-[1-(2-fluoro-4-methylsulfonylphenyl)pyrazolo[3,4-d]pyrimidin-4-yl]oxypyrrolidin-1-yl]methyl]-3-propan-2-yl-1,2,4-oxadiazole Chemical compound CC(C)C1=NOC(CN2CC(CC2)OC=2C=3C=NN(C=3N=CN=2)C=2C(=CC(=CC=2)S(C)(=O)=O)F)=N1 CWOMABNSBAMNCT-UHFFFAOYSA-N 0.000 description 1
- CQBGRLXIZNRXPE-UHFFFAOYSA-N 5-[[4-[1-(2-fluoro-4-methylsulfonylphenyl)pyrazolo[3,4-d]pyrimidin-4-yl]oxypiperidin-1-yl]methyl]-3-propan-2-yl-1,2,4-oxadiazole Chemical compound CC(C)C1=NOC(CN2CCC(CC2)OC=2C=3C=NN(C=3N=CN=2)C=2C(=CC(=CC=2)S(C)(=O)=O)F)=N1 CQBGRLXIZNRXPE-UHFFFAOYSA-N 0.000 description 1
- AUZWGLPRXPPHDO-UHFFFAOYSA-N 5-bromo-1-[4-nitro-3-(4-propylpiperidin-1-yl)phenyl]pyridin-2-one Chemical compound C1CC(CCC)CCN1C1=CC(N2C(C=CC(Br)=C2)=O)=CC=C1[N+]([O-])=O AUZWGLPRXPPHDO-UHFFFAOYSA-N 0.000 description 1
- BMNJJEMCZIRGBX-UHFFFAOYSA-N 5-bromo-2-[4-nitro-3-(4-propylpiperidin-1-yl)phenoxy]pyridine Chemical compound C1CC(CCC)CCN1C1=CC(OC=2N=CC(Br)=CC=2)=CC=C1[N+]([O-])=O BMNJJEMCZIRGBX-UHFFFAOYSA-N 0.000 description 1
- OTCNORQDEKFSQJ-UHFFFAOYSA-N 5-ethynyl-n-(2-fluoro-4-methylsulfonylphenyl)-6-[1-(3-propan-2-yl-1,2,4-oxadiazol-5-yl)piperidin-4-yl]oxypyrimidin-4-amine Chemical compound CC(C)C1=NOC(N2CCC(CC2)OC=2C(=C(NC=3C(=CC(=CC=3)S(C)(=O)=O)F)N=CN=2)C#C)=N1 OTCNORQDEKFSQJ-UHFFFAOYSA-N 0.000 description 1
- 125000006163 5-membered heteroaryl group Chemical group 0.000 description 1
- RASCGTLSTMXIPQ-UHFFFAOYSA-N 5-nitro-6-(4-phenylsulfanylpiperidin-1-yl)-n-[4-(1,2,4-triazol-1-yl)phenyl]pyrimidin-4-amine Chemical compound N1=CN=C(N2CCC(CC2)SC=2C=CC=CC=2)C([N+](=O)[O-])=C1NC(C=C1)=CC=C1N1C=NC=N1 RASCGTLSTMXIPQ-UHFFFAOYSA-N 0.000 description 1
- MYPUSSVEVJJQOX-UHFFFAOYSA-N 5-nitro-6-(4-propylpiperidin-1-yl)-n-[4-(1,2,4-triazol-1-yl)phenyl]pyrimidin-4-amine Chemical compound C1CC(CCC)CCN1C1=NC=NC(NC=2C=CC(=CC=2)N2N=CN=C2)=C1[N+]([O-])=O MYPUSSVEVJJQOX-UHFFFAOYSA-N 0.000 description 1
- XPABZYFJCKZPIF-UHFFFAOYSA-N 5-nitro-6-(4-pyridin-2-ylsulfanylpiperidin-1-yl)-n-[4-(1,2,4-triazol-1-yl)phenyl]pyrimidin-4-amine Chemical compound N1=CN=C(N2CCC(CC2)SC=2N=CC=CC=2)C([N+](=O)[O-])=C1NC(C=C1)=CC=C1N1C=NC=N1 XPABZYFJCKZPIF-UHFFFAOYSA-N 0.000 description 1
- QBJYUQXPBQMMCM-UHFFFAOYSA-N 5-nitro-6-(4-pyridin-2-ylsulfanylpiperidin-1-yl)pyrimidin-4-amine Chemical compound [N+](=O)([O-])C=1C(=NC=NC1N1CCC(CC1)SC1=NC=CC=C1)N QBJYUQXPBQMMCM-UHFFFAOYSA-N 0.000 description 1
- WUUPHVSVAJFGQY-UHFFFAOYSA-N 6-(1-butylsulfonylpiperidin-4-yl)oxy-n-(4-methylsulfonylphenyl)-5-nitropyrimidin-4-amine Chemical compound C1CN(S(=O)(=O)CCCC)CCC1OC1=NC=NC(NC=2C=CC(=CC=2)S(C)(=O)=O)=C1[N+]([O-])=O WUUPHVSVAJFGQY-UHFFFAOYSA-N 0.000 description 1
- ASBQCOPKXJXJBA-UHFFFAOYSA-N 6-(1-hexylpiperidin-4-yl)oxy-n-(4-methylsulfonylphenyl)-5-nitropyrimidin-4-amine Chemical compound C1CN(CCCCCC)CCC1OC1=NC=NC(NC=2C=CC(=CC=2)S(C)(=O)=O)=C1[N+]([O-])=O ASBQCOPKXJXJBA-UHFFFAOYSA-N 0.000 description 1
- VUQXEBQXNBVHSC-UHFFFAOYSA-N 6-[1-(1-methylimidazol-4-yl)sulfonylpiperidin-4-yl]oxy-n-(4-methylsulfonylphenyl)-5-nitropyrimidin-4-amine Chemical compound CN1C=NC(S(=O)(=O)N2CCC(CC2)OC=2C(=C(NC=3C=CC(=CC=3)S(C)(=O)=O)N=CN=2)[N+]([O-])=O)=C1 VUQXEBQXNBVHSC-UHFFFAOYSA-N 0.000 description 1
- AMORTYLNSDSJNK-UHFFFAOYSA-N 6-[1-(2-ethoxyethyl)piperidin-4-yl]oxy-n-(4-methylsulfonylphenyl)-5-nitropyrimidin-4-amine Chemical compound C1CN(CCOCC)CCC1OC1=NC=NC(NC=2C=CC(=CC=2)S(C)(=O)=O)=C1[N+]([O-])=O AMORTYLNSDSJNK-UHFFFAOYSA-N 0.000 description 1
- UGGSPMQRNUCNBE-UHFFFAOYSA-N 6-[1-(3,3-dimethylbutyl)piperidin-4-yl]oxy-n-(4-methylsulfonylphenyl)-5-nitropyrimidin-4-amine Chemical compound C1CN(CCC(C)(C)C)CCC1OC1=NC=NC(NC=2C=CC(=CC=2)S(C)(=O)=O)=C1[N+]([O-])=O UGGSPMQRNUCNBE-UHFFFAOYSA-N 0.000 description 1
- VGLGTLBVYJRXMY-UHFFFAOYSA-N 6-[1-(3-methylbutyl)piperidin-4-yl]oxy-n-(4-methylsulfonylphenyl)-5-nitropyrimidin-4-amine Chemical compound C1CN(CCC(C)C)CCC1OC1=NC=NC(NC=2C=CC(=CC=2)S(C)(=O)=O)=C1[N+]([O-])=O VGLGTLBVYJRXMY-UHFFFAOYSA-N 0.000 description 1
- FZIQGTZAADXHTO-UHFFFAOYSA-N 6-[1-(cyclopropylmethyl)piperidin-4-yl]oxy-n-(4-methylsulfonylphenyl)-5-nitropyrimidin-4-amine Chemical compound C1=CC(S(=O)(=O)C)=CC=C1NC1=NC=NC(OC2CCN(CC3CC3)CC2)=C1[N+]([O-])=O FZIQGTZAADXHTO-UHFFFAOYSA-N 0.000 description 1
- XHCKZJIDLWYGSV-UHFFFAOYSA-N 6-[1-[(2,4-dimethyl-1,3-thiazol-5-yl)sulfonyl]piperidin-4-yl]oxy-n-(4-methylsulfonylphenyl)-5-nitropyrimidin-4-amine Chemical compound S1C(C)=NC(C)=C1S(=O)(=O)N1CCC(OC=2C(=C(NC=3C=CC(=CC=3)S(C)(=O)=O)N=CN=2)[N+]([O-])=O)CC1 XHCKZJIDLWYGSV-UHFFFAOYSA-N 0.000 description 1
- JDZXKBQMDMCTHL-UHFFFAOYSA-N 6-[4-(1-benzofuran-2-yl)piperidin-1-yl]-n-(4-methylsulfonylphenyl)-5-nitropyrimidin-4-amine Chemical compound C1=CC(S(=O)(=O)C)=CC=C1NC1=NC=NC(N2CCC(CC2)C=2OC3=CC=CC=C3C=2)=C1[N+]([O-])=O JDZXKBQMDMCTHL-UHFFFAOYSA-N 0.000 description 1
- WNWQFCXDQJNLGA-UHFFFAOYSA-N 6-[4-(2-methoxyphenyl)sulfanylpiperidin-1-yl]-5-nitro-n-[4-(1,2,4-triazol-1-yl)phenyl]pyrimidin-4-amine Chemical compound COC1=CC=CC=C1SC1CCN(C=2C(=C(NC=3C=CC(=CC=3)N3N=CN=C3)N=CN=2)[N+]([O-])=O)CC1 WNWQFCXDQJNLGA-UHFFFAOYSA-N 0.000 description 1
- RMQBCFUMFGANFC-UHFFFAOYSA-N 6-[4-(3-cyclopropyl-1,2,4-oxadiazol-5-yl)piperidin-1-yl]-n-(4-methylsulfonylphenyl)-5-nitropyrimidin-4-amine Chemical compound C1=CC(S(=O)(=O)C)=CC=C1NC1=NC=NC(N2CCC(CC2)C=2ON=C(N=2)C2CC2)=C1[N+]([O-])=O RMQBCFUMFGANFC-UHFFFAOYSA-N 0.000 description 1
- RDSZTCYLOYPCLJ-UHFFFAOYSA-N 6-[4-(3-ethyl-1,2,4-oxadiazol-5-yl)piperidin-1-yl]-n-(2-fluoro-4-methylsulfonylphenyl)-5-nitropyrimidin-4-amine Chemical compound CCC1=NOC(C2CCN(CC2)C=2C(=C(NC=3C(=CC(=CC=3)S(C)(=O)=O)F)N=CN=2)[N+]([O-])=O)=N1 RDSZTCYLOYPCLJ-UHFFFAOYSA-N 0.000 description 1
- HWVVMXIHBLDSMQ-UHFFFAOYSA-N 6-[4-(3-ethyl-1,2,4-oxadiazol-5-yl)piperidin-1-yl]-n-(2-fluorophenyl)-5-nitropyrimidin-4-amine Chemical compound CCC1=NOC(C2CCN(CC2)C=2C(=C(NC=3C(=CC=CC=3)F)N=CN=2)[N+]([O-])=O)=N1 HWVVMXIHBLDSMQ-UHFFFAOYSA-N 0.000 description 1
- VJNFWQAQCOXLMV-UHFFFAOYSA-N 6-[4-(3-ethyl-1,2,4-oxadiazol-5-yl)piperidin-1-yl]-n-(4-methylsulfonylphenyl)-5-nitropyrimidin-4-amine Chemical compound CCC1=NOC(C2CCN(CC2)C=2C(=C(NC=3C=CC(=CC=3)S(C)(=O)=O)N=CN=2)[N+]([O-])=O)=N1 VJNFWQAQCOXLMV-UHFFFAOYSA-N 0.000 description 1
- NGIXNAVBOJOSMZ-UHFFFAOYSA-N 6-[4-(3-methyl-1,2,4-oxadiazol-5-yl)piperidin-1-yl]-5-nitro-n-[4-(1,2,4-triazol-1-yl)phenyl]pyrimidin-4-amine Chemical compound CC1=NOC(C2CCN(CC2)C=2C(=C(NC=3C=CC(=CC=3)N3N=CN=C3)N=CN=2)[N+]([O-])=O)=N1 NGIXNAVBOJOSMZ-UHFFFAOYSA-N 0.000 description 1
- JEUPGLYFAZECGZ-UHFFFAOYSA-N 6-[4-(3-methyl-1,2,4-oxadiazol-5-yl)piperidin-1-yl]-n-(4-methylsulfonylphenyl)-5-nitropyrimidin-4-amine Chemical compound CC1=NOC(C2CCN(CC2)C=2C(=C(NC=3C=CC(=CC=3)S(C)(=O)=O)N=CN=2)[N+]([O-])=O)=N1 JEUPGLYFAZECGZ-UHFFFAOYSA-N 0.000 description 1
- IZXAWMFOUJIWOK-UHFFFAOYSA-N 6-[4-(3-tert-butyl-1,2,4-oxadiazol-5-yl)piperidin-1-yl]-n-(4-methylsulfonylphenyl)-5-nitropyrimidin-4-amine Chemical compound CC(C)(C)C1=NOC(C2CCN(CC2)C=2C(=C(NC=3C=CC(=CC=3)S(C)(=O)=O)N=CN=2)[N+]([O-])=O)=N1 IZXAWMFOUJIWOK-UHFFFAOYSA-N 0.000 description 1
- KJDUMAGHWCUSGS-UHFFFAOYSA-N 6-[4-(4-fluorophenoxy)piperidin-1-yl]-n-(4-methylsulfonylphenyl)-5-nitropyrimidin-4-amine Chemical compound C1=CC(S(=O)(=O)C)=CC=C1NC1=NC=NC(N2CCC(CC2)OC=2C=CC(F)=CC=2)=C1[N+]([O-])=O KJDUMAGHWCUSGS-UHFFFAOYSA-N 0.000 description 1
- JEROHQOUQXIXPI-UHFFFAOYSA-N 6-[4-(4-methoxyphenyl)sulfanylpiperidin-1-yl]-n-(4-methylsulfonylphenyl)-5-nitropyrimidin-4-amine Chemical compound C1=CC(OC)=CC=C1SC1CCN(C=2C(=C(NC=3C=CC(=CC=3)S(C)(=O)=O)N=CN=2)[N+]([O-])=O)CC1 JEROHQOUQXIXPI-UHFFFAOYSA-N 0.000 description 1
- FDZXALFHMXKKKG-UHFFFAOYSA-N 6-[4-(benzenesulfonyl)piperidin-1-yl]-n-(4-methylsulfonylphenyl)-5-nitropyrimidin-4-amine Chemical compound C1=CC(S(=O)(=O)C)=CC=C1NC1=NC=NC(N2CCC(CC2)S(=O)(=O)C=2C=CC=CC=2)=C1[N+]([O-])=O FDZXALFHMXKKKG-UHFFFAOYSA-N 0.000 description 1
- JYKUNRUMBUJEAK-UHFFFAOYSA-N 6-[4-(ethoxymethyl)piperidin-1-yl]-n-(4-methylsulfonylphenyl)-5-nitropyrimidin-4-amine Chemical compound C1CC(COCC)CCN1C1=NC=NC(NC=2C=CC(=CC=2)S(C)(=O)=O)=C1[N+]([O-])=O JYKUNRUMBUJEAK-UHFFFAOYSA-N 0.000 description 1
- KHLIDOBTNFFCRR-UHFFFAOYSA-N 6-[4-[3-(cyclopropylmethyl)-1,2,4-oxadiazol-5-yl]piperidin-1-yl]-n-(2-fluoro-4-methylsulfonylphenyl)pyrimidin-4-amine Chemical compound FC1=CC(S(=O)(=O)C)=CC=C1NC1=CC(N2CCC(CC2)C=2ON=C(CC3CC3)N=2)=NC=N1 KHLIDOBTNFFCRR-UHFFFAOYSA-N 0.000 description 1
- FKWBGWZLMJQVTH-UHFFFAOYSA-N 6-[4-[3-(cyclopropylmethyl)-1,2,4-oxadiazol-5-yl]piperidin-1-yl]-n-(4-methylsulfonylphenyl)-5-nitropyrimidin-4-amine Chemical compound C1=CC(S(=O)(=O)C)=CC=C1NC1=NC=NC(N2CCC(CC2)C=2ON=C(CC3CC3)N=2)=C1[N+]([O-])=O FKWBGWZLMJQVTH-UHFFFAOYSA-N 0.000 description 1
- YJTUGKPIFVHJRH-UHFFFAOYSA-N 6-[4-[3-[(dimethylamino)methyl]-1,2,4-oxadiazol-5-yl]piperidin-1-yl]-n-(2-fluoro-4-methylsulfonylphenyl)pyrimidin-4-amine Chemical compound CN(C)CC1=NOC(C2CCN(CC2)C=2N=CN=C(NC=3C(=CC(=CC=3)S(C)(=O)=O)F)C=2)=N1 YJTUGKPIFVHJRH-UHFFFAOYSA-N 0.000 description 1
- DMJUZGRTAHYQPL-UHFFFAOYSA-N 6-[4-[5-(4-fluorophenyl)-1,3,4-oxadiazol-2-yl]piperidin-1-yl]-n-(4-methylsulfonylphenyl)-5-nitropyrimidin-4-amine Chemical compound C1=CC(S(=O)(=O)C)=CC=C1NC1=NC=NC(N2CCC(CC2)C=2OC(=NN=2)C=2C=CC(F)=CC=2)=C1[N+]([O-])=O DMJUZGRTAHYQPL-UHFFFAOYSA-N 0.000 description 1
- YYJNAHPOVDFISZ-UHFFFAOYSA-N 6-methyl-n-[[4-[[1-(4-methylsulfonylphenyl)pyrazolo[3,4-d]pyrimidin-4-yl]amino]cyclohexyl]methyl]pyridine-3-carboxamide Chemical compound C1=NC(C)=CC=C1C(=O)NCC1CCC(NC=2C=3C=NN(C=3N=CN=2)C=2C=CC(=CC=2)S(C)(=O)=O)CC1 YYJNAHPOVDFISZ-UHFFFAOYSA-N 0.000 description 1
- RNPWVVWMMDDDDF-UHFFFAOYSA-N 6-n-(4-methylsulfonylphenyl)-5-nitro-4-n-piperidin-4-ylpyrimidine-4,6-diamine Chemical compound C1=CC(S(=O)(=O)C)=CC=C1NC1=NC=NC(NC2CCNCC2)=C1[N+]([O-])=O RNPWVVWMMDDDDF-UHFFFAOYSA-N 0.000 description 1
- 125000003341 7 membered heterocyclic group Chemical group 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 102100031786 Adiponectin Human genes 0.000 description 1
- 108010076365 Adiponectin Proteins 0.000 description 1
- 229940077274 Alpha glucosidase inhibitor Drugs 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 208000037260 Atherosclerotic Plaque Diseases 0.000 description 1
- 229940123208 Biguanide Drugs 0.000 description 1
- XNCOSPRUTUOJCJ-UHFFFAOYSA-N Biguanide Chemical compound NC(N)=NC(N)=N XNCOSPRUTUOJCJ-UHFFFAOYSA-N 0.000 description 1
- GNHFRVFMMDARPQ-UHFFFAOYSA-N BrC1=CC(=C(OC2=CC(=NC=N2)OC2CCN(CC2)C(=O)O)C=C1)F Chemical compound BrC1=CC(=C(OC2=CC(=NC=N2)OC2CCN(CC2)C(=O)O)C=C1)F GNHFRVFMMDARPQ-UHFFFAOYSA-N 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- MTDASJUTEKVOEE-UHFFFAOYSA-N C(#N)C=1C(=NC=NC1NC1=C(C=C(C=C1)NC(C)C)F)OC1CCN(CC1)C(=O)O Chemical compound C(#N)C=1C(=NC=NC1NC1=C(C=C(C=C1)NC(C)C)F)OC1CCN(CC1)C(=O)O MTDASJUTEKVOEE-UHFFFAOYSA-N 0.000 description 1
- HOYYYORBLLVRSP-UHFFFAOYSA-N C(#N)C=1C(=NC=NC=1NC1=C(C=C(C=C1)NCCN1CCCC1)F)OC1CCN(CC1)C(=O)O Chemical compound C(#N)C=1C(=NC=NC=1NC1=C(C=C(C=C1)NCCN1CCCC1)F)OC1CCN(CC1)C(=O)O HOYYYORBLLVRSP-UHFFFAOYSA-N 0.000 description 1
- NVQVWSMZABRCOW-UHFFFAOYSA-N C(#N)C=1C(=NC=NC=1NC1=C(C=C(C=C1)NCCN1CCOCC1)F)OC1CCN(CC1)C(=O)O Chemical compound C(#N)C=1C(=NC=NC=1NC1=C(C=C(C=C1)NCCN1CCOCC1)F)OC1CCN(CC1)C(=O)O NVQVWSMZABRCOW-UHFFFAOYSA-N 0.000 description 1
- RINDGARHCCHYSW-UHFFFAOYSA-N C(#N)C=1C(=NC=NC=1NC1=C(C=C(C=C1)S(=O)(=O)C)F)OC1CCN(CC1)C(=O)O Chemical compound C(#N)C=1C(=NC=NC=1NC1=C(C=C(C=C1)S(=O)(=O)C)F)OC1CCN(CC1)C(=O)O RINDGARHCCHYSW-UHFFFAOYSA-N 0.000 description 1
- JYLJPHDIYKOBPS-UHFFFAOYSA-N C(#N)C=1C(=NC=NC=1NC1=C(C=C(C=C1)SCCN(C)C)F)OC1CCN(CC1)C(=O)O Chemical compound C(#N)C=1C(=NC=NC=1NC1=C(C=C(C=C1)SCCN(C)C)F)OC1CCN(CC1)C(=O)O JYLJPHDIYKOBPS-UHFFFAOYSA-N 0.000 description 1
- AVTWDWVJNCDKKE-UHFFFAOYSA-N C(#N)C=1C(=NC=NC=1NC=1C=NC(=CC=1)NCCC)OC1CCN(CC1)C(=O)O Chemical compound C(#N)C=1C(=NC=NC=1NC=1C=NC(=CC=1)NCCC)OC1CCN(CC1)C(=O)O AVTWDWVJNCDKKE-UHFFFAOYSA-N 0.000 description 1
- IZHRLBUORAMEHN-UHFFFAOYSA-N C(#N)C=1C(=NC=NC=1NC=1C=NC(=CC=1)S(=O)(=O)C)OC1CCN(CC1)C(=O)O Chemical compound C(#N)C=1C(=NC=NC=1NC=1C=NC(=CC=1)S(=O)(=O)C)OC1CCN(CC1)C(=O)O IZHRLBUORAMEHN-UHFFFAOYSA-N 0.000 description 1
- WMJXPIUPLMUBMT-UHFFFAOYSA-N C(C)(C)OCCNC1=CC=C(C(=N1)C)OC1=C(C(=NC=N1)OC1CCN(CC1)C(=O)O)C Chemical compound C(C)(C)OCCNC1=CC=C(C(=N1)C)OC1=C(C(=NC=N1)OC1CCN(CC1)C(=O)O)C WMJXPIUPLMUBMT-UHFFFAOYSA-N 0.000 description 1
- VCLRTFQCZWOLEI-UHFFFAOYSA-N C(C)C1=CC=CC(=N1)NC1=CC(=NC=N1)OC1CCN(CC1)C(=O)O Chemical compound C(C)C1=CC=CC(=N1)NC1=CC(=NC=N1)OC1CCN(CC1)C(=O)O VCLRTFQCZWOLEI-UHFFFAOYSA-N 0.000 description 1
- SVHMUULZIISJCJ-UHFFFAOYSA-N C(C)NC(=O)C1=CC(=C(C=C1)NC1=CC(=NC=N1)N(C)CC1CCN(CC1)C(=O)O)F Chemical compound C(C)NC(=O)C1=CC(=C(C=C1)NC1=CC(=NC=N1)N(C)CC1CCN(CC1)C(=O)O)F SVHMUULZIISJCJ-UHFFFAOYSA-N 0.000 description 1
- XOGBYMNQRUFSTJ-UHFFFAOYSA-N C(C1=CC=CC=C1)(=O)C1=C(OC2=C(C(=NC=N2)N2CCC(CC2)C(=O)O)[N+](=O)[O-])C=C(C=C1)OC Chemical compound C(C1=CC=CC=C1)(=O)C1=C(OC2=C(C(=NC=N2)N2CCC(CC2)C(=O)O)[N+](=O)[O-])C=C(C=C1)OC XOGBYMNQRUFSTJ-UHFFFAOYSA-N 0.000 description 1
- CNXJFYBWDBWIME-UHFFFAOYSA-N C(C1=CC=CC=C1)(=O)C1=CC=C(C=C1)NC=1C=CC(=C(C=1)N1CCC(CC1)C(=O)O)[N+](=O)[O-] Chemical compound C(C1=CC=CC=C1)(=O)C1=CC=C(C=C1)NC=1C=CC(=C(C=1)N1CCC(CC1)C(=O)O)[N+](=O)[O-] CNXJFYBWDBWIME-UHFFFAOYSA-N 0.000 description 1
- LHZCZDAABBYULK-UHFFFAOYSA-N C(N)(=N)C=1C(=NC=NC=1NC1=C(C=C(C=C1)S(=O)(=O)C)F)OC1CCN(CC1)C(=O)O Chemical compound C(N)(=N)C=1C(=NC=NC=1NC1=C(C=C(C=C1)S(=O)(=O)C)F)OC1CCN(CC1)C(=O)O LHZCZDAABBYULK-UHFFFAOYSA-N 0.000 description 1
- VZFWWPSHWOSBGL-UHFFFAOYSA-N C(N)(=O)C=1C=CC(=NC=1)NC1=CC(=NC=N1)OC1CCN(CC1)C(=O)O Chemical compound C(N)(=O)C=1C=CC(=NC=1)NC1=CC(=NC=N1)OC1CCN(CC1)C(=O)O VZFWWPSHWOSBGL-UHFFFAOYSA-N 0.000 description 1
- ASGKTOWJXQMKLB-UHFFFAOYSA-N C(N)(=O)CC1=CC=C(OC2=C(C(=NC=N2)N2CCC(CC2)C(=O)O)[N+](=O)[O-])C=C1 Chemical compound C(N)(=O)CC1=CC=C(OC2=C(C(=NC=N2)N2CCC(CC2)C(=O)O)[N+](=O)[O-])C=C1 ASGKTOWJXQMKLB-UHFFFAOYSA-N 0.000 description 1
- YGFWJDAMLAOITO-UHFFFAOYSA-N C1=NC(CCC)=CC=C1NC1=NC=NC(OC2CCN(CC2)C(O)=O)=C1C#N Chemical compound C1=NC(CCC)=CC=C1NC1=NC=NC(OC2CCN(CC2)C(O)=O)=C1C#N YGFWJDAMLAOITO-UHFFFAOYSA-N 0.000 description 1
- LDARMEAYYFGMCX-UHFFFAOYSA-N C1CC(CCC)CCN1C1=CC(OC=2C=CC(=CC=2)C2=NN(C)C(O)=C2)=CC=C1[N+]([O-])=O Chemical compound C1CC(CCC)CCN1C1=CC(OC=2C=CC(=CC=2)C2=NN(C)C(O)=C2)=CC=C1[N+]([O-])=O LDARMEAYYFGMCX-UHFFFAOYSA-N 0.000 description 1
- YNHHPLRNNJHSKN-WKILWMFISA-N C1C[C@@H](NC(=O)OC(C)C)CC[C@@H]1OC1=NC=NC(OC=2C(=CC(=CC=2)S(C)(=O)=O)F)=C1C Chemical compound C1C[C@@H](NC(=O)OC(C)C)CC[C@@H]1OC1=NC=NC(OC=2C(=CC(=CC=2)S(C)(=O)=O)F)=C1C YNHHPLRNNJHSKN-WKILWMFISA-N 0.000 description 1
- REQGOTUEMSZGNW-UHFFFAOYSA-N CC(C)(C)C(CC(CC1)N(CC2CC2)CC2=NC(C3=CC=NC=C3)=NO2)N1C(O)=O Chemical compound CC(C)(C)C(CC(CC1)N(CC2CC2)CC2=NC(C3=CC=NC=C3)=NO2)N1C(O)=O REQGOTUEMSZGNW-UHFFFAOYSA-N 0.000 description 1
- QCTQHYUWKGNKJB-UHFFFAOYSA-N CC(C)(C)C(CC(CC1)NCC2=NOC(C3=CC(C#N)=NC=C3)=N2)N1C(O)=O Chemical compound CC(C)(C)C(CC(CC1)NCC2=NOC(C3=CC(C#N)=NC=C3)=N2)N1C(O)=O QCTQHYUWKGNKJB-UHFFFAOYSA-N 0.000 description 1
- LZAMGPCQYUKCDU-UHFFFAOYSA-N CC(C)OC(=O)N1CCCCC1(N2C=CON2)OC Chemical compound CC(C)OC(=O)N1CCCCC1(N2C=CON2)OC LZAMGPCQYUKCDU-UHFFFAOYSA-N 0.000 description 1
- LDFICUDMIGQAQF-UHFFFAOYSA-N CC(C)OCCC1=CC=C(OC2=NC=NC(OC3CCN(CC3)C(O)=O)=C2C#C)C(C)=N1 Chemical compound CC(C)OCCC1=CC=C(OC2=NC=NC(OC3CCN(CC3)C(O)=O)=C2C#C)C(C)=N1 LDFICUDMIGQAQF-UHFFFAOYSA-N 0.000 description 1
- KONBLRYRRZUROC-UHFFFAOYSA-N CC(C)OCCNS(=O)(=O)C1=CC(F)=C(NC2=NC=NC(OC3CCN(CC3)C(O)=O)=C2C)C=C1 Chemical compound CC(C)OCCNS(=O)(=O)C1=CC(F)=C(NC2=NC=NC(OC3CCN(CC3)C(O)=O)=C2C)C=C1 KONBLRYRRZUROC-UHFFFAOYSA-N 0.000 description 1
- QKXUEULDQPPCPD-UHFFFAOYSA-N CC1=C(N=CN=C1OC2CCNCC2)OC3=C(C=C(C=C3)C4=NOC(=N4)COC(C)C)F Chemical compound CC1=C(N=CN=C1OC2CCNCC2)OC3=C(C=C(C=C3)C4=NOC(=N4)COC(C)C)F QKXUEULDQPPCPD-UHFFFAOYSA-N 0.000 description 1
- CFJQYAWUMVNJKJ-UHFFFAOYSA-N CC1=CC(=NN1)NC1=CC(=NC=N1)OC1CCN(CC1)C(=O)O Chemical compound CC1=CC(=NN1)NC1=CC(=NC=N1)OC1CCN(CC1)C(=O)O CFJQYAWUMVNJKJ-UHFFFAOYSA-N 0.000 description 1
- AIBVNASYTKJYQG-UHFFFAOYSA-N CC1=CC=C(NC2=NC=NC(OC3CCN(CC3)C(O)=O)=C2)C(C)=N1 Chemical compound CC1=CC=C(NC2=NC=NC(OC3CCN(CC3)C(O)=O)=C2)C(C)=N1 AIBVNASYTKJYQG-UHFFFAOYSA-N 0.000 description 1
- ARCXPVYJLSSQTP-UHFFFAOYSA-N CC1=NC(S(=O)(=O)CCOC)=CC=C1OC1=NC=NC(OC2CCN(CC2)C(O)=O)=C1C Chemical compound CC1=NC(S(=O)(=O)CCOC)=CC=C1OC1=NC=NC(OC2CCN(CC2)C(O)=O)=C1C ARCXPVYJLSSQTP-UHFFFAOYSA-N 0.000 description 1
- XMNDYTMTLDWSMN-UHFFFAOYSA-N CC1CCCC(C1)(C(C)C)OC(=O)N2CCCCC2 Chemical compound CC1CCCC(C1)(C(C)C)OC(=O)N2CCCCC2 XMNDYTMTLDWSMN-UHFFFAOYSA-N 0.000 description 1
- GRVZFBFGWCAFKL-UHFFFAOYSA-N CC=1C(=NC=NC=1OC=1C(=NC(=CC=1)CCCCC)C)OC1CCN(CC1)C(=O)O Chemical compound CC=1C(=NC=NC=1OC=1C(=NC(=CC=1)CCCCC)C)OC1CCN(CC1)C(=O)O GRVZFBFGWCAFKL-UHFFFAOYSA-N 0.000 description 1
- LJSCWHJJBGXRRX-UHFFFAOYSA-N CC=1C=CC(=NC=1)NC1=CC(=NC=N1)OC1CCN(CC1)C(=O)O Chemical compound CC=1C=CC(=NC=1)NC1=CC(=NC=N1)OC1CCN(CC1)C(=O)O LJSCWHJJBGXRRX-UHFFFAOYSA-N 0.000 description 1
- QMOBJOJZTNPJCK-SHTZXODSSA-N CCCCC[C@H]1CC[C@@H](CC1)c1nnc(s1)-c1ccncc1 Chemical compound CCCCC[C@H]1CC[C@@H](CC1)c1nnc(s1)-c1ccncc1 QMOBJOJZTNPJCK-SHTZXODSSA-N 0.000 description 1
- VHDGIXNWSHXWDM-UHFFFAOYSA-N CCCCN(CC1=NC(C2=CC=NC=C2)=NO1)C(CC1)CC(C(C)(C)C)N1C(OC(C)(C)C)=O Chemical compound CCCCN(CC1=NC(C2=CC=NC=C2)=NO1)C(CC1)CC(C(C)(C)C)N1C(OC(C)(C)C)=O VHDGIXNWSHXWDM-UHFFFAOYSA-N 0.000 description 1
- CQOYSCFCGVRQRM-UHFFFAOYSA-N CCCCOC(N(CCC(C1)OCC2=NN=C(C3=CC=NC=C3)S2)C1C(C)(C)C)=O Chemical compound CCCCOC(N(CCC(C1)OCC2=NN=C(C3=CC=NC=C3)S2)C1C(C)(C)C)=O CQOYSCFCGVRQRM-UHFFFAOYSA-N 0.000 description 1
- QEPFONSNJMGFFF-UHFFFAOYSA-N CCCN(CC1=NC(C2=CC=NC=C2)=NO1)C(CC1)CC(C(C)(C)C)N1C(O)=O Chemical compound CCCN(CC1=NC(C2=CC=NC=C2)=NO1)C(CC1)CC(C(C)(C)C)N1C(O)=O QEPFONSNJMGFFF-UHFFFAOYSA-N 0.000 description 1
- VPPPCUNHXYGSDO-UHFFFAOYSA-N CN(C(=O)CC1=CC(=C(OC2=C(C(=NC=N2)OC2CCN(CC2)C(=O)O)C)C=C1)F)C Chemical compound CN(C(=O)CC1=CC(=C(OC2=C(C(=NC=N2)OC2CCN(CC2)C(=O)O)C)C=C1)F)C VPPPCUNHXYGSDO-UHFFFAOYSA-N 0.000 description 1
- PXMKBOYSTIQHLV-UHFFFAOYSA-N CN(S(=O)(=O)C1=CC=C(C=C1)NC1=C(C(=NC=N1)N1CCC(CC1)C(=O)O)[N+](=O)[O-])C Chemical compound CN(S(=O)(=O)C1=CC=C(C=C1)NC1=C(C(=NC=N1)N1CCC(CC1)C(=O)O)[N+](=O)[O-])C PXMKBOYSTIQHLV-UHFFFAOYSA-N 0.000 description 1
- DFVOHIWTXLOKCD-UHFFFAOYSA-N COC(=O)CC(=O)C1=CC=C(OC2=C(C(=NC=N2)N2CCC(CC2)C(=O)O)[N+](=O)[O-])C=C1 Chemical compound COC(=O)CC(=O)C1=CC=C(OC2=C(C(=NC=N2)N2CCC(CC2)C(=O)O)[N+](=O)[O-])C=C1 DFVOHIWTXLOKCD-UHFFFAOYSA-N 0.000 description 1
- HTMTWKSJPPOVMT-UHFFFAOYSA-N COCCNC1=CC=C(C(=N1)C)OC1=C(C(=NC=N1)OC1CCN(CC1)C(=O)O)C Chemical compound COCCNC1=CC=C(C(=N1)C)OC1=C(C(=NC=N1)OC1CCN(CC1)C(=O)O)C HTMTWKSJPPOVMT-UHFFFAOYSA-N 0.000 description 1
- HLUGKNFEGZORAN-UHFFFAOYSA-N COCCOC1=CC=C(C(=N1)C)NC1=C(C(=NC=N1)OC1CCN(CC1)C(=O)O)C Chemical compound COCCOC1=CC=C(C(=N1)C)NC1=C(C(=NC=N1)OC1CCN(CC1)C(=O)O)C HLUGKNFEGZORAN-UHFFFAOYSA-N 0.000 description 1
- PJVOVTGNHTZMRP-UHFFFAOYSA-N CS(=O)(=O)C1=CC(F)=C(NC2=NC=NC(OC3CCN(CC3)C(O)=O)=C2C2=NCCN2)C=C1 Chemical compound CS(=O)(=O)C1=CC(F)=C(NC2=NC=NC(OC3CCN(CC3)C(O)=O)=C2C2=NCCN2)C=C1 PJVOVTGNHTZMRP-UHFFFAOYSA-N 0.000 description 1
- VCVUDNXUEZQJNZ-UHFFFAOYSA-N CS(=O)(=O)C1CN(CC1)C1=CC=C(C(=N1)C)OC1=C(C(=NC=N1)OC1CCN(CC1)C(=O)O)C Chemical compound CS(=O)(=O)C1CN(CC1)C1=CC=C(C(=N1)C)OC1=C(C(=NC=N1)OC1CCN(CC1)C(=O)O)C VCVUDNXUEZQJNZ-UHFFFAOYSA-N 0.000 description 1
- CGTWOMIQDTWMAZ-UHFFFAOYSA-N CS(=O)(=O)CCN(C1=CC=C(C(=N1)C)OC1=C(C(=NC=N1)OC1CCN(CC1)C(=O)O)C)C Chemical compound CS(=O)(=O)CCN(C1=CC=C(C(=N1)C)OC1=C(C(=NC=N1)OC1CCN(CC1)C(=O)O)C)C CGTWOMIQDTWMAZ-UHFFFAOYSA-N 0.000 description 1
- FCPAMABCCXYUID-UHFFFAOYSA-N CS(=O)(=O)CCNC1=CC=C(C(=N1)C)OC1=C(C(=NC=N1)OC1CCN(CC1)C(=O)O)C Chemical compound CS(=O)(=O)CCNC1=CC=C(C(=N1)C)OC1=C(C(=NC=N1)OC1CCN(CC1)C(=O)O)C FCPAMABCCXYUID-UHFFFAOYSA-N 0.000 description 1
- 101100294115 Caenorhabditis elegans nhr-4 gene Proteins 0.000 description 1
- KXDHJXZQYSOELW-UHFFFAOYSA-N Carbamic acid Chemical group NC(O)=O KXDHJXZQYSOELW-UHFFFAOYSA-N 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 108010012236 Chemokines Proteins 0.000 description 1
- 102000019034 Chemokines Human genes 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- 101150065749 Churc1 gene Proteins 0.000 description 1
- RIFRFLDNPDHUQJ-UHFFFAOYSA-N ClC1=CC(=C(C=N1)NC1=C(C(=NC=N1)OC1CCN(CC1)C(=O)O)C#N)F Chemical compound ClC1=CC(=C(C=N1)NC1=C(C(=NC=N1)OC1CCN(CC1)C(=O)O)C#N)F RIFRFLDNPDHUQJ-UHFFFAOYSA-N 0.000 description 1
- CTMUBCAANULVEA-UHFFFAOYSA-N ClC1=CC=C(C(=N1)C)OC1=C(C(=NC=N1)OC1CCN(CC1)C(=O)O)C Chemical compound ClC1=CC=C(C(=N1)C)OC1=C(C(=NC=N1)OC1CCN(CC1)C(=O)O)C CTMUBCAANULVEA-UHFFFAOYSA-N 0.000 description 1
- VKFBBORQRBCWOP-UHFFFAOYSA-N ClC=1N=CN(C=1Cl)C1=CC=C(C=C1)NC1=C(C(=NC=N1)N1CCC(CC1)C(=O)O)[N+](=O)[O-] Chemical compound ClC=1N=CN(C=1Cl)C1=CC=C(C=C1)NC1=C(C(=NC=N1)N1CCC(CC1)C(=O)O)[N+](=O)[O-] VKFBBORQRBCWOP-UHFFFAOYSA-N 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 229940124213 Dipeptidyl peptidase 4 (DPP IV) inhibitor Drugs 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- YENNACZZTNRZSB-UHFFFAOYSA-N FC1=C(C=C(C(=C1)CCS(=O)(=O)C)F)NC1=C(C(=NC=N1)OC1CCN(CC1)C(=O)O)C Chemical compound FC1=C(C=C(C(=C1)CCS(=O)(=O)C)F)NC1=C(C(=NC=N1)OC1CCN(CC1)C(=O)O)C YENNACZZTNRZSB-UHFFFAOYSA-N 0.000 description 1
- IPMRLMLXJHVRHR-UHFFFAOYSA-N FC1=C(C=C(C(=C1)OCCC)F)NC1=C(C(=NC=N1)OC1CCN(CC1)C(=O)O)C Chemical compound FC1=C(C=C(C(=C1)OCCC)F)NC1=C(C(=NC=N1)OC1CCN(CC1)C(=O)O)C IPMRLMLXJHVRHR-UHFFFAOYSA-N 0.000 description 1
- MSGWZVOLJMEYCM-UHFFFAOYSA-N FC1=C(C=C(C(=C1)OCCOC)F)NC1=C(C(=NC=N1)OC1CCN(CC1)C(=O)O)C Chemical compound FC1=C(C=C(C(=C1)OCCOC)F)NC1=C(C(=NC=N1)OC1CCN(CC1)C(=O)O)C MSGWZVOLJMEYCM-UHFFFAOYSA-N 0.000 description 1
- IVBUYNRPANRVSV-UHFFFAOYSA-N FC1=C(C=C(C(=C1)S(=O)(=O)C)F)C1=NN(C2=C1N=CN=C2OC1CCN(CC1)C(=O)O)C Chemical compound FC1=C(C=C(C(=C1)S(=O)(=O)C)F)C1=NN(C2=C1N=CN=C2OC1CCN(CC1)C(=O)O)C IVBUYNRPANRVSV-UHFFFAOYSA-N 0.000 description 1
- IFLJCAONEKNILG-UHFFFAOYSA-N FC1=C(C=CC(=C1)I)NC1=C(C(=NC=N1)OC1CCN(CC1)C(=O)O)C Chemical compound FC1=C(C=CC(=C1)I)NC1=C(C(=NC=N1)OC1CCN(CC1)C(=O)O)C IFLJCAONEKNILG-UHFFFAOYSA-N 0.000 description 1
- HLVHOXPYBNQLMP-UHFFFAOYSA-N FC1=C(C=CC(=C1)NCC1OCCC1)NC1=C(C(=NC=N1)OC1CCN(CC1)C(=O)O)C Chemical compound FC1=C(C=CC(=C1)NCC1OCCC1)NC1=C(C(=NC=N1)OC1CCN(CC1)C(=O)O)C HLVHOXPYBNQLMP-UHFFFAOYSA-N 0.000 description 1
- SKTPDBIWVIKLGD-UHFFFAOYSA-N FC1=C(C=CC(=C1)OCCC)NC1=C(C(=NC=N1)OC1CCN(CC1)C(=O)O)C Chemical compound FC1=C(C=CC(=C1)OCCC)NC1=C(C(=NC=N1)OC1CCN(CC1)C(=O)O)C SKTPDBIWVIKLGD-UHFFFAOYSA-N 0.000 description 1
- HZOLFYAVUHJASC-UHFFFAOYSA-N FC1=C(C=CC(=C1)OCCOC(C)C)NC1=C(C(=NC=N1)OC1CCN(CC1)C(=O)O)C Chemical compound FC1=C(C=CC(=C1)OCCOC(C)C)NC1=C(C(=NC=N1)OC1CCN(CC1)C(=O)O)C HZOLFYAVUHJASC-UHFFFAOYSA-N 0.000 description 1
- KQHNCUBQMLDLQG-UHFFFAOYSA-N FC1=C(C=CC(=C1)OCCS(=O)(=O)C)NC1=C(C(=NC=N1)OC1CCN(CC1)C(=O)O)C Chemical compound FC1=C(C=CC(=C1)OCCS(=O)(=O)C)NC1=C(C(=NC=N1)OC1CCN(CC1)C(=O)O)C KQHNCUBQMLDLQG-UHFFFAOYSA-N 0.000 description 1
- VRRMPEFXWFJDQR-UHFFFAOYSA-N FC1=C(C=CC(=C1)S(=O)(=O)C)N(C1=C(C(=NC=N1)OC1CCN(CC1)C(=O)O)C)CCOC Chemical compound FC1=C(C=CC(=C1)S(=O)(=O)C)N(C1=C(C(=NC=N1)OC1CCN(CC1)C(=O)O)C)CCOC VRRMPEFXWFJDQR-UHFFFAOYSA-N 0.000 description 1
- DSZIVWHKGJFQCK-UHFFFAOYSA-N FC1=C(C=CC(=C1)S(=O)(=O)C)NC1=C(C(=NC=N1)SC1CCN(CC1)C(=O)O)C Chemical compound FC1=C(C=CC(=C1)S(=O)(=O)C)NC1=C(C(=NC=N1)SC1CCN(CC1)C(=O)O)C DSZIVWHKGJFQCK-UHFFFAOYSA-N 0.000 description 1
- NXYSBIVXKJSHOH-UHFFFAOYSA-N FC1=C(C=NC(=C1)CCOC(C)C)NC1=NC=CC(=C1C)OC1CCN(CC1)C(=O)O Chemical compound FC1=C(C=NC(=C1)CCOC(C)C)NC1=NC=CC(=C1C)OC1CCN(CC1)C(=O)O NXYSBIVXKJSHOH-UHFFFAOYSA-N 0.000 description 1
- QAHORKPNGDMVOD-UHFFFAOYSA-N FC1=C(OC2=C(C(=NC=N2)OC2CCN(CC2)C(=O)O)C)C=CC(=C1)C(=O)N1CCN(CC1)C(C)C Chemical compound FC1=C(OC2=C(C(=NC=N2)OC2CCN(CC2)C(=O)O)C)C=CC(=C1)C(=O)N1CCN(CC1)C(C)C QAHORKPNGDMVOD-UHFFFAOYSA-N 0.000 description 1
- NYKVWUBGSSDNRS-UHFFFAOYSA-N FC1=C(OC2=C(C(=NC=N2)OC2CCN(CC2)C(=O)O)C)C=CC(=C1)C(N(C)OC)=O Chemical compound FC1=C(OC2=C(C(=NC=N2)OC2CCN(CC2)C(=O)O)C)C=CC(=C1)C(N(C)OC)=O NYKVWUBGSSDNRS-UHFFFAOYSA-N 0.000 description 1
- GRFPAKRDHWYVPR-UHFFFAOYSA-N FC1=C(OC2=C(C(=NC=N2)OC2CCN(CC2)C(=O)O)C)C=CC(=C1)C(NCCOC(C)C)=N Chemical compound FC1=C(OC2=C(C(=NC=N2)OC2CCN(CC2)C(=O)O)C)C=CC(=C1)C(NCCOC(C)C)=N GRFPAKRDHWYVPR-UHFFFAOYSA-N 0.000 description 1
- KXVZPAGVHIBVKJ-UHFFFAOYSA-N FC1=C(OC2=C(C(=NC=N2)OC2CCN(CC2)C(=O)O)C)C=CC(=C1)C(NO)=O Chemical compound FC1=C(OC2=C(C(=NC=N2)OC2CCN(CC2)C(=O)O)C)C=CC(=C1)C(NO)=O KXVZPAGVHIBVKJ-UHFFFAOYSA-N 0.000 description 1
- FVQYRLNUFBKJQA-UHFFFAOYSA-N FC1=C(OC2=C(C(=NC=N2)OC2CCN(CC2)C(=O)O)C)C=CC(=C1)CC(=O)N1CC(CCC1)O Chemical compound FC1=C(OC2=C(C(=NC=N2)OC2CCN(CC2)C(=O)O)C)C=CC(=C1)CC(=O)N1CC(CCC1)O FVQYRLNUFBKJQA-UHFFFAOYSA-N 0.000 description 1
- JZLUDNDMPRVPPN-UHFFFAOYSA-N FC1=C(OC2=C(C(=NC=N2)OC2CCN(CC2)C(=O)O)C)C=CC(=C1)CC(NCCOC(C)C)=O Chemical compound FC1=C(OC2=C(C(=NC=N2)OC2CCN(CC2)C(=O)O)C)C=CC(=C1)CC(NCCOC(C)C)=O JZLUDNDMPRVPPN-UHFFFAOYSA-N 0.000 description 1
- SAVHVAKROUVFGU-UHFFFAOYSA-N FC1=C(OC2=C(C(=NC=N2)OC2CCN(CC2)C(=O)O)C)C=CC(=C1)CCO Chemical compound FC1=C(OC2=C(C(=NC=N2)OC2CCN(CC2)C(=O)O)C)C=CC(=C1)CCO SAVHVAKROUVFGU-UHFFFAOYSA-N 0.000 description 1
- RPGCKTOJJAWFFT-UHFFFAOYSA-N FC1=C(OC2=C(C(=NC=N2)OC2CCN(CC2)C(=O)O)C)C=CC(=C1)NCC1OCCC1 Chemical compound FC1=C(OC2=C(C(=NC=N2)OC2CCN(CC2)C(=O)O)C)C=CC(=C1)NCC1OCCC1 RPGCKTOJJAWFFT-UHFFFAOYSA-N 0.000 description 1
- IHOKAZJPZHEMEY-UHFFFAOYSA-N FC1=C(OC2=C(C(=NC=N2)OC2CCN(CC2)C(=O)O)C)C=CC(=C1)S(NC(CC)=O)(=O)=O Chemical compound FC1=C(OC2=C(C(=NC=N2)OC2CCN(CC2)C(=O)O)C)C=CC(=C1)S(NC(CC)=O)(=O)=O IHOKAZJPZHEMEY-UHFFFAOYSA-N 0.000 description 1
- CEEVLGDGNVGOFB-UHFFFAOYSA-N FC1=C(OC2=C(C(=NC=N2)OC2CCN(CC2)C(=O)O)C)C=CC=C1 Chemical compound FC1=C(OC2=C(C(=NC=N2)OC2CCN(CC2)C(=O)O)C)C=CC=C1 CEEVLGDGNVGOFB-UHFFFAOYSA-N 0.000 description 1
- RGHSFGJXYJEVJD-UHFFFAOYSA-N FC1=C(OC2=C(C(=NC=N2)OC2CCN(CC2)C(=O)O)C)C=CC=C1S(N)(=O)=O Chemical compound FC1=C(OC2=C(C(=NC=N2)OC2CCN(CC2)C(=O)O)C)C=CC=C1S(N)(=O)=O RGHSFGJXYJEVJD-UHFFFAOYSA-N 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 101000887162 Gallus gallus Gallinacin-5 Proteins 0.000 description 1
- 101000887166 Gallus gallus Gallinacin-7 Proteins 0.000 description 1
- 108010088406 Glucagon-Like Peptides Proteins 0.000 description 1
- 229940089838 Glucagon-like peptide 1 receptor agonist Drugs 0.000 description 1
- FAEKWTJYAYMJKF-QHCPKHFHSA-N GlucoNorm Chemical compound C1=C(C(O)=O)C(OCC)=CC(CC(=O)N[C@@H](CC(C)C)C=2C(=CC=CC=2)N2CCCCC2)=C1 FAEKWTJYAYMJKF-QHCPKHFHSA-N 0.000 description 1
- 108091006065 Gs proteins Proteins 0.000 description 1
- 101000886868 Homo sapiens Gastric inhibitory polypeptide Proteins 0.000 description 1
- 101000684208 Homo sapiens Prolyl endopeptidase FAP Proteins 0.000 description 1
- 208000023105 Huntington disease Diseases 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 108010073961 Insulin Aspart Proteins 0.000 description 1
- 108010057186 Insulin Glargine Proteins 0.000 description 1
- 108010065920 Insulin Lispro Proteins 0.000 description 1
- COCFEDIXXNGUNL-RFKWWTKHSA-N Insulin glargine Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H]1CSSC[C@H]2C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3C=CC(O)=CC=3)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3NC=NC=3)NC(=O)[C@H](CO)NC(=O)CNC1=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(=O)NCC(O)=O)=O)CSSC[C@@H](C(N2)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)CN)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC=1C=CC=CC=1)C(C)C)C1=CN=CN1 COCFEDIXXNGUNL-RFKWWTKHSA-N 0.000 description 1
- 102000043136 MAP kinase family Human genes 0.000 description 1
- 108091054455 MAP kinase family Proteins 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- IBAQFPQHRJAVAV-ULAWRXDQSA-N Miglitol Chemical compound OCCN1C[C@H](O)[C@@H](O)[C@H](O)[C@H]1CO IBAQFPQHRJAVAV-ULAWRXDQSA-N 0.000 description 1
- 101710164423 Mitogen-activated protein kinase kinase kinase 1 Proteins 0.000 description 1
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 1
- SUAKHGWARZSWIH-UHFFFAOYSA-N N,N‐diethylformamide Chemical compound CCN(CC)C=O SUAKHGWARZSWIH-UHFFFAOYSA-N 0.000 description 1
- ZPYBZKTYLPFTJJ-UHFFFAOYSA-N N-(4-pentylcyclohexyl)oxadiazole-5-carboxamide Chemical compound C(CCCC)C1CCC(CC1)NC(=O)C1=CN=NO1 ZPYBZKTYLPFTJJ-UHFFFAOYSA-N 0.000 description 1
- QQGNLKJAIVSNCO-UHFFFAOYSA-N N-butylformamide Chemical compound CCCCNC=O QQGNLKJAIVSNCO-UHFFFAOYSA-N 0.000 description 1
- 150000001204 N-oxides Chemical class 0.000 description 1
- XNROECXUXRQQHW-UHFFFAOYSA-N N1(CCOCC1)S(=O)(=O)C1=CC=C(C=C1)NC1=C(C(=NC=N1)N1CCC(CC1)C(=O)O)[N+](=O)[O-] Chemical compound N1(CCOCC1)S(=O)(=O)C1=CC=C(C=C1)NC1=C(C(=NC=N1)N1CCC(CC1)C(=O)O)[N+](=O)[O-] XNROECXUXRQQHW-UHFFFAOYSA-N 0.000 description 1
- ZMSOGOYNUKUCPE-UHFFFAOYSA-N N1=CN=C(N(CC2CC2)CC2CCN(CC2)C(O)=O)C(C)=C1OC1=CC=C(S(C)(=O)=O)C=C1F Chemical compound N1=CN=C(N(CC2CC2)CC2CCN(CC2)C(O)=O)C(C)=C1OC1=CC=C(S(C)(=O)=O)C=C1F ZMSOGOYNUKUCPE-UHFFFAOYSA-N 0.000 description 1
- QNYXIRXRUUQYCF-UHFFFAOYSA-N NC1=C(OC2=C(C(=NC=N2)N2CCC(CC2)C(=O)O)[N+](=O)[O-])C=CC(=C1)S(=O)(=O)CC Chemical compound NC1=C(OC2=C(C(=NC=N2)N2CCC(CC2)C(=O)O)[N+](=O)[O-])C=CC(=C1)S(=O)(=O)CC QNYXIRXRUUQYCF-UHFFFAOYSA-N 0.000 description 1
- 108090000189 Neuropeptides Proteins 0.000 description 1
- YGBKNNKGICEUQC-UHFFFAOYSA-N O1C2=C(OCCC1)C=C(C=C2)NC1=C(C(=NC=N1)N1CCC(CC1)C(=O)O)[N+](=O)[O-] Chemical compound O1C2=C(OCCC1)C=C(C=C2)NC1=C(C(=NC=N1)N1CCC(CC1)C(=O)O)[N+](=O)[O-] YGBKNNKGICEUQC-UHFFFAOYSA-N 0.000 description 1
- GTPUDAOUWBBXOE-UHFFFAOYSA-N O=C(CCC1=CC=C(OC2=C(C(=NC=N2)N2CCC(CC2)C(=O)O)NC(C(F)(F)F)=O)C=C1)C Chemical compound O=C(CCC1=CC=C(OC2=C(C(=NC=N2)N2CCC(CC2)C(=O)O)NC(C(F)(F)F)=O)C=C1)C GTPUDAOUWBBXOE-UHFFFAOYSA-N 0.000 description 1
- RRWNWVGBGCZJQD-UHFFFAOYSA-N O=C1NC(C(N1)C1=CC=C(OC2=C(C(=NC=N2)N2CCC(CC2)C(=O)O)[N+](=O)[O-])C=C1)=O Chemical compound O=C1NC(C(N1)C1=CC=C(OC2=C(C(=NC=N2)N2CCC(CC2)C(=O)O)[N+](=O)[O-])C=C1)=O RRWNWVGBGCZJQD-UHFFFAOYSA-N 0.000 description 1
- 108091034117 Oligonucleotide Proteins 0.000 description 1
- 108010038807 Oligopeptides Proteins 0.000 description 1
- 102000015636 Oligopeptides Human genes 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 101150037263 PIP2 gene Proteins 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- 229940122344 Peptidase inhibitor Drugs 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- PCNDJXKNXGMECE-UHFFFAOYSA-N Phenazine Natural products C1=CC=CC2=NC3=CC=CC=C3N=C21 PCNDJXKNXGMECE-UHFFFAOYSA-N 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 241000288906 Primates Species 0.000 description 1
- 102000029797 Prion Human genes 0.000 description 1
- 108091000054 Prion Proteins 0.000 description 1
- 102000035554 Proglucagon Human genes 0.000 description 1
- 108010058003 Proglucagon Proteins 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- QOSMNYMQXIVWKY-UHFFFAOYSA-N Propyl levulinate Chemical compound CCCOC(=O)CCC(C)=O QOSMNYMQXIVWKY-UHFFFAOYSA-N 0.000 description 1
- 102100038239 Protein Churchill Human genes 0.000 description 1
- 101000608768 Rattus norvegicus Galectin-5 Proteins 0.000 description 1
- 208000017442 Retinal disease Diseases 0.000 description 1
- 206010038923 Retinopathy Diseases 0.000 description 1
- 241000283984 Rodentia Species 0.000 description 1
- 229910006069 SO3H Inorganic materials 0.000 description 1
- 101100262439 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) UBA2 gene Proteins 0.000 description 1
- 241000785681 Sander vitreus Species 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical group C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 229940100389 Sulfonylurea Drugs 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- UCKMPCXJQFINFW-UHFFFAOYSA-N Sulphide Chemical compound [S-2] UCKMPCXJQFINFW-UHFFFAOYSA-N 0.000 description 1
- 229940123464 Thiazolidinedione Drugs 0.000 description 1
- 101710120037 Toxin CcdB Proteins 0.000 description 1
- FZNCGRZWXLXZSZ-CIQUZCHMSA-N Voglibose Chemical compound OCC(CO)N[C@H]1C[C@](O)(CO)[C@@H](O)[C@H](O)[C@H]1O FZNCGRZWXLXZSZ-CIQUZCHMSA-N 0.000 description 1
- ZMBIWMANKXBTLA-ZNMIVQPWSA-N [(1S,2R,5S)-5-methyl-2-propan-2-ylcyclohexyl] piperidine-1-carboxylate Chemical compound C(C)(C)[C@@H]1[C@H](C[C@H](CC1)C)OC(=O)N1CCCCC1 ZMBIWMANKXBTLA-ZNMIVQPWSA-N 0.000 description 1
- XCYAJIWSUDCOAF-UHFFFAOYSA-N [1-[6-(1,3-benzodioxol-5-ylamino)-5-nitropyrimidin-4-yl]piperidin-4-yl]-(4-fluorophenyl)methanone Chemical compound [O-][N+](=O)C1=C(NC=2C=C3OCOC3=CC=2)N=CN=C1N(CC1)CCC1C(=O)C1=CC=C(F)C=C1 XCYAJIWSUDCOAF-UHFFFAOYSA-N 0.000 description 1
- ZGSCHDHPSAJQBY-UHFFFAOYSA-N [3-(trifluoromethyl)phenyl] piperidine-1-carboxylate Chemical compound FC(C=1C=C(C=CC1)OC(=O)N1CCCCC1)(F)F ZGSCHDHPSAJQBY-UHFFFAOYSA-N 0.000 description 1
- BNSVOPSPBMREMR-UHFFFAOYSA-N [3-[[1-(4-methylsulfonylphenyl)pyrazolo[3,4-d]pyrimidin-4-yl]amino]piperidin-1-yl]-pyridin-3-ylmethanone Chemical compound C1=CC(S(=O)(=O)C)=CC=C1N1C2=NC=NC(NC3CN(CCC3)C(=O)C=3C=NC=CC=3)=C2C=N1 BNSVOPSPBMREMR-UHFFFAOYSA-N 0.000 description 1
- NVZIVSUQFOINOQ-UHFFFAOYSA-N [4-(difluoromethoxy)phenyl]-[4-[1-(2-fluoro-4-methylsulfonylphenyl)pyrazolo[3,4-d]pyrimidin-4-yl]oxypiperidin-1-yl]methanone Chemical compound FC1=CC(S(=O)(=O)C)=CC=C1N1C2=NC=NC(OC3CCN(CC3)C(=O)C=3C=CC(OC(F)F)=CC=3)=C2C=N1 NVZIVSUQFOINOQ-UHFFFAOYSA-N 0.000 description 1
- QNLSEEZDPONOHJ-UHFFFAOYSA-N [4-[1-(2-fluoro-4-methylsulfonylphenyl)pyrazolo[3,4-d]pyrimidin-4-yl]oxypiperidin-1-yl]-[3-(trifluoromethoxy)phenyl]methanone Chemical compound FC1=CC(S(=O)(=O)C)=CC=C1N1C2=NC=NC(OC3CCN(CC3)C(=O)C=3C=C(OC(F)(F)F)C=CC=3)=C2C=N1 QNLSEEZDPONOHJ-UHFFFAOYSA-N 0.000 description 1
- IXMHOCDULCDOHH-UHFFFAOYSA-N [4-[1-(2-fluoro-4-methylsulfonylphenyl)pyrazolo[3,4-d]pyrimidin-4-yl]oxypiperidin-1-yl]-[4-(trifluoromethoxy)phenyl]methanone Chemical compound FC1=CC(S(=O)(=O)C)=CC=C1N1C2=NC=NC(OC3CCN(CC3)C(=O)C=3C=CC(OC(F)(F)F)=CC=3)=C2C=N1 IXMHOCDULCDOHH-UHFFFAOYSA-N 0.000 description 1
- LPKYDBMVAIFMTH-UHFFFAOYSA-N [4-[1-(2-fluoro-4-methylsulfonylphenyl)pyrazolo[3,4-d]pyrimidin-4-yl]oxypiperidin-1-yl]-[5-(3-methylbutylamino)pyridin-2-yl]methanone Chemical compound N1=CC(NCCC(C)C)=CC=C1C(=O)N1CCC(OC=2C=3C=NN(C=3N=CN=2)C=2C(=CC(=CC=2)S(C)(=O)=O)F)CC1 LPKYDBMVAIFMTH-UHFFFAOYSA-N 0.000 description 1
- LNWHIORNFWOBMC-UHFFFAOYSA-N [4-[1-(4-methylsulfonylphenyl)pyrazolo[3,4-d]pyrimidin-4-yl]oxypiperidin-1-yl]-(4-methylthiadiazol-5-yl)methanone Chemical compound N1=NSC(C(=O)N2CCC(CC2)OC=2C=3C=NN(C=3N=CN=2)C=2C=CC(=CC=2)S(C)(=O)=O)=C1C LNWHIORNFWOBMC-UHFFFAOYSA-N 0.000 description 1
- SQFAVQWBWMYKSG-UHFFFAOYSA-N [4-[1-(4-methylsulfonylphenyl)pyrazolo[3,4-d]pyrimidin-4-yl]oxypiperidin-1-yl]-(6-pyrazol-1-ylpyridin-3-yl)methanone Chemical compound C1=CC(S(=O)(=O)C)=CC=C1N1C2=NC=NC(OC3CCN(CC3)C(=O)C=3C=NC(=CC=3)N3N=CC=C3)=C2C=N1 SQFAVQWBWMYKSG-UHFFFAOYSA-N 0.000 description 1
- NUGQGRRVEQWRRO-UHFFFAOYSA-N [4-[1-(4-methylsulfonylphenyl)pyrazolo[3,4-d]pyrimidin-4-yl]oxypiperidin-1-yl]-[1-methyl-3-(trifluoromethyl)pyrazol-4-yl]methanone Chemical compound FC(F)(F)C1=NN(C)C=C1C(=O)N1CCC(OC=2C=3C=NN(C=3N=CN=2)C=2C=CC(=CC=2)S(C)(=O)=O)CC1 NUGQGRRVEQWRRO-UHFFFAOYSA-N 0.000 description 1
- DFTXLMKGKPGWEC-UHFFFAOYSA-N [4-[1-(4-methylsulfonylphenyl)pyrazolo[3,4-d]pyrimidin-4-yl]oxypiperidin-1-yl]-[4-(trifluoromethyl)pyridin-3-yl]methanone Chemical compound C1=CC(S(=O)(=O)C)=CC=C1N1C2=NC=NC(OC3CCN(CC3)C(=O)C=3C(=CC=NC=3)C(F)(F)F)=C2C=N1 DFTXLMKGKPGWEC-UHFFFAOYSA-N 0.000 description 1
- FSNIHMKJCFJRMG-UHFFFAOYSA-N [4-[1-(4-methylsulfonylphenyl)pyrazolo[3,4-d]pyrimidin-4-yl]oxypiperidin-1-yl]-[6-(propan-2-ylamino)pyridin-3-yl]methanone Chemical compound C1=NC(NC(C)C)=CC=C1C(=O)N1CCC(OC=2C=3C=NN(C=3N=CN=2)C=2C=CC(=CC=2)S(C)(=O)=O)CC1 FSNIHMKJCFJRMG-UHFFFAOYSA-N 0.000 description 1
- XBWIGFCYYDGDSF-UHFFFAOYSA-N [4-[1-(4-methylsulfonylphenyl)pyrazolo[3,4-d]pyrimidin-4-yl]oxypiperidin-1-yl]-[6-(trifluoromethyl)pyridin-3-yl]methanone Chemical compound C1=CC(S(=O)(=O)C)=CC=C1N1C2=NC=NC(OC3CCN(CC3)C(=O)C=3C=NC(=CC=3)C(F)(F)F)=C2C=N1 XBWIGFCYYDGDSF-UHFFFAOYSA-N 0.000 description 1
- OFNSQFCOJFAXCP-UHFFFAOYSA-N [4-[1-(4-methylsulfonylphenyl)pyrazolo[3,4-d]pyrimidin-4-yl]oxypiperidin-1-yl]-pyridazin-4-ylmethanone Chemical compound C1=CC(S(=O)(=O)C)=CC=C1N1C2=NC=NC(OC3CCN(CC3)C(=O)C=3C=NN=CC=3)=C2C=N1 OFNSQFCOJFAXCP-UHFFFAOYSA-N 0.000 description 1
- HIBNSMCPENPYFJ-UHFFFAOYSA-N [4-[1-(4-methylsulfonylphenyl)pyrazolo[3,4-d]pyrimidin-4-yl]oxypiperidin-1-yl]-pyridin-3-ylmethanone Chemical compound C1=CC(S(=O)(=O)C)=CC=C1N1C2=NC=NC(OC3CCN(CC3)C(=O)C=3C=NC=CC=3)=C2C=N1 HIBNSMCPENPYFJ-UHFFFAOYSA-N 0.000 description 1
- LPSWSLINMZEEBD-UHFFFAOYSA-N [4-[1-(4-methylsulfonylphenyl)pyrazolo[3,4-d]pyrimidin-4-yl]oxypiperidin-1-yl]-pyrimidin-5-ylmethanone Chemical compound C1=CC(S(=O)(=O)C)=CC=C1N1C2=NC=NC(OC3CCN(CC3)C(=O)C=3C=NC=NC=3)=C2C=N1 LPSWSLINMZEEBD-UHFFFAOYSA-N 0.000 description 1
- GLYJECYRMYSZOT-UHFFFAOYSA-N [4-[1-(4-methylsulfonylphenyl)pyrazolo[3,4-d]pyrimidin-4-yl]oxypiperidin-1-yl]-thiophen-2-ylmethanone Chemical compound C1=CC(S(=O)(=O)C)=CC=C1N1C2=NC=NC(OC3CCN(CC3)C(=O)C=3SC=CC=3)=C2C=N1 GLYJECYRMYSZOT-UHFFFAOYSA-N 0.000 description 1
- VAEPOXPGUPMLJK-UHFFFAOYSA-N [4-[2-nitro-5-(4-propylpiperidin-1-yl)phenoxy]phenyl]-phenylmethanone Chemical compound C1CC(CCC)CCN1C1=CC=C([N+]([O-])=O)C(OC=2C=CC(=CC=2)C(=O)C=2C=CC=CC=2)=C1 VAEPOXPGUPMLJK-UHFFFAOYSA-N 0.000 description 1
- GACZXTJOCSDCMT-UHFFFAOYSA-N [4-[3-[4-(methoxymethyl)piperidin-1-yl]-4-nitrophenoxy]phenyl]-phenylmethanone Chemical compound C1CC(COC)CCN1C1=CC(OC=2C=CC(=CC=2)C(=O)C=2C=CC=CC=2)=CC=C1[N+]([O-])=O GACZXTJOCSDCMT-UHFFFAOYSA-N 0.000 description 1
- ASJQIUWBRAKXBS-UHFFFAOYSA-N [4-[4-(3-propan-2-yl-1,2,4-oxadiazol-5-yl)piperidin-1-yl]-6-[4-(thiadiazol-4-yl)phenoxy]pyrimidin-5-yl]methanol Chemical compound CC(C)C1=NOC(C2CCN(CC2)C=2C(=C(OC=3C=CC(=CC=3)C=3N=NSC=3)N=CN=2)CO)=N1 ASJQIUWBRAKXBS-UHFFFAOYSA-N 0.000 description 1
- WVUDQXPBMXVYBW-UHFFFAOYSA-N [4-[4-nitro-3-(4-propylpiperidin-1-yl)anilino]phenyl]-phenylmethanone Chemical compound C1CC(CCC)CCN1C1=CC(NC=2C=CC(=CC=2)C(=O)C=2C=CC=CC=2)=CC=C1[N+]([O-])=O WVUDQXPBMXVYBW-UHFFFAOYSA-N 0.000 description 1
- BKBQNDQOCUNTTO-UHFFFAOYSA-N [4-[6-(2-fluoro-4-methylsulfonylanilino)pyrimidin-4-yl]oxypiperidin-1-yl]-(5-methylpyridin-3-yl)methanone Chemical compound CC1=CN=CC(C(=O)N2CCC(CC2)OC=2N=CN=C(NC=3C(=CC(=CC=3)S(C)(=O)=O)F)C=2)=C1 BKBQNDQOCUNTTO-UHFFFAOYSA-N 0.000 description 1
- JXSSKFQIDFWXDP-UHFFFAOYSA-N [4-[6-(2-fluoro-4-methylsulfonylanilino)pyrimidin-4-yl]oxypiperidin-1-yl]-(6-fluoropyridin-2-yl)methanone Chemical compound FC1=CC(S(=O)(=O)C)=CC=C1NC1=CC(OC2CCN(CC2)C(=O)C=2N=C(F)C=CC=2)=NC=N1 JXSSKFQIDFWXDP-UHFFFAOYSA-N 0.000 description 1
- XTKWSNOOMQGGJJ-UHFFFAOYSA-N [4-[6-(2-fluoro-4-methylsulfonylanilino)pyrimidin-4-yl]oxypiperidin-1-yl]-(6-methylpyridin-2-yl)methanone Chemical compound CC1=CC=CC(C(=O)N2CCC(CC2)OC=2N=CN=C(NC=3C(=CC(=CC=3)S(C)(=O)=O)F)C=2)=N1 XTKWSNOOMQGGJJ-UHFFFAOYSA-N 0.000 description 1
- GLOHGJMNGZPTQN-UHFFFAOYSA-N [4-[6-(2-fluoro-4-methylsulfonylanilino)pyrimidin-4-yl]oxypiperidin-1-yl]-pyridin-2-ylmethanone Chemical compound FC1=CC(S(=O)(=O)C)=CC=C1NC1=CC(OC2CCN(CC2)C(=O)C=2N=CC=CC=2)=NC=N1 GLOHGJMNGZPTQN-UHFFFAOYSA-N 0.000 description 1
- VWVLGJIQPZRFQV-UHFFFAOYSA-N [4-[6-(2-fluoro-4-methylsulfonylphenoxy)-5-methylpyrimidin-4-yl]oxypiperidin-1-yl]-(oxolan-2-yl)methanone Chemical compound N1=CN=C(OC=2C(=CC(=CC=2)S(C)(=O)=O)F)C(C)=C1OC(CC1)CCN1C(=O)C1CCCO1 VWVLGJIQPZRFQV-UHFFFAOYSA-N 0.000 description 1
- HDOUIWSXXJZLNT-UHFFFAOYSA-N [4-[6-(2-fluoro-4-methylsulfonylphenoxy)-5-methylpyrimidin-4-yl]oxypiperidin-1-yl]-[6-(2-pyrrolidin-1-ylethyl)pyridin-3-yl]methanone Chemical compound N1=CN=C(OC=2C(=CC(=CC=2)S(C)(=O)=O)F)C(C)=C1OC(CC1)CCN1C(=O)C(C=N1)=CC=C1CCN1CCCC1 HDOUIWSXXJZLNT-UHFFFAOYSA-N 0.000 description 1
- DADMJFSLSPECRO-UHFFFAOYSA-N [4-[6-(4-methylsulfonylanilino)-5-nitropyrimidin-4-yl]oxypiperidin-1-yl]-pyridin-2-ylmethanone Chemical compound C1=CC(S(=O)(=O)C)=CC=C1NC1=NC=NC(OC2CCN(CC2)C(=O)C=2N=CC=CC=2)=C1[N+]([O-])=O DADMJFSLSPECRO-UHFFFAOYSA-N 0.000 description 1
- ZOGSDONAVGUYKY-UHFFFAOYSA-N [4-[6-(4-methylsulfonylanilino)-5-nitropyrimidin-4-yl]oxypiperidin-1-yl]-pyridin-3-ylmethanone Chemical compound C1=CC(S(=O)(=O)C)=CC=C1NC1=NC=NC(OC2CCN(CC2)C(=O)C=2C=NC=CC=2)=C1[N+]([O-])=O ZOGSDONAVGUYKY-UHFFFAOYSA-N 0.000 description 1
- ODYPCNOVLSZVKD-UHFFFAOYSA-N [4-[9-(6-methylsulfonylpyridin-3-yl)purin-6-yl]oxypiperidin-1-yl]-pyridin-3-ylmethanone Chemical compound C1=NC(S(=O)(=O)C)=CC=C1N1C2=NC=NC(OC3CCN(CC3)C(=O)C=3C=NC=CC=3)=C2N=C1 ODYPCNOVLSZVKD-UHFFFAOYSA-N 0.000 description 1
- DRIFBFDYGLBJJR-UHFFFAOYSA-N [4-[[5-nitro-6-(4-pyridin-2-ylsulfanylpiperidin-1-yl)pyridin-2-yl]amino]phenyl]-phenylmethanone Chemical compound N1=C(N2CCC(CC2)SC=2N=CC=CC=2)C([N+](=O)[O-])=CC=C1NC(C=C1)=CC=C1C(=O)C1=CC=CC=C1 DRIFBFDYGLBJJR-UHFFFAOYSA-N 0.000 description 1
- NLQMYPRZFDDCOI-UHFFFAOYSA-N [4-[[5-nitro-6-(4-pyridin-2-ylsulfanylpiperidin-1-yl)pyrimidin-4-yl]amino]phenyl]-phenylmethanone Chemical compound N1=CN=C(N2CCC(CC2)SC=2N=CC=CC=2)C([N+](=O)[O-])=C1NC(C=C1)=CC=C1C(=O)C1=CC=CC=C1 NLQMYPRZFDDCOI-UHFFFAOYSA-N 0.000 description 1
- BILYYYDJGVAYCF-UHFFFAOYSA-N [4-methoxy-2-[5-nitro-6-(4-pyridin-2-ylsulfanylpiperidin-1-yl)pyrimidin-4-yl]oxyphenyl]-phenylmethanone Chemical compound N=1C=NC(N2CCC(CC2)SC=2N=CC=CC=2)=C([N+]([O-])=O)C=1OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1 BILYYYDJGVAYCF-UHFFFAOYSA-N 0.000 description 1
- FSEUHBQIIOWTRA-UHFFFAOYSA-N [6-(2-methylpropylamino)pyridin-3-yl]-[4-[1-(4-methylsulfonylphenyl)pyrazolo[3,4-d]pyrimidin-4-yl]oxypiperidin-1-yl]methanone Chemical compound C1=NC(NCC(C)C)=CC=C1C(=O)N1CCC(OC=2C=3C=NN(C=3N=CN=2)C=2C=CC(=CC=2)S(C)(=O)=O)CC1 FSEUHBQIIOWTRA-UHFFFAOYSA-N 0.000 description 1
- DRMFYWWADGMXGF-UHFFFAOYSA-N [6-(cyclobutylamino)pyridin-3-yl]-[4-[1-(4-methylsulfonylphenyl)pyrazolo[3,4-d]pyrimidin-4-yl]oxypiperidin-1-yl]methanone Chemical compound C1=CC(S(=O)(=O)C)=CC=C1N1C2=NC=NC(OC3CCN(CC3)C(=O)C=3C=NC(NC4CCC4)=CC=3)=C2C=N1 DRMFYWWADGMXGF-UHFFFAOYSA-N 0.000 description 1
- ZIWGTSLFGDMLCJ-UHFFFAOYSA-N [6-(ethylamino)pyridin-3-yl]-[4-[1-(4-methylsulfonylphenyl)pyrazolo[3,4-d]pyrimidin-4-yl]oxypiperidin-1-yl]methanone Chemical compound C1=NC(NCC)=CC=C1C(=O)N1CCC(OC=2C=3C=NN(C=3N=CN=2)C=2C=CC(=CC=2)S(C)(=O)=O)CC1 ZIWGTSLFGDMLCJ-UHFFFAOYSA-N 0.000 description 1
- HSTGOYWNGYXMBM-UHFFFAOYSA-N [6-(heptan-4-ylamino)pyridin-3-yl]-[4-[1-(4-methylsulfonylphenyl)pyrazolo[3,4-d]pyrimidin-4-yl]oxypiperidin-1-yl]methanone Chemical compound C1=NC(NC(CCC)CCC)=CC=C1C(=O)N1CCC(OC=2C=3C=NN(C=3N=CN=2)C=2C=CC(=CC=2)S(C)(=O)=O)CC1 HSTGOYWNGYXMBM-UHFFFAOYSA-N 0.000 description 1
- CFIMGFRDUIYUFZ-UHFFFAOYSA-N [N+](=O)([O-])C1=C(C=C(C=C1)OC1=CC=C(C=C1)CCC(C)=O)N1CCC(CC1)C(=O)O Chemical compound [N+](=O)([O-])C1=C(C=C(C=C1)OC1=CC=C(C=C1)CCC(C)=O)N1CCC(CC1)C(=O)O CFIMGFRDUIYUFZ-UHFFFAOYSA-N 0.000 description 1
- QPXBEUFPXLXCHT-UHFFFAOYSA-N [N+](=O)([O-])C=1C(=NC=NC=1NC1=CC=C(C=C1)C=1N=NSC=1)N1CCC(CC1)C(=O)O Chemical compound [N+](=O)([O-])C=1C(=NC=NC=1NC1=CC=C(C=C1)C=1N=NSC=1)N1CCC(CC1)C(=O)O QPXBEUFPXLXCHT-UHFFFAOYSA-N 0.000 description 1
- HYISMEUHFZXUPH-UHFFFAOYSA-N [N+](=O)([O-])C=1C(=NC=NC=1NC1=CC=C(C=C1)S(=O)(=O)C(F)(F)F)N1CCC(CC1)C(=O)O Chemical compound [N+](=O)([O-])C=1C(=NC=NC=1NC1=CC=C(C=C1)S(=O)(=O)C(F)(F)F)N1CCC(CC1)C(=O)O HYISMEUHFZXUPH-UHFFFAOYSA-N 0.000 description 1
- 229960002632 acarbose Drugs 0.000 description 1
- XUFXOAAUWZOOIT-UHFFFAOYSA-N acarviostatin I01 Natural products OC1C(O)C(NC2C(C(O)C(O)C(CO)=C2)O)C(C)OC1OC(C(C1O)O)C(CO)OC1OC1C(CO)OC(O)C(O)C1O XUFXOAAUWZOOIT-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-N acetic acid Substances CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 125000003295 alanine group Chemical group N[C@@H](C)C(=O)* 0.000 description 1
- 125000005596 alkyl carboxamido group Chemical group 0.000 description 1
- 125000004422 alkyl sulphonamide group Chemical group 0.000 description 1
- 239000003888 alpha glucosidase inhibitor Substances 0.000 description 1
- HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 description 1
- XXXHSQBVHSJQKS-UHFFFAOYSA-N amino benzoate Chemical compound NOC(=O)C1=CC=CC=C1 XXXHSQBVHSJQKS-UHFFFAOYSA-N 0.000 description 1
- LDXYBEHACFJIEL-HNNXBMFYSA-N anagliptin Chemical group C=1N2N=C(C)C=C2N=CC=1C(=O)NCC(C)(C)NCC(=O)N1CCC[C@H]1C#N LDXYBEHACFJIEL-HNNXBMFYSA-N 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 125000005533 aryl carboxamido group Chemical group 0.000 description 1
- 125000004104 aryloxy group Chemical group 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- 125000004566 azetidin-1-yl group Chemical group N1(CCC1)* 0.000 description 1
- 125000004273 azetidin-2-yl group Chemical group [H]N1C([H])([H])C([H])([H])C1([H])* 0.000 description 1
- 125000004567 azetidin-3-yl group Chemical group N1CC(C1)* 0.000 description 1
- 125000004266 aziridin-1-yl group Chemical group [H]C1([H])N(*)C1([H])[H] 0.000 description 1
- 125000004267 aziridin-2-yl group Chemical group [H]N1C([H])([H])C1([H])* 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- BMWITAUNXBHIPO-OZZZDHQUSA-N benzenesulfonic acid;(2s,4s)-4-fluoro-1-[2-[(1-hydroxy-2-methylpropan-2-yl)amino]acetyl]pyrrolidine-2-carbonitrile Chemical group OS(=O)(=O)C1=CC=CC=C1.OCC(C)(C)NCC(=O)N1C[C@@H](F)C[C@H]1C#N BMWITAUNXBHIPO-OZZZDHQUSA-N 0.000 description 1
- 125000005605 benzo group Chemical group 0.000 description 1
- 125000000499 benzofuranyl group Chemical group O1C(=CC2=C1C=CC=C2)* 0.000 description 1
- TUWZZXGAUMSUOB-UHFFFAOYSA-N benzyl piperidine-1-carboxylate Chemical compound C1CCCCN1C(=O)OCC1=CC=CC=C1 TUWZZXGAUMSUOB-UHFFFAOYSA-N 0.000 description 1
- 239000003124 biologic agent Substances 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000036765 blood level Effects 0.000 description 1
- 239000007767 bonding agent Substances 0.000 description 1
- 208000029028 brain injury Diseases 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- PCDHSSHKDZYLLI-UHFFFAOYSA-N butan-1-one Chemical compound CCC[C]=O PCDHSSHKDZYLLI-UHFFFAOYSA-N 0.000 description 1
- UANIRPCLRPAYGN-UHFFFAOYSA-N butyl 4-[1-(2-fluoro-4-methylsulfonylphenyl)pyrazolo[3,4-d]pyrimidin-4-yl]sulfanylpiperidine-1-carboxylate Chemical compound C1CN(C(=O)OCCCC)CCC1SC1=NC=NC2=C1C=NN2C1=CC=C(S(C)(=O)=O)C=C1F UANIRPCLRPAYGN-UHFFFAOYSA-N 0.000 description 1
- IPGMIYAOWRJGBE-UHFFFAOYSA-N butyl cyclohexanecarboxylate Chemical compound CCCCOC(=O)C1CCCCC1 IPGMIYAOWRJGBE-UHFFFAOYSA-N 0.000 description 1
- GLMHJKQHYAVPMZ-UHFFFAOYSA-N butyl piperidine-1-carboxylate Chemical compound CCCCOC(=O)N1CCCCC1 GLMHJKQHYAVPMZ-UHFFFAOYSA-N 0.000 description 1
- 210000004899 c-terminal region Anatomy 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- 150000001723 carbon free-radicals Chemical class 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 230000003293 cardioprotective effect Effects 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 230000020411 cell activation Effects 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 125000004775 chlorodifluoromethyl group Chemical group FC(F)(Cl)* 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 239000011651 chromium Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 229940110456 cocoa butter Drugs 0.000 description 1
- 235000019868 cocoa butter Nutrition 0.000 description 1
- 208000010877 cognitive disease Diseases 0.000 description 1
- 230000001149 cognitive effect Effects 0.000 description 1
- 238000011284 combination treatment Methods 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 238000013270 controlled release Methods 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 125000001047 cyclobutenyl group Chemical group C1(=CCC1)* 0.000 description 1
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- VSZRKGGSLOTGFW-UHFFFAOYSA-N cyclobutylmethyl 4-[1-(2-fluoro-4-methylsulfonylphenyl)pyrazolo[3,4-d]pyrimidin-4-yl]sulfanylpiperidine-1-carboxylate Chemical compound FC1=CC(S(=O)(=O)C)=CC=C1N1C2=NC=NC(SC3CCN(CC3)C(=O)OCC3CCC3)=C2C=N1 VSZRKGGSLOTGFW-UHFFFAOYSA-N 0.000 description 1
- VZFUCHSFHOYXIS-UHFFFAOYSA-N cycloheptane carboxylic acid Natural products OC(=O)C1CCCCCC1 VZFUCHSFHOYXIS-UHFFFAOYSA-N 0.000 description 1
- 125000000582 cycloheptyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- GLWFVBPRTKJJBY-UHFFFAOYSA-N cycloheptyl piperidine-1-carboxylate Chemical compound C1(CCCCCC1)OC(=O)N1CCCCC1 GLWFVBPRTKJJBY-UHFFFAOYSA-N 0.000 description 1
- 125000000596 cyclohexenyl group Chemical group C1(=CCCCC1)* 0.000 description 1
- GCFAUZGWPDYAJN-UHFFFAOYSA-N cyclohexyl 3-phenylprop-2-enoate Chemical compound C=1C=CC=CC=1C=CC(=O)OC1CCCCC1 GCFAUZGWPDYAJN-UHFFFAOYSA-N 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- MKKLYVIKFVIRKV-UHFFFAOYSA-N cyclopentyl piperidine-1-carboxylate Chemical compound C1CCCCN1C(=O)OC1CCCC1 MKKLYVIKFVIRKV-UHFFFAOYSA-N 0.000 description 1
- SXBARASIAVJBJW-UHFFFAOYSA-N cyclopentyl-[4-[(3-pyridin-4-yl-1,2,4-oxadiazol-5-yl)methoxy]piperidin-1-yl]methanone Chemical compound C1CC(OCC=2ON=C(N=2)C=2C=CN=CC=2)CCN1C(=O)C1CCCC1 SXBARASIAVJBJW-UHFFFAOYSA-N 0.000 description 1
- SQSSGVAAQHUQQD-UHFFFAOYSA-N cyclopentylmethyl 4-[1-(4-methylsulfonylphenyl)pyrazolo[3,4-d]pyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1=CC(S(=O)(=O)C)=CC=C1N1C2=NC=NC(OC3CCN(CC3)C(=O)OCC3CCCC3)=C2C=N1 SQSSGVAAQHUQQD-UHFFFAOYSA-N 0.000 description 1
- 125000000298 cyclopropenyl group Chemical group [H]C1=C([H])C1([H])* 0.000 description 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 1
- KCNLVJLJDUJVMD-UHFFFAOYSA-N cyclopropylmethyl 4-[1-(2-fluoro-4-methylsulfonylphenyl)pyrazolo[3,4-d]pyrimidin-4-yl]sulfanylpiperidine-1-carboxylate Chemical compound FC1=CC(S(=O)(=O)C)=CC=C1N1C2=NC=NC(SC3CCN(CC3)C(=O)OCC3CC3)=C2C=N1 KCNLVJLJDUJVMD-UHFFFAOYSA-N 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 125000001028 difluoromethyl group Chemical group [H]C(F)(F)* 0.000 description 1
- 230000003292 diminished effect Effects 0.000 description 1
- 239000003603 dipeptidyl peptidase IV inhibitor Substances 0.000 description 1
- 230000006806 disease prevention Effects 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000003974 emollient agent Substances 0.000 description 1
- 238000005538 encapsulation Methods 0.000 description 1
- 210000003890 endocrine cell Anatomy 0.000 description 1
- 239000006274 endogenous ligand Substances 0.000 description 1
- CHNUOJQWGUIOLD-NFZZJPOKSA-N epalrestat Chemical compound C=1C=CC=CC=1\C=C(/C)\C=C1/SC(=S)N(CC(O)=O)C1=O CHNUOJQWGUIOLD-NFZZJPOKSA-N 0.000 description 1
- 229950010170 epalrestat Drugs 0.000 description 1
- CHNUOJQWGUIOLD-UHFFFAOYSA-N epalrestate Natural products C=1C=CC=CC=1C=C(C)C=C1SC(=S)N(CC(O)=O)C1=O CHNUOJQWGUIOLD-UHFFFAOYSA-N 0.000 description 1
- 235000019441 ethanol Nutrition 0.000 description 1
- 125000005677 ethinylene group Chemical group [*:2]C#C[*:1] 0.000 description 1
- AEOCXXJPGCBFJA-UHFFFAOYSA-N ethionamide Chemical compound CCC1=CC(C(N)=S)=CC=N1 AEOCXXJPGCBFJA-UHFFFAOYSA-N 0.000 description 1
- SSAHEGODJYYVEM-UHFFFAOYSA-N ethyl 2-[4-[1-(4-methylsulfonylphenyl)pyrazolo[3,4-d]pyrimidin-4-yl]oxypiperidin-1-yl]acetate Chemical compound C1CN(CC(=O)OCC)CCC1OC1=NC=NC2=C1C=NN2C1=CC=C(S(C)(=O)=O)C=C1 SSAHEGODJYYVEM-UHFFFAOYSA-N 0.000 description 1
- AYMXTWMJUAASDF-UHFFFAOYSA-N ethyl 4-[1-(4-methylsulfonylphenyl)pyrazolo[3,4-d]pyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OCC)CCC1OC1=NC=NC2=C1C=NN2C1=CC=C(S(C)(=O)=O)C=C1 AYMXTWMJUAASDF-UHFFFAOYSA-N 0.000 description 1
- QXLCPRLTLCWIND-UHFFFAOYSA-N ethyl 4-[2-[1-(4-methylsulfonylphenyl)pyrazolo[3,4-d]pyrimidin-4-yl]oxyethyl]piperazine-1-carboxylate Chemical compound C1CN(C(=O)OCC)CCN1CCOC1=NC=NC2=C1C=NN2C1=CC=C(S(C)(=O)=O)C=C1 QXLCPRLTLCWIND-UHFFFAOYSA-N 0.000 description 1
- CKBQSMIDKVXIPB-UHFFFAOYSA-N ethyl 4-[2-[1-(4-methylsulfonylphenyl)pyrazolo[3,4-d]pyrimidin-4-yl]oxypropyl]piperazine-1-carboxylate Chemical compound C1CN(C(=O)OCC)CCN1CC(C)OC1=NC=NC2=C1C=NN2C1=CC=C(S(C)(=O)=O)C=C1 CKBQSMIDKVXIPB-UHFFFAOYSA-N 0.000 description 1
- 125000004494 ethyl ester group Chemical group 0.000 description 1
- 125000006125 ethylsulfonyl group Chemical group 0.000 description 1
- 125000004705 ethylthio group Chemical group C(C)S* 0.000 description 1
- 125000002534 ethynyl group Chemical group [H]C#C* 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000013265 extended release Methods 0.000 description 1
- 210000001723 extracellular space Anatomy 0.000 description 1
- 239000010685 fatty oil Substances 0.000 description 1
- RWTNPBWLLIMQHL-UHFFFAOYSA-N fexofenadine Chemical compound C1=CC(C(C)(C(O)=O)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 RWTNPBWLLIMQHL-UHFFFAOYSA-N 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 125000001153 fluoro group Chemical group F* 0.000 description 1
- 125000004216 fluoromethyl group Chemical group [H]C([H])(F)* 0.000 description 1
- YLRFCQOZQXIBAB-RBZZARIASA-N fluoxymesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1CC[C@](C)(O)[C@@]1(C)C[C@@H]2O YLRFCQOZQXIBAB-RBZZARIASA-N 0.000 description 1
- DYDNPESBYVVLBO-UHFFFAOYSA-N formanilide Chemical group O=CNC1=CC=CC=C1 DYDNPESBYVVLBO-UHFFFAOYSA-N 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- FCSGINVGPJVPMR-UHFFFAOYSA-N furan-2-yl-[4-[1-(4-methylsulfonylphenyl)pyrazolo[3,4-d]pyrimidin-4-yl]oxypiperidin-1-yl]methanone Chemical compound C1=CC(S(=O)(=O)C)=CC=C1N1C2=NC=NC(OC3CCN(CC3)C(=O)C=3OC=CC=3)=C2C=N1 FCSGINVGPJVPMR-UHFFFAOYSA-N 0.000 description 1
- 230000030136 gastric emptying Effects 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 229960004580 glibenclamide Drugs 0.000 description 1
- 229960000346 gliclazide Drugs 0.000 description 1
- WIGIZIANZCJQQY-RUCARUNLSA-N glimepiride Chemical compound O=C1C(CC)=C(C)CN1C(=O)NCCC1=CC=C(S(=O)(=O)NC(=O)N[C@@H]2CC[C@@H](C)CC2)C=C1 WIGIZIANZCJQQY-RUCARUNLSA-N 0.000 description 1
- 229960004346 glimepiride Drugs 0.000 description 1
- ZJJXGWJIGJFDTL-UHFFFAOYSA-N glipizide Chemical compound C1=NC(C)=CN=C1C(=O)NCCC1=CC=C(S(=O)(=O)NC(=O)NC2CCCCC2)C=C1 ZJJXGWJIGJFDTL-UHFFFAOYSA-N 0.000 description 1
- 229960001381 glipizide Drugs 0.000 description 1
- ZNNLBTZKUZBEKO-UHFFFAOYSA-N glyburide Chemical compound COC1=CC=C(Cl)C=C1C(=O)NCCC1=CC=C(S(=O)(=O)NC(=O)NC2CCCCC2)C=C1 ZNNLBTZKUZBEKO-UHFFFAOYSA-N 0.000 description 1
- 229940074045 glyceryl distearate Drugs 0.000 description 1
- 229940075507 glyceryl monostearate Drugs 0.000 description 1
- 125000003147 glycosyl group Chemical group 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 125000004440 haloalkylsulfinyl group Chemical group 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 125000005553 heteroaryloxy group Chemical group 0.000 description 1
- 125000005143 heteroarylsulfonyl group Chemical group 0.000 description 1
- AQDDZAJCMCBECB-UHFFFAOYSA-N hexyl piperidine-1-carboxylate Chemical compound CCCCCCOC(=O)N1CCCCC1 AQDDZAJCMCBECB-UHFFFAOYSA-N 0.000 description 1
- WNRQPCUGRUFHED-DETKDSODSA-N humalog Chemical compound C([C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CS)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](CO)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CS)NC(=O)[C@H](CS)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)CN)[C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(O)=O)C1=CC=C(O)C=C1.C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)C(C)C)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC=1C=CC=CC=1)C(C)C)C1=CN=CN1 WNRQPCUGRUFHED-DETKDSODSA-N 0.000 description 1
- 150000004677 hydrates Chemical class 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 208000006575 hypertriglyceridemia Diseases 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 description 1
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 229960004717 insulin aspart Drugs 0.000 description 1
- 239000004026 insulin derivative Substances 0.000 description 1
- 229960002869 insulin glargine Drugs 0.000 description 1
- 229960002068 insulin lispro Drugs 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 230000004068 intracellular signaling Effects 0.000 description 1
- 210000003093 intracellular space Anatomy 0.000 description 1
- 238000007918 intramuscular administration Methods 0.000 description 1
- 238000007912 intraperitoneal administration Methods 0.000 description 1
- 238000007913 intrathecal administration Methods 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 238000007914 intraventricular administration Methods 0.000 description 1
- 229940125425 inverse agonist Drugs 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 229950003188 isovaleryl diethylamide Drugs 0.000 description 1
- 238000005304 joining Methods 0.000 description 1
- 125000000468 ketone group Chemical group 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 239000004922 lacquer Substances 0.000 description 1
- 239000010410 layer Substances 0.000 description 1
- 125000003473 lipid group Chemical group 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- 235000014380 magnesium carbonate Nutrition 0.000 description 1
- 239000000395 magnesium oxide Substances 0.000 description 1
- CPLXHLVBOLITMK-UHFFFAOYSA-N magnesium oxide Inorganic materials [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 description 1
- 235000012245 magnesium oxide Nutrition 0.000 description 1
- AXZKOIWUVFPNLO-UHFFFAOYSA-N magnesium;oxygen(2-) Chemical compound [O-2].[Mg+2] AXZKOIWUVFPNLO-UHFFFAOYSA-N 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 229950004994 meglitinide Drugs 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- IAWCKSHGRKOGIJ-UHFFFAOYSA-N methyl 5-[4-[1-(4-methylsulfonylphenyl)pyrazolo[3,4-d]pyrimidin-4-yl]oxypiperidine-1-carbonyl]pyridine-2-carboxylate Chemical compound C1=NC(C(=O)OC)=CC=C1C(=O)N1CCC(OC=2C=3C=NN(C=3N=CN=2)C=2C=CC(=CC=2)S(C)(=O)=O)CC1 IAWCKSHGRKOGIJ-UHFFFAOYSA-N 0.000 description 1
- YKFLJYAKACCWMH-UHFFFAOYSA-N methyl piperidine-1-carboxylate Chemical compound COC(=O)N1CCCCC1 YKFLJYAKACCWMH-UHFFFAOYSA-N 0.000 description 1
- MGJXBDMLVWIYOQ-UHFFFAOYSA-N methylazanide Chemical compound [NH-]C MGJXBDMLVWIYOQ-UHFFFAOYSA-N 0.000 description 1
- 125000002816 methylsulfanyl group Chemical group [H]C([H])([H])S[*] 0.000 description 1
- 125000006216 methylsulfinyl group Chemical group [H]C([H])([H])S(*)=O 0.000 description 1
- 125000004170 methylsulfonyl group Chemical group [H]C([H])([H])S(*)(=O)=O 0.000 description 1
- 229960001110 miglitol Drugs 0.000 description 1
- 230000000116 mitigating effect Effects 0.000 description 1
- 125000004573 morpholin-4-yl group Chemical group N1(CCOCC1)* 0.000 description 1
- 210000002161 motor neuron Anatomy 0.000 description 1
- INKFQKXIPIYIOI-UHFFFAOYSA-N n,n-dimethyl-1-[4-[4-(3-propan-2-yl-1,2,4-oxadiazol-5-yl)piperidin-1-yl]-6-[4-(thiadiazol-4-yl)phenoxy]pyrimidin-5-yl]methanamine Chemical compound CC(C)C1=NOC(C2CCN(CC2)C=2C(=C(OC=3C=CC(=CC=3)C=3N=NSC=3)N=CN=2)CN(C)C)=N1 INKFQKXIPIYIOI-UHFFFAOYSA-N 0.000 description 1
- SKECXRFZFFAANN-UHFFFAOYSA-N n,n-dimethylmethanethioamide Chemical compound CN(C)C=S SKECXRFZFFAANN-UHFFFAOYSA-N 0.000 description 1
- XTCISMQONACVMG-UHFFFAOYSA-N n-(1,3-benzodioxol-5-yl)-5-nitro-6-(4-propylpiperidin-1-yl)pyrimidin-4-amine Chemical compound C1CC(CCC)CCN1C1=NC=NC(NC=2C=C3OCOC3=CC=2)=C1[N+]([O-])=O XTCISMQONACVMG-UHFFFAOYSA-N 0.000 description 1
- PHPWNIYPVPWOAB-UHFFFAOYSA-N n-(2,4-difluorophenyl)-5-nitro-6-(4-pyridin-2-ylsulfanylpiperidin-1-yl)pyrimidin-4-amine Chemical compound N1=CN=C(N2CCC(CC2)SC=2N=CC=CC=2)C([N+](=O)[O-])=C1NC1=CC=C(F)C=C1F PHPWNIYPVPWOAB-UHFFFAOYSA-N 0.000 description 1
- BIDHTVIADRHRJL-UHFFFAOYSA-N n-(2,5-difluorophenyl)-5-nitro-6-(4-pyridin-2-ylsulfanylpiperidin-1-yl)pyrimidin-4-amine Chemical compound N1=CN=C(N2CCC(CC2)SC=2N=CC=CC=2)C([N+](=O)[O-])=C1NC1=CC(F)=CC=C1F BIDHTVIADRHRJL-UHFFFAOYSA-N 0.000 description 1
- MIKPNFRHUSSWPW-UHFFFAOYSA-N n-(2-fluoro-4-methylsulfonylphenyl)-5-methyl-6-[1-(3-propan-2-yl-1,2,4-oxadiazol-5-yl)piperidin-4-yl]oxypyrimidin-4-amine Chemical compound CC(C)C1=NOC(N2CCC(CC2)OC=2C(=C(NC=3C(=CC(=CC=3)S(C)(=O)=O)F)N=CN=2)C)=N1 MIKPNFRHUSSWPW-UHFFFAOYSA-N 0.000 description 1
- DGBKNTVAKIFYNU-UHFFFAOYSA-N n-(2-fluoro-4-methylsulfonylphenyl)-5-nitro-6-[4-(3-propan-2-yl-1,2,4-oxadiazol-5-yl)piperidin-1-yl]pyrimidin-4-amine Chemical compound CC(C)C1=NOC(C2CCN(CC2)C=2C(=C(NC=3C(=CC(=CC=3)S(C)(=O)=O)F)N=CN=2)N(=O)=O)=N1 DGBKNTVAKIFYNU-UHFFFAOYSA-N 0.000 description 1
- XIBKTPIJCRSRAU-UHFFFAOYSA-N n-(2-fluoro-4-methylsulfonylphenyl)-6-[1-(3-propan-2-yl-1,2,4-oxadiazol-5-yl)piperidin-4-yl]oxypyrimidin-4-amine Chemical compound CC(C)C1=NOC(N2CCC(CC2)OC=2N=CN=C(NC=3C(=CC(=CC=3)S(C)(=O)=O)F)C=2)=N1 XIBKTPIJCRSRAU-UHFFFAOYSA-N 0.000 description 1
- ANVKEJUEXMCASL-UHFFFAOYSA-N n-(2-fluoro-4-methylsulfonylphenyl)-6-[1-[(3-propan-2-yl-1,2,4-oxadiazol-5-yl)methyl]piperidin-4-yl]oxypyrimidin-4-amine Chemical compound CC(C)C1=NOC(CN2CCC(CC2)OC=2N=CN=C(NC=3C(=CC(=CC=3)S(C)(=O)=O)F)C=2)=N1 ANVKEJUEXMCASL-UHFFFAOYSA-N 0.000 description 1
- YUFYAEHJBXIROF-UHFFFAOYSA-N n-(2-fluoro-4-methylsulfonylphenyl)-6-[4-(3-fluorophenoxy)piperidin-1-yl]pyrimidin-4-amine Chemical compound FC1=CC(S(=O)(=O)C)=CC=C1NC1=CC(N2CCC(CC2)OC=2C=C(F)C=CC=2)=NC=N1 YUFYAEHJBXIROF-UHFFFAOYSA-N 0.000 description 1
- LVBBNZMBUGRLAB-UHFFFAOYSA-N n-(2-fluoro-4-methylsulfonylphenyl)-6-[4-(3-propan-2-yl-1,2,4-oxadiazol-5-yl)piperidin-1-yl]pyrimidin-4-amine Chemical compound CC(C)C1=NOC(C2CCN(CC2)C=2N=CN=C(NC=3C(=CC(=CC=3)S(C)(=O)=O)F)C=2)=N1 LVBBNZMBUGRLAB-UHFFFAOYSA-N 0.000 description 1
- UZCUJAKOPXZJDL-UHFFFAOYSA-N n-(2-fluoro-4-methylsulfonylphenyl)-6-[4-(3-pyridin-3-yl-1,2,4-oxadiazol-5-yl)piperidin-1-yl]pyrimidin-4-amine Chemical compound FC1=CC(S(=O)(=O)C)=CC=C1NC1=CC(N2CCC(CC2)C=2ON=C(N=2)C=2C=NC=CC=2)=NC=N1 UZCUJAKOPXZJDL-UHFFFAOYSA-N 0.000 description 1
- LFPNPPGSLLQXGJ-UHFFFAOYSA-N n-(2-fluoro-4-methylsulfonylphenyl)-6-[4-(4-propan-2-yloxyphenyl)piperazin-1-yl]pyrimidin-4-amine Chemical compound C1=CC(OC(C)C)=CC=C1N1CCN(C=2N=CN=C(NC=3C(=CC(=CC=3)S(C)(=O)=O)F)C=2)CC1 LFPNPPGSLLQXGJ-UHFFFAOYSA-N 0.000 description 1
- VUKQHKDAHXXKSA-UHFFFAOYSA-N n-(2-fluoro-4-methylsulfonylphenyl)-6-[4-(4-propan-2-yloxyphenyl)piperidin-1-yl]pyrimidin-4-amine Chemical compound C1=CC(OC(C)C)=CC=C1C1CCN(C=2N=CN=C(NC=3C(=CC(=CC=3)S(C)(=O)=O)F)C=2)CC1 VUKQHKDAHXXKSA-UHFFFAOYSA-N 0.000 description 1
- XFIBBTUDQCRWJU-UHFFFAOYSA-N n-(2-fluoro-4-methylsulfonylphenyl)-6-[4-(4-propan-2-ylphenyl)piperidin-1-yl]pyrimidin-4-amine Chemical compound C1=CC(C(C)C)=CC=C1C1CCN(C=2N=CN=C(NC=3C(=CC(=CC=3)S(C)(=O)=O)F)C=2)CC1 XFIBBTUDQCRWJU-UHFFFAOYSA-N 0.000 description 1
- JWGXGGINTZAFIH-UHFFFAOYSA-N n-(2-fluoro-4-methylsulfonylphenyl)-6-[4-(5-propan-2-yloxypyridin-2-yl)oxypiperidin-1-yl]pyrimidin-4-amine Chemical compound N1=CC(OC(C)C)=CC=C1OC1CCN(C=2N=CN=C(NC=3C(=CC(=CC=3)S(C)(=O)=O)F)C=2)CC1 JWGXGGINTZAFIH-UHFFFAOYSA-N 0.000 description 1
- AQINFDXRZLDTQZ-UHFFFAOYSA-N n-(2-fluoro-4-methylsulfonylphenyl)-6-[4-(5-propan-2-yloxypyridin-2-yl)piperazin-1-yl]pyrimidin-4-amine Chemical compound N1=CC(OC(C)C)=CC=C1N1CCN(C=2N=CN=C(NC=3C(=CC(=CC=3)S(C)(=O)=O)F)C=2)CC1 AQINFDXRZLDTQZ-UHFFFAOYSA-N 0.000 description 1
- MJVQXQFPAIQGES-UHFFFAOYSA-N n-(2-fluoro-4-methylsulfonylphenyl)-6-[4-[2-(3-propan-2-yl-1,2,4-oxadiazol-5-yl)ethyl]piperazin-1-yl]pyrimidin-4-amine Chemical compound CC(C)C1=NOC(CCN2CCN(CC2)C=2N=CN=C(NC=3C(=CC(=CC=3)S(C)(=O)=O)F)C=2)=N1 MJVQXQFPAIQGES-UHFFFAOYSA-N 0.000 description 1
- JELMAPKGQVQBAQ-UHFFFAOYSA-N n-(2-fluoro-4-methylsulfonylphenyl)-6-[4-[3-(2-methylpropyl)-1,2,4-oxadiazol-5-yl]piperidin-1-yl]pyrimidin-4-amine Chemical compound CC(C)CC1=NOC(C2CCN(CC2)C=2N=CN=C(NC=3C(=CC(=CC=3)S(C)(=O)=O)F)C=2)=N1 JELMAPKGQVQBAQ-UHFFFAOYSA-N 0.000 description 1
- IZYFTJSFCBZZCB-UHFFFAOYSA-N n-(2-fluoro-4-methylsulfonylphenyl)-6-[4-[4-(2-methylpropyl)phenyl]piperidin-1-yl]pyrimidin-4-amine Chemical compound C1=CC(CC(C)C)=CC=C1C1CCN(C=2N=CN=C(NC=3C(=CC(=CC=3)S(C)(=O)=O)F)C=2)CC1 IZYFTJSFCBZZCB-UHFFFAOYSA-N 0.000 description 1
- PNJPNSJBUQKWSL-UHFFFAOYSA-N n-(2-fluorophenyl)-5-nitro-6-(4-pyridin-2-ylsulfanylpiperidin-1-yl)pyrimidin-4-amine Chemical compound N1=CN=C(N2CCC(CC2)SC=2N=CC=CC=2)C([N+](=O)[O-])=C1NC1=CC=CC=C1F PNJPNSJBUQKWSL-UHFFFAOYSA-N 0.000 description 1
- WOTUARKEXNYFJX-UHFFFAOYSA-N n-(2-fluorophenyl)-6-[4-(3-methyl-1,2,4-oxadiazol-5-yl)piperidin-1-yl]-5-nitropyrimidin-4-amine Chemical compound CC1=NOC(C2CCN(CC2)C=2C(=C(NC=3C(=CC=CC=3)F)N=CN=2)[N+]([O-])=O)=N1 WOTUARKEXNYFJX-UHFFFAOYSA-N 0.000 description 1
- DQBRIGDSJKZPJZ-UHFFFAOYSA-N n-(2-methoxyphenyl)-5-nitro-6-(4-pyridin-2-ylsulfanylpiperidin-1-yl)pyrimidin-4-amine Chemical compound COC1=CC=CC=C1NC1=NC=NC(N2CCC(CC2)SC=2N=CC=CC=2)=C1[N+]([O-])=O DQBRIGDSJKZPJZ-UHFFFAOYSA-N 0.000 description 1
- BTBNZCCPHWAHGE-UHFFFAOYSA-N n-(2-methylphenyl)piperidine-1-carboxamide Chemical compound CC1=CC=CC=C1NC(=O)N1CCCCC1 BTBNZCCPHWAHGE-UHFFFAOYSA-N 0.000 description 1
- XCTTVNSXEHWZBI-UHFFFAOYSA-N n-(2-methylpropyl)formamide Chemical compound CC(C)CNC=O XCTTVNSXEHWZBI-UHFFFAOYSA-N 0.000 description 1
- MPRPMZLALGYKSX-UHFFFAOYSA-N n-(3,5-dichlorophenyl)-2-[4-[6-(2-fluoro-4-methylsulfonylphenoxy)-5-methylpyrimidin-4-yl]oxypiperidin-1-yl]acetamide Chemical compound N1=CN=C(OC=2C(=CC(=CC=2)S(C)(=O)=O)F)C(C)=C1OC(CC1)CCN1CC(=O)NC1=CC(Cl)=CC(Cl)=C1 MPRPMZLALGYKSX-UHFFFAOYSA-N 0.000 description 1
- XYTXYHSAIKDPLR-UHFFFAOYSA-N n-(3-chlorophenyl)-2-[4-[6-(2-fluoro-4-methylsulfonylphenoxy)-5-methylpyrimidin-4-yl]oxypiperidin-1-yl]acetamide Chemical compound N1=CN=C(OC=2C(=CC(=CC=2)S(C)(=O)=O)F)C(C)=C1OC(CC1)CCN1CC(=O)NC1=CC=CC(Cl)=C1 XYTXYHSAIKDPLR-UHFFFAOYSA-N 0.000 description 1
- OOONYVYHCUTMFO-UHFFFAOYSA-N n-(3-methoxyphenyl)-5-nitro-6-(4-pyridin-2-ylsulfanylpiperidin-1-yl)pyrimidin-4-amine Chemical compound COC1=CC=CC(NC=2C(=C(N3CCC(CC3)SC=3N=CC=CC=3)N=CN=2)[N+]([O-])=O)=C1 OOONYVYHCUTMFO-UHFFFAOYSA-N 0.000 description 1
- SSJBYJPJNQVDTE-UHFFFAOYSA-N n-(4-chlorophenyl)-2-[4-[6-(2-fluoro-4-methylsulfonylphenoxy)-5-methylpyrimidin-4-yl]oxypiperidin-1-yl]acetamide Chemical compound N1=CN=C(OC=2C(=CC(=CC=2)S(C)(=O)=O)F)C(C)=C1OC(CC1)CCN1CC(=O)NC1=CC=C(Cl)C=C1 SSJBYJPJNQVDTE-UHFFFAOYSA-N 0.000 description 1
- YAIXFEVBIPYUCZ-UHFFFAOYSA-N n-(4-fluorophenyl)methanimine Chemical compound FC1=CC=C(N=C)C=C1 YAIXFEVBIPYUCZ-UHFFFAOYSA-N 0.000 description 1
- RGSZNJSURQGKFN-UHFFFAOYSA-N n-(4-methylsulfonylphenyl)-5-nitro-6-(1-propylsulfonylpiperidin-4-yl)oxypyrimidin-4-amine Chemical compound C1CN(S(=O)(=O)CCC)CCC1OC1=NC=NC(NC=2C=CC(=CC=2)S(C)(=O)=O)=C1[N+]([O-])=O RGSZNJSURQGKFN-UHFFFAOYSA-N 0.000 description 1
- VRBVIBUXYLJGPL-UHFFFAOYSA-N n-(4-methylsulfonylphenyl)-5-nitro-6-(1-pyridin-2-ylpiperidin-4-yl)oxypyrimidin-4-amine Chemical compound C1=CC(S(=O)(=O)C)=CC=C1NC1=NC=NC(OC2CCN(CC2)C=2N=CC=CC=2)=C1[N+]([O-])=O VRBVIBUXYLJGPL-UHFFFAOYSA-N 0.000 description 1
- OGIWNXGYRVBJBD-UHFFFAOYSA-N n-(4-methylsulfonylphenyl)-5-nitro-6-(1-thiophen-2-ylsulfonylpiperidin-4-yl)oxypyrimidin-4-amine Chemical compound C1=CC(S(=O)(=O)C)=CC=C1NC1=NC=NC(OC2CCN(CC2)S(=O)(=O)C=2SC=CC=2)=C1[N+]([O-])=O OGIWNXGYRVBJBD-UHFFFAOYSA-N 0.000 description 1
- OEBKLOOOUYPCEF-UHFFFAOYSA-N n-(4-methylsulfonylphenyl)-5-nitro-6-(4-phenylsulfanylpiperidin-1-yl)pyrimidin-4-amine Chemical compound C1=CC(S(=O)(=O)C)=CC=C1NC1=NC=NC(N2CCC(CC2)SC=2C=CC=CC=2)=C1[N+]([O-])=O OEBKLOOOUYPCEF-UHFFFAOYSA-N 0.000 description 1
- QZISRIIPECSOHR-UHFFFAOYSA-N n-(4-methylsulfonylphenyl)-5-nitro-6-(4-pyridin-2-yloxypiperidin-1-yl)pyrimidin-4-amine Chemical compound C1=CC(S(=O)(=O)C)=CC=C1NC1=NC=NC(N2CCC(CC2)OC=2N=CC=CC=2)=C1[N+]([O-])=O QZISRIIPECSOHR-UHFFFAOYSA-N 0.000 description 1
- OMSHVFLVGQVXJT-UHFFFAOYSA-N n-(4-methylsulfonylphenyl)-5-nitro-6-(4-pyridin-2-ylsulfanylpiperidin-1-yl)pyrimidin-4-amine Chemical compound C1=CC(S(=O)(=O)C)=CC=C1NC1=NC=NC(N2CCC(CC2)SC=2N=CC=CC=2)=C1[N+]([O-])=O OMSHVFLVGQVXJT-UHFFFAOYSA-N 0.000 description 1
- OEZMADKRHCYHIW-UHFFFAOYSA-N n-(4-methylsulfonylphenyl)-5-nitro-6-(4-pyridin-4-yloxypiperidin-1-yl)pyrimidin-4-amine Chemical compound C1=CC(S(=O)(=O)C)=CC=C1NC1=NC=NC(N2CCC(CC2)OC=2C=CN=CC=2)=C1[N+]([O-])=O OEZMADKRHCYHIW-UHFFFAOYSA-N 0.000 description 1
- UJRCZTGQLYANFT-UHFFFAOYSA-N n-(4-methylsulfonylphenyl)-5-nitro-6-(4-pyridin-4-ylsulfanylpiperidin-1-yl)pyrimidin-4-amine Chemical compound C1=CC(S(=O)(=O)C)=CC=C1NC1=NC=NC(N2CCC(CC2)SC=2C=CN=CC=2)=C1[N+]([O-])=O UJRCZTGQLYANFT-UHFFFAOYSA-N 0.000 description 1
- PKQRJIXXTIXGCI-UHFFFAOYSA-N n-(4-methylsulfonylphenyl)-5-nitro-6-(4-pyrimidin-2-yloxypiperidin-1-yl)pyrimidin-4-amine Chemical compound C1=CC(S(=O)(=O)C)=CC=C1NC1=NC=NC(N2CCC(CC2)OC=2N=CC=CN=2)=C1[N+]([O-])=O PKQRJIXXTIXGCI-UHFFFAOYSA-N 0.000 description 1
- VSOQVHPVCDOSJI-UHFFFAOYSA-N n-(4-methylsulfonylphenyl)-5-nitro-6-[1-(pyridin-2-ylmethyl)piperidin-4-yl]oxypyrimidin-4-amine Chemical compound C1=CC(S(=O)(=O)C)=CC=C1NC1=NC=NC(OC2CCN(CC=3N=CC=CC=3)CC2)=C1[N+]([O-])=O VSOQVHPVCDOSJI-UHFFFAOYSA-N 0.000 description 1
- TUAJGEOZZGFFFZ-UHFFFAOYSA-N n-(4-methylsulfonylphenyl)-5-nitro-6-[1-(pyridin-3-ylmethyl)piperidin-4-yl]oxypyrimidin-4-amine Chemical compound C1=CC(S(=O)(=O)C)=CC=C1NC1=NC=NC(OC2CCN(CC=3C=NC=CC=3)CC2)=C1[N+]([O-])=O TUAJGEOZZGFFFZ-UHFFFAOYSA-N 0.000 description 1
- GWURHCBAFSQBSE-UHFFFAOYSA-N n-(4-methylsulfonylphenyl)-5-nitro-6-[4-(3-propan-2-yl-1,2,4-oxadiazol-5-yl)piperidin-1-yl]pyrimidin-4-amine Chemical compound CC(C)C1=NOC(C2CCN(CC2)C=2C(=C(NC=3C=CC(=CC=3)S(C)(=O)=O)N=CN=2)[N+]([O-])=O)=N1 GWURHCBAFSQBSE-UHFFFAOYSA-N 0.000 description 1
- HROYOPFZZRTECV-UHFFFAOYSA-N n-(4-methylsulfonylphenyl)-5-nitro-6-[4-(3-propyl-1,2,4-oxadiazol-5-yl)piperidin-1-yl]pyrimidin-4-amine Chemical compound CCCC1=NOC(C2CCN(CC2)C=2C(=C(NC=3C=CC(=CC=3)S(C)(=O)=O)N=CN=2)[N+]([O-])=O)=N1 HROYOPFZZRTECV-UHFFFAOYSA-N 0.000 description 1
- RUPYSDFXVSXHKA-UHFFFAOYSA-N n-(4-methylsulfonylphenyl)-5-nitro-6-[4-(pyridin-2-ylmethyl)piperidin-1-yl]pyrimidin-4-amine Chemical compound C1=CC(S(=O)(=O)C)=CC=C1NC1=NC=NC(N2CCC(CC=3N=CC=CC=3)CC2)=C1[N+]([O-])=O RUPYSDFXVSXHKA-UHFFFAOYSA-N 0.000 description 1
- XUNXHDLCZVOLCL-UHFFFAOYSA-N n-(4-methylsulfonylphenyl)-5-nitro-6-[4-[4-(trifluoromethoxy)phenoxy]piperidin-1-yl]pyrimidin-4-amine Chemical compound C1=CC(S(=O)(=O)C)=CC=C1NC1=NC=NC(N2CCC(CC2)OC=2C=CC(OC(F)(F)F)=CC=2)=C1[N+]([O-])=O XUNXHDLCZVOLCL-UHFFFAOYSA-N 0.000 description 1
- LFEOJANOTHGPSD-UHFFFAOYSA-N n-(4-methylsulfonylphenyl)-5-nitro-6-piperidin-4-yloxypyrimidin-4-amine Chemical compound C1=CC(S(=O)(=O)C)=CC=C1NC1=NC=NC(OC2CCNCC2)=C1[N+]([O-])=O LFEOJANOTHGPSD-UHFFFAOYSA-N 0.000 description 1
- WPZQMLXTSSMDFM-UHFFFAOYSA-N n-(4-methylsulfonylphenyl)-6-(1-methylsulfonylpiperidin-4-yl)oxy-5-nitropyrimidin-4-amine Chemical compound C1CN(S(=O)(=O)C)CCC1OC1=NC=NC(NC=2C=CC(=CC=2)S(C)(=O)=O)=C1[N+]([O-])=O WPZQMLXTSSMDFM-UHFFFAOYSA-N 0.000 description 1
- XNNCVQJDWBLRCA-UHFFFAOYSA-N n-(4-methylsulfonylphenyl)-6-[4-(3-propan-2-yl-1,2,4-oxadiazol-5-yl)piperidin-1-yl]pyrimidin-4-amine Chemical compound CC(C)C1=NOC(C2CCN(CC2)C=2N=CN=C(NC=3C=CC(=CC=3)S(C)(=O)=O)C=2)=N1 XNNCVQJDWBLRCA-UHFFFAOYSA-N 0.000 description 1
- UFWPCJQMQTUXJL-CQSZACIVSA-N n-[(2r)-1-[4-[6-(2-fluoro-4-methylsulfonylphenoxy)-5-methylpyrimidin-4-yl]oxypiperidin-1-yl]-1-oxopropan-2-yl]acetamide Chemical compound C1CN(C(=O)[C@H](NC(C)=O)C)CCC1OC1=NC=NC(OC=2C(=CC(=CC=2)S(C)(=O)=O)F)=C1C UFWPCJQMQTUXJL-CQSZACIVSA-N 0.000 description 1
- AFSBDRXRSQPBOJ-OAQYLSRUSA-N n-[(2r)-1-[4-[6-(2-fluoro-4-methylsulfonylphenoxy)-5-methylpyrimidin-4-yl]oxypiperidin-1-yl]-3-methyl-1-oxobutan-2-yl]acetamide Chemical compound C1CN(C(=O)[C@H](NC(C)=O)C(C)C)CCC1OC1=NC=NC(OC=2C(=CC(=CC=2)S(C)(=O)=O)F)=C1C AFSBDRXRSQPBOJ-OAQYLSRUSA-N 0.000 description 1
- UFWPCJQMQTUXJL-AWEZNQCLSA-N n-[(2s)-1-[4-[6-(2-fluoro-4-methylsulfonylphenoxy)-5-methylpyrimidin-4-yl]oxypiperidin-1-yl]-1-oxopropan-2-yl]acetamide Chemical compound C1CN(C(=O)[C@@H](NC(C)=O)C)CCC1OC1=NC=NC(OC=2C(=CC(=CC=2)S(C)(=O)=O)F)=C1C UFWPCJQMQTUXJL-AWEZNQCLSA-N 0.000 description 1
- AFSBDRXRSQPBOJ-NRFANRHFSA-N n-[(2s)-1-[4-[6-(2-fluoro-4-methylsulfonylphenoxy)-5-methylpyrimidin-4-yl]oxypiperidin-1-yl]-3-methyl-1-oxobutan-2-yl]acetamide Chemical compound C1CN(C(=O)[C@@H](NC(C)=O)C(C)C)CCC1OC1=NC=NC(OC=2C(=CC(=CC=2)S(C)(=O)=O)F)=C1C AFSBDRXRSQPBOJ-NRFANRHFSA-N 0.000 description 1
- XXQWTCKVEQQOKU-UHFFFAOYSA-N n-[3-fluoro-4-[1-methyl-7-[1-(3-propan-2-yl-1,2,4-oxadiazol-5-yl)piperidin-4-yl]oxy-2,4-dihydropyrazolo[4,3-d]pyrimidin-3-yl]phenyl]sulfonylpropanamide Chemical compound FC1=CC(S(=O)(=O)NC(=O)CC)=CC=C1C(NN1C)=C2C1=C(OC1CCN(CC1)C=1ON=C(N=1)C(C)C)N=CN2 XXQWTCKVEQQOKU-UHFFFAOYSA-N 0.000 description 1
- MSXLPFNMZGAMGG-UHFFFAOYSA-N n-[3-fluoro-4-[1-methyl-7-[4-(3-propan-2-yl-1,2,4-oxadiazol-5-yl)cyclohexyl]oxypyrazolo[4,3-d]pyrimidin-3-yl]phenyl]sulfonylpropanamide Chemical compound FC1=CC(S(=O)(=O)NC(=O)CC)=CC=C1C(C1=NC=N2)=NN(C)C1=C2OC1CCC(C=2ON=C(N=2)C(C)C)CC1 MSXLPFNMZGAMGG-UHFFFAOYSA-N 0.000 description 1
- GMQMEDWAHVCZGG-UHFFFAOYSA-N n-[3-fluoro-4-[2-methyl-7-[1-(3-propan-2-yl-1,2,4-oxadiazol-5-yl)piperidin-4-yl]oxypyrazolo[4,3-d]pyrimidin-3-yl]phenyl]sulfonylpropanamide Chemical compound FC1=CC(S(=O)(=O)NC(=O)CC)=CC=C1C1=C2N=CN=C(OC3CCN(CC3)C=3ON=C(N=3)C(C)C)C2=NN1C GMQMEDWAHVCZGG-UHFFFAOYSA-N 0.000 description 1
- FZJBSVLETILWJA-UHFFFAOYSA-N n-[3-fluoro-4-[2-methyl-7-[4-(3-propan-2-yl-1,2,4-oxadiazol-5-yl)cyclohexyl]oxypyrazolo[4,3-d]pyrimidin-3-yl]phenyl]sulfonylpropanamide Chemical compound FC1=CC(S(=O)(=O)NC(=O)CC)=CC=C1C1=C2N=CN=C(OC3CCC(CC3)C=3ON=C(N=3)C(C)C)C2=NN1C FZJBSVLETILWJA-UHFFFAOYSA-N 0.000 description 1
- PKANRTLQPRRUFV-UHFFFAOYSA-N n-[3-fluoro-4-[4-[1-(3-propan-2-yl-1,2,4-oxadiazol-5-yl)piperidin-4-yl]oxyquinolin-8-yl]phenyl]sulfonylpropanamide Chemical compound FC1=CC(S(=O)(=O)NC(=O)CC)=CC=C1C(C1=NC=C2)=CC=CC1=C2OC1CCN(C=2ON=C(N=2)C(C)C)CC1 PKANRTLQPRRUFV-UHFFFAOYSA-N 0.000 description 1
- ZFILQIJAWYNPTQ-UHFFFAOYSA-N n-[3-fluoro-4-[4-[4-(3-propan-2-yl-1,2,4-oxadiazol-5-yl)cyclohexyl]oxyquinolin-8-yl]phenyl]sulfonylpropanamide Chemical compound FC1=CC(S(=O)(=O)NC(=O)CC)=CC=C1C(C1=NC=C2)=CC=CC1=C2OC1CCC(C=2ON=C(N=2)C(C)C)CC1 ZFILQIJAWYNPTQ-UHFFFAOYSA-N 0.000 description 1
- HALFVGHBYRPXHF-UHFFFAOYSA-N n-[3-fluoro-4-[6-[1-(3-propan-2-yl-1,2,4-oxadiazol-5-yl)piperidin-4-yl]oxypurin-9-yl]phenyl]sulfonylpropanamide Chemical compound FC1=CC(S(=O)(=O)NC(=O)CC)=CC=C1N1C2=NC=NC(OC3CCN(CC3)C=3ON=C(N=3)C(C)C)=C2N=C1 HALFVGHBYRPXHF-UHFFFAOYSA-N 0.000 description 1
- LQXPZXLFLGWDBT-UHFFFAOYSA-N n-[3-fluoro-4-[6-[4-(3-propan-2-yl-1,2,4-oxadiazol-5-yl)cyclohexyl]oxypurin-9-yl]phenyl]sulfonylpropanamide Chemical compound FC1=CC(S(=O)(=O)NC(=O)CC)=CC=C1N1C2=NC=NC(OC3CCC(CC3)C=3ON=C(N=3)C(C)C)=C2N=C1 LQXPZXLFLGWDBT-UHFFFAOYSA-N 0.000 description 1
- ZPIUQTLLLNSTMD-UHFFFAOYSA-N n-[3-fluoro-4-[7-[1-(3-propan-2-yl-1,2,4-oxadiazol-5-yl)piperidin-4-yl]oxytriazolo[4,5-d]pyrimidin-3-yl]phenyl]sulfonylpropanamide Chemical compound FC1=CC(S(=O)(=O)NC(=O)CC)=CC=C1N1C2=NC=NC(OC3CCN(CC3)C=3ON=C(N=3)C(C)C)=C2N=N1 ZPIUQTLLLNSTMD-UHFFFAOYSA-N 0.000 description 1
- QYLJDMRUUGKGLH-UHFFFAOYSA-N n-[3-fluoro-4-[7-[4-(3-propan-2-yl-1,2,4-oxadiazol-5-yl)cyclohexyl]oxytriazolo[4,5-d]pyrimidin-3-yl]phenyl]sulfonylpropanamide Chemical compound FC1=CC(S(=O)(=O)NC(=O)CC)=CC=C1N1C2=NC=NC(OC3CCC(CC3)C=3ON=C(N=3)C(C)C)=C2N=N1 QYLJDMRUUGKGLH-UHFFFAOYSA-N 0.000 description 1
- ALLGAVICJHZNDU-UHFFFAOYSA-N n-[4-[6-(2-fluoro-4-methylsulfonylphenoxy)-5-methylpyrimidin-4-yl]oxycyclohexyl]-2-methylpropanamide Chemical compound C1CC(NC(=O)C(C)C)CCC1OC1=NC=NC(OC=2C(=CC(=CC=2)S(C)(=O)=O)F)=C1C ALLGAVICJHZNDU-UHFFFAOYSA-N 0.000 description 1
- WQSFNEBZRWLSSJ-UHFFFAOYSA-N n-[4-[6-(2-fluoro-4-methylsulfonylphenoxy)-5-methylpyrimidin-4-yl]oxycyclohexyl]-3-methylbutanamide Chemical compound C1CC(NC(=O)CC(C)C)CCC1OC1=NC=NC(OC=2C(=CC(=CC=2)S(C)(=O)=O)F)=C1C WQSFNEBZRWLSSJ-UHFFFAOYSA-N 0.000 description 1
- NJAAOXLTBQRWRE-UHFFFAOYSA-N n-[4-[[1-(4-methylsulfonylphenyl)pyrazolo[3,4-d]pyrimidin-4-yl]amino]cyclohexyl]pyridine-3-carboxamide Chemical compound C1=CC(S(=O)(=O)C)=CC=C1N1C2=NC=NC(NC3CCC(CC3)NC(=O)C=3C=NC=CC=3)=C2C=N1 NJAAOXLTBQRWRE-UHFFFAOYSA-N 0.000 description 1
- FRKMENJIPGUMNR-UHFFFAOYSA-N n-[[4-[[1-(4-methylsulfonylphenyl)pyrazolo[3,4-d]pyrimidin-4-yl]amino]cyclohexyl]methyl]pyridine-3-carboxamide Chemical compound C1=CC(S(=O)(=O)C)=CC=C1N1C2=NC=NC(NC3CCC(CNC(=O)C=4C=NC=CC=4)CC3)=C2C=N1 FRKMENJIPGUMNR-UHFFFAOYSA-N 0.000 description 1
- NRMJMIGWXUCEEW-UHFFFAOYSA-N n-butan-2-ylformamide Chemical compound CCC(C)NC=O NRMJMIGWXUCEEW-UHFFFAOYSA-N 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000006095 n-butyl sulfinyl group Chemical group 0.000 description 1
- 125000006126 n-butyl sulfonyl group Chemical group 0.000 description 1
- WWQGZFLGATWRPN-UHFFFAOYSA-N n-ethyl-1-(2-fluoro-4-methylsulfonylphenyl)-n-[(1-pyridin-2-ylpiperidin-4-yl)methyl]pyrazolo[3,4-d]pyrimidin-4-amine Chemical compound N=1C=NC=2N(C=3C(=CC(=CC=3)S(C)(=O)=O)F)N=CC=2C=1N(CC)CC(CC1)CCN1C1=CC=CC=N1 WWQGZFLGATWRPN-UHFFFAOYSA-N 0.000 description 1
- ZGUKEUKYSDXPIY-UHFFFAOYSA-N n-ethyl-1-(2-fluoro-4-methylsulfonylphenyl)-n-[[1-[5-(trifluoromethyl)pyridin-2-yl]piperidin-4-yl]methyl]pyrazolo[3,4-d]pyrimidin-4-amine Chemical compound N=1C=NC=2N(C=3C(=CC(=CC=3)S(C)(=O)=O)F)N=CC=2C=1N(CC)CC(CC1)CCN1C1=CC=C(C(F)(F)F)C=N1 ZGUKEUKYSDXPIY-UHFFFAOYSA-N 0.000 description 1
- VRZWPBLNAYLXAS-UHFFFAOYSA-N n-ethyl-3-fluoro-4-[[6-[methyl(piperidin-4-ylmethyl)amino]pyrimidin-4-yl]amino]benzenesulfonamide Chemical compound FC1=CC(S(=O)(=O)NCC)=CC=C1NC1=CC(N(C)CC2CCNCC2)=NC=N1 VRZWPBLNAYLXAS-UHFFFAOYSA-N 0.000 description 1
- FJLHLDBEZKTSOK-UHFFFAOYSA-N n-ethyl-n-methylformamide Chemical compound CCN(C)C=O FJLHLDBEZKTSOK-UHFFFAOYSA-N 0.000 description 1
- YVWNKJAXQSRBPM-UHFFFAOYSA-N n-ethyl-n-methylmethanethioamide Chemical compound CCN(C)C=S YVWNKJAXQSRBPM-UHFFFAOYSA-N 0.000 description 1
- KERBAAIBDHEFDD-UHFFFAOYSA-N n-ethylformamide Chemical compound CCNC=O KERBAAIBDHEFDD-UHFFFAOYSA-N 0.000 description 1
- 125000001280 n-hexyl group Chemical group C(CCCCC)* 0.000 description 1
- ZKTLKYRAZWGBDB-UHFFFAOYSA-N n-methyl-n-propan-2-ylformamide Chemical compound CC(C)N(C)C=O ZKTLKYRAZWGBDB-UHFFFAOYSA-N 0.000 description 1
- KVTGAKFJRLBHLU-UHFFFAOYSA-N n-propan-2-ylformamide Chemical compound CC(C)NC=O KVTGAKFJRLBHLU-UHFFFAOYSA-N 0.000 description 1
- 125000006093 n-propyl sulfinyl group Chemical group 0.000 description 1
- 125000006124 n-propyl sulfonyl group Chemical group 0.000 description 1
- QEBGATMRIOQYAX-UHFFFAOYSA-N n-propyl-4-(3-pyridin-4-yl-1,2,4-oxadiazol-5-yl)piperidine-1-carboxamide Chemical compound C1CN(C(=O)NCCC)CCC1C1=NC(C=2C=CN=CC=2)=NO1 QEBGATMRIOQYAX-UHFFFAOYSA-N 0.000 description 1
- SUUDTPGCUKBECW-UHFFFAOYSA-N n-propylformamide Chemical compound CCCNC=O SUUDTPGCUKBECW-UHFFFAOYSA-N 0.000 description 1
- SDLAKRCBYGZJRW-UHFFFAOYSA-N n-tert-butylformamide Chemical compound CC(C)(C)NC=O SDLAKRCBYGZJRW-UHFFFAOYSA-N 0.000 description 1
- NDRHYUYAUAQMCW-UHFFFAOYSA-N naphthalen-1-yl piperidine-1-carboxylate Chemical compound O=C(OC1=CC=CC2=CC=CC=C12)N1CCCCC1 NDRHYUYAUAQMCW-UHFFFAOYSA-N 0.000 description 1
- DYQYKXUACSASLT-UHFFFAOYSA-N naphthalen-2-yl piperidine-1-carboxylate Chemical compound C=1C=C2C=CC=CC2=CC=1OC(=O)N1CCCCC1 DYQYKXUACSASLT-UHFFFAOYSA-N 0.000 description 1
- 125000001624 naphthyl group Chemical group 0.000 description 1
- OELFLUMRDSZNSF-BRWVUGGUSA-N nateglinide Chemical compound C1C[C@@H](C(C)C)CC[C@@H]1C(=O)N[C@@H](C(O)=O)CC1=CC=CC=C1 OELFLUMRDSZNSF-BRWVUGGUSA-N 0.000 description 1
- 229960000698 nateglinide Drugs 0.000 description 1
- 230000007823 neuropathy Effects 0.000 description 1
- 230000004112 neuroprotection Effects 0.000 description 1
- VOMXSOIBEJBQNF-UTTRGDHVSA-N novorapid Chemical compound C([C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CS)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](CO)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CS)NC(=O)[C@H](CS)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)CN)[C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(O)=O)C1=CC=C(O)C=C1.C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)C(C)C)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC=1C=CC=CC=1)C(C)C)C1=CN=CN1 VOMXSOIBEJBQNF-UTTRGDHVSA-N 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 239000003791 organic solvent mixture Substances 0.000 description 1
- 150000002902 organometallic compounds Chemical class 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- 125000006340 pentafluoro ethyl group Chemical group FC(F)(F)C(F)(F)* 0.000 description 1
- LAHXPOLBJKZGLG-UHFFFAOYSA-N pentan-3-yl 4-[1-(4-methylsulfonylphenyl)pyrazolo[3,4-d]pyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(CC)CC)CCC1OC1=NC=NC2=C1C=NN2C1=CC=C(S(C)(=O)=O)C=C1 LAHXPOLBJKZGLG-UHFFFAOYSA-N 0.000 description 1
- 125000003538 pentan-3-yl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])C([H])([H])[H] 0.000 description 1
- VLXXRHUCBHEKKU-UHFFFAOYSA-N pentyl 4-[1-(4-methylsulfonylphenyl)pyrazolo[3,4-d]pyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OCCCCC)CCC1OC1=NC=NC2=C1C=NN2C1=CC=C(S(C)(=O)=O)C=C1 VLXXRHUCBHEKKU-UHFFFAOYSA-N 0.000 description 1
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
- YXBKRUFCMRJIQY-UHFFFAOYSA-N pentyl piperidine-1-carboxylate Chemical compound CCCCCOC(=O)N1CCCCC1 YXBKRUFCMRJIQY-UHFFFAOYSA-N 0.000 description 1
- 239000000813 peptide hormone Substances 0.000 description 1
- 230000002263 peptidergic effect Effects 0.000 description 1
- 239000000816 peptidomimetic Substances 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 239000008177 pharmaceutical agent Substances 0.000 description 1
- 229940124531 pharmaceutical excipient Drugs 0.000 description 1
- XDSHDFNARKWREQ-UHFFFAOYSA-N phenyl 4-[[5-(2-cyanopyridin-4-yl)-1,2,4-oxadiazol-3-yl]methoxy]piperidine-1-carboxylate Chemical compound C1CC(OCC=2N=C(ON=2)C=2C=C(N=CC=2)C#N)CCN1C(=O)OC1=CC=CC=C1 XDSHDFNARKWREQ-UHFFFAOYSA-N 0.000 description 1
- GGZDLAOKPXEJCP-UHFFFAOYSA-N phenyl piperidine-1-carboxylate Chemical compound C1CCCCN1C(=O)OC1=CC=CC=C1 GGZDLAOKPXEJCP-UHFFFAOYSA-N 0.000 description 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
- BGSLLNIHQOTSTE-UHFFFAOYSA-N phenyl-[4-[(3-pyridin-4-yl-1,2,4-oxadiazol-5-yl)methoxy]piperidin-1-yl]methanone Chemical compound C=1C=CC=CC=1C(=O)N(CC1)CCC1OCC(ON=1)=NC=1C1=CC=NC=C1 BGSLLNIHQOTSTE-UHFFFAOYSA-N 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 230000004962 physiological condition Effects 0.000 description 1
- IBBMAWULFFBRKK-UHFFFAOYSA-N picolinamide Chemical compound NC(=O)C1=CC=CC=N1 IBBMAWULFFBRKK-UHFFFAOYSA-N 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229960005095 pioglitazone Drugs 0.000 description 1
- 125000004194 piperazin-1-yl group Chemical group [H]N1C([H])([H])C([H])([H])N(*)C([H])([H])C1([H])[H] 0.000 description 1
- RFIOZSIHFNEKFF-UHFFFAOYSA-N piperazine-1-carboxylic acid Chemical compound OC(=O)N1CCNCC1 RFIOZSIHFNEKFF-UHFFFAOYSA-N 0.000 description 1
- 125000000587 piperidin-1-yl group Chemical group [H]C1([H])N(*)C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
- 125000004482 piperidin-4-yl group Chemical group N1CCC(CC1)* 0.000 description 1
- 239000004014 plasticizer Substances 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 230000004481 post-translational protein modification Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- UFUASNAHBMBJIX-UHFFFAOYSA-N propan-1-one Chemical compound CC[C]=O UFUASNAHBMBJIX-UHFFFAOYSA-N 0.000 description 1
- YWOAQYVPBMTYJT-UHFFFAOYSA-N propan-2-yl 3-[[1-(2-fluoro-4-methylsulfonylphenyl)pyrazolo[3,4-d]pyrimidin-4-yl]amino]pyrrolidine-1-carboxylate Chemical compound C1N(C(=O)OC(C)C)CCC1NC1=NC=NC2=C1C=NN2C1=CC=C(S(C)(=O)=O)C=C1F YWOAQYVPBMTYJT-UHFFFAOYSA-N 0.000 description 1
- IACHSFVWPPFKLZ-UHFFFAOYSA-N propan-2-yl 4-[1-(2,5-difluoro-4-methoxyphenyl)pyrazolo[3,4-d]pyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1=C(F)C(OC)=CC(F)=C1N1C2=NC=NC(OC3CCN(CC3)C(=O)OC(C)C)=C2C=N1 IACHSFVWPPFKLZ-UHFFFAOYSA-N 0.000 description 1
- AGXZXBRGCXNLTK-UHFFFAOYSA-N propan-2-yl 4-[1-(2,5-difluoro-4-methylsulfonylphenyl)pyrazolo[3,4-d]pyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=NC=NC2=C1C=NN2C1=CC(F)=C(S(C)(=O)=O)C=C1F AGXZXBRGCXNLTK-UHFFFAOYSA-N 0.000 description 1
- NXPSMWADXJECBL-UHFFFAOYSA-N propan-2-yl 4-[1-(2,5-difluoro-4-sulfamoylphenyl)pyrazolo[3,4-d]pyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=NC=NC2=C1C=NN2C1=CC(F)=C(S(N)(=O)=O)C=C1F NXPSMWADXJECBL-UHFFFAOYSA-N 0.000 description 1
- KXLNADAGVPKHOF-UHFFFAOYSA-N propan-2-yl 4-[1-(2-fluoro-4-hydroxyphenyl)pyrazolo[3,4-d]pyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=NC=NC2=C1C=NN2C1=CC=C(O)C=C1F KXLNADAGVPKHOF-UHFFFAOYSA-N 0.000 description 1
- HGBUPOSAZBPBLT-UHFFFAOYSA-N propan-2-yl 4-[1-(2-fluoro-4-methoxyphenyl)pyrazolo[3,4-d]pyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound FC1=CC(OC)=CC=C1N1C2=NC=NC(OC3CCN(CC3)C(=O)OC(C)C)=C2C=N1 HGBUPOSAZBPBLT-UHFFFAOYSA-N 0.000 description 1
- XTRUQJBVQBUKSQ-UHFFFAOYSA-N propan-2-yl 4-[1-(2-fluoro-4-methylsulfonylphenyl)pyrazolo[3,4-d]pyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=NC=NC2=C1C=NN2C1=CC=C(S(C)(=O)=O)C=C1F XTRUQJBVQBUKSQ-UHFFFAOYSA-N 0.000 description 1
- VBPVOMYYXBKGGH-UHFFFAOYSA-N propan-2-yl 4-[1-(2-fluoro-4-methylsulfonylphenyl)pyrazolo[3,4-d]pyrimidin-4-yl]sulfanylpiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1SC1=NC=NC2=C1C=NN2C1=CC=C(S(C)(=O)=O)C=C1F VBPVOMYYXBKGGH-UHFFFAOYSA-N 0.000 description 1
- CRLDAOOZPLQASS-UHFFFAOYSA-N propan-2-yl 4-[1-(2-fluoro-4-morpholin-4-ylphenyl)pyrazolo[3,4-d]pyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=NC=NC2=C1C=NN2C1=CC=C(N2CCOCC2)C=C1F CRLDAOOZPLQASS-UHFFFAOYSA-N 0.000 description 1
- ZNPIOZZOAWZYJW-UHFFFAOYSA-N propan-2-yl 4-[1-(2-fluoro-4-sulfamoylphenyl)pyrazolo[3,4-d]pyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=NC=NC2=C1C=NN2C1=CC=C(S(N)(=O)=O)C=C1F ZNPIOZZOAWZYJW-UHFFFAOYSA-N 0.000 description 1
- BLURWBJGTXLEEU-UHFFFAOYSA-N propan-2-yl 4-[1-(2-methyl-4-morpholin-4-ylphenyl)pyrazolo[3,4-d]pyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=NC=NC2=C1C=NN2C1=CC=C(N2CCOCC2)C=C1C BLURWBJGTXLEEU-UHFFFAOYSA-N 0.000 description 1
- QOMNXZNQMIDJCF-UHFFFAOYSA-N propan-2-yl 4-[1-(4-aminophenyl)pyrazolo[3,4-d]pyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=NC=NC2=C1C=NN2C1=CC=C(N)C=C1 QOMNXZNQMIDJCF-UHFFFAOYSA-N 0.000 description 1
- UZRRFKXLJHGBTN-UHFFFAOYSA-N propan-2-yl 4-[1-(4-bromophenyl)pyrazolo[3,4-d]pyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=NC=NC2=C1C=NN2C1=CC=C(Br)C=C1 UZRRFKXLJHGBTN-UHFFFAOYSA-N 0.000 description 1
- NZGHDYYFDAXHPC-UHFFFAOYSA-N propan-2-yl 4-[1-(4-cyano-2-fluorophenyl)pyrazolo[3,4-d]pyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=NC=NC2=C1C=NN2C1=CC=C(C#N)C=C1F NZGHDYYFDAXHPC-UHFFFAOYSA-N 0.000 description 1
- MVXFRONNIDBVRP-UHFFFAOYSA-N propan-2-yl 4-[1-(4-fluoro-6-methoxypyridin-3-yl)pyrazolo[3,4-d]pyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1=NC(OC)=CC(F)=C1N1C2=NC=NC(OC3CCN(CC3)C(=O)OC(C)C)=C2C=N1 MVXFRONNIDBVRP-UHFFFAOYSA-N 0.000 description 1
- YIQWWYGEUNGHBF-UHFFFAOYSA-N propan-2-yl 4-[1-(4-morpholin-4-ylphenyl)pyrazolo[3,4-d]pyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=NC=NC2=C1C=NN2C1=CC=C(N2CCOCC2)C=C1 YIQWWYGEUNGHBF-UHFFFAOYSA-N 0.000 description 1
- HUIDDHCFHLIOQB-UHFFFAOYSA-N propan-2-yl 4-[1-[2-fluoro-4-(propan-2-ylamino)phenyl]pyrazolo[3,4-d]pyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound FC1=CC(NC(C)C)=CC=C1N1C2=NC=NC(OC3CCN(CC3)C(=O)OC(C)C)=C2C=N1 HUIDDHCFHLIOQB-UHFFFAOYSA-N 0.000 description 1
- VQOPUBPTOZQQOP-UHFFFAOYSA-N propan-2-yl 4-[1-[2-fluoro-4-(propanoylsulfamoyl)phenyl]pyrazolo[3,4-d]pyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound FC1=CC(S(=O)(=O)NC(=O)CC)=CC=C1N1C2=NC=NC(OC3CCN(CC3)C(=O)OC(C)C)=C2C=N1 VQOPUBPTOZQQOP-UHFFFAOYSA-N 0.000 description 1
- PQOUYHJNGOPTAJ-UHFFFAOYSA-N propan-2-yl 4-[1-[2-fluoro-4-(trifluoromethoxy)phenyl]pyrazolo[3,4-d]pyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=NC=NC2=C1C=NN2C1=CC=C(OC(F)(F)F)C=C1F PQOUYHJNGOPTAJ-UHFFFAOYSA-N 0.000 description 1
- OYFDNYVKAJBJOI-UHFFFAOYSA-N propan-2-yl 4-[1-[2-methyl-4-(propan-2-ylamino)phenyl]pyrazolo[3,4-d]pyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound CC1=CC(NC(C)C)=CC=C1N1C2=NC=NC(OC3CCN(CC3)C(=O)OC(C)C)=C2C=N1 OYFDNYVKAJBJOI-UHFFFAOYSA-N 0.000 description 1
- IUDQOYOAZPEDSK-UHFFFAOYSA-N propan-2-yl 4-[1-[2-methyl-4-(propylamino)phenyl]pyrazolo[3,4-d]pyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound CC1=CC(NCCC)=CC=C1N1C2=NC=NC(OC3CCN(CC3)C(=O)OC(C)C)=C2C=N1 IUDQOYOAZPEDSK-UHFFFAOYSA-N 0.000 description 1
- YLTVGSFPBKGJCF-UHFFFAOYSA-N propan-2-yl 4-[1-[4-(2-methoxyethylamino)phenyl]pyrazolo[3,4-d]pyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1=CC(NCCOC)=CC=C1N1C2=NC=NC(OC3CCN(CC3)C(=O)OC(C)C)=C2C=N1 YLTVGSFPBKGJCF-UHFFFAOYSA-N 0.000 description 1
- GNTJGFKHYISKHA-UHFFFAOYSA-N propan-2-yl 4-[1-[4-(cyclopropylamino)-2-methylphenyl]pyrazolo[3,4-d]pyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=NC=NC2=C1C=NN2C(C(=C1)C)=CC=C1NC1CC1 GNTJGFKHYISKHA-UHFFFAOYSA-N 0.000 description 1
- LMBLDUDHEVMYQL-UHFFFAOYSA-N propan-2-yl 4-[1-[4-(difluoromethoxy)-2-fluorophenyl]pyrazolo[3,4-d]pyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=NC=NC2=C1C=NN2C1=CC=C(OC(F)F)C=C1F LMBLDUDHEVMYQL-UHFFFAOYSA-N 0.000 description 1
- MCSGZLBZLCVYMZ-UHFFFAOYSA-N propan-2-yl 4-[1-[4-(propan-2-ylamino)phenyl]pyrazolo[3,4-d]pyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1=CC(NC(C)C)=CC=C1N1C2=NC=NC(OC3CCN(CC3)C(=O)OC(C)C)=C2C=N1 MCSGZLBZLCVYMZ-UHFFFAOYSA-N 0.000 description 1
- RMHDKAUUNXMLSL-UHFFFAOYSA-N propan-2-yl 4-[1-[4-(propylamino)phenyl]pyrazolo[3,4-d]pyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1=CC(NCCC)=CC=C1N1C2=NC=NC(OC3CCN(CC3)C(=O)OC(C)C)=C2C=N1 RMHDKAUUNXMLSL-UHFFFAOYSA-N 0.000 description 1
- GPWCCXIIUNRPIS-UHFFFAOYSA-N propan-2-yl 4-[1-[4-[2-(dimethylamino)ethylamino]-2-methylphenyl]pyrazolo[3,4-d]pyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=NC=NC2=C1C=NN2C1=CC=C(NCCN(C)C)C=C1C GPWCCXIIUNRPIS-UHFFFAOYSA-N 0.000 description 1
- WNTHAKJCMKXUDR-UHFFFAOYSA-N propan-2-yl 4-[2-[2,5-difluoro-4-(2-methylsulfonylethyl)phenoxy]-3-methylpyridin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=CC=NC(OC=2C(=CC(CCS(C)(=O)=O)=C(F)C=2)F)=C1C WNTHAKJCMKXUDR-UHFFFAOYSA-N 0.000 description 1
- KBLJCVRPWDNHPJ-UHFFFAOYSA-N propan-2-yl 4-[2-[2,5-difluoro-4-(2-propan-2-yloxyethyl)phenoxy]-3-methylpyridin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1=C(F)C(CCOC(C)C)=CC(F)=C1OC1=NC=CC(OC2CCN(CC2)C(=O)OC(C)C)=C1C KBLJCVRPWDNHPJ-UHFFFAOYSA-N 0.000 description 1
- FICUNAVENAGHSW-UHFFFAOYSA-N propan-2-yl 4-[3-(2,5-difluoro-4-methylsulfonylphenyl)-2-methylpyrazolo[4,3-d]pyrimidin-7-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC(C1=NN2C)=NC=NC1=C2C1=CC(F)=C(S(C)(=O)=O)C=C1F FICUNAVENAGHSW-UHFFFAOYSA-N 0.000 description 1
- WNVAPVSUXGJFCF-UHFFFAOYSA-N propan-2-yl 4-[3-(2,5-difluoro-4-sulfamoylphenyl)-2-methylpyrazolo[4,3-d]pyrimidin-7-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC(C1=NN2C)=NC=NC1=C2C1=CC(F)=C(S(N)(=O)=O)C=C1F WNVAPVSUXGJFCF-UHFFFAOYSA-N 0.000 description 1
- LZMFUNVBORTUEU-UHFFFAOYSA-N propan-2-yl 4-[3-(2-fluoro-4-sulfamoylphenyl)-2-methylpyrazolo[4,3-d]pyrimidin-7-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC(C1=NN2C)=NC=NC1=C2C1=CC=C(S(N)(=O)=O)C=C1F LZMFUNVBORTUEU-UHFFFAOYSA-N 0.000 description 1
- KVAOKZBNBVLJKZ-UHFFFAOYSA-N propan-2-yl 4-[3-(4-cyano-2-fluorophenyl)-2-methylpyrazolo[4,3-d]pyrimidin-7-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC(C1=NN2C)=NC=NC1=C2C1=CC=C(C#N)C=C1F KVAOKZBNBVLJKZ-UHFFFAOYSA-N 0.000 description 1
- XDCRJVJNAYJUBG-UHFFFAOYSA-N propan-2-yl 4-[3-[2-fluoro-4-(propanoylsulfamoyl)phenyl]-2-methylpyrazolo[4,3-d]pyrimidin-7-yl]oxypiperidine-1-carboxylate Chemical compound FC1=CC(S(=O)(=O)NC(=O)CC)=CC=C1C1=C2N=CN=C(OC3CCN(CC3)C(=O)OC(C)C)C2=NN1C XDCRJVJNAYJUBG-UHFFFAOYSA-N 0.000 description 1
- JSBHSPILXBGXRZ-UHFFFAOYSA-N propan-2-yl 4-[5-cyclopropyl-6-[2,5-difluoro-4-(2-hydroxyethyl)phenoxy]pyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=NC=NC(OC=2C(=CC(CCO)=C(F)C=2)F)=C1C1CC1 JSBHSPILXBGXRZ-UHFFFAOYSA-N 0.000 description 1
- ORXNZXCPVBWOOL-UHFFFAOYSA-N propan-2-yl 4-[5-ethynyl-6-[2-fluoro-4-(4-methoxypyridin-2-yl)phenoxy]pyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound COC1=CC=NC(C=2C=C(F)C(OC=3C(=C(OC4CCN(CC4)C(=O)OC(C)C)N=CN=3)C#C)=CC=2)=C1 ORXNZXCPVBWOOL-UHFFFAOYSA-N 0.000 description 1
- CVDNXRGLGVQJFR-UHFFFAOYSA-N propan-2-yl 4-[5-ethynyl-6-[4-fluoro-6-(2-methylsulfonylethyl)pyridin-3-yl]oxypyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=NC=NC(OC=2C(=CC(CCS(C)(=O)=O)=NC=2)F)=C1C#C CVDNXRGLGVQJFR-UHFFFAOYSA-N 0.000 description 1
- RLTJJAPYYDVBHI-UHFFFAOYSA-N propan-2-yl 4-[5-methyl-6-[2-methyl-6-(2-propan-2-yloxyethyl)pyridin-3-yl]oxypyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound CC1=NC(CCOC(C)C)=CC=C1OC1=NC=NC(OC2CCN(CC2)C(=O)OC(C)C)=C1C RLTJJAPYYDVBHI-UHFFFAOYSA-N 0.000 description 1
- WSSOKQLEYYKNIE-UHFFFAOYSA-N propan-2-yl 4-[5-methyl-6-[2-methyl-6-(2-propan-2-yloxyethylsulfonyl)pyridin-3-yl]oxypyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound CC1=NC(S(=O)(=O)CCOC(C)C)=CC=C1OC1=NC=NC(OC2CCN(CC2)C(=O)OC(C)C)=C1C WSSOKQLEYYKNIE-UHFFFAOYSA-N 0.000 description 1
- YLKMXWNAASOYEM-UHFFFAOYSA-N propan-2-yl 4-[6-(2-fluoro-4-methylsulfonylphenoxy)-5-(methanesulfonamido)pyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=NC=NC(OC=2C(=CC(=CC=2)S(C)(=O)=O)F)=C1NS(C)(=O)=O YLKMXWNAASOYEM-UHFFFAOYSA-N 0.000 description 1
- AQVCVWMEYVQWBA-UHFFFAOYSA-N propan-2-yl 4-[6-(6-amino-2-methylpyridin-3-yl)oxy-5-methylpyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=NC=NC(OC=2C(=NC(N)=CC=2)C)=C1C AQVCVWMEYVQWBA-UHFFFAOYSA-N 0.000 description 1
- BMQSCHGXCKJSKE-UHFFFAOYSA-N propan-2-yl 4-[6-[2,3-difluoro-4-(2-methylsulfonylethyl)phenoxy]-5-methylpyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=NC=NC(OC=2C(=C(F)C(CCS(C)(=O)=O)=CC=2)F)=C1C BMQSCHGXCKJSKE-UHFFFAOYSA-N 0.000 description 1
- TWOGYGUGMDXEQY-UHFFFAOYSA-N propan-2-yl 4-[6-[2,5-difluoro-4-(2-methylsulfonylethyl)phenoxy]-5-methylpyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=NC=NC(OC=2C(=CC(CCS(C)(=O)=O)=C(F)C=2)F)=C1C TWOGYGUGMDXEQY-UHFFFAOYSA-N 0.000 description 1
- JNLNGMYUDUZZRW-UHFFFAOYSA-N propan-2-yl 4-[6-[2,5-difluoro-4-(2-morpholin-4-ylethyl)phenoxy]-5-methylpyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=NC=NC(OC=2C(=CC(CCN3CCOCC3)=C(F)C=2)F)=C1C JNLNGMYUDUZZRW-UHFFFAOYSA-N 0.000 description 1
- AHBZBSIQXPCAGE-UHFFFAOYSA-N propan-2-yl 4-[6-[2,5-difluoro-4-(2-sulfamoylethyl)phenoxy]-5-ethynylpyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=NC=NC(OC=2C(=CC(CCS(N)(=O)=O)=C(F)C=2)F)=C1C#C AHBZBSIQXPCAGE-UHFFFAOYSA-N 0.000 description 1
- QGCFLMKKPXDPKJ-UHFFFAOYSA-N propan-2-yl 4-[6-[2,5-difluoro-4-(trifluoromethoxy)phenoxy]-5-ethynylpyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=NC=NC(OC=2C(=CC(OC(F)(F)F)=C(F)C=2)F)=C1C#C QGCFLMKKPXDPKJ-UHFFFAOYSA-N 0.000 description 1
- UEZRYSSOLPIHEX-UHFFFAOYSA-N propan-2-yl 4-[6-[2-fluoro-4-(2-pyridin-2-ylethoxy)phenoxy]-5-methylpyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=NC=NC(OC=2C(=CC(OCCC=3N=CC=CC=3)=CC=2)F)=C1C UEZRYSSOLPIHEX-UHFFFAOYSA-N 0.000 description 1
- AXGSNYXPMJFUFJ-UHFFFAOYSA-N propan-2-yl 4-[6-[2-fluoro-4-(2-sulfamoylethyl)phenoxy]-5-methylpyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=NC=NC(OC=2C(=CC(CCS(N)(=O)=O)=CC=2)F)=C1C AXGSNYXPMJFUFJ-UHFFFAOYSA-N 0.000 description 1
- PGKJGOFQPMALGJ-UHFFFAOYSA-N propan-2-yl 4-[6-[2-fluoro-4-(3-methoxypropoxy)phenoxy]-5-methylpyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound FC1=CC(OCCCOC)=CC=C1OC1=NC=NC(OC2CCN(CC2)C(=O)OC(C)C)=C1C PGKJGOFQPMALGJ-UHFFFAOYSA-N 0.000 description 1
- OMLJEUKKPUKHNB-UHFFFAOYSA-N propan-2-yl 4-[6-[2-fluoro-4-(3-methoxypropylsulfonyl)phenoxy]-5-methylpyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound FC1=CC(S(=O)(=O)CCCOC)=CC=C1OC1=NC=NC(OC2CCN(CC2)C(=O)OC(C)C)=C1C OMLJEUKKPUKHNB-UHFFFAOYSA-N 0.000 description 1
- WMZJVGAPOFVIPY-UHFFFAOYSA-N propan-2-yl 4-[6-[2-fluoro-4-(3-methoxypyridin-2-yl)phenoxy]-5-methylpyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound COC1=CC=CN=C1C(C=C1F)=CC=C1OC1=NC=NC(OC2CCN(CC2)C(=O)OC(C)C)=C1C WMZJVGAPOFVIPY-UHFFFAOYSA-N 0.000 description 1
- CZZOGDHQLJVGGT-UHFFFAOYSA-N propan-2-yl 4-[6-[2-fluoro-4-(5-methoxypyridin-2-yl)phenoxy]-5-methylpyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound N1=CC(OC)=CC=C1C(C=C1F)=CC=C1OC1=NC=NC(OC2CCN(CC2)C(=O)OC(C)C)=C1C CZZOGDHQLJVGGT-UHFFFAOYSA-N 0.000 description 1
- UMCWFDFYNNIRQR-UHFFFAOYSA-N propan-2-yl 4-[6-[2-fluoro-4-(oxan-4-yloxy)phenoxy]-5-methylpyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=NC=NC(OC=2C(=CC(OC3CCOCC3)=CC=2)F)=C1C UMCWFDFYNNIRQR-UHFFFAOYSA-N 0.000 description 1
- MZRJRANLKQTSCY-UHFFFAOYSA-N propan-2-yl 4-[6-[2-fluoro-4-(pyridine-2-carbonyl)phenoxy]-5-methylpyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=NC=NC(OC=2C(=CC(=CC=2)C(=O)C=2N=CC=CC=2)F)=C1C MZRJRANLKQTSCY-UHFFFAOYSA-N 0.000 description 1
- ADTXKBXANHVSEM-UHFFFAOYSA-N propan-2-yl 4-[6-[2-fluoro-4-(thiophene-2-carbonyl)phenoxy]-5-methylpyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=NC=NC(OC=2C(=CC(=CC=2)C(=O)C=2SC=CC=2)F)=C1C ADTXKBXANHVSEM-UHFFFAOYSA-N 0.000 description 1
- IPDOEFHZTJEYFN-UHFFFAOYSA-N propan-2-yl 4-[6-[2-fluoro-4-[(1-hydroxycyclopropyl)methyl]phenoxy]-5-methylpyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=NC=NC(OC=2C(=CC(CC3(O)CC3)=CC=2)F)=C1C IPDOEFHZTJEYFN-UHFFFAOYSA-N 0.000 description 1
- TZLYKVMHYOOBQU-UHFFFAOYSA-N propan-2-yl 4-[6-[2-fluoro-4-[2-(2-methylpropoxy)ethoxy]phenoxy]-5-methylpyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound FC1=CC(OCCOCC(C)C)=CC=C1OC1=NC=NC(OC2CCN(CC2)C(=O)OC(C)C)=C1C TZLYKVMHYOOBQU-UHFFFAOYSA-N 0.000 description 1
- OLMMVFWYFBTBAH-UHFFFAOYSA-N propan-2-yl 4-[6-[2-fluoro-4-[2-(propanoylsulfamoyl)ethyl]phenoxy]-5-methylpyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound FC1=CC(CCS(=O)(=O)NC(=O)CC)=CC=C1OC1=NC=NC(OC2CCN(CC2)C(=O)OC(C)C)=C1C OLMMVFWYFBTBAH-UHFFFAOYSA-N 0.000 description 1
- HMGKNQLILIKVCU-UHFFFAOYSA-N propan-2-yl 4-[6-[4-(2-cyclopropyloxyethoxy)-2-fluorophenoxy]-5-methylpyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=NC=NC(OC=2C(=CC(OCCOC3CC3)=CC=2)F)=C1C HMGKNQLILIKVCU-UHFFFAOYSA-N 0.000 description 1
- VODFVJZYYILJHH-UHFFFAOYSA-N propan-2-yl 4-[6-[4-(2-ethoxyethoxy)-2-fluorophenoxy]-5-methylpyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound FC1=CC(OCCOCC)=CC=C1OC1=NC=NC(OC2CCN(CC2)C(=O)OC(C)C)=C1C VODFVJZYYILJHH-UHFFFAOYSA-N 0.000 description 1
- WGEATORUYINAEO-UHFFFAOYSA-N propan-2-yl 4-[6-[4-fluoro-6-(2-methylsulfonylethyl)pyridin-3-yl]oxy-5-methylpyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=NC=NC(OC=2C(=CC(CCS(C)(=O)=O)=NC=2)F)=C1C WGEATORUYINAEO-UHFFFAOYSA-N 0.000 description 1
- JWMZGUNZIJMGJJ-UHFFFAOYSA-N propan-2-yl 4-[6-[6-(2-cyclopropyloxyethylamino)-2-methylpyridin-3-yl]oxy-5-methylpyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=NC=NC(OC=2C(=NC(NCCOC3CC3)=CC=2)C)=C1C JWMZGUNZIJMGJJ-UHFFFAOYSA-N 0.000 description 1
- CGTLTGSMTRRXDP-UHFFFAOYSA-N propan-2-yl 4-[6-[6-(2-fluoroethyl)-2-methylpyridin-3-yl]oxy-5-methylpyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=NC=NC(OC=2C(=NC(CCF)=CC=2)C)=C1C CGTLTGSMTRRXDP-UHFFFAOYSA-N 0.000 description 1
- HXLXAAZWRJAZSF-UHFFFAOYSA-N propan-2-yl 4-[6-[6-(5-methoxypyridin-2-yl)-2-methylpyridin-3-yl]oxy-5-methylpyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound N1=CC(OC)=CC=C1C(N=C1C)=CC=C1OC1=NC=NC(OC2CCN(CC2)C(=O)OC(C)C)=C1C HXLXAAZWRJAZSF-UHFFFAOYSA-N 0.000 description 1
- NVMHDJQDTCMXLH-UHFFFAOYSA-N propan-2-yl piperidine-1-carboxylate Chemical compound CC(C)OC(=O)N1CCCCC1 NVMHDJQDTCMXLH-UHFFFAOYSA-N 0.000 description 1
- 125000001501 propionyl group Chemical group O=C([*])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- ZWGMYSLDSCSTGG-UHFFFAOYSA-N propyl piperidine-1-carboxylate Chemical compound CCCOC(=O)N1CCCCC1 ZWGMYSLDSCSTGG-UHFFFAOYSA-N 0.000 description 1
- 235000013772 propylene glycol Nutrition 0.000 description 1
- 235000019833 protease Nutrition 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 125000004307 pyrazin-2-yl group Chemical group [H]C1=C([H])N=C(*)C([H])=N1 0.000 description 1
- 125000003373 pyrazinyl group Chemical group 0.000 description 1
- 125000002098 pyridazinyl group Chemical group 0.000 description 1
- 125000004076 pyridyl group Chemical group 0.000 description 1
- 125000004528 pyrimidin-5-yl group Chemical group N1=CN=CC(=C1)* 0.000 description 1
- 125000000714 pyrimidinyl group Chemical group 0.000 description 1
- JWVCLYRUEFBMGU-UHFFFAOYSA-N quinazoline Chemical compound N1=CN=CC2=CC=CC=C21 JWVCLYRUEFBMGU-UHFFFAOYSA-N 0.000 description 1
- GHBFNMLVSPCDGN-UHFFFAOYSA-N rac-1-monooctanoylglycerol Chemical compound CCCCCCCC(=O)OCC(O)CO GHBFNMLVSPCDGN-UHFFFAOYSA-N 0.000 description 1
- 239000003488 releasing hormone Substances 0.000 description 1
- 229960002354 repaglinide Drugs 0.000 description 1
- 108091008146 restriction endonucleases Proteins 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 238000011808 rodent model Methods 0.000 description 1
- 229960004586 rosiglitazone Drugs 0.000 description 1
- 230000036186 satiety Effects 0.000 description 1
- 235000019627 satiety Nutrition 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 125000003548 sec-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 235000015424 sodium Nutrition 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000012453 solvate Substances 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 125000003107 substituted aryl group Chemical group 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 125000001174 sulfone group Chemical group 0.000 description 1
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 description 1
- YROXIXLRRCOBKF-UHFFFAOYSA-N sulfonylurea Chemical class OC(=N)N=S(=O)=O YROXIXLRRCOBKF-UHFFFAOYSA-N 0.000 description 1
- 125000003375 sulfoxide group Chemical group 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid group Chemical class S(O)(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000002700 tablet coating Substances 0.000 description 1
- 238000009492 tablet coating Methods 0.000 description 1
- 108010009573 talabostat Proteins 0.000 description 1
- MHASFNPRXPJOHH-UHFFFAOYSA-N tert-butyl 3-[1-(2-fluoro-4-methylsulfonylphenyl)pyrazolo[3,4-d]pyrimidin-4-yl]oxypyrrolidine-1-carboxylate Chemical compound C1N(C(=O)OC(C)(C)C)CCC1OC1=NC=NC2=C1C=NN2C1=CC=C(S(C)(=O)=O)C=C1F MHASFNPRXPJOHH-UHFFFAOYSA-N 0.000 description 1
- FENXWPABLIJPAV-UHFFFAOYSA-N tert-butyl 3-[1-(4-methylsulfonylphenyl)pyrazolo[3,4-d]pyrimidin-4-yl]oxypyrrolidine-1-carboxylate Chemical compound C1N(C(=O)OC(C)(C)C)CCC1OC1=NC=NC2=C1C=NN2C1=CC=C(S(C)(=O)=O)C=C1 FENXWPABLIJPAV-UHFFFAOYSA-N 0.000 description 1
- PCDSGRHPHAGREU-UHFFFAOYSA-N tert-butyl 4-(3-pyridin-4-yl-1,2,4-oxadiazol-5-yl)piperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)(C)C)CCC1C1=NC(C=2C=CN=CC=2)=NO1 PCDSGRHPHAGREU-UHFFFAOYSA-N 0.000 description 1
- WESIASPLBWOSTO-UHFFFAOYSA-N tert-butyl 4-[(2-pyridin-4-yl-1,3-thiazol-4-yl)methyl]piperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)(C)C)CCC1CC1=CSC(C=2C=CN=CC=2)=N1 WESIASPLBWOSTO-UHFFFAOYSA-N 0.000 description 1
- QKGFZALRECXFAU-UHFFFAOYSA-N tert-butyl 4-[(3-pyridin-4-yl-1,2,4-oxadiazol-5-yl)methylamino]piperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)(C)C)CCC1NCC1=NC(C=2C=CN=CC=2)=NO1 QKGFZALRECXFAU-UHFFFAOYSA-N 0.000 description 1
- DHIBFGHZLMBADV-UHFFFAOYSA-N tert-butyl 4-[(4-pyridin-4-yl-1,3-thiazol-2-yl)methoxy]piperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)(C)C)CCC1OCC1=NC(C=2C=CN=CC=2)=CS1 DHIBFGHZLMBADV-UHFFFAOYSA-N 0.000 description 1
- FDRHMAIJPIXWBZ-UHFFFAOYSA-N tert-butyl 4-[(5-pyridin-4-yl-1,2-oxazol-3-yl)methoxy]piperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)(C)C)CCC1OCC1=NOC(C=2C=CN=CC=2)=C1 FDRHMAIJPIXWBZ-UHFFFAOYSA-N 0.000 description 1
- OKPNANBGMBXLNA-UHFFFAOYSA-N tert-butyl 4-[(5-pyridin-4-yl-1,2-oxazol-3-yl)methyl]piperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)(C)C)CCC1CC1=NOC(C=2C=CN=CC=2)=C1 OKPNANBGMBXLNA-UHFFFAOYSA-N 0.000 description 1
- DACZUWPWIZNMIG-UHFFFAOYSA-N tert-butyl 4-[(5-pyridin-4-yl-1,3,4-oxadiazol-2-yl)methoxy]piperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)(C)C)CCC1OCC1=NN=C(C=2C=CN=CC=2)O1 DACZUWPWIZNMIG-UHFFFAOYSA-N 0.000 description 1
- KRCCTTRJUJRZKA-UHFFFAOYSA-N tert-butyl 4-[1-(2-fluoro-4-methylsulfonylphenyl)pyrazolo[3,4-d]pyrimidin-4-yl]sulfanylpiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)(C)C)CCC1SC1=NC=NC2=C1C=NN2C1=CC=C(S(C)(=O)=O)C=C1F KRCCTTRJUJRZKA-UHFFFAOYSA-N 0.000 description 1
- TVVRUELYQUKMOC-UHFFFAOYSA-N tert-butyl 4-[1-(4-methylsulfonylphenyl)pyrazolo[3,4-d]pyrimidin-4-yl]sulfanylpiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)(C)C)CCC1SC1=NC=NC2=C1C=NN2C1=CC=C(S(C)(=O)=O)C=C1 TVVRUELYQUKMOC-UHFFFAOYSA-N 0.000 description 1
- XGFMCNHAXDSQDV-UHFFFAOYSA-N tert-butyl 4-[1-(4-methylsulfonylphenyl)pyrazolo[3,4-d]pyrimidin-4-yl]sulfinylpiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)(C)C)CCC1S(=O)C1=NC=NC2=C1C=NN2C1=CC=C(S(C)(=O)=O)C=C1 XGFMCNHAXDSQDV-UHFFFAOYSA-N 0.000 description 1
- NCSITIFSUWIJJL-UHFFFAOYSA-N tert-butyl 4-[1-(4-methylsulfonylphenyl)pyrazolo[3,4-d]pyrimidin-4-yl]sulfonylpiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)(C)C)CCC1S(=O)(=O)C1=NC=NC2=C1C=NN2C1=CC=C(S(C)(=O)=O)C=C1 NCSITIFSUWIJJL-UHFFFAOYSA-N 0.000 description 1
- KWSDPAKJYOSPMU-UHFFFAOYSA-N tert-butyl 4-[1-[2-(dimethylamino)-4-methylsulfonylphenyl]pyrazolo[3,4-d]pyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound CN(C)C1=CC(S(C)(=O)=O)=CC=C1N1C2=NC=NC(OC3CCN(CC3)C(=O)OC(C)(C)C)=C2C=N1 KWSDPAKJYOSPMU-UHFFFAOYSA-N 0.000 description 1
- RQQQYPCTPNNFSJ-UHFFFAOYSA-N tert-butyl 4-[2-(1-methyl-5-pyridin-4-ylpyrazol-3-yl)ethyl]piperidine-1-carboxylate Chemical compound C1=C(C=2C=CN=CC=2)N(C)N=C1CCC1CCN(C(=O)OC(C)(C)C)CC1 RQQQYPCTPNNFSJ-UHFFFAOYSA-N 0.000 description 1
- DBPSZYKBBJUSMW-UHFFFAOYSA-N tert-butyl 4-[2-(2-methyl-5-pyridin-4-ylpyrazol-3-yl)ethyl]piperidine-1-carboxylate Chemical compound CN1N=C(C=2C=CN=CC=2)C=C1CCC1CCN(C(=O)OC(C)(C)C)CC1 DBPSZYKBBJUSMW-UHFFFAOYSA-N 0.000 description 1
- RQTQJJFTLHQWLJ-UHFFFAOYSA-N tert-butyl 4-[2-(3-pyridin-4-yl-1,2,4-oxadiazol-5-yl)ethyl]piperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)(C)C)CCC1CCC1=NC(C=2C=CN=CC=2)=NO1 RQTQJJFTLHQWLJ-UHFFFAOYSA-N 0.000 description 1
- BHOGBIUUVFUONZ-UHFFFAOYSA-N tert-butyl 4-[2-(5-pyridin-4-yl-1,2-oxazol-3-yl)ethyl]piperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)(C)C)CCC1CCC1=NOC(C=2C=CN=CC=2)=C1 BHOGBIUUVFUONZ-UHFFFAOYSA-N 0.000 description 1
- HIKDUJLDWLIQCD-UHFFFAOYSA-N tert-butyl 4-[[5-(2-cyanopyridin-4-yl)-1,2,4-oxadiazol-3-yl]methoxy]piperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)(C)C)CCC1OCC1=NOC(C=2C=C(N=CC=2)C#N)=N1 HIKDUJLDWLIQCD-UHFFFAOYSA-N 0.000 description 1
- JEOZIJHJXPFRCE-UHFFFAOYSA-N tert-butyl 4-[[5-(2-cyanopyridin-4-yl)-1,2,4-oxadiazol-3-yl]methyl-ethylamino]piperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)(C)C)CCC1N(CC)CC(N=1)=NOC=1C1=CC=NC(C#N)=C1 JEOZIJHJXPFRCE-UHFFFAOYSA-N 0.000 description 1
- NDHJNDFBRYXBSE-UHFFFAOYSA-N tert-butyl 4-[[ethyl-[(3-pyridin-4-yl-1,2,4-oxadiazol-5-yl)methyl]amino]methyl]piperidine-1-carboxylate Chemical compound N=1C(C=2C=CN=CC=2)=NOC=1CN(CC)CC1CCN(C(=O)OC(C)(C)C)CC1 NDHJNDFBRYXBSE-UHFFFAOYSA-N 0.000 description 1
- HGLYPDQMORSSFJ-UHFFFAOYSA-N tert-butyl 4-[ethyl-[(3-pyridin-4-yl-1,2,4-oxadiazol-5-yl)methyl]amino]piperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)(C)C)CCC1N(CC)CC(ON=1)=NC=1C1=CC=NC=C1 HGLYPDQMORSSFJ-UHFFFAOYSA-N 0.000 description 1
- PEEHJFFHPDUBTQ-UHFFFAOYSA-N tert-butyl 4-[methyl-[(3-pyridin-4-yl-1,2,4-oxadiazol-5-yl)methyl]amino]piperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)(C)C)CCC1N(C)CC(ON=1)=NC=1C1=CC=NC=C1 PEEHJFFHPDUBTQ-UHFFFAOYSA-N 0.000 description 1
- FQFILJKFZCVHNH-UHFFFAOYSA-N tert-butyl n-[3-[(5-bromo-2-chloropyrimidin-4-yl)amino]propyl]carbamate Chemical compound CC(C)(C)OC(=O)NCCCNC1=NC(Cl)=NC=C1Br FQFILJKFZCVHNH-UHFFFAOYSA-N 0.000 description 1
- 125000001973 tert-pentyl group Chemical group [H]C([H])([H])C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 125000001391 thioamide group Chemical group 0.000 description 1
- 125000002813 thiocarbonyl group Chemical group *C(*)=S 0.000 description 1
- 125000000464 thioxo group Chemical group S=* 0.000 description 1
- 239000004408 titanium dioxide Substances 0.000 description 1
- 230000002110 toxicologic effect Effects 0.000 description 1
- 231100000027 toxicology Toxicity 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 125000004306 triazinyl group Chemical group 0.000 description 1
- 125000005034 trifluormethylthio group Chemical group FC(S*)(F)F 0.000 description 1
- 125000001889 triflyl group Chemical group FC(F)(F)S(*)(=O)=O 0.000 description 1
- 208000035408 type 1 diabetes mellitus 1 Diseases 0.000 description 1
- 125000003774 valeryl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229960001729 voglibose Drugs 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
- G01N33/76—Human chorionic gonadotropin including luteinising hormone, follicle stimulating hormone, thyroid stimulating hormone or their receptors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/401—Proline; Derivatives thereof, e.g. captopril
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4196—1,2,4-Triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/12—Ophthalmic agents for cataracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/72—Assays involving receptors, cell surface antigens or cell surface determinants for hormones
- G01N2333/726—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/04—Endocrine or metabolic disorders
- G01N2800/042—Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
- G01N2800/2814—Dementia; Cognitive disorders
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
- G01N2800/2835—Movement disorders, e.g. Parkinson, Huntington, Tourette
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
- G01N2800/2857—Seizure disorders; Epilepsy
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
- G01N2800/2871—Cerebrovascular disorders, e.g. stroke, cerebral infarct, cerebral haemorrhage, transient ischemic event
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Immunology (AREA)
- Endocrinology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Diabetes (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Food Science & Technology (AREA)
- Cardiology (AREA)
- Pathology (AREA)
- Cell Biology (AREA)
- General Physics & Mathematics (AREA)
- Microbiology (AREA)
- Analytical Chemistry (AREA)
- Heart & Thoracic Surgery (AREA)
- Biotechnology (AREA)
- Obesity (AREA)
- Ophthalmology & Optometry (AREA)
- Reproductive Health (AREA)
- Psychology (AREA)
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US64308605P | 2005-01-10 | 2005-01-10 | |
| US643086P | 2005-01-10 | ||
| US68317205P | 2005-05-19 | 2005-05-19 | |
| US683172P | 2005-05-19 | ||
| US72688005P | 2005-10-14 | 2005-10-14 | |
| US726880P | 2005-10-14 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2327872T3 true ES2327872T3 (es) | 2009-11-04 |
Family
ID=36570727
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES07004743T Active ES2327872T3 (es) | 2005-01-10 | 2006-01-09 | Terapia combinada para el tratamiento de la diabetes y afecciones relacionadas y para el tratamiento de afecciones mejoradas por el incremento del nivel de glp-1 en sangre. |
| ES06717678T Active ES2327268T5 (es) | 2005-01-10 | 2006-01-09 | Método de identificación de secretagogos de GLP-1 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES06717678T Active ES2327268T5 (es) | 2005-01-10 | 2006-01-09 | Método de identificación de secretagogos de GLP-1 |
Country Status (35)
Families Citing this family (98)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CZ305402B6 (cs) * | 2001-02-24 | 2015-09-02 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Xanthinové deriváty, jejich výroba a použití v kombinační terapii |
| EP2022505B1 (en) | 2001-07-31 | 2011-12-14 | The Government of the United States of America, as represented by the Secretary of the Department of Health and Human Services | GLP-1, exendin-4, peptide analogs and uses thereof |
| US7407955B2 (en) | 2002-08-21 | 2008-08-05 | Boehringer Ingelheim Pharma Gmbh & Co., Kg | 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions |
| PT1599468E (pt) | 2003-01-14 | 2008-01-14 | Arena Pharm Inc | Derivados de arilo e heteroarilo 1,2,3.-trissubstituídos comomoduladores do metabolismo, e profilaxia e tratamento dedesordens relacionadas tais como diabetes e hiperglicemia |
| AR045047A1 (es) * | 2003-07-11 | 2005-10-12 | Arena Pharm Inc | Derivados arilo y heteroarilo trisustituidos como moduladores del metabolismo y de la profilaxis y tratamiento de desordenes relacionados con los mismos |
| EP2287165A3 (en) | 2003-07-14 | 2011-06-22 | Arena Pharmaceuticals, Inc. | Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto |
| US7501426B2 (en) | 2004-02-18 | 2009-03-10 | Boehringer Ingelheim International Gmbh | 8-[3-amino-piperidin-1-yl]-xanthines, their preparation and their use as pharmaceutical compositions |
| DE102004054054A1 (de) | 2004-11-05 | 2006-05-11 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Verfahren zur Herstellung chiraler 8-(3-Amino-piperidin-1-yl)-xanthine |
| NZ556017A (en) * | 2004-12-24 | 2009-10-30 | Prosidion Ltd | G-protein coupled receptor (gpr116) agonists and use thereof for treating obesity and diabetes |
| MY148521A (en) * | 2005-01-10 | 2013-04-30 | Arena Pharm Inc | Substituted pyridinyl and pyrimidinyl derivatives as modulators of metabolism and the treatment of disorders related thereto |
| DOP2006000008A (es) * | 2005-01-10 | 2006-08-31 | Arena Pharm Inc | Terapia combinada para el tratamiento de la diabetes y afecciones relacionadas y para el tratamiento de afecciones que mejoran mediante un incremento de la concentración sanguínea de glp-1 |
| CN101166527A (zh) | 2005-04-27 | 2008-04-23 | 艾尼纳制药公司 | 用于治疗肥胖症和糖尿病以及其相关病况和用于治疗可通过增加血液glp-1含量改善的病况的组合疗法 |
| MX2007016508A (es) * | 2005-06-30 | 2008-03-04 | Prosidion Ltd | Agonistas del receptor acoplado a la proteina g. |
| DE102005035891A1 (de) | 2005-07-30 | 2007-02-08 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | 8-(3-Amino-piperidin-1-yl)-xanthine, deren Herstellung und deren Verwendung als Arzneimittel |
| US20070179123A1 (en) * | 2005-11-08 | 2007-08-02 | Chiang Peter K | Methods and compositions for treating diseases associated with pathogenic proteins |
| DK1971862T3 (da) * | 2006-04-11 | 2011-02-14 | Arena Pharm Inc | Fremgangsmåder til anvendelse af GPR119-receptor til identificering af forbindelser anvendelige til øgning af knoglemasse hos en person |
| PE20071221A1 (es) * | 2006-04-11 | 2007-12-14 | Arena Pharm Inc | Agonistas del receptor gpr119 en metodos para aumentar la masa osea y para tratar la osteoporosis y otras afecciones caracterizadas por masa osea baja, y la terapia combinada relacionada a estos agonistas |
| EA030606B1 (ru) | 2006-05-04 | 2018-08-31 | Бёрингер Ингельхайм Интернациональ Гмбх | Способы приготовления лекарственного средства, содержащего полиморфы |
| EP1852108A1 (en) | 2006-05-04 | 2007-11-07 | Boehringer Ingelheim Pharma GmbH & Co.KG | DPP IV inhibitor formulations |
| PE20110235A1 (es) | 2006-05-04 | 2011-04-14 | Boehringer Ingelheim Int | Combinaciones farmaceuticas que comprenden linagliptina y metmorfina |
| WO2008008887A2 (en) * | 2006-07-13 | 2008-01-17 | Smithkline Beecham Corporation | Gpr119 agonists for treating metabolic disorders |
| AU2007291252A1 (en) * | 2006-08-30 | 2008-03-06 | Inovacia Ab | Pyridine compounds for treating GPR119 related disorders |
| AU2007334519A1 (en) * | 2006-12-14 | 2008-06-26 | Merck Sharp & Dohme Corp. | Acyl bipiperidinyl compounds, compositions containing such compounds and methods of treatment |
| US7638541B2 (en) | 2006-12-28 | 2009-12-29 | Metabolex Inc. | 5-ethyl-2-{4-[4-(4-tetrazol-1-yl-phenoxymethyl)-thiazol-2-yl]-piperidin-1-yl}-pyrimidine |
| AR064735A1 (es) * | 2007-01-04 | 2009-04-22 | Prosidion Ltd | Agonistas de gpcr y composicion farmaceutica en base al compuesto |
| RS52065B (sr) * | 2007-01-04 | 2012-06-30 | Prosidion Ltd | Piperidinski gpcr agonisti |
| PE20081849A1 (es) * | 2007-01-04 | 2009-01-26 | Prosidion Ltd | Derivados de piperidin-4-il-propoxi-benzamida como agonistas de gpcr |
| WO2008141074A1 (en) * | 2007-05-10 | 2008-11-20 | Salk Institute For Biological Studies | Identification of compounds that protect against amyloid diseases |
| CA2693169C (en) | 2007-07-19 | 2016-01-12 | Metabolex, Inc. | N-linked heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders |
| PE20090938A1 (es) * | 2007-08-16 | 2009-08-08 | Boehringer Ingelheim Int | Composicion farmaceutica que comprende un derivado de benceno sustituido con glucopiranosilo |
| CN101801954B (zh) * | 2007-09-20 | 2013-10-09 | Irm责任有限公司 | 作为gpr119活性调节剂的化合物和组合物 |
| WO2009117421A2 (en) * | 2008-03-17 | 2009-09-24 | Kalypsys, Inc. | Heterocyclic modulators of gpr119 for treatment of disease |
| CL2009000782A1 (es) * | 2008-03-31 | 2010-04-30 | Metabolex Inc | Metodo que comprende un compuesto derivado de oximetilen-arilo sustituido, inhibidores de dpp-iv; y su uso en el tratamiento de la diabetes y disminucion de trigliceridos, entre otras enfermedades. |
| PE20140960A1 (es) | 2008-04-03 | 2014-08-15 | Boehringer Ingelheim Int | Formulaciones que comprenden un inhibidor de dpp4 |
| EP2146210A1 (en) * | 2008-04-07 | 2010-01-20 | Arena Pharmaceuticals, Inc. | Methods of using A G protein-coupled receptor to identify peptide YY (PYY) secretagogues and compounds useful in the treatment of conditions modulated by PYY |
| AU2009249237A1 (en) * | 2008-05-19 | 2009-11-26 | Schering Corporation | Bicyclic heterocycle derivatives and use thereof as GPR119 modulators |
| ATE557024T1 (de) * | 2008-07-10 | 2012-05-15 | Prosidion Ltd | Piperidinverbindungen als gpcr-agonisten |
| UY32030A (es) | 2008-08-06 | 2010-03-26 | Boehringer Ingelheim Int | "tratamiento para diabetes en pacientes inapropiados para terapia con metformina" |
| KR20200118243A (ko) | 2008-08-06 | 2020-10-14 | 베링거 인겔하임 인터내셔날 게엠베하 | 메트포르민 요법이 부적합한 환자에서의 당뇨병 치료 |
| MX2011002558A (es) * | 2008-09-10 | 2011-04-26 | Boehringer Ingelheim Int | Terapia de combinacion para el tratamiento de diabetes y estados relacionados. |
| US20200155558A1 (en) | 2018-11-20 | 2020-05-21 | Boehringer Ingelheim International Gmbh | Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral antidiabetic drug |
| KR101054911B1 (ko) | 2008-10-17 | 2011-08-05 | 동아제약주식회사 | 디펩티딜펩티다아제-ⅳ의 활성을 저해하는 화합물 및 다른 항당뇨 또는 항비만 약물을 유효성분으로 함유하는 당뇨 또는 비만의 예방 및 치료용 약학적 조성물 |
| CN101723947B (zh) * | 2008-10-21 | 2012-05-30 | 山东轩竹医药科技有限公司 | 二肽酶-ⅳ抑制剂化合物 |
| CN102256976A (zh) | 2008-12-23 | 2011-11-23 | 贝林格尔.英格海姆国际有限公司 | 有机化合物的盐形式 |
| WO2010074271A1 (ja) * | 2008-12-26 | 2010-07-01 | 武田薬品工業株式会社 | 糖尿病治療剤 |
| TW201036975A (en) | 2009-01-07 | 2010-10-16 | Boehringer Ingelheim Int | Treatment for diabetes in patients with inadequate glycemic control despite metformin therapy |
| US20220387305A1 (en) * | 2009-01-12 | 2022-12-08 | Biokier, Inc. | Composition and method for treatment of diabetes |
| LT2395983T (lt) | 2009-02-13 | 2020-07-10 | Boehringer Ingelheim International Gmbh | Farmacinė kompozicija, apimanti sglt2 inhibitorių, dpp-iv inhibitorių ir, pasirinktinai, papildomą priešdiabetinį agentą, bei jos panaudojimas |
| US8580807B2 (en) | 2009-04-03 | 2013-11-12 | Merck Sharp & Dohme Corp. | Bicyclic piperidine and piperazine derivatives as GPCR modulators for the treatment of obesity, diabetes and other metabolic disorders |
| WO2010140092A1 (en) * | 2009-06-05 | 2010-12-09 | Pfizer Inc. | L- ( piperidin-4-yl) -pyrazole derivatives as gpr 119 modulators |
| TW201111361A (en) | 2009-06-24 | 2011-04-01 | Boehringer Ingelheim Int | New compounds, pharmaceutical composition and methods relating thereto |
| US8481731B2 (en) | 2009-06-24 | 2013-07-09 | Boehringer Ingelheim International Gmbh | Compounds, pharmaceutical composition and methods relating thereto |
| AR077642A1 (es) | 2009-07-09 | 2011-09-14 | Arena Pharm Inc | Moduladores del metabolismo y el tratamiento de trastornos relacionados con el mismo |
| KR102093612B1 (ko) * | 2009-09-28 | 2020-03-26 | 인타르시아 세라퓨틱스 인코포레이티드 | 실질 항정상태 약물 전달의 신속 확립 및/또는 종결 |
| CA2775840C (en) | 2009-10-01 | 2018-02-06 | Metabolex, Inc. | Substituted tetrazol-1-yl-phenoxymethyl-thiazol-2-yl-piperidinyl-pyrimidine salts |
| JP2013510834A (ja) | 2009-11-16 | 2013-03-28 | メリテク | [1,5]‐ジアゾシン誘導体 |
| EA034869B1 (ru) | 2009-11-27 | 2020-03-31 | Бёрингер Ингельхайм Интернациональ Гмбх | Лечение генотипированных пациентов с диабетом ингибиторами дпп-4, такими как линаглиптин |
| JP5856980B2 (ja) | 2010-01-27 | 2016-02-10 | アリーナ ファーマシューティカルズ, インコーポレイテッド | (R)−2−(7−(4−シクロペンチル−3−(トリフルオロメチル)ベンジルオキシ)−1,2,3,4−テトラヒドロシクロペンタ[b]インドール−3−イル)酢酸およびその塩の調製のためのプロセス |
| US20120035103A1 (en) * | 2010-01-29 | 2012-02-09 | Pillion Dennis J | Method for administration of insulin and pharmaceutical composition thereof |
| JP2013522279A (ja) * | 2010-03-18 | 2013-06-13 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 糖尿病及び関連状態の治療で用いるgpr119作動薬とddp−iv阻害薬リナグリプチンの組合せ |
| MX2012011631A (es) | 2010-04-06 | 2013-01-18 | Arena Pharm Inc | Moduladores del receptor gpr119 y el tratamiento de trastornos relacionados con el mismo. |
| KR101819609B1 (ko) | 2010-05-05 | 2018-01-17 | 베링거 인겔하임 인터내셔날 게엠베하 | 체중 감소 치료에 후속하는 dpp-4 억제제에 의한 순차적 병용 요법 |
| ES2676209T3 (es) | 2010-06-23 | 2018-07-17 | Metabolex Inc. | Composiciones de 5-etil-2-{4-[4-(4-tetrazol-1-il-fenoximetil)-tiazol-2-il]-piperidin-1-il}-pirimidina |
| KR20230051307A (ko) | 2010-06-24 | 2023-04-17 | 베링거 인겔하임 인터내셔날 게엠베하 | 당뇨병 요법 |
| JP5941916B2 (ja) | 2010-09-22 | 2016-06-29 | アリーナ ファーマシューティカルズ, インコーポレイテッド | Gpr119レセプターのモジュレーターおよびそれに関連する障害の処置 |
| AR083878A1 (es) | 2010-11-15 | 2013-03-27 | Boehringer Ingelheim Int | Terapia antidiabetica vasoprotectora y cardioprotectora, linagliptina, metodo de tratamiento |
| WO2014011926A1 (en) | 2012-07-11 | 2014-01-16 | Elcelyx Therapeutics, Inc. | Compositions comprising statins, biguanides and further agents for reducing cardiometabolic risk |
| UY33937A (es) | 2011-03-07 | 2012-09-28 | Boehringer Ingelheim Int | Composiciones farmacéuticas que contienen inhibidores de dpp-4 y/o sglt-2 y metformina |
| US20140018371A1 (en) | 2011-04-01 | 2014-01-16 | Arena Pharmaceuticals, Inc. | Modulators Of The GPR119 Receptor And The Treatment Of Disorders Related Thereto |
| WO2012145361A1 (en) | 2011-04-19 | 2012-10-26 | Arena Pharmaceuticals, Inc. | Modulators of the gpr119 receptor and the treatment of disorders related thereto |
| WO2012145604A1 (en) | 2011-04-22 | 2012-10-26 | Arena Pharmaceuticals, Inc. | Modulators of the gpr119 receptor and the treatment of disorders related thereto |
| WO2012145603A1 (en) | 2011-04-22 | 2012-10-26 | Arena Pharmaceuticals, Inc. | Modulators of the gpr119 receptor and the treatment of disorders related thereto |
| WO2012170702A1 (en) | 2011-06-08 | 2012-12-13 | Arena Pharmaceuticals, Inc. | Modulators of the gpr119 receptor and the treatment of disorders related thereto |
| MX366629B (es) | 2011-07-15 | 2019-07-17 | Boehringer Ingelheim Int | Quinazolinas sustituidas, su preparación y su uso en composiciones farmacéuticas. |
| WO2013055910A1 (en) | 2011-10-12 | 2013-04-18 | Arena Pharmaceuticals, Inc. | Modulators of the gpr119 receptor and the treatment of disorders related thereto |
| US9555001B2 (en) | 2012-03-07 | 2017-01-31 | Boehringer Ingelheim International Gmbh | Pharmaceutical composition and uses thereof |
| JP6218811B2 (ja) | 2012-05-14 | 2017-10-25 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | Sirs及び/又は敗血症の治療に用いるdpp−4阻害薬としてのキサンチン誘導体 |
| EP2849755A1 (en) | 2012-05-14 | 2015-03-25 | Boehringer Ingelheim International GmbH | A xanthine derivative as dpp -4 inhibitor for use in the treatment of podocytes related disorders and/or nephrotic syndrome |
| WO2013174767A1 (en) | 2012-05-24 | 2013-11-28 | Boehringer Ingelheim International Gmbh | A xanthine derivative as dpp -4 inhibitor for use in modifying food intake and regulating food preference |
| WO2014074668A1 (en) | 2012-11-08 | 2014-05-15 | Arena Pharmaceuticals, Inc. | Modulators of gpr119 and the treatment of disorders related thereto |
| CN103344773B (zh) * | 2013-06-19 | 2015-04-15 | 天津美德太平洋科技有限公司 | 一种胰高血糖素样肽-1生物学活性检测试剂及检测方法和试剂盒 |
| US10493042B2 (en) | 2013-08-01 | 2019-12-03 | University-Industry Cooperation Group Of Kyung Hee University | Method for preventing or treating diabetes mellitus, and method for screening for diabetes mellitus therapeutic agent |
| WO2015016682A1 (ko) | 2013-08-01 | 2015-02-05 | 경희대학교 산학협력단 | 당뇨병 예방 또는 치료용 약학적 조성물, 당뇨병 예방 또는 치료 방법, 및 당뇨병 치료제 스크리닝 방법 |
| WO2015128453A1 (en) | 2014-02-28 | 2015-09-03 | Boehringer Ingelheim International Gmbh | Medical use of a dpp-4 inhibitor |
| PL3242666T3 (pl) | 2015-01-06 | 2025-02-17 | Arena Pharmaceuticals, Inc. | Związek do zastosowania w leczeniu dolegliwości związanych z receptorem s1p1 |
| AU2016229982B2 (en) | 2015-03-09 | 2020-06-18 | Intekrin Therapeutics, Inc. | Methods for the treatment of nonalcoholic fatty liver disease and/or lipodystrophy |
| DK3310760T3 (da) | 2015-06-22 | 2022-10-24 | Arena Pharm Inc | Krystallinsk L-argininsalt af (R)-2-(7-(4-cyclopentyl-3-(trifluormethyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta[b]indol-3- yl)eddikesyre til anvendelse ved S1P1-receptor-associerede lidelser |
| US10155000B2 (en) | 2016-06-10 | 2018-12-18 | Boehringer Ingelheim International Gmbh | Medical use of pharmaceutical combination or composition |
| EP3493807A1 (en) | 2016-08-03 | 2019-06-12 | CymaBay Therapeutics, Inc. | Oxymethylene aryl compounds for treating inflammatory gastrointestinal diseases or gastrointestinal conditions |
| CN110520124A (zh) | 2017-02-16 | 2019-11-29 | 艾尼纳制药公司 | 用于治疗原发性胆汁性胆管炎的化合物和方法 |
| JP2020515639A (ja) | 2017-04-03 | 2020-05-28 | コヒラス・バイオサイエンシズ・インコーポレイテッド | 進行性核上性麻痺の処置のためのPPARγアゴニスト |
| JP2020524181A (ja) | 2017-06-19 | 2020-08-13 | アリーナ ファーマシューティカルズ, インコーポレイテッド | Nafldおよびnashの治療のための化合物および方法 |
| BR112020024762A2 (pt) | 2018-06-06 | 2021-03-23 | Arena Pharmaceuticals, Inc. | métodos de tratamento de condições relacionadas ao receptor s1p1 |
| SI3827829T1 (sl) | 2018-09-12 | 2025-07-31 | Dong-A St Co., Ltd. | Farmacevtska sestava za uporabo pri preprečevanju ali zdravljenju nealkoholne maščobne bolezni jeter, ki vsebuje ligand gpr119 kot aktivno sestavino |
| US20220265652A1 (en) | 2019-07-08 | 2022-08-25 | Mankind Pharma Ltd. | Combination therapy of gpr119 agonists and dpp-4 inhibitors |
| JP7446465B2 (ja) * | 2020-03-11 | 2024-03-08 | トンア・エスティー・カンパニー・リミテッド | 糖尿およびそれに伴う代謝疾患の予防または治療用の薬学的組成物 |
| EP4227299A4 (en) * | 2020-10-12 | 2025-04-09 | Hangzhou Zhongmeihuadong Pharmaceutical Co., Ltd. | GLP-1 RECEPTOR AGONIST, BENZIMIDAZOLONE AND ITS USE |
| US20240190868A1 (en) * | 2022-11-10 | 2024-06-13 | Acerand Therapeutics (Usa) Limited | Sos1 inhibitors |
Family Cites Families (286)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US751426A (en) * | 1904-02-02 | Safety hair-pin | ||
| US747699A (en) * | 1903-09-05 | 1903-12-22 | Achilles C Gough | Universal sanding-machine. |
| US4166452A (en) | 1976-05-03 | 1979-09-04 | Generales Constantine D J Jr | Apparatus for testing human responses to stimuli |
| US4256108A (en) | 1977-04-07 | 1981-03-17 | Alza Corporation | Microporous-semipermeable laminated osmotic system |
| US4704362A (en) * | 1977-11-08 | 1987-11-03 | Genentech, Inc. | Recombinant cloning vehicle microbial polypeptide expression |
| US4265874A (en) | 1980-04-25 | 1981-05-05 | Alza Corporation | Method of delivering drug with aid of effervescent activity generated in environment of use |
| DD296075A5 (de) | 1989-08-07 | 1991-11-21 | Martin-Luther-Universitaet Halle-Wittenberg,De | Verfahren zur herstellung neuer inhibitoren der dipeptidyl peptidase iv |
| DE69124371T2 (de) | 1990-04-14 | 1997-06-12 | New England Medical Center Inc | Typ-iv-dipeptidyl-aminopeptidase-inhibitoren |
| US5462856A (en) | 1990-07-19 | 1995-10-31 | Bunsen Rush Laboratories, Inc. | Methods for identifying chemicals that act as agonists or antagonists for receptors and other proteins involved in signal transduction via pathways that utilize G-proteins |
| JPH07504158A (ja) | 1991-10-22 | 1995-05-11 | ニュー イングランド メディカル センター ホスピタルズ インク | ジペプチジル−アミノペプチダーゼiv型のインヒビタ |
| MX9206628A (es) | 1991-11-22 | 1993-05-01 | Boehringer Ingelheim Pharma | Ester de prolinaboronato y metodo para su preparacion. |
| US6100042A (en) * | 1993-03-31 | 2000-08-08 | Cadus Pharmaceutical Corporation | Yeast cells engineered to produce pheromone system protein surrogates, and uses therefor |
| IL111785A0 (en) | 1993-12-03 | 1995-01-24 | Ferring Bv | Dp-iv inhibitors and pharmaceutical compositions containing them |
| US5543396A (en) | 1994-04-28 | 1996-08-06 | Georgia Tech Research Corp. | Proline phosphonate derivatives |
| DE122010000020I1 (de) | 1996-04-25 | 2010-07-08 | Prosidion Ltd | Verfahren zur Senkung des Blutglukosespiegels in Säugern |
| US20020006899A1 (en) | 1998-10-06 | 2002-01-17 | Pospisilik Andrew J. | Use of dipeptidyl peptidase IV effectors for lowering blood pressure in mammals |
| WO1998018763A1 (en) | 1996-10-25 | 1998-05-07 | Tanabe Seiyaku Co., Ltd. | Tetrahydroisoquinoline derivatives |
| TW492957B (en) | 1996-11-07 | 2002-07-01 | Novartis Ag | N-substituted 2-cyanopyrrolidnes |
| US6040145A (en) | 1997-05-07 | 2000-03-21 | Tufts University | Potentiation of the immune response |
| US6100234A (en) | 1997-05-07 | 2000-08-08 | Tufts University | Treatment of HIV |
| US6183974B1 (en) * | 1997-07-31 | 2001-02-06 | The General Hospital Corporation | Screening assays for G protein coupled receptor agonists and antagonists |
| BR9813233A (pt) | 1997-09-29 | 2000-08-22 | Point Therapeutics Inc | Estimulação de células hematopoéticas in vitro |
| JP4095772B2 (ja) | 1997-11-18 | 2008-06-04 | 財団法人微生物化学研究会 | 新規生理活性物質スルフォスチン、その製造法及びその用途 |
| WO1999038501A2 (en) | 1998-02-02 | 1999-08-05 | Trustees Of Tufts College | Method of regulating glucose metabolism, and reagents related thereto |
| US5922576A (en) * | 1998-02-27 | 1999-07-13 | The John Hopkins University | Simplified system for generating recombinant adenoviruses |
| WO1999056753A1 (en) | 1998-05-04 | 1999-11-11 | Point Therapeutics, Inc. | Hematopoietic stimulation |
| DE19823831A1 (de) | 1998-05-28 | 1999-12-02 | Probiodrug Ges Fuer Arzneim | Neue pharmazeutische Verwendung von Isoleucyl Thiazolidid und seinen Salzen |
| JP2002517401A (ja) | 1998-06-05 | 2002-06-18 | ポイント セラピューティクス, インコーポレイテッド | 環状ボロプロリン化合物 |
| DE19828114A1 (de) * | 1998-06-24 | 2000-01-27 | Probiodrug Ges Fuer Arzneim | Produgs instabiler Inhibitoren der Dipeptidyl Peptidase IV |
| DE19828113A1 (de) | 1998-06-24 | 2000-01-05 | Probiodrug Ges Fuer Arzneim | Prodrugs von Inhibitoren der Dipeptidyl Peptidase IV |
| DE19834591A1 (de) | 1998-07-31 | 2000-02-03 | Probiodrug Ges Fuer Arzneim | Verfahren zur Steigerung des Blutglukosespiegels in Säugern |
| KR20010079669A (ko) | 1998-08-21 | 2001-08-22 | 바바라 피. 월너 | 기질 활성의 조절 |
| JP2002526554A (ja) * | 1998-10-07 | 2002-08-20 | メディカル カレッジ オブ ジョージア リサーチ インスティチュート,インコーポレイテッド | 骨親和性ホルモンとして用いられるグルコース依存性インスリン親和性ペプチド |
| US6242422B1 (en) | 1998-10-22 | 2001-06-05 | Idun Pharmacueticals, Inc. | (Substituted)Acyl dipeptidyl inhibitors of the ice/ced-3 family of cysteine proteases |
| EP1133559B1 (en) * | 1998-11-20 | 2005-08-10 | Arena Pharmaceuticals, Inc. | Human orphan g protein-coupled receptor rup3 |
| CO5150173A1 (es) | 1998-12-10 | 2002-04-29 | Novartis Ag | Compuestos n-(glicilo sustituido)-2-cianopirrolidinas inhibidores de peptidasa de dipeptidilo-iv (dpp-iv) los cuales son efectivos en el tratamiento de condiciones mediadas por la inhibicion de dpp-iv |
| JP2000191616A (ja) | 1998-12-24 | 2000-07-11 | Senju Pharmaceut Co Ltd | 新規ジペプチジルアルデヒド誘導体およびそれを含有する医薬 |
| US20030125539A1 (en) * | 1999-02-22 | 2003-07-03 | Synaptic Pharmaceutical Corporation | DNA encoding SNORF25 receptor |
| US6221660B1 (en) * | 1999-02-22 | 2001-04-24 | Synaptic Pharmaceutical Corporation | DNA encoding SNORF25 receptor |
| AU3960400A (en) * | 1999-03-05 | 2000-09-28 | Molteni L. E C. Dei Fratelli Alitti Societa' Di Esercizio S.P.A. | Use of metformin in the preparation of pharmaceutical compositions capable of inhibiting the enzyme dipeptidyl peptidase iv |
| GB9906714D0 (en) | 1999-03-23 | 1999-05-19 | Ferring Bv | Compositions for improving fertility |
| GB9906715D0 (en) | 1999-03-23 | 1999-05-19 | Ferring Bv | Compositions for promoting growth |
| JP4121215B2 (ja) | 1999-05-17 | 2008-07-23 | 財団法人微生物化学研究会 | スルフォスチン類縁体、並びにスルフォスチン及びその類縁体の製造方法 |
| CA2373643A1 (en) | 1999-05-25 | 2000-11-30 | Point Therapeutics, Inc. | Anti-tumor comprising boroproline compounds |
| US6617340B1 (en) | 1999-07-29 | 2003-09-09 | Novartis Ag | N-(substituted glycyl)-pyrrolidines, pharmaceutical compositions containing them and their use in inhibiting dipeptidyl peptidase-IV |
| DE19940130A1 (de) * | 1999-08-24 | 2001-03-01 | Probiodrug Ges Fuer Arzneim | Neue Effektoren der Dipeptidyl Peptidase IV zur topischen Anwendung |
| US6653064B1 (en) * | 1999-09-23 | 2003-11-25 | Boehringer Ingelheim International Gmbh | Method for identifying compounds useful in the therapy of bone disorders |
| GB9923177D0 (en) | 1999-09-30 | 1999-12-01 | Pfizer Ltd | Novel polypeptide |
| AU1916401A (en) | 1999-11-12 | 2001-06-06 | Guilford Pharmaceuticals Inc. | Dipeptidyl peptidase iv inhibitors and methods of making and using dipeptidyl peptidase iv inhibitors |
| US6380398B2 (en) | 2000-01-04 | 2002-04-30 | Novo Nordisk A/S | Therapeutically active and selective heterocyclic compounds that are inhibitors of the enzyme DPP-IV |
| CA2673615C (en) | 2000-01-21 | 2013-07-16 | Novartis Ag | Combinations comprising dipeptidylpeptidase-iv inhibitors and antidiabetic agents |
| AU2001228309A1 (en) | 2000-01-24 | 2001-08-07 | Novo-Nordisk A/S | N-substituted 2-cyanopyroles and -pyrrolines which are inhibitors of the enzyme dpp-iv |
| US6395767B2 (en) | 2000-03-10 | 2002-05-28 | Bristol-Myers Squibb Company | Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase IV and method |
| US6608038B2 (en) * | 2000-03-15 | 2003-08-19 | Novartis Ag | Methods and compositions for treatment of diabetes and related conditions via gene therapy |
| GB0010183D0 (en) | 2000-04-26 | 2000-06-14 | Ferring Bv | Inhibitors of dipeptidyl peptidase IV |
| GB0010188D0 (en) | 2000-04-26 | 2000-06-14 | Ferring Bv | Inhibitors of dipeptidyl peptidase IV |
| AU6744501A (en) | 2000-05-18 | 2001-11-26 | Bayer Aktiengesellschaft | Regulation of human dopamine-like g protein-coupled receptor |
| TW583185B (en) | 2000-06-13 | 2004-04-11 | Novartis Ag | N-(substituted glycyl)-2-cyanopyrrolidines and pharmaceutical composition for inhibiting dipeptidyl peptidase-IV (DPP-IV) or for the prevention or treatment of diseases or conditions associated with elevated levels of DPP-IV comprising the same |
| US6432969B1 (en) | 2000-06-13 | 2002-08-13 | Novartis Ag | N-(substituted glycyl)-2 cyanopyrrolidines, pharmaceutical compositions containing them and their use in inhibiting dipeptidyl peptidase-IV |
| US20030219825A1 (en) * | 2000-06-13 | 2003-11-27 | Haizlip Jill Elaine | High throughput method for screening candidate compounds for biological activity |
| GB0014969D0 (en) | 2000-06-19 | 2000-08-09 | Smithkline Beecham Plc | Novel method of treatment |
| EP1301187B1 (en) | 2000-07-04 | 2005-07-06 | Novo Nordisk A/S | Purine-2,6-diones which are inhibitors of the enzyme dipeptidyl peptidase iv (dpp-iv) |
| DE60128475T2 (de) * | 2000-07-25 | 2008-02-07 | Merck & Co., Inc. | N-substituierte indole mit anwendung in der behandlung von diabetes |
| CA2418656C (en) * | 2000-08-10 | 2011-02-01 | Mitsubishi Pharma Corporation | Proline derivatives and use thereof as drugs |
| AU9419601A (en) | 2000-10-06 | 2002-04-22 | Tanabe Seiyaku Co | Nitrogenous five-membered ring compounds |
| JP2004035574A (ja) | 2000-10-06 | 2004-02-05 | Tanabe Seiyaku Co Ltd | 脂肪族含窒素五員環化合物 |
| JP4329291B2 (ja) | 2000-10-06 | 2009-09-09 | 田辺三菱製薬株式会社 | 含窒素五員環化合物 |
| JP4329290B2 (ja) | 2000-10-06 | 2009-09-09 | 田辺三菱製薬株式会社 | 脂肪族含窒素五員環化合物 |
| AUPR107800A0 (en) | 2000-10-27 | 2000-11-23 | University Of Sydney, The | Peptide and nucleic acid molecule ii |
| TWI243162B (en) | 2000-11-10 | 2005-11-11 | Taisho Pharmaceutical Co Ltd | Cyanopyrrolidine derivatives |
| CA2429860A1 (en) | 2000-11-27 | 2002-05-30 | Arena Pharmaceuticals, Inc. | Endogenous and non-endogenous versions of human g protein-coupled receptors |
| WO2002044362A1 (en) * | 2000-12-01 | 2002-06-06 | Yamanouchi Pharmaceutical Co., Ltd. | Method of screening remedy for diabetes |
| CA2433090A1 (en) | 2000-12-27 | 2002-07-04 | Kyowa Hakko Kogyo Co., Ltd. | Dipeptidyl peptidase iv inhibitor |
| JP4170758B2 (ja) | 2001-01-16 | 2008-10-22 | 日本化薬株式会社 | 骨髄抑制治療剤、感染症治療剤及び白血球数増加剤 |
| US6397767B1 (en) * | 2001-02-01 | 2002-06-04 | Case Corporation | Knife applicator for applying liquid fertilizer in the ground |
| JP4213390B2 (ja) | 2001-02-02 | 2009-01-21 | 武田薬品工業株式会社 | 縮合複素環化合物 |
| HUP0400058A2 (hu) | 2001-02-02 | 2004-04-28 | Takeda Chemical Industries, Ltd. | Kondenzált heterogyűrűs vegyületek, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk |
| CZ305402B6 (cs) * | 2001-02-24 | 2015-09-02 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Xanthinové deriváty, jejich výroba a použití v kombinační terapii |
| JP2002265439A (ja) | 2001-03-08 | 2002-09-18 | Mitsubishi Pharma Corp | シアノピロリジン誘導体およびその医薬用途 |
| DE60226723D1 (de) | 2001-03-27 | 2008-07-03 | Merck & Co Inc | Dipeptidylpeptidase-hemmer für die behandlung oder prävention von diabetes |
| EA006556B1 (ru) * | 2001-03-27 | 2006-02-24 | Те Риджентс Оф Те Юниверсити Оф Калифорния | Способы, соединения и композиции для борьбы с ожирением и регулирования метаболизма жирных кислот |
| FR2822826B1 (fr) * | 2001-03-28 | 2003-05-09 | Servier Lab | Nouveaux derives sulfonyles d'alpha-amino-acides, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| GB0109146D0 (en) | 2001-04-11 | 2001-05-30 | Ferring Bv | Treatment of type 2 diabetes |
| US6573287B2 (en) * | 2001-04-12 | 2003-06-03 | Bristo-Myers Squibb Company | 2,1-oxazoline and 1,2-pyrazoline-based inhibitors of dipeptidyl peptidase IV and method |
| FR2824825B1 (fr) | 2001-05-15 | 2005-05-06 | Servier Lab | Nouveaux derives d'alpha-amino-acides, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| DE60209348T2 (de) | 2001-06-20 | 2006-10-12 | Merck & Co., Inc. | Dipeptidylpeptidase-hemmer zur behandlung von diabetes |
| CA2450579A1 (en) | 2001-06-20 | 2003-01-03 | Merck & Co., Inc. | Dipeptidyl peptidase inhibitors for the treatment of diabetes |
| GB0115517D0 (en) | 2001-06-25 | 2001-08-15 | Ferring Bv | Novel antidiabetic agents |
| RU2299066C2 (ru) | 2001-06-27 | 2007-05-20 | Пробиодруг Аг | Новые ингибиторы дипептидилпептидазы iv и их применение в качестве противораковых агентов |
| WO2003072556A1 (en) | 2001-06-27 | 2003-09-04 | Prosidion Ltd. | Glutaminyl based dpiv inhibitors |
| IL158923A0 (en) | 2001-06-27 | 2004-05-12 | Smithkline Beecham Corp | Fluoropyrrolidines as dipeptidyl peptidase inhibitors |
| WO2003002553A2 (en) | 2001-06-27 | 2003-01-09 | Smithkline Beecham Corporation | Fluoropyrrolidines as dipeptidyl peptidase inhibitors |
| US20030130199A1 (en) * | 2001-06-27 | 2003-07-10 | Von Hoersten Stephan | Dipeptidyl peptidase IV inhibitors and their uses as anti-cancer agents |
| DE10154689A1 (de) | 2001-11-09 | 2003-05-22 | Probiodrug Ag | Substituierte Aminoketonverbindungen |
| US7368421B2 (en) * | 2001-06-27 | 2008-05-06 | Probiodrug Ag | Use of dipeptidyl peptidase IV inhibitors in the treatment of multiple sclerosis |
| ATE380175T1 (de) | 2001-06-27 | 2007-12-15 | Smithkline Beecham Corp | Pyrrolidine als dipeptidyl peptidase inhibitoren |
| US6869947B2 (en) * | 2001-07-03 | 2005-03-22 | Novo Nordisk A/S | Heterocyclic compounds that are inhibitors of the enzyme DPP-IV |
| ATE388951T1 (de) | 2001-07-03 | 2008-03-15 | Novo Nordisk As | Dpp-iv-inhibierende purin-derivative zur behandlung von diabetes |
| UA74912C2 (en) | 2001-07-06 | 2006-02-15 | Merck & Co Inc | Beta-aminotetrahydroimidazo-(1,2-a)-pyrazines and tetratriazolo-(4,3-a)-pyrazines as inhibitors of dipeptylpeptidase for the treatment or prevention of diabetes |
| DE10143840A1 (de) | 2001-09-06 | 2003-03-27 | Probiodrug Ag | Neue Inhibitoren der Dipeptidylpeptidase I |
| US6844316B2 (en) * | 2001-09-06 | 2005-01-18 | Probiodrug Ag | Inhibitors of dipeptidyl peptidase I |
| WO2003026661A1 (fr) * | 2001-09-14 | 2003-04-03 | Yamanouchi Pharmaceutical Co., Ltd. | Accelerateur de secretion de l'insuline et nouveau derive de pyrimidine |
| JPWO2003024942A1 (ja) | 2001-09-14 | 2004-12-24 | 三菱ウェルファーマ株式会社 | チアゾリジン誘導体およびその医薬用途 |
| JP2005509603A (ja) | 2001-09-19 | 2005-04-14 | ノボ ノルディスク アクティーゼルスカブ | Dpp−iv酵素の阻害剤であるヘテロ環化合物 |
| EP1572892A4 (en) * | 2001-10-18 | 2007-08-22 | Bristol Myers Squibb Co | HUMAN GLUCAGON-LIKE-PEPTIDE-1 MIMICS AND THEIR USE IN THE TREATMENT OF DIABETES AND RELATED CONDITIONS |
| US7238671B2 (en) * | 2001-10-18 | 2007-07-03 | Bristol-Myers Squibb Company | Human glucagon-like-peptide-1 mimics and their use in the treatment of diabetes and related conditions |
| GB0125446D0 (en) | 2001-10-23 | 2001-12-12 | Ferring Bv | Novel anti-diabetic agents |
| GB0125445D0 (en) | 2001-10-23 | 2001-12-12 | Ferring Bv | Protease Inhibitors |
| US6861440B2 (en) | 2001-10-26 | 2005-03-01 | Hoffmann-La Roche Inc. | DPP IV inhibitors |
| CA2464995A1 (en) | 2001-10-31 | 2003-05-08 | Novartis Ag | Methods to treat diabetes and related conditions based on polymorphisms in the tcf1 gene |
| US20030125304A1 (en) * | 2001-11-09 | 2003-07-03 | Hans-Ulrich Demuth | Substituted amino ketone compounds |
| AU2002360453C1 (en) | 2001-11-26 | 2009-06-18 | The Brigham And Women's Hospital, Inc. | Methods for treating autoimmune disorders, and reagents related thereto |
| JP4771661B2 (ja) | 2001-11-26 | 2011-09-14 | トラスティーズ オブ タフツ カレッジ | Post−プロリン開裂酵素の擬ペプチド性阻害剤 |
| AU2002360732A1 (en) | 2001-12-26 | 2003-07-24 | Guilford Pharmaceuticals | Change inhibitors of dipeptidyl peptidase iv |
| US6727261B2 (en) | 2001-12-27 | 2004-04-27 | Hoffman-La Roche Inc. | Pyrido[2,1-A]Isoquinoline derivatives |
| AU2003248360A1 (en) | 2002-02-08 | 2003-09-09 | Idun Pharmaceuticals, Inc. | (substituted)acyl dipeptidyl inhibitors of the ice/ced-3 family of cysteine proteases |
| ES2345096T3 (es) | 2002-02-13 | 2010-09-15 | F. Hoffmann-La Roche Ag | Nuevos derivados de piridina y pirimidina. |
| ATE309988T1 (de) | 2002-02-13 | 2005-12-15 | Hoffmann La Roche | Neue pyridin- und quinolin-derivate |
| US6906074B2 (en) | 2002-02-22 | 2005-06-14 | Nippon Zoki Pharmaceutical Co., Ltd. | 2-phenylpiperazine derivatives |
| JP2004043429A (ja) | 2002-02-25 | 2004-02-12 | Eisai Co Ltd | 新規キサンチン誘導体およびdppiv阻害剤 |
| EP1338595B1 (en) * | 2002-02-25 | 2006-05-03 | Eisai Co., Ltd. | Xanthine derivatives as DPP-IV inhibitors |
| EP1480961B1 (en) | 2002-02-28 | 2006-12-27 | Prosidion Ltd. | Glutaminyl based dpiv inhibitors |
| HUP0200849A2 (hu) * | 2002-03-06 | 2004-08-30 | Sanofi-Synthelabo | N-aminoacetil-2-ciano-pirrolidin-származékok, e vegyületeket tartalmazó gyógyszerkészítmények és eljárás előállításukra |
| AU2003225916A1 (en) | 2002-03-25 | 2003-10-13 | Merck & Co., Inc. | Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| DE60322857D1 (de) | 2002-03-25 | 2008-09-25 | Nippon Kayaku Kk | Neues alpha-amino-n-(diaminophosphinyl)lactamderivat |
| JP4329382B2 (ja) | 2002-04-04 | 2009-09-09 | 田辺三菱製薬株式会社 | 医薬組成物 |
| JP4329381B2 (ja) | 2002-04-04 | 2009-09-09 | 田辺三菱製薬株式会社 | 医薬組成物 |
| MXPA04009784A (es) | 2002-04-08 | 2004-12-13 | Torrent Pharmaceuticlas Ltd | Tiazolidin-4-carbonitrilos y analogos y su uso como inhibidores de dipeptidil-peptidas. |
| JP2003300977A (ja) | 2002-04-10 | 2003-10-21 | Sumitomo Pharmaceut Co Ltd | キサンチン誘導体 |
| AU2003235913A1 (en) | 2002-05-09 | 2003-11-11 | Taisho Pharmaceutical Co., Ltd. | Cyanopyrrolidine derivatives |
| JP2004026820A (ja) | 2002-05-09 | 2004-01-29 | Taisho Pharmaceut Co Ltd | ジペプチジルペプチダーゼiv阻害剤 |
| JP2003327532A (ja) | 2002-05-10 | 2003-11-19 | Takeda Chem Ind Ltd | ペプチダーゼ阻害剤 |
| GB0212412D0 (en) | 2002-05-29 | 2002-07-10 | Novartis Ag | Combination of organic compounds |
| DE60326232D1 (de) | 2002-06-03 | 2009-04-02 | Novartis Ag | Verwendung von substituierten cyanopyrrolidinen zur behandlung von hyperlipidämie |
| WO2003101958A2 (en) | 2002-06-04 | 2003-12-11 | Pfizer Products Inc. | Flourinated cyclic amides as dipeptidyl peptidase iv inhibitors |
| US6710040B1 (en) | 2002-06-04 | 2004-03-23 | Pfizer Inc. | Fluorinated cyclic amides as dipeptidyl peptidase IV inhibitors |
| WO2003101449A2 (en) | 2002-06-04 | 2003-12-11 | Pfizer Products Inc. | Process for the preparation of 3,3,4,4-tetrafluoropyrrolidine and derivatives thereof |
| PL374007A1 (en) | 2002-06-06 | 2005-09-19 | Eisai Co, Ltd. | Novel fused imidazole derivative |
| HUP0202001A2 (hu) | 2002-06-14 | 2005-08-29 | Sanofi-Aventis | DDP-IV gátló hatású azabiciklooktán- és nonánszármazékok |
| JP2004026678A (ja) | 2002-06-24 | 2004-01-29 | Microbial Chem Res Found | 2型糖尿病治療剤 |
| EP1578362A4 (en) | 2002-07-09 | 2008-11-05 | Point Therapeutics Inc | COMBINATION THERAPY WITH A BOROPROLINE COMPOUND |
| AU2003248259A1 (en) | 2002-07-10 | 2004-02-02 | Yamanouchi Pharmaceutical Co., Ltd. | Novel azetidine derivative or salt thereof |
| JP4530852B2 (ja) | 2002-07-15 | 2010-08-25 | メルク・シャープ・エンド・ドーム・コーポレイション | 糖尿病治療のためのピペリジノピリミジンジペプチジルペプチダーゼ阻害剤 |
| TW200401635A (en) | 2002-07-23 | 2004-02-01 | Yamanouchi Pharma Co Ltd | 2-Cyano-4-fluoropyrrolidine derivative or salt thereof |
| TW200404060A (en) | 2002-08-08 | 2004-03-16 | Takeda Chemical Industries Ltd | Fused heterocyclic compounds |
| JP4542757B2 (ja) | 2002-08-08 | 2010-09-15 | 武田薬品工業株式会社 | 縮合複素環化合物 |
| DE10236667B4 (de) * | 2002-08-09 | 2007-06-06 | J. Eberspächer GmbH & Co. KG | Abgasanlage für den Verbrennungsmotor eines Kraftfahrzeugs |
| US20050101542A1 (en) * | 2002-08-20 | 2005-05-12 | Regents Of The University Of California | Combination therapy for controlling appetites |
| US7407955B2 (en) * | 2002-08-21 | 2008-08-05 | Boehringer Ingelheim Pharma Gmbh & Co., Kg | 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions |
| KR101150449B1 (ko) | 2002-08-21 | 2012-06-01 | 베링거 잉겔하임 파르마 게엠베하 운트 코 카게 | 8-[3-아미노-피페리딘-1-일]-크산틴, 이의 제조방법 및 이를 포함하는 약제학적 조성물 |
| DE10238243A1 (de) | 2002-08-21 | 2004-03-04 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | 8-[3-Amino-piperidin-1-yl]-xanthine, deren Herstellung und deren Verwendung als Arzneimittel |
| DE10238477A1 (de) | 2002-08-22 | 2004-03-04 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue Purinderivate, deren Herstellung und deren Verwendung als Arzneimittel |
| DE10238470A1 (de) | 2002-08-22 | 2004-03-04 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue Xanthinderivate, deren Herstellung und deren Verwendung als Arzneimittel |
| AU2003261748B2 (en) | 2002-08-29 | 2006-11-23 | Taisho Pharmaceutical Co., Ltd. | Benzenesulfonate of 4-fluoro-2-cyanopyrrolidine derivative |
| US20060039974A1 (en) * | 2002-09-11 | 2006-02-23 | Takeda Pharmaceutical Company Limited | Sustained release preparation |
| CA2489405A1 (en) * | 2002-09-11 | 2004-03-25 | Yamanouchi Pharmaceutical Co., Ltd. | Screening method of agents for increasing insulin content |
| JP4491346B2 (ja) | 2002-10-07 | 2010-06-30 | メルク・シャープ・エンド・ドーム・コーポレイション | 抗糖尿病ベータアミノ複素環ジペプチジルペプチダーゼ阻害剤 |
| WO2004033455A2 (en) | 2002-10-08 | 2004-04-22 | Novo Nordisk A/S | Hemisuccinate salts of heterocyclic dpp-iv inhibitors |
| AR041470A1 (es) * | 2002-10-17 | 2005-05-18 | Upjohn Co | Compuestos de pirrolo (1,2 - b) piridazina y sus usos |
| EP1556362B1 (en) | 2002-10-18 | 2008-03-26 | Merck & Co., Inc. | Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| AU2003282983A1 (en) | 2002-10-23 | 2004-05-13 | Bristol-Myers Squibb Company | Glycinenitrile-based inhibitors of dipeptidyl peptidase iv and methods |
| AU2003286776A1 (en) | 2002-10-30 | 2004-06-07 | Guilford Pharmaceuticals Inc. | Novel inhibitors of dipeptidyl peptidase iv |
| AU2003280680A1 (en) | 2002-11-01 | 2004-06-18 | Sumitomo Pharmaceuticals Co., Ltd. | Xanthine compound |
| AU2003290577B2 (en) | 2002-11-07 | 2008-12-11 | Merck Sharp & Dohme Corp. | Phenylalanine derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| DE10251927A1 (de) | 2002-11-08 | 2004-05-19 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue Xanthinderivate, deren Herstellung und deren Verwendung als Arzneimittel |
| US7482337B2 (en) * | 2002-11-08 | 2009-01-27 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Xanthine derivatives, the preparation thereof and their use as pharmaceutical compositions |
| MXPA05005260A (es) | 2002-11-18 | 2005-07-25 | Pfizer Prod Inc | Amidas ciclicas fluoradas que inhiben la dipeptidil peptidasa iv. |
| DE10256264A1 (de) | 2002-12-03 | 2004-06-24 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue substituierte Imidazo-pyridinone und Imidazo-pyridazinone, ihre Herstellung und ihre Verwendung als Arzneimittel |
| UY28103A1 (es) | 2002-12-03 | 2004-06-30 | Boehringer Ingelheim Pharma | Nuevas imidazo-piridinonas sustituidas, su preparación y su empleo como medicacmentos |
| AU2003297564A1 (en) * | 2002-12-04 | 2004-06-23 | Merck & Co., Inc. | Phenylalanine derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| US7420079B2 (en) | 2002-12-09 | 2008-09-02 | Bristol-Myers Squibb Company | Methods and compounds for producing dipeptidyl peptidase IV inhibitors and intermediates thereof |
| PT1572196E (pt) | 2002-12-10 | 2008-11-20 | Novartis Ag | Combinação de um inibidor da dpp-iv e um composto ppar alfa |
| WO2004058266A1 (en) | 2002-12-20 | 2004-07-15 | Merck & Co., Inc. | 3-amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| US6982164B2 (en) * | 2003-01-10 | 2006-01-03 | Mgp Ingredients, Inc. | Unhydrolyzed jojoba protein products having high simmondsin concentration |
| PT1599468E (pt) * | 2003-01-14 | 2008-01-14 | Arena Pharm Inc | Derivados de arilo e heteroarilo 1,2,3.-trissubstituídos comomoduladores do metabolismo, e profilaxia e tratamento dedesordens relacionadas tais como diabetes e hiperglicemia |
| EP1589969A4 (en) | 2003-01-17 | 2008-08-13 | Merck & Co Inc | 3-AMINO-4-PHENYLBUTANEAN DERIVATEALS DIPEPTIDYLPEPTIDASE INHIBITORS FOR THE TREATMENT OR PREVENTION OF DIABETES |
| JP2004244412A (ja) | 2003-01-20 | 2004-09-02 | Kotobuki Seiyaku Kk | 4位に置換基を有する2−シアノピロリジン誘導体及びその製造方法並びにそれを含有する薬剤 |
| EP1592689A4 (en) * | 2003-01-31 | 2008-12-24 | Merck & Co Inc | 3-AMINO-4-PHENYLBUTANEAN DERIVATIVES AS DIPEPTIDYLPEPTIDASE INHIBITORS FOR THE TREATMENT OR PREVENTION OF DIABETES |
| CA2514191C (en) | 2003-01-31 | 2011-10-11 | Sanwa Kagaku Kenkyusho Co., Ltd. | Compound inhibiting dipeptidyl peptidase iv |
| WO2004071454A2 (en) | 2003-02-13 | 2004-08-26 | Guilford Pharmaceuticals Inc. | Substituted azetidine compounds as inhibitors of dipeptidyl peptidase iv |
| US20070066590A1 (en) * | 2003-02-24 | 2007-03-22 | Jones Robert M | Phenyl-and pyridylpiperidine-derivatives as modulators of glucose metabolism |
| WO2004076434A1 (en) | 2003-02-28 | 2004-09-10 | Aic | Dipeptidyl peptidase inhibitors |
| WO2004076433A1 (en) | 2003-02-28 | 2004-09-10 | Aic | Dipeptidyl peptidase inhibitors |
| JP2004269468A (ja) | 2003-03-12 | 2004-09-30 | Yamanouchi Pharmaceut Co Ltd | ピリミジン誘導体又はその塩 |
| JP2004269469A (ja) * | 2003-03-12 | 2004-09-30 | Yamanouchi Pharmaceut Co Ltd | ピリミジン誘導体又はその塩 |
| AR043515A1 (es) | 2003-03-19 | 2005-08-03 | Merck & Co Inc | Procedimiento para preparar derivados quirales beta aminoacidos mediante hidrogenacion asimetrica |
| WO2004085661A2 (en) | 2003-03-24 | 2004-10-07 | Merck & Co., Inc | Process to chiral beta-amino acid derivatives |
| US7550590B2 (en) | 2003-03-25 | 2009-06-23 | Takeda Pharmaceutical Company Limited | Dipeptidyl peptidase inhibitors |
| WO2004087650A2 (en) | 2003-03-27 | 2004-10-14 | Merck & Co. Inc. | Process and intermediates for the preparation of beta-amino acid amide dipeptidyl peptidase-iv inhibitors |
| WO2004092128A1 (en) | 2003-04-10 | 2004-10-28 | Smithkline Beecham Corporation | Anhydrous crystalline forms of (2s, 4s)-1-{(2r)-2-amino-3-‘4-methoxybenzyl)sulfonyl!-3-methylbutanoyl}-4-fluoropyrrolindine-2-carbonitrile |
| WO2004096806A1 (ja) | 2003-04-30 | 2004-11-11 | Sumitomo Pharmaceuticals Co. Ltd. | 縮合イミダゾール誘導体 |
| WO2004099134A2 (en) | 2003-05-05 | 2004-11-18 | Prosidion Ltd. | Glutaminyl based dp iv-inhibitors |
| ZA200508439B (en) * | 2003-05-05 | 2007-03-28 | Probiodrug Ag | Medical use of inhibitors of glutaminyl and glutamate cyclases |
| US7083933B1 (en) * | 2003-05-09 | 2006-08-01 | Prosidion Limited | Methods for identification of modulators of OSGPR116 activity |
| US7560455B2 (en) | 2003-05-14 | 2009-07-14 | Merck & Co., Inc. | 3-Amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| JP2007511467A (ja) | 2003-05-14 | 2007-05-10 | タケダ サン ディエゴ インコーポレイテッド | ジペプチジルペプチダーゼインヒビター |
| CN1791575A (zh) | 2003-05-15 | 2006-06-21 | 大正制药株式会社 | 氰基氟代吡咯烷 |
| WO2004104215A2 (en) | 2003-05-21 | 2004-12-02 | Bayer Healthcare Ag | Diagnostics and therapeutics for diseases associated with dipeptidylpeptidase 7 (dpp7) |
| WO2004104216A2 (en) | 2003-05-21 | 2004-12-02 | Bayer Healthcare Ag | Diagnostics and therapeutics for diseases associated with dipeptidylpeptidase iv (dpp4) |
| AU2003902828A0 (en) | 2003-06-05 | 2003-06-26 | Fujisawa Pharmaceutical Co., Ltd. | Dpp-iv inhibitor |
| US20070099884A1 (en) | 2003-06-06 | 2007-05-03 | Erondu Ngozi E | Combination therapy for the treatment of diabetes |
| EP1635818B1 (en) | 2003-06-06 | 2010-04-07 | Merck Sharp & Dohme Corp. | Fused indoles as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| AU2003902946A0 (en) | 2003-06-12 | 2003-06-26 | Fujisawa Pharmaceutical Co., Ltd. | Dpp-iv inhibitor |
| WO2004112701A2 (en) | 2003-06-17 | 2004-12-29 | Merck & Co., Inc. | Cyclohexylglycine derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| DE10327439A1 (de) | 2003-06-18 | 2005-01-05 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue Imidazopyridazinon- und Imidazopyridonderivate, deren Herstellung und deren Verwendung als Arzneimittel |
| MXPA05013904A (es) | 2003-06-20 | 2006-02-24 | Hoffmann La Roche | Derivados de pirido[2,1-a] isoquinolinas como inhibidores de dipeptidil-peptidasa iv(dpp-iv). |
| WO2005000846A1 (en) | 2003-06-20 | 2005-01-06 | F.Hoffmann-La Roche Ag | Hexahydropyridoisoqinolines as dpp-iv inhibitors |
| JO2625B1 (en) | 2003-06-24 | 2011-11-01 | ميرك شارب اند دوم كوربوريشن | Phosphoric acid salts of dipeptidyl betidase inhibitor 4 |
| JP2005023038A (ja) | 2003-07-04 | 2005-01-27 | Taisho Pharmaceut Co Ltd | 慢性腎疾患治療薬 |
| AR045047A1 (es) * | 2003-07-11 | 2005-10-12 | Arena Pharm Inc | Derivados arilo y heteroarilo trisustituidos como moduladores del metabolismo y de la profilaxis y tratamiento de desordenes relacionados con los mismos |
| EP2287165A3 (en) * | 2003-07-14 | 2011-06-22 | Arena Pharmaceuticals, Inc. | Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto |
| DE602004017325D1 (de) | 2003-07-21 | 2008-12-04 | Smithkline Beecham Corp | (2s,4s)-4-fluor-1-ä4-fluor-beta-(4-fluorphenyl)-l-phenylalanylü-2-pyrrolidincarbonitril-p-toluolsulfonsäuresalz und wasserfreie kristalline formen davon |
| US7008957B2 (en) * | 2003-07-25 | 2006-03-07 | Sanofi-Aventis Deutschland Gmbh | Bicyclic cyanoheterocycles, process for their preparation and their use as medicaments |
| US7094800B2 (en) * | 2003-07-25 | 2006-08-22 | Sanofi-Aventis Deutschland Gmbh | Cyanopyrrolidides, process for their preparation and their use as medicaments |
| DE10333935A1 (de) | 2003-07-25 | 2005-02-24 | Aventis Pharma Deutschland Gmbh | Neue bicyclische Cyanoheterocyclen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
| PE20050249A1 (es) | 2003-07-25 | 2005-06-01 | Aventis Pharma Gmbh | Nuevas cianopirrolididas y procedimiento para su preparacion como medicamentos |
| US7259160B2 (en) | 2003-07-31 | 2007-08-21 | Merck & Co., Inc. | Hexahydrodiazepinones as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes |
| US6995183B2 (en) | 2003-08-01 | 2006-02-07 | Bristol Myers Squibb Company | Adamantylglycine-based inhibitors of dipeptidyl peptidase IV and methods |
| WO2005019168A2 (en) * | 2003-08-20 | 2005-03-03 | Pfizer Products Inc. | Fluorinated lysine derivatives as dipeptidyl peptidase iv inhibitors |
| HU227684B1 (en) | 2003-08-29 | 2011-11-28 | Sanofi Aventis | Adamantane and azabicyclo-octane and nonane derivatives and their use as dpp-iv inhibitors |
| JPWO2005021550A1 (ja) | 2003-08-29 | 2006-10-26 | 大日本住友製薬株式会社 | 二環性ピラゾール誘導体 |
| AU2004268024B2 (en) | 2003-09-02 | 2007-07-12 | Merck Sharp & Dohme Llc | Novel crystalline forms of a phosphoric acid salt of a dipeptidyl peptidase-IV inhibitor |
| WO2005023762A1 (en) | 2003-09-04 | 2005-03-17 | Abbott Laboratories | Pyrrolidine-2-carbonitrile derivatives and their use as inhibitors of dipeptidyl peptidase-iv (dpp-iv) |
| EP1699777B1 (en) | 2003-09-08 | 2012-12-12 | Takeda Pharmaceutical Company Limited | Dipeptidyl peptidase inhibitors |
| JP2007513058A (ja) | 2003-09-08 | 2007-05-24 | 武田薬品工業株式会社 | ジペプチジルぺプチダーゼ阻害剤 |
| PE20050948A1 (es) | 2003-09-09 | 2005-12-16 | Japan Tobacco Inc | Compuestos de carbamoil-amina como inhibidores de la dipeptidil peptidasa iv |
| EP1667524A4 (en) | 2003-09-23 | 2009-01-14 | Merck & Co Inc | NEW CRYSTALLINE FORM OF A PHOSPHORIC ACID SALT OF A DIPEPTIDYLPEPTIDASE IV INHIBITOR |
| ATE534404T1 (de) | 2003-10-03 | 2011-12-15 | Takeda Pharmaceutical | Dipeptidylpeptidase-iv-inhibitoren zur behandlung von diabetes-patienten mit sekundärversagen durch sulfonylharnstoffe |
| WO2005033099A2 (en) | 2003-10-03 | 2005-04-14 | Glenmark Pharmaceuticals Ltd. | Novel dipeptidyl peptidase iv inhibitors; processes for their preparation and compositions thereof |
| DE10348022A1 (de) | 2003-10-15 | 2005-05-25 | Imtm Gmbh | Neue Dipeptidylpeptidase IV-Inhibitoren zur funktionellen Beeinflussung unterschiedlicher Zellen und zur Behandlung immunologischer, entzündlicher, neuronaler und anderer Erkrankungen |
| DE10348044A1 (de) | 2003-10-15 | 2005-05-19 | Imtm Gmbh | Duale Alanyl-Aminopeptidase- und Dipeptidylpeptidase IV-Inhibitoren zur funktionellen Beeinflussung unterschiedlicher Zellen und zur Behandlung immunologischer, entzündlicher, neuronaler und anderer Erkrankungen |
| GB0324236D0 (en) | 2003-10-16 | 2003-11-19 | Astrazeneca Ab | Chemical compounds |
| TW200519105A (en) | 2003-10-20 | 2005-06-16 | Lg Life Science Ltd | Novel inhibitors of DPP-IV, methods of preparing the same, and pharmaceutical compositions containing the same as an active agent |
| TW200523252A (en) | 2003-10-31 | 2005-07-16 | Takeda Pharmaceutical | Pyridine compounds |
| US7238683B2 (en) | 2003-11-04 | 2007-07-03 | Merck & Co., Inc. | Fused phenylalanine derivatives as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes |
| US7674913B2 (en) | 2003-11-12 | 2010-03-09 | Phenomix Corporation | Heterocyclic boronic acid compounds |
| CN1905876B (zh) | 2003-11-17 | 2010-06-09 | 诺瓦提斯公司 | 二肽基肽酶iv抑制剂的用途 |
| DE10355304A1 (de) * | 2003-11-27 | 2005-06-23 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue 8-(Piperazin-1-yl)-und 8-([1,4]Diazepan-1-yl)-xanthine, deren Herstellung und deren Verwendung als Arzneimittel |
| WO2005058849A1 (en) | 2003-12-15 | 2005-06-30 | Glenmark Pharmaceuticals Ltd. | New dipeptidyl peptidase in inhibitors; process for their preparation and compositions containing them |
| US7217711B2 (en) * | 2003-12-17 | 2007-05-15 | Boehringer Ingelheim International Gmbh | Piperazin-1-yl and 2-([1,4]diazepan-1-yl)-imidazo[4,5-d]-pyridazin-4-ones, the preparation thereof and their use as pharmaceutical compositions |
| DE10360835A1 (de) | 2003-12-23 | 2005-07-21 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Bicyclische Imidazolverbindungen, deren Herstellung und deren Verwendung als Arzneimittel |
| BRPI0418149A (pt) * | 2003-12-24 | 2007-04-17 | Prosidion Ltd | derivados heterocìclicos como agonistas do receptor de gprc |
| EP1708571A4 (en) | 2004-01-16 | 2009-07-08 | Merck & Co Inc | NEW CRYSTALLINE SALTS OF A DIPEPTIDYLPEPTIDASE IV HEMMER |
| WO2005075426A1 (en) | 2004-02-03 | 2005-08-18 | Glenmark Pharmaceuticals Ltd. | Novel dipeptidyl peptidase iv inhibitors; processes for their preparation and compositions thereof |
| US7501426B2 (en) * | 2004-02-18 | 2009-03-10 | Boehringer Ingelheim International Gmbh | 8-[3-amino-piperidin-1-yl]-xanthines, their preparation and their use as pharmaceutical compositions |
| BRPI0507905A (pt) | 2004-02-20 | 2007-07-10 | Novartis Ag | uso de compostos orgánicos |
| KR101292707B1 (ko) | 2004-02-23 | 2013-08-02 | 트러스티즈 오브 터프츠 칼리지 | 디펩티딜펩티다아제 ⅳ의 억제제 |
| BRPI0507971A (pt) | 2004-02-23 | 2007-07-24 | Tufts College | composto, composição farmacêutica, uso de um composto,método para inibir a atividade proteolìtica de uma enzima de clivagem pós-prolina e remédio empacotado |
| DE102004009039A1 (de) * | 2004-02-23 | 2005-09-08 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | 8-[3-Amino-piperidin-1-yl]-xanthine, deren Herstellung und Verwendung als Arzneimittel |
| CA2559611C (en) | 2004-03-09 | 2012-01-17 | National Health Research Institutes | Pyrrolidine compounds |
| EA011671B1 (ru) * | 2004-06-04 | 2009-04-28 | Арена Фармасьютикалз, Инк. | Замещенные производные арила и гетероарила в качестве модуляторов метаболизма и для профилактики и лечения связанных с ним расстройств |
| US20060024313A1 (en) * | 2004-07-06 | 2006-02-02 | Xin Chen | Agents that disrupt dimer formation in DPP-IV family of prolyl dipeptidases |
| WO2006019965A2 (en) * | 2004-07-16 | 2006-02-23 | Takeda San Diego, Inc. | Dipeptidyl peptidase inhibitors |
| DE102004037554A1 (de) | 2004-08-03 | 2006-03-16 | Sanofi-Aventis Deutschland Gmbh | Substituierte 8-Aminoalkylthio-xanthine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
| DE102004038268A1 (de) | 2004-08-06 | 2006-03-16 | Sanofi-Aventis Deutschland Gmbh | Substituierte, bizyklische 8-Pyrrolidino-xanthine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
| US20060046978A1 (en) * | 2004-08-31 | 2006-03-02 | Morphochem Ag | Novel compounds that inhibit dipeptidyl peptidase (DPP-IV) and neprilysin (NEP) and/or angiotensin converting enzyme (ACE) |
| DE102004043944A1 (de) | 2004-09-11 | 2006-03-30 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue 8-(3-Amino-piperidin-1-yl)-7-(but-2-inyl)-xanthine, deren Herstellung und deren Verwendung als Arzneimittel |
| DE102004044221A1 (de) * | 2004-09-14 | 2006-03-16 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue 3-Methyl-7-butinyl-xanthine, deren Herstellung und deren Verwendung als Arzneimittel |
| CA2582588A1 (en) * | 2004-10-07 | 2006-04-20 | Merck & Co., Inc. | Acyclic hydrazides as cannabinoid receptor modulators |
| AU2005299808B2 (en) * | 2004-10-25 | 2009-08-20 | Novartis Ag | Combination of DPP-IV inhibitor, PPAR antidiabetic and metformin |
| US7411093B2 (en) * | 2004-12-20 | 2008-08-12 | Hoffman-La Roche Inc. | Aminocycloalkanes as DPP-IV inhibitors |
| JP2008524331A (ja) * | 2004-12-21 | 2008-07-10 | 武田薬品工業株式会社 | ジペプチジルペプチダーゼ阻害剤 |
| CN101103032B (zh) | 2004-12-24 | 2011-05-11 | 大日本住友制药株式会社 | 双环吡咯衍生物 |
| US7589088B2 (en) * | 2004-12-29 | 2009-09-15 | Bristol-Myers Squibb Company | Pyrimidine-based inhibitors of dipeptidyl peptidase IV and methods |
| MY148521A (en) * | 2005-01-10 | 2013-04-30 | Arena Pharm Inc | Substituted pyridinyl and pyrimidinyl derivatives as modulators of metabolism and the treatment of disorders related thereto |
| DOP2006000008A (es) * | 2005-01-10 | 2006-08-31 | Arena Pharm Inc | Terapia combinada para el tratamiento de la diabetes y afecciones relacionadas y para el tratamiento de afecciones que mejoran mediante un incremento de la concentración sanguínea de glp-1 |
| WO2006086727A2 (en) * | 2005-02-09 | 2006-08-17 | Entelos, Inc. | Treating diabetes with glucagon-like peptide-1 secretagogues |
| CN101166527A (zh) * | 2005-04-27 | 2008-04-23 | 艾尼纳制药公司 | 用于治疗肥胖症和糖尿病以及其相关病况和用于治疗可通过增加血液glp-1含量改善的病况的组合疗法 |
| WO2006132406A1 (ja) | 2005-06-09 | 2006-12-14 | Banyu Pharmaceutical Co., Ltd. | 下痢を伴う疾患の治療剤としてのnpy y2アゴニスト |
| EP1907383A1 (en) * | 2005-06-30 | 2008-04-09 | Prosidion Limited | Gpcr agonists |
| WO2007003961A2 (en) * | 2005-06-30 | 2007-01-11 | Prosidion Limited | Gpcr agonists |
| CA2613236A1 (en) * | 2005-06-30 | 2007-01-11 | Prosidion Limited | G-protein coupled receptor agonists |
| US7708191B2 (en) * | 2005-07-28 | 2010-05-04 | Edwin Vega | Telebanking apparatus for transferring money or cash value between two parties in the same country or across national borders, for paying bills and browsing the internet |
| JP4827483B2 (ja) * | 2005-10-04 | 2011-11-30 | キヤノン株式会社 | 核酸試料処理装置 |
| DK1971862T3 (da) * | 2006-04-11 | 2011-02-14 | Arena Pharm Inc | Fremgangsmåder til anvendelse af GPR119-receptor til identificering af forbindelser anvendelige til øgning af knoglemasse hos en person |
| PE20071221A1 (es) * | 2006-04-11 | 2007-12-14 | Arena Pharm Inc | Agonistas del receptor gpr119 en metodos para aumentar la masa osea y para tratar la osteoporosis y otras afecciones caracterizadas por masa osea baja, y la terapia combinada relacionada a estos agonistas |
| WO2008008887A2 (en) * | 2006-07-13 | 2008-01-17 | Smithkline Beecham Corporation | Gpr119 agonists for treating metabolic disorders |
| AU2007291252A1 (en) * | 2006-08-30 | 2008-03-06 | Inovacia Ab | Pyridine compounds for treating GPR119 related disorders |
| EP2325182A1 (en) * | 2006-12-06 | 2011-05-25 | Glaxosmithkline LLC | Bicyclic compounds and use as antidiabetics |
| AU2007334519A1 (en) * | 2006-12-14 | 2008-06-26 | Merck Sharp & Dohme Corp. | Acyl bipiperidinyl compounds, compositions containing such compounds and methods of treatment |
| CL2009000782A1 (es) * | 2008-03-31 | 2010-04-30 | Metabolex Inc | Metodo que comprende un compuesto derivado de oximetilen-arilo sustituido, inhibidores de dpp-iv; y su uso en el tratamiento de la diabetes y disminucion de trigliceridos, entre otras enfermedades. |
| EP2146210A1 (en) * | 2008-04-07 | 2010-01-20 | Arena Pharmaceuticals, Inc. | Methods of using A G protein-coupled receptor to identify peptide YY (PYY) secretagogues and compounds useful in the treatment of conditions modulated by PYY |
| WO2009150144A1 (en) * | 2008-06-10 | 2009-12-17 | Inovacia Ab | New gpr119modulators |
| MX2011002558A (es) * | 2008-09-10 | 2011-04-26 | Boehringer Ingelheim Int | Terapia de combinacion para el tratamiento de diabetes y estados relacionados. |
| WO2010074271A1 (ja) * | 2008-12-26 | 2010-07-01 | 武田薬品工業株式会社 | 糖尿病治療剤 |
| US20140193463A1 (en) * | 2013-01-04 | 2014-07-10 | China Medical University | Peptide for inhibiting dipeptidyl-peptidase iv |
-
2006
- 2006-01-05 DO DO2006000008A patent/DOP2006000008A/es unknown
- 2006-01-06 PE PE2010000178A patent/PE20100398A1/es not_active Application Discontinuation
- 2006-01-06 GT GT200600004A patent/GT200600004A/es unknown
- 2006-01-06 PE PE2006000045A patent/PE20061116A1/es not_active Application Discontinuation
- 2006-01-09 PT PT06717678T patent/PT1758565E/pt unknown
- 2006-01-09 AR ARP060100072A patent/AR052082A1/es unknown
- 2006-01-09 ES ES07004743T patent/ES2327872T3/es active Active
- 2006-01-09 SG SG201000208-7A patent/SG158876A1/en unknown
- 2006-01-09 EP EP10010819A patent/EP2322151A3/en not_active Withdrawn
- 2006-01-09 PT PT07004743T patent/PT1808168E/pt unknown
- 2006-01-09 SI SI200630362T patent/SI1758565T1/sl unknown
- 2006-01-09 WO PCT/US2006/000510 patent/WO2006076231A2/en not_active Ceased
- 2006-01-09 AT AT06717678T patent/ATE431139T1/de active
- 2006-01-09 DE DE602006006765T patent/DE602006006765D1/de active Active
- 2006-01-09 JP JP2007550512A patent/JP4118323B1/ja not_active Expired - Fee Related
- 2006-01-09 SG SG2013026273A patent/SG189762A1/en unknown
- 2006-01-09 DK DK06717678.4T patent/DK1758565T4/da active
- 2006-01-09 CN CN2011100978256A patent/CN102218141A/zh active Pending
- 2006-01-09 KR KR1020107010978A patent/KR101016890B1/ko not_active Expired - Fee Related
- 2006-01-09 NZ NZ556219A patent/NZ556219A/en not_active IP Right Cessation
- 2006-01-09 RS RSP-2009/0354A patent/RS51127B/sr unknown
- 2006-01-09 AT AT07004743T patent/ATE432693T1/de active
- 2006-01-09 TW TW095100807A patent/TW200637534A/zh unknown
- 2006-01-09 BR BRPI0606727-1A patent/BRPI0606727A/pt not_active IP Right Cessation
- 2006-01-09 RS RSP-2009/0366A patent/RS51174B/sr unknown
- 2006-01-09 ES ES06717678T patent/ES2327268T5/es active Active
- 2006-01-09 HN HN2006000971A patent/HN2006000971A/es unknown
- 2006-01-09 AU AU2006205164A patent/AU2006205164B2/en not_active Ceased
- 2006-01-09 KR KR1020107023765A patent/KR20100129328A/ko not_active Ceased
- 2006-01-09 CA CA2593427A patent/CA2593427C/en not_active Expired - Fee Related
- 2006-01-09 NZ NZ578502A patent/NZ578502A/en not_active IP Right Cessation
- 2006-01-09 DK DK07004743T patent/DK1808168T3/da active
- 2006-01-09 KR KR1020127029863A patent/KR20120139849A/ko not_active Withdrawn
- 2006-01-09 EP EP10010818A patent/EP2322150A3/en not_active Withdrawn
- 2006-01-09 EP EP07004743A patent/EP1808168B1/en not_active Revoked
- 2006-01-09 MX MX2007008376A patent/MX2007008376A/es active IP Right Grant
- 2006-01-09 KR KR1020077018318A patent/KR20070095400A/ko not_active Ceased
- 2006-01-09 EP EP10010656A patent/EP2322156A1/en not_active Withdrawn
- 2006-01-09 HR HRP20090403TT patent/HRP20090403T4/hr unknown
- 2006-01-09 EP EP09006268A patent/EP2116235A1/en not_active Withdrawn
- 2006-01-09 PL PL06717678T patent/PL1758565T5/pl unknown
- 2006-01-09 SI SI200630363T patent/SI1808168T1/sl unknown
- 2006-01-09 CA CA2654733A patent/CA2654733C/en not_active Expired - Fee Related
- 2006-01-09 EP EP10010820A patent/EP2322152A1/en not_active Withdrawn
- 2006-01-09 EA EA200701469A patent/EA011883B1/ru not_active IP Right Cessation
- 2006-01-09 PL PL07004743T patent/PL1808168T3/pl unknown
- 2006-01-09 KR KR1020137032119A patent/KR20130140226A/ko not_active Ceased
- 2006-01-09 NZ NZ587368A patent/NZ587368A/en not_active IP Right Cessation
- 2006-01-09 NZ NZ578504A patent/NZ578504A/en not_active IP Right Cessation
- 2006-01-09 CN CN201310606771.0A patent/CN103611161A/zh active Pending
- 2006-01-09 EP EP10010659A patent/EP2322157A1/en not_active Withdrawn
- 2006-01-09 EP EP06717678A patent/EP1758565B2/en active Active
- 2006-01-09 DE DE602006007093T patent/DE602006007093D1/de active Active
- 2006-01-09 US US11/328,405 patent/US20060154866A1/en not_active Abandoned
- 2006-01-09 EP EP08009893A patent/EP1997484A3/en not_active Withdrawn
- 2006-01-10 PA PA20068659301A patent/PA8659301A1/es unknown
- 2006-11-22 US US11/603,417 patent/US7803754B2/en not_active Expired - Fee Related
- 2006-11-22 US US11/603,410 patent/US7803753B2/en not_active Expired - Fee Related
-
2007
- 2007-07-02 CR CR9220A patent/CR9220A/es not_active Application Discontinuation
- 2007-07-02 IL IL184364A patent/IL184364A0/en unknown
- 2007-07-09 NI NI200700174A patent/NI200700174A/es unknown
- 2007-07-20 NO NO20073816A patent/NO331089B1/no not_active IP Right Cessation
- 2007-09-06 JP JP2007232094A patent/JP4787804B2/ja not_active Expired - Fee Related
-
2008
- 2008-03-17 JP JP2008068597A patent/JP4221444B2/ja not_active Expired - Fee Related
- 2008-03-17 JP JP2008068598A patent/JP4237243B2/ja not_active Expired - Fee Related
- 2008-03-17 JP JP2008068596A patent/JP4807887B2/ja not_active Expired - Fee Related
- 2008-04-16 JP JP2008107320A patent/JP4912349B2/ja not_active Expired - Fee Related
-
2009
- 2009-07-17 AU AU2009202900A patent/AU2009202900B8/en not_active Ceased
- 2009-07-17 AU AU2009202898A patent/AU2009202898B2/en not_active Ceased
- 2009-08-03 CY CY20091100816T patent/CY1109260T1/el unknown
- 2009-08-19 CY CY20091100881T patent/CY1109321T1/el unknown
- 2009-08-20 HR HR20090446T patent/HRP20090446T1/hr unknown
- 2009-10-30 US US12/609,599 patent/US20100137293A1/en not_active Abandoned
- 2009-11-02 US US12/610,639 patent/US8198232B2/en not_active Expired - Fee Related
- 2009-11-02 US US12/610,877 patent/US8022034B2/en not_active Expired - Fee Related
- 2009-11-02 US US12/610,885 patent/US20100286168A1/en not_active Abandoned
- 2009-11-02 US US12/610,674 patent/US8030270B2/en not_active Expired - Fee Related
- 2009-11-02 US US12/610,967 patent/US20100298333A1/en not_active Abandoned
- 2009-11-02 US US12/610,682 patent/US8003597B2/en not_active Expired - Fee Related
- 2009-11-02 US US12/610,918 patent/US20100286153A1/en not_active Abandoned
- 2009-11-02 US US12/610,490 patent/US20100285494A1/en not_active Abandoned
-
2010
- 2010-05-31 CL CL2010000565A patent/CL2010000565A1/es unknown
- 2010-12-09 NO NO20101746A patent/NO20101746L/no not_active Application Discontinuation
-
2011
- 2011-02-01 DO DO2011000040A patent/DOP2011000040A/es unknown
- 2011-06-07 JP JP2011127707A patent/JP2011184458A/ja not_active Withdrawn
- 2011-08-05 JP JP2011172381A patent/JP2012017330A/ja not_active Withdrawn
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2327872T3 (es) | Terapia combinada para el tratamiento de la diabetes y afecciones relacionadas y para el tratamiento de afecciones mejoradas por el incremento del nivel de glp-1 en sangre. | |
| HK1100353B (en) | Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood glp-1 level | |
| HK1157233A (en) | Method of preparing a composition comprising a gpr119 agonist | |
| HK1120227A (en) | Method of identifying glp-1 secretagogues | |
| HK1136510A (en) | Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood glp-1 level | |
| HK1157231A (en) | Composition for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood glp-1 level |